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Cost-Effective, Commercial Scale Production of Tanespimycin
Abstract
Recent approaches to cancer therapy have centered on developing small molecule inhibitors for signaling
pathways deranged in common cancers; these compounds are sometimes referred to as tumor antibiotics.
One promising target for tumor antibiotics is Hsp90, a heat shock protein that plays a central role in
promoting the functionality and stability of a group of proteins associated with cancer called client proteins.
Hsp90 inhibitors have been receiving extensive research attention, with geldanamycin, tanespimycin, and
their derivatives at the forefront. This report describes a novel, cost-effective, commercial scale process design
for the production of tanespimycin. The proposed production facility is designed to deliver 1,084 kg/year
through 55 batches, requiring operation of 293 days/year. Detailed economic analysis suggest the
recuperation of funds after an initial investment into the biopharmaceutical plant and Phase III trials, which
suggest that further investment in this process design would be highly profitable.
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Dear Advisors: 
Enclosed is a detailed analysis of the economic and process design for the production of 
tanespimycin, a cancer therapeutic abandoned by Bristol-Myers Squibb after successful Phase II 
clinical trials.  The current process as outlined in a 2003 patent was scaled up so as to meet the 
production goal of 1000 kg/year calculated from market analysis, which would allow for 
treatment of 112,000 patients per year.  As such, it is recommended that two 50,000 L 
bioreactors staggered by 5 days operate for approximately 295 days/year in order to meet the 
production needs of geldanamycin, the precursor compound to our desired product.  
This report details the equipment and units necessary for our proposed process, provides a 
thorough market analysis meant to simulate realistic capture of the breast cancer market, and 
describes a financial analysis that outlines a competitive pricing for tanespimycin which allows 
for greater capture of the prospective market and recoup of funds invested in phase III clinical 
trials and biopharamaceutical facility production. The plant will require an initial investment of 
the phase III clinical trial of an estimated $2 billion, as well as a total capital investment of $387 
million.  The internal rate of return (IRR) is 33% and the net present value of about $3.2 billion, 
assuming the plant operates for 14 years and the drug can be sold at a price of $2,136,752 per kg 
of tanespimycin, or $20,000 per treatment. 
After careful consideration, we submit this report for review with strong recommendations to 
build the facility to produce tanespimycin, pending its success in Phase III trials to treat breast 
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Recent approaches to cancer therapy have centered on developing small molecule inhibitors for 
signaling pathways deranged in common cancers; these compounds are sometimes referred to as tumor 
antibiotics. One promising target for tumor antibiotics is Hsp90, a heat shock protein that plays a central 
role in promoting the functionality and stability of a group of proteins associated with cancer called client 
proteins. Hsp90 inhibitors have been receiving extensive research attention, with geldanamycin, 
tanespimycin, and their derivatives at the forefront. 
This report describes a novel, cost-effective, commercial scale process design for the production 
of tanespimycin. The proposed production facility is designed to deliver 1,084 kg/year through 55 
batches, requiring operation of 293 days/year. Detailed economic analysis suggest the recuperation of 
funds after an initial investment into the biopharmaceutical plant and Phase III trials, which suggest that 
further investment in this process design would be highly profitable.  
 





2.1 Project Background 
The pharmaceutical industry is driven financially by the number of lucrative drugs in each 
company’s pipeline. As technologies grow and develop over time, advancements can be made that allow 
for new drugs to come to fruition.  However, each of these new drugs must undergo a series of expensive 
and time consuming FDA regulated clinical trials before being sold as a good in the marketplace. The vast 
majority of drugs in the pipeline will fail in these trials; therefore, companies must be selective in 
choosing which drugs to pursue and which to abandon. Sometimes the expected return on investment 
projected by the company drives the discontinuation of a pipeline drug; other times it can be a change in a 
company’s focus.  Because the ebb and flow of drug markets is so transient, a useful thought experiment 
involves returning to ideas that were once halted and revisiting whether a once-abandoned drug has the 
potential to become profitable to a company. 
Tanespimycin was a cancer therapeutic abandoned by Bristol-Myers Squibb (BMS) in 2010 for 
reasons that will not be disclosed but are not due to lack of efficacy or 
high levels of toxicity in patients.  After successful Phase I and II 
trials, the company decided to halt its production before finishing 
Phase III trials.    The drug, also known as 17-N-allylamino-17-
demethoxygeldanamycin, or 17-AAG, had been particularly 
promising as a treatment for breast cancer, multiple myelomas, and 
childhood leukemias.  
The precursor to tanespimycin is geldanamycin, which was first isolated as a fermentation 
product of the organism Streptomyces hygroscopicus, a general class of benzoquinone ansamycins. In the 
1980s, research suggested that this molecule could act as a tyrosine kinase inhibitor through heat shock 
protein 90 (HSP90) chaperone function; however, clinical trials were never performed due to the toxicity 
of this molecule (NCI). More recently, several derivatives of geldanamycin have been investigated as 
alternatives to the parent compound with lower toxicity and greater chemical stability. 
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HSP90s are important for the folding, activation, and assembly of many proteins and specifically 
those involved in signal transduction, cell cycle control, and transcriptional regulation (from 2009 17-
AAG patent), however, most heat shock proteins (HSPs) are 
molecular chaperones.  Proper protein synthesis and folding is 
supported in vivo by molecular chaperones (Powers, 2007). These 
molecular chaperone facilitate the correct folding of nascent 
polypeptides, prevent non-specific interactions, and repair damage 
proteins (J.C. Young, 2004). Research suggests that HSPs have an 
important role in the pathology of cancer (Whitesell, 2005). This 
protein has been shown to aid other proteins found in tumor growth, which is why it has recently become 
to target of many cancer drugs, including tanespimycin. At the time of this publication, however, no 
HSP90 inhibitors have made it successfully through clinical trials and FDA recognition. 
 Although tanespimycin was not further pursued by Bristol-Myers Squibb at the beginning of the 
decade, the recent expiry of the original patent in 2014 has prompted a deeper investigation into the 
profitability of this drug, along with the potential for generic production in the future.  As members of the 
company, we have been tasked with reevaluating the financials to decide if this drug is a potential 
moneymaker for BMS and if it could be competitive in today’s market.  BMS recently completed a new 
biologics production facility in Devens, Massachusetts, which offers over 60 acres of usable real estate 
for the large scale production of tanespimycin.  As such, it will be assumed that as a group internal to 
Bristol-Myers Squibb, common-use equipment will be readily available to those on the production team. 
 This equipment would include, but is not limited to, a waste neutralization system, industrial autoclaves, 
biosafety cabinets, a water purification system and WFI still, a steam generator, and any quality assurance 
equipment and testing necessary to ensure the purity of the product.   
The installation of this facility is necessarily contingent upon the success of the Phase III trials for 
tanespimycin.  A contract manufacturing organization will be used to produce the small amount of 17-
AAG necessary for the trials.  After FDA acceptance, the plant in Massachusetts will then be completed. 
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 The financial analysis of this project assumes Phase III success for tanespimycin.  However, many 
proposed drugs in pharmaceutical pipelines fail in Phase III.  In fact, roughly 62% of drugs fail to yield 
results that are statistically significant.  With this in mind, our analysis will shift to show the expected 
value of the return on investment is still lucrative enough to move forward with the production of the 
plant. 
 The plant itself and design process for tanespimycin was based off a 2009 patent from Conforma, 
but the parent geldanamycin will be produced using the language from a 2003 patent application from 
Upjohn Pharmaceuticals, which was acquired by Pfizer.  In both cases, the process was scaled so as to 
meet the needs defined in the market analysis so as to minimize disposal costs and increase the efficiency 




2.2 Project Charter 
Project Name: Cost Effective, Commercial Scale Production of Tanespimycin 
Project Leaders: Rocky Diegmiller, Alexanra Dreyfuss, Shira Redlich, Melissa Schantz 
Specific Goal: To design a biologics plant and process to produce tanespimycin in bulk from its 
precursor geldanamycin, isolated from Streptomyces hygroscopicus cells. 
Project Scope:  
In Scope: 
 Manufacturing process for tanespimycin from geldanamycin parent compound 
 Post-manufacturing purification steps of geldanamycin from final fermentation to reactor for 
allylamine addition to become 17-AAG 
 Meet current health and safety and health regulations for biologics 
 Adherence to good manufacturing practices (GMP) 
Out of Scope: 
 Clinical Trials (assumed to have passed Phase I and II) 
 Packaging and distribution of drug 
 Cell line development 
Deliverables:  Business opportunity assessment 
 What is the market for tanespimycin and breast cancer treatments in general? 
  Technical feasibility assessment 
 Is it technically feasible to manufacture tanespimycin on a large scale using scale up from a 
baseline process following a patent? 
  Manufacturing capability assessment 
 Can this facility be built and the process utilized without significant capital investment? 
 Will this process satisfy FDA regulations? 
Time Line: Facility and process design along with economic analysis within four months 
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3.0 Market and Competitive Analysis 
The antitumor effect of tanespimycin has been demonstrated in a variety of Phase II clinical trials. 
Specifically, tanespimycin has been used to successfully treat patients suffering from renal tumors due to 
Von Hippel Lindau disease, pediatric acute lymphoblastic leukemia, and HER2-positive breast cancer. 
Focus should be placed on the largest target population due to the expense of a Phase III clinical trial that 
can conservatively be estimated to cost $2 billion dollars. 
Dr. Diamond from the University of Pennsylvania, an expert in biotechnology, states that, if only 
considering the costs of treating the patients, a Phase III trial will cost $200 million to $500 million. The 
$2 billion dollar estimate includes the cost of failed trials suspecting that one drug may get approved for 
$500 million, but three others will fail at $500 million thus yielding the $2 billion dollar figure per drug. 
Also the $2 billion figure accounts for the opportunity cost of committing $1 billion dollars for 10 years, 
which could otherwise be invested for 5 percent for 10 years. 
As seen in Figure 3.1, HER2-positive breast cancer patients represent the majority of potential 
beneficiaries of tanespimycin treatment; therefore, this will be the target patient population for this 
production. 
  




         The 2011 clinical trial detailing tanespimycin treatment for HER2-positive patients used a 
combination therapy with Herceptin, a humanized monoclonal antibody that blocks HER2 function. In 
order to define a production goal, limitations of the population of HER2-positive patients must be 
defined. The patient population is first narrowed to the percentage that already uses Herceptin in 
treatment. With further consideration that only a subset of these patients will respond positively and that 
not all Herceptin users will additionally choose to use tanespimycin, the target population is further 
limited to 6 percent of the total HER2-positive patients.  
Following the dosing of the successful Phase II clinical trial, patients will receive weekly 
treatments of tanespimycin at 450 mg/m
2
. The average treatment duration was three months thus yielding 
13 weeks of therapy. With the average woman having a surface area of 1.6m
2
, 9.36 grams of 
tanespimycin are needed for one treatment. Using the narrowed target population, a production goal of 
approximately 1109 kg of tanespimycin per annum is achieved. Due to the limitations of the equipment 
yields, the process proposed maximally yields 1084 kg per year. To account for bad batches and potential 
equipment failure, only 95 percent of the maximal yield will be sold for treatment and accounted for in 
projected sales. 
         Medical News Today, estimated that in 2012 the average cost of a full course of Herceptin 
treatment costs about $70,000 according to various medical sources. Because tanespimycin will be used 
in conjunction to this drug the price will not be directly competitive, for combination treatment would 
then be twice as expensive as using Herceptin alone. Instead tanespimycin will be priced at XXX per 
treatment to account for the hesitancy to use a new method of treatment as well as the added expense of 




4.0 Preliminary Process Synthesis 
The overarching goal of this project is to design the most economically efficient process for the 
production of tanespimycin. To do so, it was first determined that the commercial price of geldanamycin 
(precursor to tanespimycin) of $383 million / 1.2 kg was indefensibly high (NCI, 2013). This motivated 
the undertaking of our own production of geldanamycin.  
Figure 4.1 outlines a ‘Decision Map’ depicting the alternative flow sheets considered, and the 
process by which the final design for both geldanamycin and tanespimycin production was reached.  
 
 
Figure 4.1 ‘Decision Map’ documenting the alternative flow sheets considered in reaching the final design for geldanamycin and 
tanespimycin production.  
 
4.0.1 Geldanamycin Patent Design 
The design displayed in Figure 4.2 was used as a starting point for geldanamycin production 
design (Pharmacia & Upjohn Company, 2004). The process consists of three fermentation steps with 
~25x scale-up between each, followed by several downstream isolation and purification steps: rotary 
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vacuum filtration to remove biomass, cellulose-based filtration to remove media, extraction to remove the 
cellulose-based filter media, distillation to concentrate the geldanamycin solution, crystallization, and 
recrystallization. The process produces 3.375 kg geldanamycin / batch  with a 45% yield resulting from 
loss of product in downstream processing. 
Figure 4.2 Base design of geldanamycin production, modeled after Pharmacia & Upjohn Company’s 2003 design.  
 
4.0.2 Initial Production Goal 
The initial process goal was to produce 100-200 kg tanespimycin / year. Since conversion of 
geldanamycin to tanespimycin is achieved with >85 % yield (Conforma Therapeutics Corporation, 2009),  
the original design was adjusted and tailored to produce ~200 kg geldanamycin / year. Two designs for 
the upstream process were considered, with downstream processing remaining the same albeit equipment 
sizing adjustments.  
For the first design, it was determined that the cycle time of the described process was 15 days - 3 
days for each of the first two fermentations, 8 days for the final fermentation, and 1 day for downstream 
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processing. Assuming operation of the plant for ~300 days / year, three fermentation trains running in 
parallel would yield (300/15)*3.375*3 = 202.5 kg geldanamycin / year.  
Alternatively, by identifying the bottleneck of the process as the large fermenter with a total 
fermentation time of 8 days, we investigated the result of staggering two fermentation trains by 4 days. 
The total output from this design, again assuming 300 days of operation, was estimated as (1+ 
285/4)*3.375 = 240 kg geldanamycin / year. Thus, this design was pursued.  
 
4.0.3 Revised Production Goal & Scale-Up  
Upon further analysis of the potential market, it became desirable to increase production to 1000 
kg tanespimycin/ year, or ~1100 kg geldanamycin / year. (Refer to Chapter 3 for in-detail discussion of 
market analysis.) Two alternatives for scale up were proposed. The difference in each design was in the 
upstream geldanamycin production process, so only this portion of the process is shown in Figures 4.3 
and 4.4.  
Five-Fold Replication. The block block diagram for the five-fold replication of the base process 
design is displayed in Figure 4.3 Sizing of fermenters and storage tanks remain identical to that in the 
original process design, and each pair of fermenters remains staggered by 4 days. The total amount of 















Figure 4.3 Upstream design replicated 5 times to achieve ~1000 kg geldanamycin / year. Vessel volumes shown in red. Pairs of 




Six-Fold Volume Scale-Up. The block diagram for the six-fold enlargement design is displayed in 
Figure 4.4. The most notable change in this design is the increased fermentation time of the 50,000 L 
fermenter from 8 days to 10 days. Thus, the two fermentation trains are staggered by five days, not four, 
with each fermenter giving 21.9 kg geldanamycin / batch. The total amount of geldanamycin produced / 
year is then (~55 batches*21.9) = 1205 kg/year..  
Figure 4.4 Block Diagram of six-fold volume scale up design for >1000 kg geldanamycin production/year.  
 
The purchase cost of two 50,000 L fermenters (estimated by scaling up the price of two 8,000 L 
fermenters by 10^.6) as compared to the purchase cost of an additional eight 8,000 L fermenters would 
clearly require less investment. Additionally, when considering maintenance requirements, number of 
employees, and number of pumps for two larger or  ten smaller fermenters, it is clear that a fewer number 
of large fermenters would have an overall lower cost. Thus, the six-fold volume scale up of the base 
design fermenters was pursued.  
 
4.0.4 Tanespimycin Base Design & Scale-up.  
Following the determination of a process design for geldanamycin, the design of a process on the 
appropriate scale for the conversion of geldanamycin to tanespimycin was needed. Conforma 
Therapeutics Corporation’s bench-scale design was used as a basis, and two options for scale up were 
considered. 
Reactor Volume Increase. This design, depicted in Figure 4.5, involves the scaling up of reactor 
volume to ~1000 L, accommodating the increased geldanamycin produced. However, this adjustment was 
not feasible because the reaction of geldanamycin with allylamine to produce tanespimycin would have 
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taken at least 90 days; allylamine must be added dropwise over an extended period of time (Conforma 
Therapeutics Corporation, 2009). In order to keep the reaction time under 5 days (duration of bottleneck 















Figure 4.5 Reactor volume scale up to accommodate increase in geldanamycin being produced. Design not feasible due to the 
impractical duration of time needed to conduct the reaction on such a large scale.   
 
Reactor Number Increase. To avoid the impractical reaction time resulting from reactor volume 
increase, reactor number increase was investigated. It was desirable to keep the reaction time under 5 
days, as anything above 5 days would result in less batches/year and lower production rate. It was 
determined that 18 reactors were required to process the amount of geldanamycin produced/batch in the 








Figure 4.6  Reactor number increase to accommodate increase in geldanamycin production, while maintaining a reaction time of 





4.0.5 Final Design 
The final process for the production of tanespimycin is a combination of the diagrams discussed 
above, and is shown in Figure 4.6. A detailed description can be found in Chapter 7. Additionally, 







Figure 4.6 Block diagram of final process design for tanespimycin production 
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5.0 Assembly of Database 
 
The database of chemical used throughout the process can be found in Appendix E as MSDS 
sheets.  As such, it is worth noting that the only chemicals that have been deemed hazardous in this 
production process  are that of methylene chloride and isooctane.  Methylene chloride is a known 
carcinogen, which ensures that extra caution is taken when handling.  Additionally, exposure to isooctane 
can cause damage to the central nervous system, as well as to the eye and stomach if contacted.  Prices for 
all of the chemicals in the database are given in Table 5.1  
 
Table 5.1 Principle Chemical Purchase Costs.  
Component Price($/Kg) Source 
Glucose Monohydrate 47.83 Millipore 
Yeast Extract 192.02 Fisher BioReagents 
Peptone Extract 194.99 Fisher BioReagents 
Ampule (10 mg/mL) 354.24 ATCC 
PEG (1.128 g/mL) 69.925 MP Biomedicals 
Soyflour 9.48 MP Biomedicals 
Corn Starch 22.35 Fisher Scientific 
Ammonium Sulfate 33.14 Millipore 
Calcium Carbonate 63.12 Fisher Chemical 
Cobalt Chloride Dihydrate 650.63 MP Biomedicals 
Ferrous Sulfate Heptahydrate 225.28 Millipore 
Alpha Amylase 540.80 MP Biomedicals 
Soybean Oil 165.57 MP Biomedicals 
Polyalkylene Glycol 116.51 Sigma Aldrich 
Filter Aid 16.98 Fisher Scientific 
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Cellulose-based Filter Media 16.98 Fisher Scientific 
Methylene Chloride 37.25 Fisher Scientific 
Isooctane 233.35 Fisher Scientific 
THF 83.52 Fisher Scientific 
Allylamine 251.64 Fisher Scientific 
 
6.0 Process Flow Diagram & Material Balance 
This chapter presents the proposed process flow diagram for tanespimycin production. The 
complete process flow diagram is shown in Figure 6.1. The overall component material balance is 
displayed in Table 1. Material flow rates, temperature, and pressure are also presented for each stream in 
Table 2. The ensuing sections of this chapter subdivide the process into three parts: upstream 
geldanamycin production, downstream geldanamycin production, and tanespimycin production, with 
respective flow diagrams and material balances on each piece of equipment presented. Material balances 
calculations were performed by scaling up patent specifications when applicable. All other calculations, 





























Component Input Output Produced Consumed/Lost/Discarded Out-In 
Glucose Monohydrate 14.021 0.000 0.000 14.021 0.000 
Yeast Extract 3.505 0.000 0.000 3.505 0.000 
Peptone Extract 14.021 0.000 0.000 14.021 0.000 
Cells 0.173 0.000 371.966 371.966 0.000 
PEG 2.343 0.000 0.000 2.343 0.000 
Geldanamycin 0.000 0.000 48.685 48.685 0.000 
Soyflour 1217.137 0.000 0.000 1217.137 0.000 
Corn Starch 2839.987 0.000 0.000 2839.987 0.000 
Ammonium Sulfate 81.142 0.000 0.000 81.142 0.000 
Calcium Carbonate 243.427 0.000 0.000 243.427 0.000 
Cobalt Chloride Dihydrate 0.325 0.000 0.000 0.325 0.000 
Ferrous Sulfate Heptahydrate 3.651 0.000 0.000 3.651 0.000 
Alpha Amylase 1.623 0.000 0.000 1.623 0.000 
Soybean Oil 0.001 0.000 0.000 0.001 0.000 
Polyalkyleneglycol 5.193 0.000 0.000 5.193 0.000 
Water Shots 5842.259 0.000 0.000 5842.259 0.000 
Methylene Chloride 3464.650 0.000 0.000 3464.650 0.000 
Isooctane 1725.000 0.000 0.000 1725.000 0.000 
THF 627.232 0.000 0.000 627.232 0.000 
Allyl Amine  34.685 0.000 0.000 34.685 0.000 
H20 204.475 0.040 0.000 204.435 0.000 
Tanespimycin 0.000 19.717 21.742 2.025 0.000 
* Filter Aid 1352.912 0.000 0.000 1352.912 0.000 
* Cellulose-based Filter Media 1352.912 0.000 0.000 1352.912 0.000 
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Table 6.2 Material Flow Rates, Temperatures, and Pressures of each stream. 
 
Stream Summary  S1 S2 S3 S4 S5 S6 S7 
Component (kg/batch)        
Media 1.17 1.17 0.00 0.00 0.58 31.54 0.58 
Ampule (10 mg/mL) 0.00 0.00 0.17 0.17 0.00 0.00 0.00 
Biomass 0.00 0.00 0.00 0.00 0.76 0.00 0.76 
Geldanamycin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Water Shots 0.00 0.00 0.00 0.00 0.00 0.00 0.00 





Stream Summary  S8 S9 S10 S11 S12 S13 S14 S15 
Component (kg/batch)         
Media 31.54 29.52 4392.49 29.52 4392.49 4242.165 4242.165 4242.165 
Ampule (10 mg/mL) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Biomass 0.00 3.37 0.00 3.37 0.00 372.139 372.139 372.139 
Geldanamycin 0.00 0.00 0.00 0.00 0.00 48.69 48.69 48.69 
Water Shots 0.00 0.00 5842.26 0.00 5842.26 5604.65 5604.65 5604.65 






Stream Summary S16 S17 S18 S19 S20 S21 S22 
Component (kg/batch)        
Fermentation Media  0.00 9846.81 9846.81 7877.45 1969.36 1969.36 1969.36 
Biomass 372.14 0.00 0.00 0.00 0.00 0.00 0.00 
Geldanamycin 9.74 38.95 38.95 3.90 35.05 35.05 10.52 
Filter Aid 1352.91 0.00 0.00 0.00 0.00 0.00 0.00 
Cellulose-based Filter Media 0.00 0.00 0.00 0.00 1352.91 1352.91 1352.91 
Methylene Chloride 0.00 0.00 0.00 0.00 0.00 0.00 6.65 
Isooctane 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Total Mass (kg/batch) 1734.79 9885.77 9885.77 7881.35 3357.33 3357.33 3339.44 
 
 
Stream Summary S23 S24 S25 S26 S27 S28 S29 S30 
Component (kg/batch)         
Fermentation Media  0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Biomass 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Geldanamycin 24.54 0.00 24.54 2.45 22.08 22.08 0.18 21.91 
Filter Aid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Cellulose-based Filter Media 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Methylene Chloride 3458.00 133.00 3325.00 3291.75 33.25 33.25 33.25 0.00 
Isooctane 0.00 0.00 0.00 1707.75 17.25 17.25 17.25 0.00 






Stream Summary S31 S32 S33 S34 S35 S36 S37 
Component (kg/batch)        
Geldanamycin 21.91 1.10 0.00 1.10 1.10 1.10 0.00 
THF 627.23 627.23 608.14 18.82 18.82 18.82 0.00 
Allyl Amine in THF (1 mol/mL) 34.69 32.01 0.00 32.01 32.01 32.01 0.00 
Tanespimycin 0.00 21.74 0.00 21.74 21.74 2.03 19.72 
WFI 0.00 0.00 0.00 0.00 0.00 204.44 0.04 









6.1 Upstream Geldanamycin  




6.1.2 Vessel Material Balances  
Vessel names are obtained from the flowsheet in Figure 6.1 All mass values are presented in 
kg/batch and represent values for one fermentation train. Additionally, temperatures in vessels are 
included when notable deviations from room temperature are required. Temperature specifications 
are also addressed in Chapter 7. 
 
1st-SEED. 
Component Input Output /Ferm Train Produced Consumed/Lost Out - In 
Glucose Monohydrate 1.039 0.519 0.000 0.000 0.000 
Yeast Extract 0.260 0.130 0.000 0.000 0.000 
Peptone Extract 1.039 0.519 0.000 0.000 0.000 
 
52EF-1  , 52EF-1. 
Masses represent the input and output of all 52 erlenmeyer flasks combined.  
Temperature = 28 °C 
Component Input Output Produced Consumed/Lost Out - In 
1° Seed Medium 1.168 0.578 0.000 0.591 0.000 
Ampule (10 mg/mL) 0.173 0.764 0.591 0.000 0.000 
 
2NDSEED1 , 2NDSEED2. 
Temperature = 28 °C 
Component Input Output Produced Consumed/Lost Out - In 
1° Seed Medium 0.578 0.531 0.000 0.047 0.000 
Cells 0.764 3.373 2.609 0.000 0.000 
Glucose Monohydrate 12.983 11.929 0.000 1.054 0.000 
Yeast Extract 3.246 2.982 0.000 0.264 0.000 
Peptone Extract 12.983 11.929 0.000 1.054 0.000 





FERM1 , FERM2. 
Temperature = 28 °C 
Component Input Output Produced Consumed/Lost Out - In 
1° ,  2° Seed Medium 29.523 28.322 0.000 1.201 0.000 
Biomass 3.373 372.139 368.766 0.000 0.000 
Geldanamycin 0.000 48.685 48.685 0.000 0.000 
Soy flour 1217.137 1167.636 0.000 49.501 0.000 
Corn Starch 2839.987 2791.994 0.000 47.993 0.000 
Ammonium Sulfate 81.142 79.771 0.000 1.371 0.000 
Calcium Carbonate 243.427 239.314 0.000 4.114 0.000 
Cobalt Chloride Dihydrate 0.325 0.319 0.000 0.006 0.000 
Ferrous Sulfate Heptahydrate 3.651 3.589 0.000 0.062 0.000 
Alpha Amylase 1.623 1.595 0.000 0.028 0.000 
Soybean Oil 0.00060 0.001 0.000 0.000 0.000 
Polyalkylene glycol 5.193 5.105 0.000 0.088 0.000 






6.2 Downstream Geldanamycin  
 







6.2.2 Material Balances by Vessel 
Downstream processing consists of both batch and continuous processes. Batch step material 
balances are presented in kg/batch, while continuous steps material balances are presented in kg/hr. 
Continuous steps are denoted with a ‘*’. Additionally, temperatures in vessels are included when 
notable deviations from room temperature are required.  
 
ROTV-FLT.* 
Component Input Discarded Kept 
Fermentation Media  2874.442 0.000 2874.442 
Biomass 106.325 106.325 0.000 
Geldanamycin 13.910 2.782 11.128 
Filter Aid 386.546 386.546 0.000 
 
CLL-FLT. 
Component Input Discarded Kept 
Fermentation Media 10060.548 8048.439 2012.110 
Geldanamycin 38.948 3.895 35.054 
Cellulose-based Filter Media 1352.912 0.000 1352.912 
 
EXTRCTION.* 
Component Input Discarded Kept 
Fermentation Media 1006.055 1006.055 0.000 
Geldanamycin 17.527 5.258 12.269 
Methylene Chloride 1732.325 3.325 1729.000 













Component Input Discarded Kept 
Geldanamycin 3.505 0.000 3.505 




Temperature = 35-40°C  
Component Input Discarded Kept 
Geldanamycin 3.505 0.350 3.155 
Methylene Chloride 475.000 470.250 4.750 
Isooctane 246.429 243.964 2.464 
 
ROSENMUND. 
Component Input Discarded Kept 
Geldanamycin 22.084 0.176 21.908 
Methylene Chloride 33.250 33.250 0.000 






6.3 Tanespimycin Production 
 






6.3.2 Material Balances by Vessel 
Conversion of geldanamycin to tanespimycin consists of both batch and continuous 
processing. Batch step material balances are presented in kg / batch, while continuous steps material 
balances are presented in kg/hr. Continuous steps are denoted with a ‘*. 
 
REACTOR.  
Masses are for all 18 reactors combined. 
Temperature = ~45-50°C, slightly below THF boiling point of 66°C 
Component Input Output Produced Consumed/Lost Out - In 
Geldanamycin 21.908 1.095 0.000 20.813 0.000 
THF 627.232 627.232 0.000 0.000 0.000 
Allyl Amine in THF 34.685 32.005 0.000 2.680 0.000 
Tanespimycin 0.000 21.742 21.742 0.000 0.000 
 
ROT-EVAP.* 
Component Input Discarded Kept 
Geldanamycin 0.548 0.000 0.548 
THF 313.616 304.208 9.408 
Allyl Amine 16.002 0.000 16.002 
Tanespimycin 10.871 0.000 10.871 
 
FLTR-DRY. 
Component Input Discarded Kept 
Geldanamycin 1.095 1.095 0.000 
THF 18.817 18.817 0.000 
Allyl Amine 32.005 32.005 0.000 
Tanespimycin 21.742 2.025 19.717 






7.0 Process Description  
7.0.1 Process Overview  
The tanespimycin production process is designed to run for 293 days/year. One batch will 
give 21.91 kg geldanamycin (45% yield), and then 19.7 kg tanespimycin (90% yield). The longest 
step in the process is the 10-day duration of the 50,000 L fermentor (cleaning time included). Thus, 
two identical fermentation processes will run staggered by 5 days. Every 5 days after the first 23 days 
(total process time = 15.75 day geldanamycin upstream + 2.25 days geldanamycin downstream + 5 
days tanespimycin) 21.91 kg geldanamycin will be produced. The total mass of tanespimycin 
produced/year will then be 1084 kg. (55 batches/year) Accounting for bad batches, the total amount 
of usable tanespimycin produced/year, can be estimated according to Morphotek as approximately 
95% of overall mass, or 1030 kg tanespimycin/year.  
Important process parameters are: cycle time of 23 days, batch time of 5 days, and bottleneck 
of  50,000 L fermentation lasting 10 days. A Gantt Chart can be found in Chapter 7.  
 
7.0.2 Employee Requirement 
For the upstream and downstream geldanamycin process, a total of  13 employees per shift are 
required: 1 employee for fifty-two 2 L fermentors of both trains who will have a break every 5 days to 
monitor downstream, 1 employee for secondary fermentor of both trains who will have a break every 5 
days to monitor downstream, 1 employee on each of the 50,000 L bioreactors at all times, and 1 employee 
at each of the downstream processes (ROTV-FLT, BIOINACT, CLL-FLT, NEUTRLZ1, EXTRCTON, 
DISTILL, CRYST, ROSEMUND, and 34-DRUMS) . For the tanespimycin production process, 11 
employees per shift are required: 9 total employees for the 18 reactors, 1 employee for downstream, and 1 
employee for maintenance. Assuming four 8-hour shifts/day, full time salary is required for 96 
employees. Each employee will be paid $47,000/year (Bureau of Labor Statistics, 2014), for a total 




7.0.3 Piping and Flow Rates 
Flow rate of material between vessels throughout the entire tanespimycin production process 
occurs in pipes approximately 3” in diameter, corresponding to a flow rate of 400 LPM. Since many 
steps in the process involve solid-bearing liquids, all pipes will maintain at least a 5 ft/sec velocity to 
prevent the solids from settling out in the pipeline and provide sufficient turbulent conditions to keep 
the solids in suspension. At the end of every slurry transfer, the pipes will be flushed with clear liquid 
to sweep out all solids.    


















7.1 Geldanamycin Upstream Process 
Upstream processing consists of three fermentation steps, each at 28°C and successive 25x scale-
up. The fermentation is expected to produce 48.684 kg geldanamycin/batch requiring subsequent isolation 
and purification.  
Input materials include serum-free media and the natural organism Streptomyces hygroscopicus 
in a 10 mg/mL solution stored at -80°C. This process treats the organism’s doubling time as 1.4 days with 
a yield coefficient of 0.13.  Literature reports of 1.4-2 day doubling time and a yield coefficient of 0.1708 
show that these parameters in this process are on the conservative side, potentially allowing for even 
greater yields (Subhasish Dutta, 2013). 
The ensuing description gives numbers for operation of one of the two fermentation trains, as 
each operates in alternating 5 day periods. Additionally, page references to descriptions of each piece of 
equipment in Chapter 9 are bracketed at the end of each equipment/step subsection. 
 
7.1.1 Primary Seed Media Preparation 
Primary media preparation consists of mixing glucose monohydrate, yeast extract, and peptone 
extract for a total volume of (52x2) L in a (65x2) L vessel every 10 days, starting on day 5 of operation. 1 
L of the media will be dispensed into fifty-two 2 L erlenmeyer flasks, which will then be autoclaved for 
45 minutes and subsequently cooled for approximately 30 minutes. Each erlenmeyer flask will be sealed 
with a membrane cap by DURANO. 
 
7.1.2 Inoculation 
Following cooling, each flask will be inoculated with 1 L of an ampule culture (10 mg/mL, 1.4 
day doubling time) of Streptomyces hygroscopicus variety geldanus variety nova (NRRL 3602). The 
culture should be previously cultured in primary seed medium, mixed with 15% glycerol, and stored at -
80°C. Each of the fifty-two 2 L flasks will then be incubated for 3 days at 28°C on a rotary shaker, after 
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which the flasks’ contents will be transferred along with secondary seed medium to an 1750 L fermenter. 
Cleaning time for the fifty-two 2 L erlenmeyer flasks is approximately 4 hours. 
 
7.1.3 Secondary Seed Preparation 
Secondary seed media preparation consists of mixing glucose monohydrate, yeast extract, 
peptone extract, and PEG for a total volume of (1300x2) L in a (1600x2) L tank every 10 days starting on 
day 8 of operation. 
 
7.1.4 Secondary Fermenter 
Half of the secondary media storage vessel content along with all material from the fifty two 2 L 
erlenmeyer flasks will be transferred to an 1750 L fermenter. The reactor is maintained at 28°C without 
pH control, at 7 psi backpressure, 200 SLM, and 250 rpm. Incubation will occur for 3 days before all 
material is transferred to the final 50,000 L fermenter.  Cleaning time is approximately 4 hours. 
 
7.1.5 Fermentation Media Preparation 
The fermentation media consists of mixing soy flour, corn starch, ammonium sulfate, calcium 
carbonate, cobalt chloride dihydrate, ferrous sulfate heptahydrate, alpha amylase, soybean oil for a total 
volume of (32,500x2) in an 82,000 L tank every 10 days starting on day 11.  Polyalkylene Glycol is 
added to help minimize foam before transfer to a 50,0000 L fermentor. 
 
7.1.6 Fermentation 
Half of the secondary media storage vessel content along with all material from the secondary 
fermenter will be transferred to a 50,000 L fermenter. The fermentation is maintained at 28°C and the pH 
is controlled between 6.25 and 7.75. The back pressure is maintained between 7 and 20 psi with stirring 
between 180-220 rpm, and aeration between 1000-5000 SLM. The fermentation will run for 9.75 days, 
and receive 1460 L water shots on days 6, 7, 8, and 9.. At harvest, the entire contents of the fermenter 
tank are pushed to a 50,000 L storage tank for cooling, and then isolation. Cleaning time for the fermenter 





The resulting product from the 50,000 L fermenter will be transferred to a 50,000 L storage tank 
which will cool the material to 5°C over a 3 hour period. 
 
7.2 Geldanamycin Downstream Process 
The isolation and purification of a fermentation product is essential to any commercial process. 
Since the chemical nature of a fermentation broth is complex, and extremely high purity is required for a 
pharmaceutical product intended for patients as tanespimycin is, recovery and purification requires many 
processing steps. (Shuler & Kargi, 2002) In this design, isolation and purification of tanespimycin are a 
combination of batch and continuous processes, in contrast to the original patent in which all steps were 
batch.  Continuous processing was employed when possible to exploit: lack of vessel size restrictions, less 
costly and time consuming cleaning/rinsing cycle, no time loss filling and emptying tanks, and less 
manual operation (Miteco, 2015). Storage tanks are used when a switch from batch to continuous or vice 
versa is required. 
 
7.2.1 Rotary Vacuum Filtration: Biomass Removal  
The rotary vacuum filter is operates through a revolving drum; each revolution of the drum 
consists of cake formation, cake washing (if needed), dewatering or drying, and cake discharge. As the 
drum rotates under vacuum, a thin layer of cells will adhere to the drum. A vacuum maintained in the 
drum will provide the driving force for liquid flow (Shuler & Kargi, 2002, pg 332).  
A mixture of diatomaceous earth produced by Eagle-Picher Industries in Reno, NV and 
diatomaceous earth produced by Celite Corporation in Lompac, CA filter aids (1/1) will coat the rotary 
vacuum filter drum, in an amount of 4 kg filter aid/100 L of fermentation medium. The fermentation 
medium will be filtered continuously over a period of 3.5 hours. The solid cake that forms, comprised of 
biomass and filter aid, will be scraped off the vacuum filtration unit as the drum rotates and discarded into 
a biowaste tank containing water where they will mix to create a liquid that can be pumped to the 
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facility’s built-in biowaste inactivation system. The filtrate containing the geldanamycin product will be 
transferred to a 50,000 L storage vessel (STORAGE2/V102) to aid the switch from continuous to batch 
processing, and cooled to 5°C in approximately 3 hours. [,] 
 
7.2.2 Cellulose-Based Filtration: Crude Crystals Isolation 
The filtrate obtained from rotary vacuum filtration/storage vessel  will be contacted with 
cellulose-based filter media of type 10A produced by Cuno Incorporated, Meriden, CT in a batch-
processing step that will take approximately 5 hours.  The clarified filtrate obtained will be discarded into 
an 11,355 L neutralization tank. Crude geldanamycin crystals along with cellulose-based filter media will 
be subsequently transferred to a 8500 L storage tank (XTRSTRG1/V-105) to avoid the need to stop the 
process if the extractor in the next step, whose contents often emulsify, needs to be adjusted. Material will 
be transferred to the storage tank with a pump, as enough liquid fermentation media will be present and 
flow at >5 ft/sec which will keep the solids flowing.  
 
7.2.3 Extraction with Methylene Chloride    
The crude geldanamycin crystals and cellulose-based filter media will be contacted with 
methylene chloride in a 10,000 L extractor to extract the filter media continuously. The extractor will 
have two stages which operate in reverse flow. Each of the two phases will be fed into the respective 
opposite stage with a metering pump and run through the system due to the conveyance effect of the 
stirrers. The overflow phases will be collected in two receivers.  
        The methylene chloride will be recycled through the filter elements for 2 hours. In contrast to many 
liquid liquid extractions in which multiple steps are used to maximize product recovery, only one step 
will be used in this solid-liquid extraction. The filter media will be discarded into several 55 gallon drums 
that will be removed by a contracted waste management company. Geldanamycin will be obtained 




7.2.4 Concentration with Distillation  
Excess methylene chloride will be removed with continuous distillation lasting approximately 7 
hours. Continuous distillation technology used will be provided by Armfield, Inc. and suitable for at least 
500 L of material. The product obtained from this process will still be liquid methylene chloride with 
dissolved geldanamycin, but at a higher, still unsaturated, concentration which will allow for better 
crystallization of product in the next step. Evaporated methylene chloride will be transferred to 55 gallon 
drums that will be removed by a contracted waste management company. (BP Geldanamycin = 783.86 
°C, BP Methylene Chloride = 39.6 °C)  
 
7.2.5 Crystallization  
The dissolved geldanamycin is continuously crystallized by mixing with isooctane over 7 hours, 
maintaining a temperature of 35-40°C. (MP Geldanamycin = 255°C, MP Isooctane = 107.32 °C) 
Methylene chloride and isooctane will be transferred to 55 gallon drums that will be removed by a 
contracted waste management company. The crystal slurry will be transferred with a conveyer to a 65 L 
storage tank (STORAGE3/V-101) and then cooled to 5°C (3 hours) once all product from the 
crystallization is processed.  
 
7.2.6. Rosenmund Filter/Drying 
Instead of tray drying as specified by the original patent (Gillespie, 2004), this design will use a 
Rosenmund Nutsche filter to dry the crystals and purify the geldanamycin to increase efficiency in 
washing and drying, allow for quick turn around, and enable visual and physical inspection of product. 
The Rosenmund unit will have an internal agitator which will go in one direction to "plow up" the crystals 
for washing and drying and reverse to discharge the crystals through a side chute.  
The batch washing and drying of the geldanamycin crystal cake will take 14 hours. Methylene 
chloride and isooctane will be discarded into 55 gallon drums that will be removed by a contracted waste 
management company. The geldanamycin crystals will be collected in drums and dumped or conveyed 
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(with a Schutte-Koerting solids ejector or a pneumatic unit from DeDietrich) into each of the next 18 
reactors. 
 
7.3 Tanespimycin Production 
The goal of the last part of the process is to convert isolated and purified geldanamycin to 
tanespimycin, which will then be isolated and purified. The process consists of a reaction taking place 
simultaneously in 18 reactors, which then feed into one train of two isolation/purification steps, the first 
being continuous and the second being batch. A storage tank aids the switch.  
 
7.3.1 Reaction Conversion of Geldanamycin to Tanespimycin 
The purified and dried geldanamycin will be transferred in equal amounts to 18 identical stainless 
steel 60 L reactors along with THF (solvent). Allyl amine dissolved in THF will be added over a period of 
4.5 days - the entire reaction time. ~95% of the geldanamycin will react to give tanespimycin and reaction 
completion will be verified with a TLC column. The entire reactors content will be pushed to isolation. 
 
7.3.2 Rotary Evaporation 
A rotary evaporator suitable for 750 L of liquid will be used to continuously remove solvent over 
a period of 2 hours. The liquid to be processed in the rotary evaporator is fed directly into the rotary flask 
by a feed pipe conducted through the condenser part. Evaporation takes place in the externally heated 
rotary flask, and the rotational movement of the piston ensures a good intermixing of the medium, thus 
providing regular temperature distribution (De Dietrich, 2014). The THF will be discarded into a 1040.9L 
neutralization tank before passing through the facility’s built-in neutralization system. The rest of the 
reactor contents will be transferred to a 100 L storage tank (STORAGE4 / V-102) to aid the switch from 
continuous to batch before Rosenmund drying.  
 
7.3.3 Rosenmund: Filter/Drying 
Instead of tray drying, as specified by the original patent (Gillespie, 2004), this design will use a 
Rosenmund Nutsche filter to dry the crystals and purify the geldanamycin to increase efficiency in 
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washing and drying, allow for quick turn around, and enable visual and physical inspection of product. 
The Rosenmund here will have a filtration area of 5.6 sq. ft., and a 32” diameter suitable for ~250 L of 
material.  
Filtering/drying will remove any unreacted geldanamycin and allylamine, and the rest of the THF 
in a batch-wise manner for approximately 10 hours. Discarded material will be transferred to the same 
1040.9L neutralization tank before passing through the facility’s built-in neutralization system. H20 will 
be added to aid precipitation and crystallization of the tanespimycin. The Rosenmund will be positioned 
above the the nitrogen blanket for direct discharge into that next vessel for storage of the final product. 





8.0 Utility Requirements 
 
 The primary requirements of the plant are electricity, steam, and process water.  Of these, 
electricity is most expensive, making up 96.5% of the total utility cost per year.  These calculations are 
based off a $0.08 per kWh rate from NSTAR, a Massachusetts energy provider.  Of the electricity-
requiring processes, the HVAC process consumes 36.3% of the total energy required.  The other major 
energy consumers are the distillation column (37.3%) and the production bioreactors (9.75% for both). 
 The table shown in the next section shows the exact amounts of energy listed for each energy-consuming 
portion of the plant. 
 Steam and process water are the other two main contributors to the utility costs.  The plant will 
need roughly 40,000 lb of steam and 230,000 gal of cooling water per year.  The steam will be used in the 
steam-in-place setup, while the cooling water will be used in the upstream process to offset the heat 
released by the growing organisms in the fermentor.  The larger heat duty needed for downstreams 
process will be covered by roughly 120,000 kg of propylene glycol per year, which has a much lower 
freezing point.  At a rate of $0.543 per 1000 L from the Aquarion Water Company in Massachusetts, 





Table 8.1: Utility Costs Per Unit Equipment 




52-2L, EF (2) 2.67 $0.21 $11.73 
2ND-SEED (2) 193.75 $15.50 $852.50 





   ROTV-FLT 143.80 $11.50 $632.72 
CLL-FLT 3.97 $0.32 $17.47 
EXTRCTON 18.50 $1.48 $81.40 
DISTILL 16349.00 $1,307.92 $71,935.60 
CRYST 110.00 $8.80 $484.00 





   ROT-EVAP 143.80 $11.50 $632.72 





   HVAC 15927.30 $1,274.18 $70,080.12 
Incubators 49.92 $3.99 $219.65 
CIP/SIP 163.97 $13.12 $721.46 
Water Treatment 734.09 $58.73 $3,230.00 
WFI 2391.59 $191.33 $10,523.00 
Waste Neutralization 1145.20 $91.62 $5,038.88 
Clean Steam 938.48 $75.08 $4,129.31 










Figure 8.1 Percent of Total Utility Cost 
 
 




9.0 Equipment List and Unit Descriptions 
9.1 Equipment List  
Equipment Description Process Unit Vendor 
Geldanamycin Upstream Process Equipment 












2L Erlenmeyer Flasks (104) 52EF-1 SFR-104 &  
52EF-2 SFR-101 
DURAN 
1750 L Secondary Fermentor 2ND-SEED1/SFR-105 & 2NDSEED2/SFR-103 ABEC 
50000L Fermentor  FERM1-FR-102 & FERM2/FR-101 ABEC 
Media Filters (6) S-1, S-2, S-8, S-6, S-12, S-10 Sartorius Stedim 
Biotech 
Upstream Pumps (8) S-8, S-6, S-12, S-10, S-14, S-13, S-11, S-9 Watson-Marlow 
50000L Surge Tank STORAGE`1/V-101 Sharpsville 
Container 
Geldanamycin Downstream Process Equipment 
RotaryVacuum Filter ROTV-FLT/RVF-102 Komline-Sanderson 
Storage Tank (50,000L) STORAGE2/V-102 Sharpsville 
Container 
Cellulose-based filter CLL-FLT/CL-101 Ertel Alsop 
Storage Tank XTRSTRG1/V-105 Sharpsville 
Container 
Extraction Unit (EXTRCTON/V-103) Sulzer Chemtech 
Distillation Unit DISTILL/V-104 Amfield, Inc.  
Crystallization Unit CRYST/CR-101 Conair Group 
Storage Tank (65L) STORAGE3/V-101 Sharpsville 
Container 




Downstream Pumps (14) S-15, S-16, S-17, S-18, S-20, S-21, S-22, S-23, S-24, S-
25, S-26, S-27, S-28, S-29 
Watson-Marlow 
Storage Tubs DRUM/V-101 Sharpsville 
Container 
Tanespimycin Production 
60L Reactor (18) REACTOR/PFR-101 ABEC 
Rotarry Evaporator ROT-EVAP/RVF-101 De Dietrich Process 
Systems 
Storage STORAGE4/V-102 Sharpsville 
Container 
Rosenmund Filter FLTR-DRY/GVX-101 De Dietrich Process 
Systems 
Pumps (14) S-32 (x10), S-33, S-34, S-35, S-36 Watson-Marlow 
Additional Equipment 
Biosafety Cabinet Assumed in existing BMS facility Thermo Scientific 
Cell Bank Assumed in existing BMS facility LabRepCo 
Air Generator Assumed in existing BMS facility BMS 
Clean Steam Generator Assumed in existing BMS facility BMS 
CIP Skids Assumed in existing BMS facility SaniMatic 
Filter Integrity Tester Assumed in existing BMS facility Millipore 
WFI Still Assumed in existing BMS facility Paul Mueller Co. 
Biowaste Inactivation and 
Neutralization Tanks 
BIOINACT/LD-101 
NEUTRLZ1/LD-101 & NEUTRALZ2/LD-102 
Sharpsville 
Container, Zurn 
Biowaste Inactivation System Assumed in existing BMS facility BMS 
Waste Neutralization System Assumed in existing BMS facility BMS 
Methylene Chloride Drumming 34-DRUMS/LD-103 Clean Harbors 
Quality Control Laboratory Assumed in existing BMS facility BMS 
Portable Pumps on Cart (7) n/a Watson-Marlow 




9.2 Equipment Selection 
Equipment units were selected based on the maximum efficiency of the process with advice from 
industrial consultants as well as specific vendors. Units were chosen to optimize careful preservation of 
the product as well as maximum yield while complying with GMP regulations.  
 
9.3 Common Units 
9.3.1 Pumps  
A peristaltic pump is used to transfer fluid from throughout the process. The pump can be 
purchased from Watson Marlow and is the 825 Peristaltic Pump. In both the stirred tank and fluidized 
bioreactor processes, the power of the pump ranges from 1.5-5.0 hp. The pumps operate at room 
temperature and a 50 psi (3.5 bar) pressure drop with maximum flow rate of 33.3 L/min. The pump will 
be sterilized and are purchased from Watson Marlow for the cost of $13,000 per pump. Watson Marlow 
Bioprene sterile tubing is used to transfer the fluid through the variety of processes. There are a total of 8 
pumps in the upstream processing (S-8, S-6, S-12, S-10, S-14, S-13, S-11, S-9), 14 pumps in the 
downstream processing (S-15, S-16, S-17, S-18, S-20, S-21, S-22, S-23, S-24, S-25, S-26, S-27, S-28, S-
29) , 14 pumps in the final processing for 17-AAG (S-32 (x10), S-33, S-34, S-35, S-36), and 7 spare 
pumps accounted for. The resulting prices for pumping for upstream, downstream, final processing, and 
spares respectively are $104000, $182000, $182000, and $91000.    
 
9.3.2 Media Sterilization Filters  
The 0.2 micron filter is used to purify the media by removing any impurities and toxins before 
introduction to the bioreactors. The filter is 30 inches in size and the filtration area is 1.8m2 (18ft2 ). The 
membrane filter material is Polyethersulfone (PES) and operates at room temperature with a max 
differential pressure of 0.5 bar. The filters require a type of housing for security that requires a one-time 
purchase from Sartorius Stedim Biotech for the cost of $2,000. The filters are disposable and replaced 
after every batch. They are purchased from Sartorious Stedim Biotech under the model name Sartopore 2 




9.4 Upstream Equipment 
9.4.1 Primary Seed Media Preparation Tank (1ST-SEED/V-102) 
The Primary Seed Media tank (130L) is used to mix the primary seed media composed of 
Glucose Monohydrate, Yeast Extract, and Peptone Extract.  This tank is required to ensure proper mixing 
of the media before it is fed through a sterile filter and added to the Initial Ampule in 2 L flasks (52EF-1 
SFR-104 & 52EF-2 SFR-101).  The tank is made from stainless steel 316 with a volume of 130L and 
working capacity of 80%. It is elecro-polished and equipment with an agitator with hydrofoil impellers 
and a dimple style jacket . For sterilization, CIP and SIP are used each time the tank is fully emptied 
(every 2 batches). The tank operates at room temperature and 1 bar. The tank is fabricated by Sharpsville 
Container and has a purchase cost of $19,765.  
9.4.2 Secondary Seed Media Preparation Tank (2ND-TRG/V-103) 
The Secondary Seed Media tank (3250L) is used to mix the primary seed media composed of 
Glucose Monohydrate, Yeast Extract, Peptone Extract, and PEG/L.  This tank is required to ensure proper 
mixing of the media before it is fed through a sterile filter and added along with the primary flask broth to 
each Secondary Seed Fermentor (2ND-SEED1/SFR-105 & 2NDSEED2/SFR-103). The tank is made 
from stainless steel 316 with a volume of 3250L and working capacity of 80%. It is elecro-polished and 
equipment with an agitator with hydrofoil impellers and a dimple style jacket. For sterilization, CIP and 
SIP are used each time the tank is fully emptied (every 2 batches). The tank operates at room temperature 
and 1 bar. The tank is fabricated by Sharpsville Container and has a purchase cost of $51,995.  
 
9.4.3 Fermentation Media Preparation Tank (FERM-STR/V-104) 
The Fermentation Media tank (81,150L) is used to mix the primary seed media composed of 
Glucose Monohydrate, Yeast Extract, and PEG/L.  This tank is required to ensure proper mixing of the 
media before it is fed through a sterile filter and added to each Fermentor (FERM1-FR-102 & 
FERM2/FR-101).  The tank is made from stainless steel 316 with a volume of 50,000L and working 
capacity of 80%. It is elecro-polished and equipment with an agitator with hydrofoil impellers and a 
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dimple style jacket. For sterilization, CIP and SIP are used each time the tank is fully emptied (every 2 
batches). The tank operates at room temperature and 1 bar. The tank is fabricated by Sharpsville 
Container and has a purchase cost of $302,765.   
 
9.4.4 Erlenmeyer Flasks (52 x 2) (52EF-1 SFR-104 & 52EF-2 SFR-101) 
The Erlenmeyer Flasks are used to grow the Initial Ampule of bacteria.  This flask is required to 
ensure proper growth of the bacteria in primary media before it is added to the Secondary Fermentor 
(2ND-SEED1/SFR-105 & 2NDSEED2/SFR-103).  Each flask will be inoculated with 1L of primary seed 
media and 0.3L of ampule. The glass flasks have an easy-to-read scale and large labelling field for easy 
marking in fired-on, highly durable, white ceramic. The flasks will also have membrane caps, as they 
allow for a more definable and reproducible gas exchange than a cotton cap. For sterilization, the flasks 
will be autoclaved, as the membrane cap allows pressure equalization and tight sealing, greatly reducing 
the risk of contamination. After inoculation, the flasks will be incubated for 3 days at 28℃ on a rotary 
shaker. The tank is fabricated by DURANO and has a purchase cost of about $40 per flask.  
9.4.5 Secondary Fermentor (2ND-SEED1/SFR-105 & 2NDSEED2/SFR-103) 
The Seed Fermentor (1750L) is used to grow the Primary Seed to Flask bacteria/media mixture. 
 This fermentor is required to ensure proper growth of the bacteria before it is added to the production 
fermentor (FERM1-FR-102 & FERM2/FR-101).  The unit is made of stainless steel and finished by 
electro-polishing. The pH, temperature, and oxygen levels are controlled with PID controls. The tank has 
a volume of 1750L and a working volume of 1366L. The tank is fabricated by ABEC and has a purchase 
cost of $925,848.50 each, which is $1,851,697 for 2 fermentors.  
 
9.4.6 Production Fermentor (FERM1-FR-102 & FERM2/FR-101) 
The Production Fermentor is used to grow the Seed to Fermentor bacteria/media mixture.  This 
fermentor is required to ensure proper growth of the bacteria and production of geldanamycin for 
purification.  The unit is made of stainless steel and finished by electro-polishing. The pH, temperature, 
and oxygen levels are controlled with PID controls. The tank has a volume of 50,000L and a working 
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volume of 39664.9L. The tank is fabricated by ABEC and has a purchase cost of $8,461,649.5 each, 
which amounts to $16,923,299 for 2 fermentors. 
9.4.7 Surge Tank (STORAGE 1/V-101) 
The outputs from both production fermentors (staggered) are stored into the 50,000L surge tank 
before downstream processing and isolation. The surge tank will keep at 5℃ to ensure the stability of the 
product as well as the bacteria still present in the solution. It is elecro-polished and equipment with an 
agitator with hydrofoil impellers and a dimple style jacket. The tank is fabricated by Sharpsville 
Container and has a purchase cost of $501431. 
 
9.5 Downstream Equipment 
The specific vessels utilized for downstream processing were chosen to optimize efficiency as 
well as specificity of the separation process. In this design, isolation and purification of tanespimycin are 
a combination of batch and continuous processes.  
 
9.5.2 Rotary Drum Vacuum Filtration Unit (ROTV-FLT/RVF-102) 
The Rotary Vacuum Filtration unit is used to separate unwanted solids from the geldanamycin 
product.  This process is required to eliminate extraneous biological wastes in order to isolate the desired 
drug. The unit is fabricated by Komline-Sanderson and has a purchase cost of $150,000. The rotary 
vacuum filter will have a filtering area of 200 sq. ft., corresponding to a K-S drum filter diameter of 8 ft. 
The Komline-Sanderson Rotary Drum Vacuum Filter specifically provides continuous liquid/solid 
separation with minimal operator attention and low maintenance and will be specifically designed for this 
process. 
 
9.5.3 Storage Tank (50,000L) (STORAGE2/V-102) 
The 50,000L jacketed storage tank will store the the filtrate containing the geldanamycin product 
from the rotary drum vacuum filtration unit. This unit will aid the switch from continuous to batch 
processing and will cooled to 5°C to ensure the stability of its contents. The tank is made of electro-
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polished 316L stainless steel  and is equipment with an agitator with hydrofoil impellers and a dimple 
style jacket. The tank is fabricated by Sharpsville Container and has a purchase cost of $501,431. 
 
9.5.4 Cellulose-Based Filtratio (CLL-FLT/CL-101) 
This Clarifier is used to separate solid geldanamycin from liquid filtrate.  This process is required 
to purify the geldanamycin for entrance into the Extraction vessel.  The unit is fabricated by Ertel Alsop 
and has a purchase cost of $500,000. 
 
9.5.5 Storage Tank (8500L) (XTRSTRG1/V-105) 
The 8500L jacketed storage tank will store the the filtrate containing the output from the cellulose 
filtration unit before further downstream processing. This unit will avoid the need to stop the process if 
the extractor in the next step needs to be adjusted to emulsification. The tank is made of electro-polished 
316L stainless steel and is equipment with an agitator with hydrofoil impellers and a dimple style jacket. 
The tank is fabricated by Sharpsville Container and has a purchase cost of $100,000. 
 
9.5.6 Extraction Vessel (EXTRCTON/V-103) 
This Extraction vessel (10,000L) is used to dissolve geldanamycin into dichloromethane.  This 
process is required to amass the crude geldanamycin for further purification.  The glass unit provided by 
De Dietrich will ensure inertness and allow for observation of the mixing and separation process, enabling 
their easy optimization. The unit is fabricated by Sulzer Chemtech and has a purchase cost of $500,000.   
 
9.5.7 Distillation Vessel (DISTILL/V-104) 
This Distillation Column used to condense the dissolved geldanamycin in methylene chloride. 
 This continuous process is required to allow for higher yield upon crystallization in the Crystallizer 
(CRYST/CR-101). The unit is suitable for 500L of material and is made out of stainless steel. The unit is 




9.5.8 Crystallizer (CRYST/CR-101) 
This Crystallizer is used to precipitate and isolate the geldanamycin product.  The unit is 
fabricated by Conair Group. The specific unit chosen for this process is the CR135 made of PET with a 
purchase cost of $500,000.   
 
9.5.9 Storage Tank (65L) (STORAGE3/V-101) 
The 65L jacketed storage tank will store the crystal slurry from the crystallizer (CRYST/CR-101). 
The tank is made of electro-polished 316L stainless steel and is equipment with an agitator with hydrofoil 
impellers and a dimple style jacket. The tank is fabricated by Sharpsville Container and has a purchase 
cost of $15,000. 
 
9.5.10 Rosenmund Filter Dryer (ROSENMUND/GBX-101) 
This Rosenmund Filter Dryer used to dry 22kg of geldanamycin product. Rosenmund filters 
demonstrate high efficiency in washing and isolate pharmaceuticals. A few upgraded features of this 
system include side discharge including a side discharge valve for pressure-tight closure after each 
product discharge to insure no contamination. In addition, this vessel contains a three-blade agitator for 
efficient agitation and discharge. The total discharge system with the gas knife allows for product 
discharge without manual intervention, therefore increasing efficiency and reliability. The equipment also 
allows for efficient CIP/WIP and SIP cleaning. The application of specialised spray systems and 
sterilisation methods validation of the vessel preparation process. The vessel has a filtration area of 0.16 
sq ft and a 18’’ diameter for about 50L of material. The unit is fabricated by De Dietrich and has a 
purchase cost of 500,000.  
 
9.5.11 Tubs for geldanamycin product (DRUM/V-101) 
The geldanamycin crystals from the Rosenmund Filter will be collected in drums and manually 





9.6 Tanespimycin Production Equipment 
9.6.1 Reactor (REACTOR/PFR-101) 
18 60L reactors will be used for the reaction of geldanamycin and allyl amine to produce 17-
AAG. The unit is fabricated by Biomashin, Inc and has a purchase cost of $24,000 per reactor, which 
amounts to $432,000 for all eighteen reactors. Biomashin’s pharmaceutical-grade reactor complies with 
the highest requirements in accordance with GMP and accompanied by validation documentation IQ, OQ, 
FAT, SAT inclusively. The reactor is made of stainless steel AISI 316L with surfaces in contact with the 
product Ra 1.6÷0.4um. The vessel is insulated with PU-foam covered with fully welded insulation 
cladding. The piece of equipment also includes safety armature and electro-sensors for the control of the 
process.  
 
9.6.2 Rotary Evaporator (ROT-EVAP/RVF-101) 
The rotary evaporator continuously removes remaining solvent to further purify 17-AAG. The 
unit is specifically named the QVF Rotary Evaporator has a working volume of 750L and is made of 
borosilicate 3.3 glass and PTFE, offering the following benefits: 1) proper observability of all process 2) 
total chemical resistance against nearly all mediums 3) careful evaporation. In addition, the QVC Rotary 
Evaporator features robust driving of the rotary flask by a PTFE-lined steel sleeve shaft. This unit is 
fabricated by De Dietrich Process Systems, Inc and has a purchase cost of $500,000. 
 
9.6.3 Storage Tank (100L) (STORAGE4/V-102) 
The 100L jacketed storage tank will store the product from the Rotary Evaporator (ROT-
EVAP/RVF-101) to aid the switch from continuous to batch prior to final isolation through Rosenmund 
drying. The tank is made of electro-polished 316L stainless steel  and is equipment with an agitator with 
hydrofoil impellers and a dimple style jacket. The tank is fabricated by Sharpsville Container and has a 




9.6.4 Rosenmund Filter (FLTR-DRY/GBX-101) 
This Rosenmund Filter Dryer used to recrystallize the geldanamycin final product. Rosenmund 
filters demonstrate high efficiency in washing and isolate pharmaceuticals. A few upgraded features of 
this system include side discharge including a side discharge valve for pressure-tight closure after each 
product discharge to insure no contamination. In addition, this vessel contains a three-blade agitator for 
efficient agitation and discharge. The total discharge system with the gas knife allows for product 
discharge without manual intervention, therefore increasing efficiency and reliability. The equipment also 
allows for efficient CIP/WIP and SIP cleaning and the application of specialized spray systems and 
sterilization methods as a method of validation of the vessel preparation process. This specific vessel has 
a filtration area of 5.6 sq ft and a 32” diameter, suitable for about 250L of material. The unit is fabricated 
by De Dietrich and has a purchase cost of $500,000.  
 
9.7 Additional Equipment 
9.7.1 Biosafety Cabinet 
Biosafety cabinets are required to provide a sterile environment to prepare ampule and inoculate 
the primary seed medium. Five biosafety cabinets will be needed in order to prepare ampule at a 
concentration of 10mg/mL. 104 2L flasks containing 1L primary seed medium will then be inoculated 
with 0.3 of this ampule. These biosafety cabinets are standard issue manufactured by Thermo 
Scientific
TM
. These cabinets can be assumed to be preexisting within the BMS facility and thus incur no 
additional cost. 
9.7.2 Cell Bank 
The bacteria will initially be purchased from ATCC for a one-time cost of $354. Cells will then 
be grown to a final cell density of 1x10
8
 cells/mL and then placed in 2 ml vials. These vials will be placed 
stored in a liquid nitrogen cryogenic sample storage vessel in order to create a cell bank. This freezer can 
be obtained from LabRepCo for $2,070. 
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9.7.3 Air Generator (HVAC Equipment) 
Purified air will be the source of oxygen throughout the process and will be provided by an 
HVAC system. The system will supply clean air to fermenters, clean rooms, and other process equipment 
with oxygen requirements. The air generator can be assumed to be preexisting within the BMS facility 
and thus incur no additional cost. 
9.7.4 Clean Steam Generator 
The clean steam generator is used to produce steam from WFI for SIP procedures. The clean 
steam generator can be assumed to be preexisting within the BMS facility therefore the cost of this system 
is just its utilities, which are accounted for in annual expenses. 
9.7.5 CIP Skids 
Clean-In-Place (CIP) is a technique used to clean equipment. A CIP skid is portable and contains 
the necessary equipment and cleaning solution in order for proper cleaning. In order to clean all the unit 
operations and storage tanks, fifteen CIP skids will be needed for this process. These skids can be 
assumed to be preexisting within the BMS facility and thus incur no additional cost. 
9.7.6 Filter Integrity Tester 
Disposable filters are used throughout this process; however, due to quality standards, they must 
be tested before each use to ensure they are not clogged, torn, or unusable. This testing will also prevent 
loss of product. This tester can be obtained from Millipore, although it can be assumed to be preexisting 
within the BMS facility and thus incur no additional cost. 
9.7.7 WFI Still 
A WFI still is used to purify water for use with cell culture. WFI water is used to both ensure the 
sterility of the product and to prevent and eliminate cross-contamination issues. The still can be obtained 
by the Paul Mueller Co. although the still can be assumed to be preexisting within the BMS facility and 
thus incur no additional cost. 
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9.7.8 Biowaste and Neutralization Tanks 
Two different types of tanks will be used to collect the waste generated by the process. If waste 
contains live culture it must be sent to a biowaste tank. All other waste, with the exception of that 
containing methylene chloride, is sent to neutralization tanks. The only bioactive waste in this process is 
the biomass disposed of after the rotary vacuum filtration. The biomass will be mixed with water in a 
biowaste tank 
        All waste containing bioactive matter must be treated properly before disposal. The biomass that 
is removed after rotary vacuum filtration contains live bacterial culture and is therefore transported to the 
biowaste tank where it is mixed with water to create a liquid that can be pumped to the biowaste 
inactivation system. This tank must be 1,000L to sufficiently hold the approximately 60kg of biomass 
produced per batch and necessary water for mixing. This tank can be bought from Sharpsville Container 
for $125,000. 
        All other waste, excluding that containing methylene chloride, is pumped directly to 
neutralization tanks. 8,150L of waste is produced from the cellulose-based filtration and an additional 
920L from the reaction process. A 3,000 gallon (11,355L) and 275 gallon (1040.9L) neutralization tanks 
can be purchased from Zurn for $90,000 and $18,000 respectively. 
9.7.9 Biowaste Inactivation System 
        This system kills any live mass remaining in the biowaste tank. This system includes the CIP and 
SIP washes. The system heats the waste to 80C for one minute to inactivate living cell cultures. This 
system can be assumed to be preexisting within the BMS facility and thus incur no additional cost. 
9.7.10 Waste Neutralization System 
        The system operates by adjusting the waste to a pH to 7.0. This allows the waste to be sent to the 




9.7.11 Methylene Chloride Drumming 
        Methylene chloride is a health hazard and therefore must be removed by a specialty waste 
company. The waste streams from the extraction, distillation, and crystallization/drying processes all 
contain methylene chloride. This waste can be sent to fill 55 gallon drums. Clean Harbors a specialty 
waste disposal company can then safely dispose of these drums for $290 per drum. There is an additional 
$30 transport cost per drum and a diesel surcharge price of 11.5% of the total invoice. Empty drums can 
also be delivered by Clean Harbors for $30 a drum. A total of 34 drums are filled for each batch. 
9.7.12 Quality Control Lab 
        A quality control lab will be needed to test the all factors involved in production. Samples will be 
taken throughout the process in order to test for a specific set of quality assurance criteria. This lab can be 
assumed to be preexisting within the BMS facility and thus incur no additional cost. 
9.7.13 Portable Pump on Cart 
        In preparation for pump malfunction, 7 extra replacement pumps will be stored on portable carts. 
 These pumps will be that same 825 Peristaltic pumps used in the process costing $13,000 per pump and 
can be acquired from Watson Marlow. 
9.7.14 Final Packaging 
        The final product from this process will not be ready for direct administration, for it is not 
separated in the proper dosing increments nor placed in final packaging. The tanespimycin must be 
packaged and shipped to doctors or hospitals where it will be administered to patients intravenously. 
BMS has an internal department that can finalize the packaging requirements for this drug. An estimated 
$10 will be spent to package and ship each treatment of tanespimycin yielding an additional $1.1 million 
expense for this process. The packaging must be non-reactive, clean, and sanitized, and records must be 
kept for each shipment of product. Packaging labels must also include special transport and storage 





10.0 Specification Sheets  
 





130L Tank used to store and mix the primary seed media prior to being pumped 
through a sterile filter and used to seed the ampule in 2 L flasks.  
Vendor: Sharpsville Container 
Operation: Batch   

















316 L Stainless Steel  
Electro-polished 
Agitator with Hydrofoil 
Impellers 











1 bar  
 
 
Purchase Cost $19,765 
 
 










3250L Tank used to store and mix the primary seed media prior to being 
pumped through a sterile filter and into the secondary seed ferment or.  
Vendor: Sharpsville Container 
Operation: Batch   



















316 L Stainless Steel  
Electro-polished 
Agitator with Hydrofoil 
Impellers 















Purchase Cost $51,995  










81,150L Tank used to store and mix the Fermentation media prior to being 
pumped through a sterile filter and into the 50,000 L Ferment or.  
Vendor: Sharpsville Container 
Operation: Batch   





Cobalt Chloride Dihydrate 
























316 L Stainless Steel  
Electro-polished 
Agitator with Hydrofoil 
Impellers 











1 bar  
 
Purchase Cost $302,765 
 
 





2 L Erlenmeyer Flasks (104)  




DURAN Erlenmeyer flask with DIN threads and closed with membrane cap to 
allow for gas exchange. Flasks will be used for initial bacterial seeding and placed 
on a rotary shaker in an incubator at 37℃.  
Vendor: DURAN Group   


































Purchase Cost $4,160 (104 flasks)  





1750L Secondary Seed Fermenter (2) 




1750L Secondary Seed Fermenter. Charged with filtered secondary seed media 
and cell solution from the 2L flasks 
 
Vendor: ABEC   
Operation: Batch   
Materials Handled: Input 
Primary Seed with cells 































Purchase Cost $925,848.50 each 
$1,851,697 for 2 fermenters 
(Includes jacketed tank with controls, 
agitators, filters, TCM)  





50,000L Fermenter (2) 




50,000L Fermenter.   
Vendor: ABEC   
Operation: Batch   
Materials Handled: Input 
Secondary Seed  





























Purchase Cost $8,461,649.5 each 
$16,923,299 for 2 
fermenters 
(Includes jacketed tank with controls, agitators, 
filters, TCM)  









Sterilization filters 0.2um to remove bacteria and other impurities from media prior to 
feeding the flasks and fermenters. A onetime purchase of the housing unit must be 
made and then the filter capsule membranes are disposable and refilled for every use.  
Vendor: Sartorius Stedim Biotech 





Max. Differential Pressure: 
Membrane Unit Sterilization: 
Membrane Sterilization: 
















Purchase Cost $2,000 
 
$700 
Filter Housing (one-time 
purchase) 
Filter Membrane, one-
time use (included in 
materials price) 










50,000L cooled surge tank to store output of 50,000L fermenter before downstream 
processing of geldanamycin. Contents of storage tank cooled to 5℃ with cooling 
water running through the tank jacket.  
Vendor: Sharpsville Container 
















316 L Stainless Steel  
Electro-polished 
Flat Top and Sloped Bottom 






Temp: 5℃ (cooling) 
 
Purchase Cost $501,431 Jacketed with TCM and spray ball 










Pump to transfer fluid. High-flow hygienic pumps that are designed for low-shear 
sanitary pumping. They are ideal for viscous or shear sensitive products. 
Vendor: Watson-Marlow   







825 Peristaltic Pump  
304 Stainless Steel  
33.3 L/min  
3.5 bar  













Purchase Cost $13,000  
$104,000 total 
per pump 
(8 upstream pumps) 
 










The rotary vacuum filter will be fed by the surge tank (STORAGE`1/V-101) in 
order to separate out the biomass from the fermentation broth.  
Vendor: Komline-Sanderson 
Operation: Continuous   

















Electro-polished stainless steel 










Purchase Cost $150,000  











50,000L cooled storage tank to store output of rotary vacuum filter before further 
downstream processing of geldanamycin. Contents of storage tank cooled to 5℃ 
with cooling water running through the tank jacket.  
Vendor: Sharpsville Container 

















316 L Stainless Steel  
Electro-polished 
Flat Top and Sloped Bottom 





Temp: 5℃ (cooled) 
 
Purchase Cost $501,431 Jacketed with TCM and spray ball 









Description and Function: Cellulose-Based Filter for clarification 
Vendor: Ertel Alsop 
Operation: Batch   
Materials Handled: Input 
Fermentation Media 
Geldanamycin 








Characteristics: Sterilization: SIP/CIP  
Purchase Cost $500,000  










8500L cooled storage tank to store output of cellulose based filtration before further 
downstream processing of geldanamycin. Contents of storage tank cooled to 5℃ 
with cooling water running through the tank jacket.  
Vendor: Sharpsville Container 




















316 L Stainless Steel  
Electro-polished 
Flat Top and Sloped Bottom 








Purchase Cost $100,000 Jacketed with TCM and spray 
ball 










Liquid extraction with methylene chloride to remove excess media from 
cellulose-based filtration. 
Vendor: Sulzer Chemtech 
Operation: Continuous   






























Purchase Cost $500,000  









The product will be further concentrated by heating off the Methylene 
chloride. 
Vendor: Armfield Inc. 
Operation: Continuous   
























Purchase Cost $500,000  









The product will be crystallized in order to be stored and reacted to form the 
tanespimycin product further downstream 
Vendor: Conair Group 
Operation: Continuous   





















Operating Conditions Temp: 35-40℃ 
 
 










65L cooled storage tank to store crystal slurry from the crystallizer before further 
downstream processing of geldanamycin. Contents of storage tank cooled to 5℃ 
with cooling water running through the tank jacket.  
Vendor: Sharpsville Container 















316 L Stainless Steel  
Electro-polished 
Flat Top and Sloped Bottom 







Purchase Cost $15,000 Jacketed with TCM and spray ball 










The Rosenmund filter is used to dry 22kg of geldanamycin. The use of the 
Rosenmund filter increases efficiency and allows for easy and sterile discharge of 
the product with no manual intervention.  
Vendor: De Dietrich Process Systems 





























Purchase Cost $500,000  
















Pumps to transfer fluid. High-flow hygienic pumps that are designed for low-shear 
sanitary pumping. They are ideal for viscous or shear sensitive products. 
Vendor: Watson-Marlow   







825 Peristaltic Pump  
304 Stainless Steel  
33.3 L/min  
3.5 bar  













Purchase Cost $13,000  
$182,000 total 
per pump 
(14 downstream pumps) 
 





60L Reactor (x18)  
(REACTOR/PFR-101) 
 
Description and Function: Reaction of geldanamycin and allylamine to produce tanespimycin. 
Vendor: Biomashin 
Operation: Batch   
Materials Handled: 
(per each reactor) 
Input (per reactor) 
Geldanamycin 
THF 

















   
Purchase Cost $100,000 
$1,800,000 
per reactor 
for 18 reactors 








Description and Function:  
Vendor: De Dietrich Process Systems 
Operation: Continuous   


















Corrosion-resistant borosilicate 3.3 glass 
750 L 
SIP-CIP 
Purchase Cost $500,000  










100L cooled storage tank to store product from Rotary Evaporator before further 
downstream processing of 17-AAG. Contents of storage tank cooled to 5℃ with 
cooling water running through the tank jacket.  
Vendor: Sharpsville Container 
Operation: Batch   




















316 L Stainless Steel  
Electro-polished 
Flat Top and Sloped 
Bottom 







Purchase Cost $12,000 Jacketed with TCM 
and spray ball 










The Rosenmund filter is used to dry 19.717 kg of Tanespimycin. The use of the 
Rosenmund filter increases efficiency and allows for easy and sterile discharge of 
the product with no manual intervention.  
Vendor: De Dietrich Process Systems 




























Purchase Cost $500,000  





Pumps for 17-AAG Process 




Pumps to transfer fluid. High-flow hygienic pumps that are designed for low-shear 
sanitary pumping. They are ideal for viscous or shear sensitive products. 
Vendor: Watson-Marlow   







825 Peristaltic Pump  
304 Stainless Steel  
33.3 L/min  
3.5 bar  



























Spare pumps in case there is a malfunction. Pumps to transfer fluid. High-flow 
hygienic pumps that are designed for low-shear sanitary pumping. They are ideal for 
viscous or shear sensitive products. 
Vendor: Watson-Marlow   







825 Peristaltic Pump  
304 Stainless Steel  
33.3 L/min  
3.5 bar  













Purchase Cost $13,000  
$91,000 total 
per pump 
7 spare pumps 
 








Description and Function:  
Vendor:  
Operation: Batch   












Operating Conditions Temp:  
Purchase Cost $125,000  










11,355L Neutralization tank used to store waste exiting the cellulose-based filtration 
unit in the geldanamycin production process. All contents of this tank will be 
pumped to a neutralization system before being disposed of through the sewage.  
Vendor: Zurn 




Fermentation Media  
Geldanamycin  
Total 



















Purchase Cost $90,000  










1040.9L Neutralization tank used to store waste from the rotary evaporation and 
filter/drying units in tanespimycin production process. All contents of this tank will 
be pumped to a neutralization system before being disposed of through the sewage.  
Vendor: Zurn 






























Purchase Cost $18,000  







11.0 Equipment Cost Summary 
This chapter contains a table with each equipment unit in the process flow diagram (Chapter 
6) including the unit number, purchase cost of 1 unit, the number of units, as well as the vendor. 
Price estimations were obtained from the individual vendors unless otherwise noted. Vendor sheets 
as well as individual quotes are included in the Appendix. Note that additional equipment assumed to 
be part of the existing BMS facility are not included here since they are not included in the cost 
analysis, but are included in Chapter 9, Equipment list and Unit Descriptions.  
11.1 Geldanamycin Upstream Process Equipment 





Primary Seed Media Prep 
Tank (130L) 
1ST-SEED/V-102 $19,765 1 Sharpsville 
Container 
Secondary Seed Media 
Prep Tank (3250L) 
2ND-TRG/V-103 $51,995 1 Sharpsville 
Container 
Fermentation Media Prep 
Tank (81,150L) 
FERM-STR/V-104 $302,765 1 Sharpsville 
Container 
2L Erlenmeyer Flasks 
(104) 
52EF-1 SFR-104 &  
52EF-2 SFR-101 
$40 104 DURAN 




$925,849 2 ABEC (quote: 
consultants) 
50000L Fermenter  FERM1-FR-102 & 
FERM2/FR-101 
$8,461,649 2 ABEC (Quote: 
consultants) 
Media Filters (6) S-1, S-2, S-8, S-6, S-12, S-10 $2,000 6 Sartorious Stedim 
Biotech 
Upstream Pumps (8) S-8, S-6, S-12, S-10, S-14, S-
13, S-11, S-9 
$13,000 8 Watson-Marlow 
50000L Surge Tank STORAGE`1/V-101 $501,431 1 Sharpsville 
Container 
 
11.2 Downstream Process Equipment 
Equipment 
Description 
Unit number Purchase 














CLL-FLT/CL-101 $500,000 1 Ertel Alsop 
Storage Tank  XTRSTRG1/V-105 $100,000 1 Sharpsville 
Container 
Extraction Unit (EXTRCTON/V-103) $500,000 1 Sulzer Chemtech 
Distillation Unit DISTILL/V-104 $500,000 1 Armfield, Inc.  
Crystallization 
Unit 
CRYST/CR-101 $500,000 1 Conair Group 
Storage Tank 
(65L) 
STORAGE3/V-101 $15,000 1 Sharpsville 
Container 




S-15, -16, -17, -18, -20, -21, -22, -
23, -24, -25, -26, -27, -28, -29 
$13000 14 Watson-Marlow 
Storage Tubs DRUM/V-101 $20 1 Sharpsville 
Container 
 
11.3 Tanespimycin Reaction Process Equipment 
Equipment 
Description 





60L Reactor (18) REACTOR/PFR-101 $100,000 18 ABEC 
Rotary Evaporator ROT-EVAP/RVF-101 $500,000 1 De Dietrich Process 
Systems 
Storage Tank STORAGE4/V-102 $12,000 1 Sharpsville Container 
Rosenmund Filter FLTR-DRY/GVX-101 $500,000 1 De Dietrich Process 
Systems 
Pumps (14) S-32 (x10), S-33, S-34, S-
35, S-36 

















Spare Pumps (7) n/a $13,000 7 Watson-Marlow 
Biowaste Tank BIOINACT/LD-101 $125,000 1 Sharpsville 
Container 
Neutralization Tank 1 NEUTRLZ1/LD-
102 
$90,000 1 Zurn 
Neutralization Tank 2 NEUTRLZ2/LD-
101 





12.0 Fixed Capital Investment 
 
This chapter will describe the fixed capital investment; including the equipment bare module 
costs and the total permanent investment, which accounts for the cost of site preparations, service 
facilities, contingencies and contractor fees, and plant start-up. To perform the economic analysis of the 
outlined production of tanespimycin, the Profitability Analysis-4.0.xls spreadsheet by Brian K. Downey 
(2008) was used. While the inputs are explained in this chapter, the results from the profitability analysis 
as well as an input summary are included in Chapter 15. 
 
12.1 Equipment Costs 
 
12.1.1 Unit Purchase Costs and Bare Module Costs 
 
Purchases costs for each unit of equipment were determined either from the respective vendor or 
industrial consultants (More information in Chapter 11) and bare module costs were calculated by 
multiplying by specific bare module factors, as explained in section 12.1.2. The majority of the equipment 
bare module costs is from the geldanamycin upstream process equipment, which amounts to 
$116,673,310. The total geldanamycin downstream process equipment bare module cost is $13,604,500, 
while the Total 17-AAG reaction process Bare Module Costs is $12,287,120, and the Total Additional 
Equipment Bare Module Costs is $1,048,230. The bare module costs by unit are presented in Tables 12.1, 
12.2, 12.3, and 12.4. The total bare module cost, $143,613,160, is used to determine the cost of site 
preparations, service facilities, contingencies and contractor fees, and plant start-up. 
Table 12.1 Geldanamycin Upstream Process Equipment 
Equipment 
Description 















1ST-SEED/V-102 $19,765 1 4.16 $82,222 Sharpsville 
Container 













52EF-1 SFR-104 &  
52EF-2 SFR-101 




















S-1, S-2, S-8, S-6, S-
12, S-10 





S-8, S-6, S-12, S-10, 
S-14, S-13, S-11, S-9 




STORAGE`1/V-101 $501,431 1 4.16 $2,085,953 Sharpsville 
Container 
Total Geldanamycin Upstream Process Equipment Bare Module Costs: $116,673,310 
 
Table 12.2 Geldanamycin Downstream Process Equipment 
Equipment 
Description 























CLL-FLT/CL-101 $500,000 1 4.16 $2,080,000 Ertel Alsop 
Storage Tank  XTRSTRG1/V-105 $100,000 1 3.21 $321,000 Sharpsville 
Container 
Extraction Unit (EXTRCTON/V-103) $500,000 1 4.16 $2,080,000 Sulzer 
Chemtech 














ROSENMUND/GBX-101 $500,000 1 4.16 
 





S-15, -16, -17, -18, -
20, -21, -22, -23, -24, -
25, -26, -27, -28, -29 
$13000 14 3.3 $600,600 Watson-
Marlow 
Storage Tubs DRUM/V-101 $20 1 3.3 $1,156 Sharpsville 
Container 
Total Geldanamycin Downstream Process Equipment Bare Module Costs: $13,604,500 
 
Table 12.3 Tanespimycin Reaction Process 
Equipment 
Description 





















$500,000 1 4.16 $2,080,000 De Dietrich 
Process 
Systems 






$500,000 1 4.16 $2,080,000 De Dietrich 
Process 
Systems 
Pumps (14) S-32 (x10), S-33, S-
34, S-35, S-36 




Total Tanespimycin Reaction Process Equipment Bare Module Costs: $12,287,120 
 
Table 12.4 Additional Equipment 
Equipment 
Description 
Unit number Purchase 





























$18,000 1 3.21 $57,780 Zurn 
Total Additional Equipment Bare Module Costs: $1,048,230 
 
12.1.2 Bare Module Factor Assumptions 
 
Bare module factors were chosen as per guidance from the faculty advisors and industrial 
consultants. Table 12.3.1 indicates the assumed bar module factors for each type of equipment. The 
default in the profitability spreadsheet calculates a bare module factor of 3.21. This calculation is shown 
in Table 12.3.2. This value was used for the general storage tanks and neutralization/biowaste tanks. A 
bare module factor of 6 was used for the fermenters, as the consultants noted that pharmaceutical grade 
products that are involved in cell expansion and growth require additional care for installation and 
materials. The other values were selected based on Chapter 22 of Product and Process Design Principles 
(Seider, et al.).  
Table 12.5 Assumed Bare Module Factors for Equipment Units 
Equipment Assumed Bare 
Module Factor 
Media Prep Tanks 4.14 
Erlenmeyer Flasks  2 
Fermenters 6 
Surge Tank & Storage Tanks & Waste Tanks 3.21 
Pumps 3.3 
Sterile Filters 2.32 









Table 12.6 Bare Module Factor Calculator from profitability Spreadsheet 
Bare Module Factor Calculator: 
    Use the tool below to calculate a particular bare module factor, then input in the required column to the 
left: 
(Note, if no bare module factor is entered, the default of 3.21 will be used) 
 
       
       
  
Cost of Installation Materials: 71% of Equipment Purchase Cost 
  
Cost of Installation Labor: 54% of Equipment Purchase Cost 
  
Cost for Freight, Insurances, and Taxes: 9% of Equipment Purchase Cost 
  
Cost of Construction Overhead: 57% of Equipment Purchase Cost 
    Cost of Contractor Engineering Expenses: 30% of Equipment Purchase Cost 
       
  
Total Derived Bare Module Factor: 3.21 of Equipment Purchase Cost 
        
12.2 Permanent Investment Costs  
This section includes permanent investment costs related to Site Preparation, Facilities, 
Contingencies and Contractor Fees. 
As indicated in Table 12.7, the Total Permanent Investment inputs from the profitability 
spreadsheet, the cost of site preparations is set to 1.00%, of the total bare module costs, as the equipment 
will all be installed in an existing pharmaceutical manufacturing facility. In addition, the cost of service 
facilities will be 5.0% of the Total Bare Module cost, the cost of contingencies and contractor fees will be 
10.0% of the Total Depreciable Capital. Since this manufacturing facility will be within an existing 
manufacturing facility, there are no costs associated with the land or plant start-up. An overall view of the 








Table 12.7 Total Permanent Investment Table 
Total 
Permanent 
Investment               
          
    
% of Total Permanent Investment 
   
  
Year: 2021 100% 
 
(default is first year of Construction, otherwise over-ride this year) 
   
2022 0% 
     
   
2023 0% 
     
   
2024 0% 
     
          
     
Cost of Site Preparations: 1.00% of Total Bare Module Costs 
     
Cost of Service Facilities: 5.00% of Total Bare Module Costs 
     
Allocated Costs for utility plants and 
related facilities: $0  
   
     
Cost of Contingencies and Contractor 
Fees: 10.00% of Direct Permanent Investment 
 
     
Cost of Land: 0.00% of Total Depreciable Capital 
 
     
Cost of Royalties: $0  
   
     
Cost of Plant Start-Up: 0.00% of Total Depreciable Capital 
 
          
12.3 The cost of Clinical Trial 









13.0 Operating Cost- Cost of Manufacture: Input Summary 
 
This chapter will describe the various operating costs involved in the economic analysis of the 
outlined production of tanespimycin. To perform the economic analysis of the outlined production of 
tanespimycin, the Profitability Analysis-4.0.xls spreadsheet by Brian K. Downey (2008) was used. While 
the inputs are explained in this chapter, the results from the profitability analysis as well as an input 
summary are included in Chapter 15. 
13.1 Raw Materials 
The purchase cost of all raw materials was determined by contact with vendors and consultants 
(More information in Chapter 5). The cost of raw materials per kg of Tanespimycin is about $43,698. 
Table 13.1 Raw Material Costs per kg of Tanespimycin. 
Raw Materials               
 
 
Raw Material: Unit: Required Ratio: 
 
Cost of Raw Material: 




Media amount per 1kg 1 amount per 1kg per kg of Tanespimycin  $199.31 per amount per 1kg 
 3 Fermentation Media amount per 1kg 1 amount per 1kg per kg of Tanespimycin  $4,840.59 per amount per 1kg 
 4 WFI amount per 1kg 1 amount per 1kg per kg of Tanespimycin  $1.45 per amount per 1kg 
 5 Filter Aid amount per 1kg 1 amount per 1kg per kg of Tanespimycin  $1,604.59 per amount per 1kg 
 6 Methylene Chloride amount per 1kg 1 amount per 1kg per kg of Tanespimycin $4,352.78 per amount per 1kg 
 7 Isooctane amount per 1kg 1 amount per 1kg per kg of Tanespimycin $29,587.73 per amount per 1kg 
 8 Allylamine amount per 1kg 1 amount per 1kg per kg of Tanespimycin  $437.14 per amount per 1kg 
 9 THF amount per 1kg 1 amount per 1kg per kg of Tanespimycin  $2,658.57 per amount per 1kg 
 
 





    





13.2 Utilities  
The utility requirements can be found in the Utility summary from the profitability 
spreadsheet. Utilities demand about $929.346 per kg of 17-AAG produced. This utility calculation 
includes high pressure steam, process water, cooling water, electricity, propylene glycol for cooling, 
as well as the estimated cost of disposing of specific wastes throughout the process.  
Table 13.2: Utility Costs per kg of Tanespimycin 
Utilities 














Steam lb 0 lb per kg of Tanespimycin  $0.000E+00 per lb 
 3 Process Water gal 1110 gal per kg of Tanespimycin  $2.055E-03 per gal 
 4 Cooling Water lb 127 lb per kg of Tanespimycin  $2.250E-03 per lb 
 5 Electricity kWh 2.22E+03 kWh per kg of Tanespimycin  $0.080 per kWh 
 6 Wastes total waste 1 total waste per kg of Tanespimycin $657.000 per total waste 
 
7 Propylene Glycol total amount 1 
total amount per kg of 
Tanespimycin $85.070 per total amount 
 8 
       9 
       10               
 
Total Weighted Average: 
  
$929.347 per kg of Tanespimycin (17-AAG) 
  
13.3 Fixed Costs 
For the upstream and downstream geldanamycin process, a total of 13 employees per shift are 
required: 1 employee for fifty-two 2 L fermenters of both trains who will have a break every 5 days to 
monitor downstream, 1 employee for secondary fermenter of both trains who will have a break every 5 
days to monitor downstream, 1 employee on each of the 50,000 L bioreactors at all times, and 1 employee 
at each of the downstream. For the tanespimycin production process, 11 employees per shift are required: 
9 total employees for the 18 reactors, 1 employee for downstream and 1 employee for maintenance. 
Assuming four 8-hour shifts/day, full time salary is required for 96 employees. Each employee will be 
paid $47,000/year (Bureau of Labor Statistics, 2014), for a total employee cost of $4,512,000/year.  
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Maintenance and quality control personnel must also be accounted for in order to manage all CIP, 
SIP, and waste management procedures. For the facilities, regulatory personnel are also needed. Lastly, 
management positions will be needed to manage the engineering, financial, and human resources related 
issues.  
Since this process is being developed in an existing BMS facility, technical assistance to 
manufacturing and a control laboratory are not taken into account in this profitability analysis. Many of 
the defaults remain the same in the spreadsheet, as indicated in the fixed cost summary, but property taxes 
and insurance were set to zero to the existence of the facility. 
Table 13.3 Fixed Costs, Profitability Spreadsheet 
Fixed 




       
   
Operators per Shift: 24 
(assumin
g 4 shifts) 
  
   
Direct Wages and Benefits: $40  /operator hour 
   
   
Direct Salaries and Benefits: 15% of Direct Wages and Benefits 
  
   
Operating Supplies and 
Services: 6% of Direct Wages and Benefits 
  
   
Technical Assistance to 
Manufacturing: $0.00 
per year, for each Operator per 
Shift 
  
   
Control Laboratory: $0.00 
per year, for each Operator per 
Shift 
  
          
 
Maintenance 
       
   
Wages and Benefits: 4.50% of Total Depreciable Capital 
  
   
Salaries and Benefits: 25.00% 
of Maintenance Wages and 
Benefits 
  
   
Materials and Services: 
100.00
% 
of Maintenance Wages and 
Benefits 
  
   
Maintenance Overhead: 5.00% 
of Maintenance Wages and 
Benefits 
  
          
 
Operating Overhead 
       
          
   
General Plant Overhead: 7.10% of Maintenance and Operations Wages and Benefits 
   
Mechanical Department 
Services: 2.40% of Maintenance and Operations Wages and Benefits 
   
Employee Relations Department 5.90% of Maintenance and Operations Wages and Benefits 
   
Business Services 7.40% of Maintenance and Operations Wages and Benefits 
          




Property Taxes and Insurance 
      
   
Property Taxes and Insurance: 0.00% of Total Depreciable Capital 
  
          
 
Straight Line Depreciation 
      
 
Direct 
Plant: 8.00% of Total Depreciable Capital, less 1.18 times the Allocated Costs  
       




Plant: 6.00% of 1.18 
times the Allocated Costs for Utility Plants and 
Related Facilities 
 
Other Annual Expenses 
      
   
Rental Fees (Office and 
Laboratory Space): $0 
     
   
Licensing Fees: $0 
     
   
Miscellaneous: $0 
     
          
 
Depletion Allowance 
       
   
Annual Depletion Allowance: $0 
                       
  
Moreover, the spreadsheet allows for the specification of the percentages of product sales charged 
for selling/transfer expenses, direct research, allocated research, administrative expenses, and 
management incentives compensation. It was assumed that about 1.5% of sales would be spent on 
selling/transfer expenses with 0.5% of sales allocated to direct research and 4% of sales to allocated 
research. It was also assumed that the administrative expenses and management incentive compensation 
were both about 1.00% of sales.  
The working capital is defined as the sum of the cash reserves, inventory, and accounts 
receivable, minus the accounts payable. The cash reserves is set to include 30 days of raw materials, 
utilities operation, and maintenance.4 days of product inventory and 2 days of raw material inventory has 
also been assumed. 
Table 13.4 Other Variable Costs and Working Capital, Profitability Spreadsheet 
Other Variable Costs             
 
General Expenses 
      
         
   
Selling / Transfer Expenses: 1.50% of Sales 
   
   
Direct Research: 0.50% of Sales 
   
   
Allocated Research: 4.00% of Sales 
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Administrative Expense: 1.00% of Sales 
   
   
Management Incentive 
Compensation: 1.00% of Sales 
   
         
         Working Capital               






























          
 
14.0 Other Important Considerations 
In the designing of an economical production process for tanespimycin, efforts were made to 
address environmental concerns and follow good manufacturing practices (GMP) and FDA regulations. 
Additionally, an IP expert was consulted to prevent intellectual property infringement due to the pre-
existing patents.    
  
14.1 Environmental Concerns 
        Environmental concerns for the process are governed by the biological and non-biological wastes 
produced. The biological waste, including the biomass removed from the rotary vacuum filtration, is 
considered class II biohazard and must be treated by a biowaste inactivation package. The package heats 
the contents to 80C for one minute to inactivate any living cells. After inactivation, the biomass which 
was previously mixed with water in order to allow it to be pumped is transferred and combined with the 
non-biological waste in the waste neutralization tanks. These tanks neutralize all contained contents to a 
pH of 7 and discharges neutralized waste to the sewage system. 
        Due to their adverse health and environmental effects, special care must be taken when disposing 
of methylene chloride and isooctane. In order to eliminate potential human contact with these chemicals, 
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methylene chloride and isooctane are directly pumped into 55 gallon drums, followed by removal by 
Clean Harbors - the contracted waste management company which will disposes the contents according to 
EPA regulated protocols. 
        No disposable equipment is used in this process; instead large equipment is cleaned using CIP 
measures, and small equipment is autoclaved. Additionally, limited landfill waste helps reduce the carbon 
footprint of this plant. 
14.2 Good Manufacturing Practices 
        Current good manufacturing practices (cGMP) are a set of principles and procedures that must be 
followed by manufactures for therapeutic goods in order to ensure that the final product has the required 
quality. 
First the plant must be reviewed by a quality management team to approve that the plant complies 
with regulations. These standards will be met by accounting for the needs such as WFI, CIP, SIP, 
adequate ventilation, and quality materials. Additionally, there must always be an adequate number of 
workers and personnel who are versed on the hygiene standards and trained with sufficient experience at 
the plant to perform their assigned tasks. 
        Final quality assurance testing of the product is not sufficient to ensure quality consistent with 
FDA regulations. Instead sampling and testing of in-process materials and drug products must be 
completed at different checkpoints throughout the process to insure batch uniformity and integrity of drug 
products.  Checkpoints will be placed at the commencement or completion of all significant phases or 
after storage for long periods. Samples will be taken from transfer streams and tested for identity, 
strength, quality, and purity as appropriate. In addition, all raw materials will be checked by quality 
control personnel before moving to the production floor. 
Storage tanks are put in place after each process in the upstream and downstream production. 
These tanks can be utilized in the case that the output of a process produces a product that fails quality 
control testing resulting in rejected materials. Once the rejected materials are pumped into the tank, the 
contents will be disposed of according to FDA regulation and not further processed. These tanks will limit 
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the downtime between failed batches and further costs associated with processing an unsatisfactory 
product. 
A final quality check will be performed at the end of the process before transport to the internal 
BMS packaging branch. The packaging branch will also abide by cGMP. The packaging must be non-
reactive, clean, and sanitized. Detailed labeling practices must be followed such as all labels must include 
details of the contents, strength, and dose form. Shipments with obsolete, insufficient, or outdated labels 
shall be destroyed. 
        All relevant information regarding these procedures as well as detailed descriptions of each 
practice are found in the Code of Federal Regulation 21 Part 211 (21 CFR 211) available electronically 
through the FDA website. 
14.3 Intellectual Property/Patent Considerations 
        The production process for geldanamycin and tanespimycin presented in this report uses 
information and data from a 2003 geldanamycin production application patent and a 2009 tanespimycin 
production patent. To better understand the qualifications for infringement of the intellectual property 
protected by these patents, Dr. Brandt, a patent agent at Johnson and Johnson was consulted.  
This report’s process design for geldanamycin uses information from Upjohn Pharmaceuticals’ 
2003 patent application from Upjohn Pharmaceuticals. As a patent application is merely a pending 
request at the patent office, any aspects of the process described in the application are not protected by 
patent law, eliminating concerns of infringement.   
This report’s process design for tanespimycin uses a 2009 patent from Conforma. Upon 
consultation with Dr. Brandt, it became clear that the extreme specificity of the inventions described in 
the patent rendered infringement highly unlikely (unless an exact replica of the described process was 
pursued.) Thus, upon scale up modifications, equipment adjustments, and a shift from several batch to 
continuous processing steps, we are confident that the proposed design does not bear any infringement 




15.0 Profitability Analysis 
To determine the profitability of the outlined production of tanespimycin, the Profitability 
Analysis-4.0.xls spreadsheet by Brian K. Downey (2008) was used. However, because this costing 
estimation does not have the ability to account for the Phase III clinical trial cost of $2 billion, the most 
significant expense, additional calculation were conducted in order to account for this cost in year 2020 in 
the net present value (NPV) and internal rate of return (IRR). 
15.1.0 Profitability Analysis 
For the profitability analysis, it is assumed that the plant’s effective tax rate is 37%, and that the 
cost of capital for the plant will be 15%. The economic analysis shows that the process for the final case 
has a net present value (at 15% and a life of 14 years) of about $3.2 billion and an internal rate of return 
(IRR) of 33 percent. The NPV and IRR are greatly dependent upon the cost the Phase III clinical trial 
estimate, and selling price of tanespimycin. A sensitivity analysis is performed at the end of this chapter 
in order to illustrate their dependency of these costs and values. 
While the spreadsheet does not conveniently allow for integration of the Phase III trial cost into 
the spreadsheet, the IRR and NPV values were calculated independently and are included in section 
15.1.1. Table 15.1 summarizes the end of the year cash flows each year as well as the cumulative net 
present value calculated per year. Excel’s IRR function was used to determine the calculated 33 percent 
and included each year’s cash flow incorporating the negative $2 billion in year 2020 incurred due to the 




15.1.1 Profitability Measures 
Profitability Measures           
        The Internal Rate of Return (IRR) for this project is 
  
33.00% 
        The Net Present Value (NPV) of this project in 2020 is 
  
$3,172,265,206.53      
        
        ROI Analysis (Third Production Year) 
    




     
2,200,427,350  




       
(253,163,493) 




         
(14,686,597) 




       
(715,053,586) 




      
1,217,523,674  
   
 
Total Capital Investment 
         
387,535,769  





    
Table 15.1 End of year cash flows in each year and corresponding cumulative net present worth using a discount 
rate of 15%. 
Year Cash Flow (Billions) Cumulative NPV (Billions) 
2020 -2.00 -2.00 
2021 -0.29 -2.25 
2022 0.56 -1.82 
2023 0.88 -1.24 
2024 1.24 -0.53 
2025 1.23 0.08 
2026 1.23 0.62 
2027 1.23 1.08 
2028 1.23 1.48 
2029 1.23 1.83 
2030 1.23 2.13 
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2031 1.23 2.39 
2032 1.23 2.62 
2033 1.23 2.82 
2034 1.23 3.00 




15.1.2 Price of Tanespimycin 
As stated in the Market and Competitive Analysis, the cost of a full course of Herceptin 
treatment costs about $70,000 reported by Medical News Daily. Because tanespimycin will be used 
in conjunction with this treatment its price must be lower for it is not directly competing with 
Herceptin, but rather sharing the patient market. Also the patent on Herceptin expires in 2014 in 
Europe and in 2019 in the United States. Normally this would result in the production of a 
chemically identical generic version of the drug, which may be sold at a much lower price, for 
research and trial costs do not need to be recouped by generic manufacturers. However, Herceptin is 
a monoclonal antibody, which is a unique large-molecule drug. The manufacturing is complex and 
subject to lack of uniformity by nature (Mulcahy, 2013). Therefore, a chemically identical generic is 
impossible to produce, and instead, a biosimilar can be synthesized. This process is much more 
difficult and currently only combination therapies are been proposed rather than substitution 
therapies for Herceptin. Thus the patent expiration will not have the significant price dropping 
implications that usually occur in the pharmaceutical market. Additionally a conservative selling 
price is used because breast cancer is a popular field of research. With all the previously mentioned 
factors considered, a selling price of $20,000 per treatment will be utilized. Thus tanespimycin will 
cost approximately $2,137,000 per kilogram. 
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15.1.3 Plant Life 
The new facility is expected to have a life of about 14 years. While most of the capital 
investment could technically have a longer lifespan, the marketing life of the drug can assumed to be 
less. Fourteen years is used as a conservative estimation of the number of years of production, but it 
could be more. General patent protection lasts 20 years. With a conservative guess, that the patent 
protection begins before the clinical trial begins, and assuming a clinical trial of 5 years and then an 
additional year for FDA paperwork and final approval, it is estimated that there will be 14 years that 
the drug can be produced under patent protection before generics jump into the market. While this 
may be longer (due to method of treatment patents filed during clinical trials or shorter clinical 
trials), for the purposes of the economic calculations, it is assumed that the plant will operate for 14 
years with 2 additional years for design and construction. Since phase three clinical trials still need to 
be performed, the analysis is also based on the premise that installation of the equipment will begin 
in 2020, allowing for at least 5 years of the clinical trial to be underway before proceeding. In 
addition, it is important to note that the profitability analysis included here takes into account a 




15.1.4 Input and Cost Summaries 
Input and cost summaries generated from the profitability spreadsheet are included below. 
Assumptions are explained in Chapter 12 for fixed-capital investment, and chapter 13 for operating costs. 
The primary costs are capital investment and variable costs totaling $344 million and $233 million 
respectively, and fixed costs only total $31 million.  
General Information               
 
Process Title: 
The production of Tanespimycin: Final 
Case 
    
 
Product: Tanespimycin (17-AAG) 
     
 
Plant Site Location: Philadelphia 
      
 
Site Factor: 1.10 
      
 
Operating Hours per 
Year: 7919 
      
 
Operating Days Per 
Year: 330 
      
 
Operating Factor: 0.9040 
      
         
         Product Information               
This Process will Yield 
       
  
0 kg of Tanespimycin (17-AAG) per hour 
   
  
3 kg of Tanespimycin (17-AAG) per day 
   
  
1,084 kg of Tanespimycin (17-AAG) per year 
   
         
 
Price $2,136,752.14  /kg 
     
         Chronology               
  
Distribution of Production  Depreciation Product Price 
 Year Action Permanent Investment Capacity 5 year MACRS 
  2020 Design 
 
0.0% 
    2021 Construction 100% 0.0% 
    2022 Production 0% 47.5% 20.00% 
 
$2,136,752.14  
 2023 Production 0% 71.3% 32.00% 
 
$2,136,752.14  
 2024 Production 0% 95.0% 19.20% 
 
$2,136,752.14  



























































         
 
Variable Cost 
Summary             
 
Variable Costs at 100% Capacity: 
    
        
 
General Expenses 
     
        
  
Selling / Transfer Expenses: 
  






















Management Incentive Compensation: 
 
 $     
23,162,393  
 
        
 
Total General Expenses 
   
 $   
185,299,145  
 
        
 
Raw Materials $43,697.477811 per kg of Tanespimycin (17-AAG) $47,368,066  
 
        
 
Byproducts $0.000000 per kg of Tanespimycin (17-AAG) $0  
 




$929.347332 per kg of Tanespimycin (17-AAG) $1,007,413  
 
        
 
Total Variable Costs 
   
 $233,674,624  
 
         
Fixed Cost Summary             
        
        
 
Operations 
      
        
  
Direct Wages and Benefits 
  
 $       7,987,200  
 
  
Direct Salaries and Benefits 
  
 $       1,198,080  
 
  
Operating Supplies and 
  






Technical Assistance to Manufacturing 
 





 $                   -    
 




 $       9,664,512  
 
        
 
Maintenance 
     
  
Wages and Benefits 
  
 $       7,510,191  
 
  
Salaries and Benefits 
  
 $       1,877,548  
 
  
Materials and Services 
  





 $          375,510  
 




 $     17,273,440  
 
        
 
Operating Overhead 
     
        
  
General Plant Overhead: 
  

















 $       1,374,403  
 
        
  
Total Operating Overhead 
  
 $       4,234,648  
 
        
 
Property Taxes and Insurance 
    
        
  
Property Taxes and Insurance: 
  
 $                   -    
 
        
 
Other Annual Expenses 
     
        
  
Rental Fees (Office and Laboratory Space): 
 





   




   
 $                   -    
 
        
  
Total Other Annual Expenses 
  
 $                   -    
 
        
 
Total Fixed Costs 
   
 $     31,172,601  
 
         
Investment Summary             
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Total Bare Module Costs: 
      
 
Fabricated Equipment 
   




   




    




    




   




    
 $                   -    
  
 
Computers, Software, Etc. 
   
 $                   -    
  
         
 
Total Bare Module Costs: 
    
 $        143,133,057  
 
         Direct Permanent Investment 
      
         
 
Cost of Site Preparations: 
   
 $       1,431,331  
  
 
Cost of Service Facilities: 
   
 $       7,156,653  
  
 
Allocated Costs for utility plants and related facilities: 
 
 $                   -    
  
         
 
Direct Permanent Investment 
   
 $        151,721,040  
 
         
         Total Depreciable Capital 
      
         
 
Cost of Contingencies & Contractor Fees 
  
 $     15,172,104  
  
         
         
 
Total Depreciable Capital 
    
 $        166,893,144  
 
         Total Permanent Investment 
      
         
 
Cost of Land: 
   
 $                   -    
  
 
Cost of Royalties: 
   
 $                   -    
  
 
Cost of Plant Start-Up: 
   
 $                   -    
  
         
 
Total Permanent Investment - Unadjusted 
   








Total Permanent Investment 
   
 $        183,582,459  
 
          
Working 
Capital               
         
   





 $     90,428,521   $          45,214,261  




 $       1,256,343   $               628,171  




 $     (1,888,632)  $             (944,316) 
 $      
(944,316) 
Tanespimycin (17-AAG) Inventory 
 
 $     12,057,136   $            6,028,568  




 $          123,287   $                 61,643  





 $   101,976,655   $          50,988,328  
 $   
50,988,328  
        
  
Present Value at 15% 
 
 $    88,675,353   $         38,554,501  
$  
33,525,653  




    
 $        344,337,965  
 
          
 
Although these costs are all important to consider ensuring that this process is economical, the 
dominating cost is the $2 billion clinical trial cost in 2020. Due to its importance, a sensitivity analysis of 
the trial expense is presenting in the following section. 
15.2.0 Sensitivity Analysis 
A sensitivity analysis must be preformed for critical price parameters and values including the 
Phase III clinical trial price estimate and the selling price for tanespimycin treatment. This analysis will 
dictate which price estimations and considerations are worth altering based of the desired NPV and IRR.  
 
15.2.1 Phase III Clinical Trial Cost Estimate 
 As discussed in Chapter 3, a conservative $2 billion Phase III clinical trial cost estimate was used 
to include the cost of the treating trial patients and adjust for the associated risk and opportunity cost of 
the trial investment. This cost trumps all other expenses involved, for the second largest expense is the 
equipment costs, which are on the order of millions. A less conservative Phase III clinical trial cost would 
therefore considerably impact both the NPV and IRR. NPV will vary linearly with the trial cost, for this 
expense is a present value sunk cost in year zero. Figure 15.1 demonstrates this linear NPV relationship as 
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well as the IRR relation to clinical trial cost. This IRR is more sensitive to trial cost when it is less than $1 
billion, for once it exceeds $1 billion the trial cost trumps all other expenses and the IRR is less affected 
by additional increase. 
 
 
Figure15.1 Sensitivity analysis of the Phase III clinical trial cost on NPV and IRR. 
 
15.2.2 Selling Price of Tanespimycin  
 As discussed in 15.1.2 the selling price of tanespimycin will be set at $20,000 per treatment after 
considering Herceptin pricing and recent patent expiration. This price is also subject to alteration due to 
the assumptions and estimations used in its calculation. Figure 15.2, illustrates that the NPV linearly 
increases as the selling price of tanespimycin increases. It is critical to note that the break even selling 
price per treatment is $7,833, for a negative NPV is achieved if sold below this minimum. The IRR also 
increases with the selling price; the IRR is more sensitive to price change below $40,000 and sensitivity 
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Net Present Value 

































































Selling Price of Tanespimycin 
Selling Price Sensitivity 
Net Present Value 
Internal Rate of Return 
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16.0 Conclusions and Recommendations 
 
This report describes an economical, scaled-up process design for the production of 
tanespimycin. The proposed facility requires full operation for 293 days/year, with fermentation 
yielding 21.9 kg/batch geldanamycin and subsequent reaction with allylamine at 90% yield giving 
19.7 kg tanespimycin/ batch. Abiding by the timing and scheduling presented in Chapter 7 and the 
Appendix, 55 batches/year should produce 1030 kg of usable tanespimycin per year (95% of total 
 tanespimycin produced), adequately meeting market demands.  
From a financial standpoint, it is highly recommended that BMS move forward with this 
process design. Selling tanespimycin at a price of $20,000/kg, corresponding to a price of 
_____/treatment, BMS can expect an NPV of ______, an IRR of _____, and a ____% ROI after ____ 
years.  This financial analysis has taken into account the cost of Phase III FDA clinical trials, as well 
as a price decrease for the proposed method of treatment with Herceptin, which will be going off-
patent in the United States in 2019 (Mulcahy). Thus, these numbers motivate further investigation 
and investment in this project by BMS, as a financially feasible design for a cancer therapeutic with 
tremendous market potential will prove to be a great asset to the company. However, in order to 
adequately carry out the outlined proposal, it is highly recommended that BMS conserve initial 
capital by allowing Phase III clinical trials to use drug created by a CMO.  Once tanespimycin has 
been approved by the FDA, it is recommended that BMS use an existing laboratory, such as the 
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Material Safety Data Sheet  
Creation Date 27-Jan-2010  Revision Date 27-Oct-2014  Revision Number 1  
 
 
1. PRODUCT AND COMPANY IDENTIFICATION  
 
Product Name  Methylene chloride  
 









Recommended Use  
 
Company  
Fisher Scientific  
One Reagent Lane  
Fair Lawn, NJ 07410 







D37-1; D37-4; D37-20; D37-200; D37-200LC; D37-500; D37FB-19;  
D37FB-50; D37FB-115; D37FB-200; D37POP-19; D37POPB-50; 
D37POPB-200; D37RB-19; D37RB-50; D37RB-115; D37RB-200;  
D37RS-19; D37RS-28; D37RS-50; D37RS-115; D37RS-200; D37SK-4;  
D37SK-4LC; D37SS-28; D37SS-50; D37SS-115; D37SS-200;  
D37SS-1350  
 
Dichloromethane; DCM  
 
Laboratory chemicals  
 
Emergency Telephone Number  
CHEMTREC, Inside the USA: 800-424-9300  




2. HAZARDS IDENTIFICATION  
 
 
Emergency Overview  
 
Possible cancer hazard. May cause cancer based on animal data. Irritating to eyes and skin. May be harmful if  
inhaled. May cause irritation of respiratory tract. Inhalation may cause central nervous system effects. WARNING! This 
product contains a chemical known in the State of California to cause birth defects or other reproductive harm.  
Very toxic: danger of very serious irreversible effects in contact with skin. Flammable. Harmful if swallowed. May  
cause allergic respiratory reaction. Toxic to aquatic organisms.  
Appearance Colorless  Physical State Liquid  Odor sweet  
 
Target Organs  
 
 
Potential Health Effects  
 
Acute Effects  
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Chronic Effects  
Avoid repeated exposure  
 
 
Aggravated Medical Conditions  
 
Irritating to skin. May be harmful in contact with skin. May cause eye/skin irritation.  
May be harmful if inhaled. Inhalation may cause central nervous system effects. May cause 
irritation of respiratory tract.  
May be harmful if swallowed. Ingestion may cause gastrointestinal irritation, nausea, 





Central nervous system disorders. Preexisting eye disorders. Skin disorders. Kidney 
disorders. Liver disorders.  
 
3. COMPOSITION/INFORMATION ON INGREDIENTS  
 
Component  
Methylene chloride  










4. FIRST AID MEASURES  
 
Weight %  
>99.5  
0 - 0.4  
0 - 0.01 0 - 
0.01  
 
Eye Contact  
 
 










Flash Point  
Method -  
 
Autoignition Temperature  
 




Suitable Extinguishing Media  
 
 
Unsuitable Extinguishing Media  
 
Hazardous Combustion Products  
 
Sensitivity to Mechanical Impact  
Sensitivity to Static Discharge  
 
Rinse immediately with plenty of water, also under the eyelids, for at least 15 minutes. Obtain 
medical attention.  
 
Wash off immediately with plenty of water for at least 15 minutes. Obtain medical attention.  
 
Move to fresh air. If breathing is difficult, give oxygen. Obtain medical attention.  
 
Clean mouth with water and drink afterwards plenty of water.  
 
Treat symptomatically  
 
5. FIRE-FIGHTING MEASURES  
 
No information available No 
information available  
 
556 °C / 1032.8 °F  
 
 
23 vol % 13 vol 
%  
 
Use water spray, alcohol-resistant foam, dry chemical or carbon 
dioxide.  
 
No information available  
 
No information available.  
 
No information available No 
information available  
 
Specific Hazards Arising from the Chemical  
Thermal decomposition can lead to release of irritating gases and vapors. Keep product and empty container away from heat and  
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Protective Equipment and Precautions for Firefighters  
As in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full  
protective gear.  
 
NFPA  Health 2  Flammability 1  Instability 0  Physical hazards N/A  
 
6. ACCIDENTAL RELEASE MEASURES  
 
Personal Precautions  Use personal protective equipment. Ensure adequate ventilation.  
 
Environmental Precautions  Should not be released into the environment. See Section 12 for additional ecological  
information.  
 
Methods for Containment and Clean Soak up with inert absorbent material. Keep in suitable, closed containers for disposal.  
Up  
 
7. HANDLING AND STORAGE  
 
Handling  Wear personal protective equipment. Ensure adequate ventilation. Do not get in eyes, on  
skin, or on clothing. Avoid ingestion and inhalation.  
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8. EXPOSURE CONTROLS/PERSONAL PROTECTION  
 
Engineering Measures  Use only under a chemical fume hood. Ensure adequate ventilation, especially in confined  
areas. Ensure that eyewash stations and safety showers are close to the workstation  
location.  
 
Exposure Guidelines  
 
Component  




Methyl alcohol  
 
ACGIH TLV  




TWA: 200 ppm 
STEL: 250 ppm  
Skin  
 
OSHA PEL  
(Vacated) TWA: 500 ppm  
(Vacated) STEL: 2000 ppm 
(Vacated) Ceiling: 1000 ppm  
TWA: 25 ppm  
STEL: 125 ppm  
(Vacated) TWA: 200 ppm  
(Vacated) TWA: 260 mg/m3  
(Vacated) STEL: 250 ppm 
(Vacated) STEL: 325 mg/m3  
Skin  
 
NIOSH IDLH  




IDLH: 6000 ppm  
TWA: 200 ppm  
TWA: 260 mg/m3  
STEL: 250 ppm 







Methylene chloride  
 
 





TWA: 50 ppm  
TWA: 174 mg/m3  
TWA: 200 ppm  
TWA: 260 mg/m3  
(Vacated) TWA: 300 ppm  
(Vacated) TWA: 1015 mg/m3  
TWA: 300 ppm  
TWA: 1015 mg/m3  
Mexico OEL (TWA)  
TWA: 100 ppm  
TWA: 330 mg/m3  
 
 
IDLH: 2000 ppm  
TWA: 300 ppm  
TWA: 1015 mg/m3  
 
Ontario TWAEV  
TWA: 50 ppm  
 
 
Methyl alcohol  
 
 
TWA: 200 ppm  
TWA: 262 mg/m3  
STEL: 250 ppm 
STEL: 328 mg/m3  
STEL: 500 ppm  
STEL: 1740 mg/m3  
TWA: 200 ppm  
TWA: 260 mg/m3  
STEL: 250 ppm  
STEL: 310 mg/m3  
 
 
TWA: 200 ppm 
STEL: 250 ppm  
Skin  
Skin  
Cyclohexene  TWA: 300 ppm  TWA: 300 ppm  TWA: 300 ppm  
TWA: 1010 mg/m3  TWA: 1015 mg/m3  
Legend  
 
NIOSH IDLH: The National Institute for Occupational Safety and Health Immediately Dangerous to Life or Health  
 
 
Personal Protective Equipment  
 
Eye/face Protection  
Skin and body protection  







Physical State  
Appearance  
Odor  
Odor Threshold  
pH  
 
Vapor Pressure  
Vapor Density  
 
Tightly fitting safety goggles. Face-shield. Long 
sleeved clothing.  
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard  
EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if  
exposure limits are exceeded or if irritation or other symptoms are experienced.  
 
 





No information available  
Not applicable  
 
20 mmHg @ 3502°C  
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Melting Point/Range  
Decomposition Temperature  
Flash Point  
Evaporation Rate  
Specific Gravity  
Solubility  
log Pow  
Molecular Weight  






Conditions to Avoid  
 
Incompatible Materials  
 
Hazardous Decomposition Products  
 
 
Hazardous Polymerization  
 
Hazardous Reactions  
 
No information available  
39 °C / 102.2 °F  
-97 °C / -142.6 °F  
No information available No 
information available No 
information available  
1.33  
No information available  
No data available  
84.93  
C H2 Cl2  
 
10. STABILITY AND REACTIVITY  
 
Stable under normal conditions.  
 
Incompatible products. Excess heat.  
 
Strong oxidizing agents, Strong acids, Amines  
 
Carbon monoxide (CO), Carbon dioxide (CO2), Hydrogen  
chloride gas, Phosgene  
 
Hazardous polymerization does not occur.  
 
None under normal processing.  
 
11. TOXICOLOGICAL INFORMATION  
 
Acute Toxicity  
 
Product Information  
 
Component Information  
Component  
Methylene chloride  
Methyl alcohol  
Cyclohexene  
2-Methyl-2-butene  
LD50 Oral  
> 2000 mg/kg ( Rat )  
6200 mg/kg ( Rat )  
Not listed  
700-2600 mg/kg ( Rat )  
LD50 Dermal  
> 2000 mg/kg ( Rat )  
Not listed  
>200 mg/kg (Rat)  
>2000 mg/kg ( Rat )  
LC50 Inhalation  
53 mg/L ( Rat ) 6 h  
22500 ppm ( Rat ) 8 h  
>21.6 mg/L/4h (rat)  




Toxicologically Synergistic  
Products  
 




Irritating to eyes and skin  
 





The table below indicates whether each agency has listed any ingredient as a carcinogen.  
 
Component  ACGIH  IARC  NTP  OSHA  Mexico  
Methylene chloride  A3  Group 2B  Reasonably  X A3  
Anticipated  
ACGIH: (American Conference of Governmental Industrial Hygienists)  
A1 - Known Human Carcinogen  
A2 - Suspected Human Carcinogen  
A3 - Animal Carcinogen  
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IARC: (International Agency for Research on Cancer)  
IARC: (International Agency for Research on Cancer)  
Group 1 - Carcinogenic to Humans  
Group 2A - Probably Carcinogenic to Humans Group 2B - 
Possibly Carcinogenic to Humans  
NTP: (National Toxicity Program)  
NTP: (National Toxicity Program)  
Known - Known Carcinogen  
Reasonably Anticipated - Reasonably Anticipated to be a Human Carcinogen  
Mexico - Occupational Exposure Limits - Carcinogens  
Mexico - Occupational Exposure Limits - Carcinogens  
A1 - Confirmed Human Carcinogen A2 - 
Suspected Human Carcinogen A3 - Confirmed 
Animal Carcinogen  
A4 - Not Classifiable as a Human Carcinogen A5 - Not 




Mutagenic Effects  
 
Reproductive Effects  
 




Other Adverse Effects  
 
 






No information available  
 
Mutagenic effects have occured in microorganisms.  
 
Experiments have shown reproductive toxicity effects on laboratory animals.  
 
Developmental effects have occurred in experimental animals.  
 
No information available.  
 
Tumorigenic effects have been reported in experimental animals. See actual entry in 
RTECS for complete information.  
 
No information available  
 
12. ECOLOGICAL INFORMATION  
 
Component  Freshwater Algae  Freshwater Fish  Microtox  Water Flea  
Methylene chloride  EC50:>660 mg/L/96h  Pimephales promelas:  EC50: 1 mg/L/24 h  EC50: 140 mg/L/48h  
LC50:193 mg/L/96h  EC50: 2.88 mg/L/15 min  
Methyl alcohol  Not listed  Pimephales promelas: LC50 EC50 = 39000 mg/L 25 min  EC50 > 10000 mg/L 24h  
> 10000 mg/L 96h  EC50 = 40000 mg/L 15 min  
EC50 = 43000 mg/L 5 min  
Cyclohexene  Not listed  Poecillia reticulata: 7.1  Not listed  Daphnia: EC50: 5.3  
mg/L/96h  mg/L/48h  
2-Methyl-2-butene  Not listed  Not listed  Not listed  3 mg/L EC50 = 48 h  
Persistence and Degradability  . 
 
Bioaccumulation/ Accumulation  No information available.  
 
Mobility  Will likely be mobile in the environment due to its volatility.  
 
Component  log Pow  
Methylene chloride  1.25  
Methyl alcohol  -0.74  
Cyclohexene  3.27  
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Waste Disposal Methods  Chemical waste generators must determine whether a discarded chemical is classified as a  
hazardous waste. Chemical waste generators must also consult local, regional, and  
national hazardous waste regulations to ensure complete and accurate classification.  
 
Component  RCRA - U Series Wastes  RCRA - P Series Wastes  
Methylene chloride - 75-09-2  U080  - 
Methyl alcohol - 67-56-1  U154  - 
 
14. TRANSPORT INFORMATION  
 
DOT  
UN-No  UN1593  
Proper Shipping Name  DICHLOROMETHANE  
Hazard Class  6.1  
Packing Group  III  
 
TDG  
UN-No  UN1593  
Proper Shipping Name  DICHLOROMETHANE  
Hazard Class  6.1  




Proper Shipping Name  
Hazard Class  




Proper Shipping Name  
Hazard Class  













15. REGULATORY INFORMATION  
 
All of the components in the product are on the following Inventory lists: X = listed  
 
International Inventories  
Component  TSCA  DSL  NDSL EINECS ELINCS NLP  PICCS ENCS  AICS  IECSC  KECL  
Methylene chloride  X X - 200-838-  - X X X X X 
9 
Methyl alcohol  X X - 200-659-  - X X X X X 
6 
Cyclohexene  X X - 203-807-  - X X X X X 
8 




X - Listed  
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F - Indicates a substance that is the subject of a Section 5(f) Rule under TSCA.  
 
N - Indicates a polymeric substance containing no free-radical initiator in its inventory name but is considered to cover the designated polymer 
made with any free-radical initiator regardless of the amount used.  
 
P - Indicates a commenced PMN substance  
 
R - Indicates a substance that is the subject of a Section 6 risk management rule under TSCA.  
 
S - Indicates a substance that is identified in a proposed or final Significant New Use Rule  
 
T - Indicates a substance that is the subject of a Section 4 test rule under TSCA.  
 
XU - Indicates a substance exempt from reporting under the Inventory Update Rule, i.e. Partial Updating of the TSCA Inventory Data Base 
Production and Site Reports (40 CFR 710(B).  
 
Y1 - Indicates an exempt polymer that has a number-average molecular weight of 1,000 or greater.  
 
Y2 - Indicates an exempt polymer that is a polyester and is made only from reactants included in a specified list of low concern reactants that 
comprises one of the eligibility criteria for the exemption rule.  
 
 
U.S. Federal Regulations  
 
TSCA 12(b)  
 





Methylene chloride  
Methyl alcohol  
SARA 311/312 Hazardous Categorization  
Acute Health Hazard  
Chronic Health Hazard  
Fire Hazard  
Sudden Release of Pressure Hazard  
Reactive Hazard  
 















Weight %  
 
>99.5 
0 - 0.4  
 
 
SARA 313 - Threshold  





Component  CWA - Hazardous  CWA - Reportable  CWA - Toxic Pollutants CWA - Priority Pollutants  
Substances  Quantities  
Methylene chloride  - - X X 
75-09-2 ( >99.5 )  




Methylene chloride  
75-09-2 ( >99.5 )  
Methyl alcohol  
67-56-1 ( 0 - 0.4 )  
 
 






Class 1 Ozone Depletors  
 
 




OSHA Occupational Safety and Health Administration  
Not applicable  
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Methylene chloride  125 ppm STEL  - 
75-09-2 ( >99.5 )  12.5 ppm Action Level  
25 ppm TWA  
CERCLA  
This material, as supplied, contains one or more substances regulated as a hazardous substance under the Comprehensive  
Environmental Response Compensation and Liability Act (CERCLA) (40 CFR 302)  
 
Component  
Methylene chloride  
Methyl alcohol  
California Proposition 65  
 
Hazardous Substances RQs  
1000 lb 1 lb  
5000 lb  
 
CERCLA EHS RQs  
- 
- 
This product contains the following Proposition 65 chemicals:  
Component  CAS-No  California Prop. 65  Prop 65 NSRL  Category  
Methylene chloride  75-09-2  Carcinogen  200 µg/day  Carcinogen  
50 µg/day  
Methyl alcohol  67-56-1  Developmental  - Developmental  
 
State Right-to-Know  
 
 
Component  Massachusetts  New Jersey  Pennsylvania  Illinois  Rhode Island  
Methylene chloride  X X X X X 
Methyl alcohol  X X X X X 
Cyclohexene  X X X - X 
2-Methyl-2-butene  X X X - - 
U.S. Department of Transportation  
 
Reportable Quantity (RQ):  YDOT 
Marine Pollutant  NDOT 
Severe Marine Pollutant  N 
 
U.S. Department of Homeland Security  
This product does not contain any DHS chemicals.  
 
Other International Regulations  
 




This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations (CPR) and  
the MSDS contains all the information required by the CPR  
 
WHMIS Hazard Class  
D1B Toxic materials  
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Creation Date  
 
Print Date  
 
Revision Summary  




Regulatory Affairs  
Thermo Fisher Scientific  





The information provided on this Safety Data Sheet is correct to the best of our knowledge, information and belief at the  
date of its publication. The information given is designed only as a guide for safe handling, use, processing, storage,  
transportation, disposal and release and is not to be considered as a warranty or quality specification. The information  
relates only to the specific material designated and may not be valid for such material used in combination with any other material 
or in any process, unless specified in the text.  
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1. PRODUCT AND COMPANY IDENTIFICATION  
 
 
Product Name  Isooctane  








Recommended Use  
 
Company  
Fisher Scientific  
One Reagent Lane  
Fair Lawn, NJ 07410 
Tel: (201) 796-7100  
O296-1; O296-4; O296RS-28; O296RS-115; O296SK-1; O296SK-4;  
O296SS-28; O296SS-50; O296SS-115; O296SS-200; O297-4; O299-1;  
O299-4; O299FB-50; O299FB-200; O299RS-115; O299SS-28; O299SS-50;  
O299SS-115; O299SS-200; O300-1; O300-4; O301-1; O301-4  
 
2,2,4-Trimethylpentane; Isobutyltrimethylmethane (HPLC/Pesticide/Certified  
ACS/Spectranalyzed/Optima)  
 
Laboratory chemicals  
 
Emergency Telephone Number  
CHEMTREC®, Inside the USA: 800-  
424-9300  










Emergency Overview  
Flammable liquid and vapor. Causes eye, skin, and respiratory tract irritation. Vapors may cause drowsiness and  
dizziness. Aspiration hazard if swallowed - can enter lungs and cause damage. Very toxic to aquatic organisms, may  
cause long-term adverse effects in the aquatic environment.  
 
Appearance Colorless  Physical State Liquid  odor Petroleum distillates  
 
 
Target Organs  
 
Potential Health Effects  
 
Acute Effects  













Irritating to eyes.  
Irritating to skin. May be harmful in contact with skin.  
Irritating to respiratory system. May be harmful if inhaled. Inhalation may cause central nervous 
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Ingestion  May be harmful if swallowed. Aspiration hazard. Ingestion may cause gastrointestinal irritation,  
nausea, vomiting and diarrhea.  
 
Chronic Effects  Mutagenic effects have occurred in experimental animals.. May cause adverse kidney effects.  
 
See Section 11 for additional Toxicological information.  
 
Aggravated Medical Conditions  No information available.  
 




Component  CAS-No  Weight %  
Isooctane  540-84-1  99  
 
4. FIRST AID MEASURES  
 
 
Eye Contact  
 
 

















Autoignition Temperature  
 




Suitable Extinguishing Media  
 
 
Unsuitable Extinguishing Media  
 
 
Hazardous Combustion Products  
 
 
Rinse immediately with plenty of water, also under the eyelids, for at least 15 minutes. Obtain 
medical attention.  
 
Wash off immediately with plenty of water for at least 15 minutes. Obtain medical attention.  
 
Move to fresh air. If breathing is difficult, give oxygen. Do not use mouth-to-mouth resuscitation  
if victim ingested or inhaled the substance; induce artificial respiration with a respiratory 
medical device. Obtain medical attention.  
 
Do not induce vomiting. Call a physician or Poison Control Center immediately.  
 
Treat symptomatically.  
 
5. FIRE-FIGHTING MEASURES  
 
 
-12°C / 10.4°F  
 
No information available.  
 
417°C / 782.6°F  
 
 
6.0 vol % 1.1 vol 
%  
 
CO2, dry chemical, dry sand, alcohol-resistant foam. Use water 
spray to cool unopened containers.  
 
Water may be ineffective, Do not use a solid water stream as it may  
scatter and spread fire  
 
No information available.  
 
Sensitivity to mechanical impact  No information available. 
Sensitivity to static discharge  No information available.  
 
Specific Hazards Arising from the Chemical  
Flammable. Risk of ignition. Vapors may form explosive mixtures with air. Vapors may travel to source of ignition and flash back.  
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Protective Equipment and Precautions for Firefighters  
As in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full protective  
gear. Thermal decomposition can lead to release of irritating gases and vapors.  
 
NFPA  Health 1  Flammability 3  Instability 0  Physical hazards N/A  
 
6. ACCIDENTAL RELEASE MEASURES  
 
 
Personal Precautions  Use personal protective equipment. Remove all sources of ignition. Take precautionary  
measures against static discharges. Do not get in eyes, on skin, or on clothing.  
 
Environmental Precautions  Should not be released into the environment.  
 




















Exposure Guidelines  
measures against static discharges. Keep in suitable and closed containers for disposal.  
 
7. HANDLING AND STORAGE  
 
 
Use only under a chemical fume hood. Use explosion-proof equipment. Wear personal  
protective equipment. Keep away from open flames, hot surfaces and sources of ignition. Take 
precautionary measures against static discharges.  
 
Keep away from open flames, hot surfaces and sources of ignition. Keep containers tightly 
closed in a dry, cool and well-ventilated place. Flammables area.  
 
8. EXPOSURE CONTROLS / PERSONAL PROTECTION  
 
 
Use only under a chemical fume hood. Use explosion-proof  
electrical/ventilating/lighting/equipment. Ensure that eyewash stations and safety showers are 
close to the workstation location.  
 
Component  ACGIH TLV  OSHA PEL  NIOSH IDLH  
Isooctane  TWA: 300 ppm  
 
 
NIOSH IDLH: Immediately Dangerous to Life or Health  
 
Personal Protective Equipment  
Eye/face Protection  
 
Skin and body protection  







Physical State  
Appearance  
odor  
Odor Threshold  
Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's  
eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166. 
Wear appropriate protective gloves and clothing to prevent skin exposure.  
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN  
149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits 
are exceeded or if irritation or other symptoms are experienced.  
 





Petroleum distillates  
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9. PHYSICAL AND CHEMICAL PROPERTIES  
pH  
Vapor Pressure  
Vapor Density  
Viscosity  
Boiling Point/Range  
Melting Point/Range  
Decomposition temperature  
Flash Point  
Evaporation Rate  
Specific Gravity  
Solubility  
log Pow  
Molecular Weight  







Conditions to Avoid  
 
Incompatible Materials  
 
Hazardous Decomposition Products  
 
Hazardous Polymerization  
 





Acute Toxicity  
Not applicable  
51 mbar @ 20 °C  
3.94 (Air = 1.0)  
0.51 mPa s at 22 °C  
98 - 99°C / 208.4 - 210.2°F@ 760 mmHg  
-107°C / -160.6°F  
No information available.  
-12°C / 10.4°F  
No information available.  
0.690  
Insoluble in water No 




10. STABILITY AND REACTIVITY  
 
 
Stable under normal conditions.  
 
Incompatible products. Heat, flames and sparks.  
 
Strong oxidizing agents, Strong acids, Strong bases  
 
Carbon monoxide (CO), Carbon dioxide (CO2)  
 
Hazardous polymerization does not occur.  
 
None under normal processing..  
 




Component Information  
Component  LD50 Oral  LD50 Dermal  LC50 Inhalation  
Isooctane  2500 mg/kg ( Rat )  Not listed  34.7 mg/L ( Rat ) 4 h  
















Irritating to eyes, respiratory system and skin  
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Mutagenic Effects  
 
Reproductive Effects  
 




Other Adverse Effects  
 
 








No information available.  
 
Mutagenic effects have occurred in experimental animals.  
 
No information available.  
 
No information available.  
 
No information available.  
 
The toxicological properties have not been fully investigated.. See actual entry in RTECS for 
complete information.  
 
No information available  
 
12. ECOLOGICAL INFORMATION  
Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.  
 
Persistence and Degradability  
 



















Proper Shipping Name  
Hazard Class  





Proper Shipping Name  
Hazard Class  





No information available  
 
No information available  
 
No information available  
 
 
13. DISPOSAL CONSIDERATIONS  
 
 
Chemical waste generators must determine whether a discarded chemical is classified as a  
hazardous waste. Chemical waste generators must also consult local, regional, and national  
hazardous waste regulations to ensure complete and accurate classification  
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14. TRANSPORT INFORMATION  
UN-No  UN1262  
Proper Shipping Name  OCTANES  
Hazard Class  3 





Proper Shipping Name  
Hazard Class  

















15. REGULATORY INFORMATION  
Component  TSCA  DSL  NDSL EINECS ELINCS  NLP  PICCS  ENCS  AICS  CHINA  KECL  
Isooctane  X X - 208-759-  - X X X X KE-  




X - Listed  
E - Indicates a substance that is the subject of a Section 5(e) Consent order under TSCA. F - Indicates 
a substance that is the subject of a Section 5(f) Rule under TSCA.  
N - Indicates a polymeric substance containing no free-radical initiator in its inventory name but is considered to cover the designated polymer 
made with any free-radical initiator regardless of the amount used.  
P - Indicates a commenced PMN substance  
R - Indicates a substance that is the subject of a Section 6 risk management rule under TSCA.  
S - Indicates a substance that is identified in a proposed or final Significant New Use Rule T - 
Indicates a substance that is the subject of a Section 4 test rule under TSCA.  
XU - Indicates a substance exempt from reporting under the Inventory Update Rule, i.e. Partial Updating of the TSCA Inventory Data Base 
Production and Site Reports (40 CFR 710(B).  
Y1 - Indicates an exempt polymer that has a number-average molecular weight of 1,000 or greater.  
Y2 - Indicates an exempt polymer that is a polyester and is made only from reactants included in a specified list of low concern reactants that comprises 
one of the eligibility criteria for the exemption rule.  
 
 
U.S. Federal Regulations  
 
TSCA 12(b) Not applicable  
 
SARA 313  
Not applicable  
 
 
SARA 311/312 Hazardous Categorization  
Acute Health Hazard  
Chronic Health Hazard  
Fire Hazard  
Sudden Release of Pressure Hazard  
Reactive Hazard  
Yes  
No  
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Clean Water Act  
Not applicable  
 
 
Clean Air Act  
 
Component  HAPS Data  Class 1 Ozone Depletors  Class 2 Ozone Depletors  




Not applicable  
 
CERCLA  
This material, as supplied, contains one or more substances regulated as a hazardous substance under the Comprehensive  





California Proposition 65  
This product does not contain any Proposition 65 chemicals.  
 
 
State Right-to-Know  
 
Hazardous Substances RQs  
1000 lb  
 
CERCLA EHS RQs  
- 
 
Component  Massachusetts  New Jersey  Pennsylvania  Illinois  Rhode Island  
I s ooc t ane  X X X X - 
 
 
U.S. Department of Transportation  
Reportable Quantity (RQ):  Y 
DOT Marine Pollutant  NDOT 
Severe Marine Pollutant  N 
 
U.S. Department of Homeland Security  
This product does not contain any DHS chemicals.  
 
Other International Regulations  
 




This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations (CPR) and the 
MSDS contains all the information required by the CPR.  
 
WHMIS Hazard Class  
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Creation Date  
 
Print Date  
 













16. OTHER INFORMATION  
 
 
Regulatory Affairs  
Thermo Fisher Scientific  






"***", and red text indicates revision  
The information provided on this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date  
of its publication. The information given is designed only as a guide for safe handling, use, processing, storage,  
transportation, disposal and release and is not to be considered as a warranty or quality specification. The information  
relates only to the specific material designated and may not be valid for such material used in combination with any other 
material or in any process, unless specified in the text.  
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Product Name  
 




Recommended Use  
 
Company  
Fisher Scientific  
One Reagent Lane  
Fair Lawn, NJ 07410 






Material Safety Data Sheet  
Revision Date 23-Oct-2014  
 
 
1. PRODUCT AND COMPANY IDENTIFICATION  
 
Molecular Biology Grade Ethanol  
 
BP2818-4, BP2818-100, BP2818-500  
 
Ethyl alcohol; Absolute ethanol  
 
Laboratory chemicals  
 
Emergency Telephone Number  
CHEMTREC, Inside the USA: 800-424-9300  




2. HAZARDS IDENTIFICATION  
 
 
Emergency Overview  
 
 
Revision Number 1  
 
Extremely flammable liquid and vapor. Vapor may cause flash fire. Aspiration hazard if swallowed - can enter lungs  
and cause damage. Harmful by inhalation, in contact with skin and if swallowed. Irritating to eyes. Cancer hazard.  
This substance has caused adverse reproductive and fetal effects in humans. Hygroscopic.  
Appearance Clear, Colorless  Physical State Liquid  Odor sweet, Characteristic  
 
Target Organs  
 
Potential Health Effects  
 
Acute Effects  









Chronic Effects  
 






Irritating to eyes.  
May cause irritation. Harmful in contact with skin.  
May cause irritation of respiratory tract. Inhalation may cause central nervous system effects. 
Harmful by inhalation.  
Harmful if swallowed. Aspiration hazard if swallowed - can enter lungs and cause damage. 
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Cancer hazard: This substance has caused adverse reproductive and fetal effects in humans: Substances known to cause  
developmental toxicity in humans: Tumorigenic effects have been reported in experimental animals: May cause adverse liver  
effects: May cause adverse kidney effects  
 
 
Aggravated Medical Conditions  Central nervous system disorders. Preexisting eye disorders. Liver disorders. Skin  
disorders.  
 
3. COMPOSITION/INFORMATION ON INGREDIENTS  
 
Component  CAS-No  Weight %  
Ethyl alcohol  64-17-5  99-100  
 
4. FIRST AID MEASURES  
 
Eye Contact  
 
 












Flash Point  
 
Method -  
 
Autoignition Temperature  
 








Unsuitable Extinguishing Media  
 
 
Hazardous Combustion Products  
 
Sensitivity to Mechanical Impact  
Sensitivity to Static Discharge  
 
Rinse immediately with plenty of water, also under the eyelids, for at least 15 minutes. Obtain 
medical attention.  
 
Wash off immediately with plenty of water for at least 15 minutes. Get medical attention if 
symptoms occur.  
 
Move to fresh air. If breathing is difficult, give oxygen. Get medical attention immediately if 
symptoms occur.  
 
Do not induce vomiting. Obtain medical attention.  
 
Treat symptomatically  
 
5. FIRE-FIGHTING MEASURES  
 
12 °C / 53.6 °F  
 
No information available  
 
363 °C / 685.4 °F  
 
 
19 vol % 3.3 vol 
%  
 
Use water spray, alcohol-resistant foam, dry chemical or carbon  
dioxide. Use water spray to cool unopened containers. Cool 
closed containers exposed to fire with water spray.  
 
Water may be ineffective, Do not use a solid water stream as it  
may scatter and spread fire  
 
No information available.  
 
No information available No 
information available  
 
Specific Hazards Arising from the Chemical  
Flammable. Risk of ignition. Vapors may form explosive mixtures with air. Vapors may travel to source of ignition and flash back.  
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Protective Equipment and Precautions for Firefighters  
As in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full  
protective gear. Thermal decomposition can lead to release of irritating gases and vapors.  
 








Environmental Precautions  
 
6. ACCIDENTAL RELEASE MEASURES  
 
Use personal protective equipment. Ensure adequate ventilation. Remove all sources of 
ignition. Take precautionary measures against static discharges. Do not get in eyes, on skin, or 
on clothing.  
 
Should not be released into the environment.  
 












closed containers for disposal. Take precautionary measures against static discharges. Use  
spark-proof tools and explosion-proof equipment.  
 
7. HANDLING AND STORAGE  
 
Wear personal protective equipment. Ensure adequate ventilation. Keep away from open 
flames, hot surfaces and sources of ignition. Take precautionary measures against static  
discharges. Do not breathe vapors or spray mist. Do not get in eyes, on skin, or on clothing. Do not 
ingest. Use spark-proof tools and explosion-proof equipment.  
 
Keep containers tightly closed in a dry, cool and well-ventilated place. Keep away from open 
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8. EXPOSURE CONTROLS/PERSONAL PROTECTION  
 
Engineering Measures  Ensure adequate ventilation, especially in confined areas. Use explosion-proof  
electrical/ventilating/lighting/equipment. Ensure that eyewash stations and safety showers  
are close to the workstation location.  
 
Exposure Guidelines  
 
Component 




Ethyl alcohol  
 
ACGIH TLV  





TWA: 1000 ppm  
TWA: 1880 mg/m3  
 
OSHA PEL  
(Vacated) TWA: 1000 ppm  
(Vacated) TWA: 1900 mg/m3  
TWA: 1000 ppm  
TWA: 1900 mg/m3  
Mexico OEL (TWA)  
TWA: 1000 ppm  
TWA: 1900 mg/m3  
 
NIOSH IDLH  
IDLH: 3300 ppm  
TWA: 1000 ppm 
TWA: 1900 mg/m3  
 
Ontario TWAEV 
STEL: 1000 ppm  
Legend  
 
NIOSH IDLH: The National Institute for Occupational Safety and Health Immediately Dangerous to Life or Health  
 
 
Personal Protective Equipment  
 
Eye/face Protection  
 
 
Skin and body protection  







Physical State  
Appearance  
Odor  
Odor Threshold  
pH  
 
Vapor Pressure  
Vapor Density  
Viscosity  
Boiling Point/Range 
Melting Point/Range  
Decomposition Temperature  
Flash Point  
Evaporation Rate  
Specific Gravity  
Solubility  
log Pow  
Molecular Weight  






Wear appropriate protective eyeglasses or chemical safety goggles as described by  
OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.  
Wear appropriate protective gloves and clothing to prevent skin exposure.  
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard  
EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if  
exposure limits are exceeded or if irritation or other symptoms are experienced.  
 
 
9. PHYSICAL AND CHEMICAL PROPERTIES  
 
Liquid  
Clear, Colorless  
sweet, Characteristic  
No information available No 
information available  
 
No information available No 
information available No 
information available  
78 °C / 172.4 °F  
-114 °C / -173.2 °F  
No information available  
12 °C / 53.6 °F  
No information available No 
information available No 
information available  
No data available  
46.07  
C2 H6 O  
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Conditions to Avoid  
 
 
Incompatible Materials  
 
 
Hazardous Decomposition Products  
 
Hazardous Polymerization  
 
Hazardous Reactions  
 
Incompatible products. Heat, flames and sparks. Keep away from 
open flames, hot surfaces and sources of ignition.  
 
Strong oxidizing agents, Strong acids, Acid anhydrides, Acid  
chlorides  
 
Carbon monoxide (CO), Carbon dioxide (CO2)  
 
Hazardous polymerization does not occur.  
 
None under normal processing.  
 
11. TOXICOLOGICAL INFORMATION  
 
Acute Toxicity  
 
Product Information  
 
Component Information  
Component  LD50 Oral  LD50 Dermal  LC50 Inhalation  
Ethyl alcohol  3450 mg/kg ( Mouse )  Not listed  20000 ppm/10H ( Rat )  
 
Irritation  Irritating to eyes  
 
Toxicologically Synergistic  No information available  
Products  
 
Chronic Toxicity  
 
Carcinogenicity  The table below indicates whether each agency has listed any ingredient as a carcinogen.  
 
Component  ACGIH  IARC  NTP  OSHA  Mexico 
Ethyl alcohol  A3  Group 1  Not listed  X Not listed  
ACGIH: (American Conference of Governmental Industrial Hygienists)  
A1 - Known Human Carcinogen  
A2 - Suspected Human Carcinogen  
A3 - Animal Carcinogen  
ACGIH: (American Conference of Governmental Industrial Hygienists)  
OSHA: (Occupational Safety & Health Administration)  
OSHA: (Occupational Safety & Health Administration)  
X - Present  
Mexico - Occupational Exposure Limits - Carcinogens  
Mexico - Occupational Exposure Limits - Carcinogens  
A1 - Confirmed Human Carcinogen A2 - 
Suspected Human Carcinogen A3 - Confirmed 
Animal Carcinogen  
A4 - Not Classifiable as a Human Carcinogen A5 - Not 




Mutagenic Effects  
 
Reproductive Effects  
 




Other Adverse Effects  
 
No information available  
 
Mutagenic effects have occurred in humans.  
 
Adverse reproductive effects have occurred in humans.  
 
Substances known to cause developmental toxicity in humans.  
 
Teratogenic effects have occurred in humans.  
 
Tumorigenic effects have been reported in experimental animals. See actual entry in 
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Endocrine Disruptor Information  No information available  
 




Component  Freshwater Algae  Freshwater Fish  Microtox  Water Flea  
Ethyl alcohol  EC50 (72h) = 275 mg/l  Fathead minnow  Photobacterium  EC50 = 9268 mg/L/48h  
(Chlorella vulgaris)  (Pimephales promelas)  phosphoreum:EC50 = 34634  EC50 = 10800 mg/L/24h  
LC50 = 14200 mg/l/96h  mg/L/30 min  
Photobacterium  
phosphoreum:EC50 = 35470  
mg/L/5 min  
Persistence and Degradability  Readily biodegradable.  
 





















Ethyl alcohol  
 
Will likely be mobile in the environment due to its water solubility.  
 
log Pow  
-0.32  
 
13. DISPOSAL CONSIDERATIONS  
 
Chemical waste generators must determine whether a discarded chemical is classified as a  
hazardous waste. Chemical waste generators must also consult local, regional, and 
national hazardous waste regulations to ensure complete and accurate classification.  
 




Proper Shipping Name  ETHANOL  
Hazard Class  3 
Packing Group  II  
 
TDG  
UN-No  UN1170  
Proper Shipping Name  ETHANOL  
Hazard Class  3 




Proper Shipping Name  
Hazard Class  




Proper Shipping Name  
Hazard Class  
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15. REGULATORY INFORMATION  
 
International Inventories  
Component  TSCA  DSL  NDSL EINECS ELINCS NLP  PICCS ENCS  AICS  IECSC  KECL  




X - Listed  
 
E - Indicates a substance that is the subject of a Section 5(e) Consent order under TSCA.  
 
F - Indicates a substance that is the subject of a Section 5(f) Rule under TSCA.  
 
N - Indicates a polymeric substance containing no free-radical initiator in its inventory name but is considered to cover the designated polymer 
made with any free-radical initiator regardless of the amount used.  
 
P - Indicates a commenced PMN substance  
 
R - Indicates a substance that is the subject of a Section 6 risk management rule under TSCA.  
 
S - Indicates a substance that is identified in a proposed or final Significant New Use Rule  
 
T - Indicates a substance that is the subject of a Section 4 test rule under TSCA.  
 
XU - Indicates a substance exempt from reporting under the Inventory Update Rule, i.e. Partial Updating of the TSCA Inventory Data Base 
Production and Site Reports (40 CFR 710(B).  
 
Y1 - Indicates an exempt polymer that has a number-average molecular weight of 1,000 or greater.  
 
Y2 - Indicates an exempt polymer that is a polyester and is made only from reactants included in a specified list of low concern reactants that 
comprises one of the eligibility criteria for the exemption rule.  
 
 
U.S. Federal Regulations  
 
TSCA 12(b) Not applicable  
 
SARA 313  
Not applicable  
 
SARA 311/312 Hazardous Categorization  
Acute Health Hazard  
Chronic Health Hazard  
Fire Hazard  
Sudden Release of Pressure Hazard  
Reactive Hazard  
 
Clean Water Act  
Not applicable  
 
Clean Air Act Not 
applicable  
 
OSHA Occupational Safety and Health Administration  
Not applicable  
 
CERCLA  
Not applicable  
Yes  
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California Proposition 65  
This product contains the following Proposition 65 chemicals: Ethyl alcohol is only a considered a Proposition 65 developmental  
hazard when it is ingested as an alcoholic beverage  
Component  CAS-No  California Prop. 65  Prop 65 NSRL  Category  
Ethyl alcohol  64-17-5  Developmental  - Developmental  
Carcinogen  
 
State Right-to-Know  
 
 
Component  Massachusetts  New Jersey  Pennsylvania  Illinois  Rhode Island  
Ethyl alcohol  X X X X X 
U.S. Department of Transportation  
 
Reportable Quantity (RQ):  NDOT 
Marine Pollutant  NDOT 
Severe Marine Pollutant  N 
 
U.S. Department of Homeland Security  
This product does not contain any DHS chemicals.  
 
Other International Regulations  
 




This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations (CPR) and  
the MSDS contains all the information required by the CPR  
 
WHMIS Hazard Class  
B2 Flammable liquid  
D2A Very toxic materials  
















Creation Date  
 
Print Date  
 
Revision Summary  










16. OTHER INFORMATION  
 
Regulatory Affairs  
Thermo Fisher Scientific  
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The information provided on this Safety Data Sheet is correct to the best of our knowledge, information and belief at the  
date of its publication. The information given is designed only as a guide for safe handling, use, processing, storage,  
transportation, disposal and release and is not to be considered as a warranty or quality specification. The information  
relates only to the specific material designated and may not be valid for such material used in combination with any other material 
or in any process, unless specified in the text.  
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Material Safety Data Sheet  
Allylamine, 97%  
 
 
MSDS# 87403  
 
 
MSDS Name:  




Company Identification:  
Section 1 - Chemical Product and Company Identification  
Allylamine, 97%  
AC220730000, AC220730010, AC220730500, AC220732500  
3-Amino-1-propene;3-aminopropylene;2-propen-1-amine  
Acros Organics BVBA  
Janssen Pharmaceuticalaan 3a  
2440 Geel, Belgium  
Acros Organics  
Company Identification: (USA)  
 
For information in the US, call: 
For information in Europe, call:  
Emergency Number, Europe:  
Emergency Number US:  
CHEMTREC Phone Number, US:  
CHEMTREC Phone Number, Europe:  
One Reagent Lane  
Fair Lawn, NJ 07410  
800-ACROS-01 +32 
14 57 52 11 +32 14 












Hazard Symbols:  
















Risk Phrases:  11 23/24/25  
Section 3 - Hazards Identification  
EMERGENCY OVERVIEW  
Danger! May be fatal if absorbed through the skin. Causes severe eye and skin burns. Harmful if inhaled or swallowed.  
Causes digestive and respiratory tract irritation with possible burns. Extremely flammable liquid and vapor. Vapor may  
cause flash fire. Target Organs: Eyes, skin, mucous membranes.  
Potential Health Effects  




Lachrymator (substance which increases the flow of tears).  
May be fatal if absorbed through the skin. Causes severe burns.  
Ingestion: Harmful if swallowed. May cause irritation of the digestive tract.  
May be fatal if inhaled. Exposure to high concentrations may produce narcosis, nausea and loss of  
Inhalation: consciousness. Causes respiratory tract irritation with possible burns. May cause severe tearing, conjunctivitis,  
corneal edema, coughing, nausea, and pulmonary edema.  




























Section 4 - First Aid Measures  
Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower  
eyelids. Get medical aid immediately. Do NOT allow victim to rub eyes or keep eyes closed.  
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while  
removing contaminated clothing and shoes. Remove contaminated clothing and shoes.  
Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give  
anything by mouth to an unconscious person. Get medical aid immediately.  
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing,  




Section 5 - Fire Fighting Measures  
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved  
or equivalent), and full protective gear. Vapors may form an explosive mixture with air. Vapors can travel to  
a source of ignition and flash back. Combustion generates toxic fumes. Use water spray to keep fire-  
exposed containers cool. Extremely flammable liquid and vapor. Vapors may be heavier than air. They can 
spread along the ground and collect in low or confined areas. Will be easily ignited by heat, sparks or flame. 
Containers may explode when heated.  
For small fires, use dry chemical, carbon dioxide, water spray or alcohol-resistant foam. Use water spray to  
cool fire-exposed containers. Water may be ineffective. For large fires, use water spray, fog or alcohol- 
resistant foam. Do NOT use straight streams of water. Cool containers with flooding quantities of water 
until well after fire is out.  
Autoignition 705 deg F ( 373.89 deg C)  
Temperature:  
Flash Point: -20 deg C ( -4.00 deg F)  
Explosion 2.0 vol %  
Limits: Lower:  
Explosion  
Limits: Upper: 22.00 vol %  








Section 6 - Accidental Release Measures  
 
Use proper personal protective equipment as indicated in Section 8.  
 
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Remove all  
sources of ignition. A vapor suppressing foam may be used to reduce vapors. Water spray may reduce 
vapor but may not prevent ignition in closed spaces.  
Section 7 - Handling and Storage  
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Ground and bond  
containers when transferring material. Do not get in eyes, on skin, or on clothing. Empty containers retain product  
Handling: residue, (liquid and/or vapor), and can be dangerous. Keep container tightly closed. Keep away from heat,  
sparks and flame. Do not ingest or inhale. Use only in a chemical fume hood. Do not pressurize, cut, weld, braze, 
solder, drill, grind, or expose empty containers to heat, sparks or open flames.  
Keep away from heat, sparks, and flame. Keep away from sources of ignition. Store in a tightly closed container.  
Storage: Keep from contact with oxidizing materials. Store in a cool, dry, well-ventilated area away from incompatible  
substances. Keep away from acids.  
Section 8 - Exposure Controls, Personal Protection  
+-------------------- +------------------- +------------------- +----------------- +  
| Chemical Name  | ACGIH  | NIOSH  |OSHA - Final PELs|  
|-------------------- |------------------- |------------------- |----------------- |  
| Allylamine  |none listed  |none listed  |none listed  | 
+-------------------- +------------------- +------------------- +----------------- +  
 
OSHA Vacated PELs: Allylamine: None listed  
Engineering Controls:  
Use only under a chemical fume hood.  
Exposure Limits  
Personal Protective Equipment  




protection regulations in 29 CFR 1910.133 or European Standard EN166.  
Wear appropriate protective gloves to prevent skin exposure.  
Clothing: Wear appropriate protective clothing to prevent skin exposure.  
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a  
Respirators: NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if  
irritation or other symptoms are experienced.  
Section 9 - Physical and Chemical Properties  
Physical State: Liquid  
Color: clear light yellow  
Odor: Strong ammoniacal odor  
pH: Not available  
Vapor Pressure: 242 mm Hg @25C  
Vapor Density: 1.97  
Evaporation Rate: Not available  
Viscosity: 0.44 cP 25 deg C  
Boiling Point: 55-58C  
Freezing/Melting Point: -123 deg C ( -189.40 F)  
Decomposition Temperature: Not available  
Solubility in water: soluble  
Specific Gravity/Density: .7610g/cm3  
Molecular Formula: C3H7N  
Molecular Weight: 57.09  
Section 10 - Stability and Reactivity  
Chemical Stability:  Stable under normal temperatures and pressures.  
Conditions to Avoid:  High temperatures, incompatible materials, ignition sources.  
Incompatibilities with Other  Metals, oxidizing agents, acids, amines, halogenated agents, alkalies, chlorine,  
Materials  hypochlorite.  
Hazardous Decomposition Products Carbon monoxide, oxides of nitrogen, carbon dioxide.  
Hazardous Polymerization  May occur.  













CAS# 107-11-9: BA5425000  
RTECS:  
CAS# 107-11-9: Draize test, rabbit, skin: 500 mg/24H Severe;  
Inhalation, rat: LC50 = 177 ppm/8H;  
Oral, mouse: LD50 = 57 mg/kg;  
Oral, rat: LD50 = 102 mg/kg;  
Skin, rabbit: LD50 = 35 mg/kg; . 
Allylamine - Not listed as a carcinogen by ACGIH, IARC, NTP, or CA Prop 65. See 
actual entry in RTECS for complete information.  
Section 12 - Ecological Information  
Ecotoxicity: Bacteria: Phytobacterium phosphoreum: EC50 = 16 mg/L; 5, 15 minutes; Microtox test; 14.9-15.1 degrees C  
Section 13 - Disposal Considerations  
Dispose of in a manner consistent with federal, state, and local regulations.  
Section 14 - Transport Information  
US DOT  
Shipping Name: ALLYLAMINE  
Hazard Class: 6.1  
UN Number: UN2334  
Packing Group: I  
Canada TDG  
Shipping Name: Not available  
Hazard Class: UN 
Number:  
Packing Group:  
 
 
Section 15 - Regulatory Information  
European/International Regulations  
European Labeling in Accordance with EC Directives  
Hazard Symbols: T F  
Risk Phrases:  
R 11 Highly flammable.  
R 23/24/25 Toxic by inhalation, in contact with skin and if swallowed.  
Safety Phrases:  
S 9 Keep container in a well-ventilated place.  
S 16 Keep away from sources of ignition - No smoking. S 
24/25 Avoid contact with skin and eyes.  
S 45 In case of accident or if you feel unwell, seek medical advice immediately (show the label where  
possible).  
S 61 Avoid release to the environment. Refer to special instructions/safety data sheets.  
WGK (Water Danger/Protection)  
CAS# 107-11-9: 2  
Canada  
CAS# 107-11-9 is listed on Canada's DSL List  
Canadian WHMIS Classifications: B2  
This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations  
and the MSDS contains all of the information required by those regulations.  
CAS# 107-11-9 is listed on Canada's Ingredient Disclosure List  
US Federal  
TSCA  
CAS# 107-11-9 is listed on the TSCA  
Inventory.  
Section 16 - Other Information  
MSDS Creation Date: 5/10/1999  
Revision #5 Date 7/20/2009  
 
 
The information above is believed to be accurate and represents the best information currently available  
to us. However, we make no warranty of merchantibility or any other warranty, express or implied,  
with respect to such information, and we assume no liability resulting from its use. Users should make  
their own investigations to determine the suitability of the information for their particular purposes. In no 
event shall the company be liable for any claims, losses, or damages of any third party or for lost profits or 
any special, indirect, incidental, consequential, or exemplary damages howsoever arising, even if the 
company has been advised of the possibility of such damages.  
--------------------------------------------------------------------------------  
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1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING  
 
Pfizer Inc  
Pfizer Pharmaceuticals Group  
235 East 42nd Street  
New York, New York 10017  
1-212-573-2222  
 
Emergency telephone number:  
CHEMTREC (24 hours): 1-800-424-9300  
 
Pfizer Ltd  
Ramsgate Road 
Sandwich, Kent  
CT13 9NJ  
United Kingdom  
+00 44 (0)1304 616161  
Emergency telephone number:  
International CHEMTREC (24 hours): +1-703-527-3887  
Contact E-Mail:  pfizer-MSDS@pfizer.com  
 
 
Material Name: Water for injection, USP  
 
Trade Name:  
Chemical Family:  
Intended Use:  
 





Statement of Hazard:  
 
EU Indication of danger:  
 





Not established  
Not applicable  





Clear, colorless liquid  
 
Non-hazardous in accordance with international standards for workplace safety.  
 
Not classified  
 
Non-Hazardous Substance. Non-Dangerous Goods.  
 
 
This document has been prepared in accordance with standards for workplace safety, which  
require the inclusion of all known hazards of the active substance or its intermediates  
regardless of the potential risk. The precautionary statements and warnings included may not  





3. COMPOSITION/INFORMATION ON INGREDIENTS  
 
 
Ingredient  CAS Number  EU EINECS/ELINCS List EU Classification  % 
Water for injection  7732-18-5  231-791-2  Not Listed  100  
 
Additional Information:  Ingredient(s) indicated as hazardous have been assessed under standards for workplace  
safety.  
 
4. FIRST AID MEASURES  
 
 
Eye Contact:  Due to the nature of this material first aid is not normally required.  
_______________________________________________________________________________________________________  
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5. FIRE FIGHTING MEASURES  
 
 
Extinguishing Media:  
 
Hazardous Combustion Products:  
 
Fire Fighting Procedures:  
 
Fire / Explosion Hazards:  
 
 
Due to the nature of this material first aid is not normally required.  
 
Due to the nature of this material first aid is not normally required.  
 





As for primary cause of fire.  
 
Not applicable  
 
Not applicable  
 
Not applicable  
 
6. ACCIDENTAL RELEASE MEASURES  
 
 
Health and Safety Precautions:  
 
Measures for Cleaning / Collecting:  
 
Measures for Environmental  
Protections:  
 
Additional Consideration for Large  
Spills:  
 
Additional Information:  
 
7. HANDLING AND STORAGE  
 
General Handling:  
Storage Conditions:  
 
Not applicable  
 












No special handling requirements for normal use of this material. 
Store as directed by product packaging.  
 
8. EXPOSURE CONTROLS / PERSONAL PROTECTION  
No Occupational Exposure Limit (OEL) or Short Term Exposure Limit (STEL) has been identified.  
 
Engineering Controls:  
Environmental Exposure Controls:  
 






Respiratory protection:  
 
Engineering controls should be used as the primary means to control exposures.  
Refer to specific Member State legislation for requirements under Community environmental 
legislation.  
Refer to applicable national standards and regulations in the selection and use of personal 
protective equipment (PPE).  
 
Not required for the normal use of this product. Not 
required under normal conditions of use.  
Not required for the normal use of this product. None 
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9. PHYSICAL AND CHEMICAL PROPERTIES  
 
Physical State:  
Odor:  




Melting/Freezing Point (°C):  



















10. STABILITY AND REACTIVITY  
 
Chemical Stability:  Stable 
Conditions to Avoid:  None 
Incompatible Materials:  None  
 







12. ECOLOGICAL INFORMATION  




13. DISPOSAL CONSIDERATIONS  
 
 
Waste Treatment Methods:  
 
Dispose of waste in accordance with all applicable laws and regulations. Member State  
specific and Community specific provisions must be considered. Considering the relevant  
known environmental and human health hazards of the material, review and implement  
appropriate technical and procedural waste water and waste disposal measures to prevent  
occupational exposure and environmental release. It is recommended that waste minimization  
be practiced. The best available technology should be utilized to prevent environmental 
releases. This may include destructive techniques for waste and wastewater.  
 
14. TRANSPORT INFORMATION  
The following refers to all modes of transportation unless specified below.  
 






15. REGULATORY INFORMATION  
 
 
EU Indication of danger:  Not classified  
_______________________________________________________________________________________________________  
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OSHA Label:  
Non-hazardous in accordance with international standards for workplace safety.  
 
 
Canada - WHMIS: Classifications  
WHMIS hazard class:  
None required  
 
 
Water for injection  
Inventory - United States TSCA - Sect. 8(b)  
Australia (AICS):  
REACH - Annex IV - Exemptions from the  
obligations of Register:  












Data Sources:  Publicly available toxicity information.  
 
Reasons for Revision:  Updated Section 1 - Identification of the Substance/Preparation and the Company/Undertaking.  
 
Prepared by:  Product Stewardship Hazard Communication  
Pfizer Global Environment, Health, and Safety Operations  
 
Pfizer Inc believes that the information contained in this Material Safety Data Sheet is accurate, and while it is provided in good faith, it  
is without warranty of any kind, expressed or implied. If data for a hazard are not included in this document there is no known 
information at this time.  
 




















Material Safety Data Sheet  
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1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND COMPANY INFORMATION  
 
 
Catalog Number: 960024  
 
Product name: SOY FLOUR  
 
Supplier:  
MP Biomedicals, LLC  
29525 Fountain Parkway  
Solon, OH 44139 tel: 440-
337-1200  
 
Emergency telephone number: CHEMTREC: 1-800-424-9300 (1-703-527-3887)  
 




Components  CAS Number  Weight %  ACGIH Exposure Limits:  OSHA Exposure Limits:  
SOY FLOUR  N/A  90 - 100%  None  None  
 
3. HAZARDS IDENTIFICATION  
 
 




Principle routes of exposure: Skin  
Inhalation: May cause irritation of respiratory tract 
Ingestion: May be harmful if swallowed.  
Skin contact: May cause allergic skin reaction  
Eye contact: Avoid contact with eyes  
 
Statements of hazard MAY CAUSE ALLERGIC SKIN REACTION.  
Statement of Spill or Leak - ANSI Label Eliminate all ignition sources. Absorb and/or contain spill with inert materials  
(e.g., sand, vermiculite). Then place in appropriate container. For large spills, use water spray to disperse vapors, flush 
spill area. Prevent runoff from entering waterways or sewers.  
 
4. FIRST AID MEASURES  
 
General advice: In the case of accident or if you feel unwell, seek medical advice immediately (show the label where 
possible).  
Inhalation: Move to fresh air. Call a physician immediately.  
Skin contact: Rinse immediately with plenty of water and seek medical advice 
Ingestion: Do not induce vomiting without medical advice.  
Eye contact: In the case of contact with eyes, rinse immediately with plenty of water and seek medical advice.  
Protection of first-aiders: No information available  
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5. FIRE FIGHTING MEASURES  
 
Suitable extinguishing media:  
Specific hazards: 
Unusual hazards:  
Special protective equipment for firefighters:  
 
 
Specific methods:  
Flash point:  
Autoignition temperature:  
NFPA rating:  
 
Use dry chemical, CO2, water spray or "alcohol" foam 
Burning produces irritant fumes.  
None known  
As in any fire, wear self-contained breathing apparatus  
pressure-demand, MSHA/NIOSH (approved or equivalent)  
and full protective gear  
Water mist may be used to cool closed containers.  
Not determined Not 
determined  
NFPA Health:  
NFPA Flammability:  





Personal precautions:  
Environmental precautions:  









6. ACCIDENTAL RELEASE MEASURES  
 
Use personal protective equipment.  
Prevent product from entering drains.  
Sweep up and shovel into suitable containers for disposal.  
 
7. HANDLING AND STORAGE  




Safe handling advice:  
Incompatible products:  
 
Use only in area provided with appropriate exhaust 
ventilation.  
Wear personal protective equipment.  
Oxidising and spontaneously flammable products  
 
8. EXPOSURE CONTROLS / PERSONAL PROTECTION  
 
Engineering measures: Ensure adequate ventilation.  
PERSONAL PROTECTIVE EQUIPMENT  
Respiratory protection: Breathing apparatus only if aerosol or dust is formed.  
Hand protection: Pvc or other plastic material gloves  
Skin and body protection: Usual safety precautions while handling the product will provide adequate protection against 
this potential effect.  
Eye protection: Safety glasses with side-shields  





9. PHYSICAL AND CHEMICAL PROPERTIES  
 
Physical state:  
Formula:  
Melting point/range: 
Boiling point/range:  
Density:  
Vapor pressure:  
Evaporation rate:  
Vapor density:  
Catalog Number: 960024  
 
Powder  
Not applicable  
No data available at this time. 
No Data available at this time.  
No data available 
No data available 
No data available 
No data available  
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Solubility (in water):  No data available  
Flash point:  Not determined  
Autoignition temperature:  Not determined  
 




Hazardous decomposition products:  
 
Materials to avoid:  
Conditions to avoid:  
 
Stable under recommended storage conditions. 
None under normal processing.  
Thermal decomposition can lead to release of irritating 
gases and vapours such as carbon oxides.  
Strong oxidising agents  
Exposure to air or moisture over prolonged periods.  
 
11. TOXICOLOGICAL INFORMATION  
 
Product Information  
Acute toxicity  
Components  
SOY FLOUR  
RTECS Number:  
Not Available  
Selected LD50s and LC50s  
Not Determined  
 
Chronic toxicity:  
 
Local effects:  
 
Specific effects:  
 
Primary irritation:  
Carcinogenic effects:  
Mutagenic effects:  







Ecotoxicity effects:  
Aquatic toxicity:  
 
Chronic exposure may cause nausea and vomiting, higher exposure causes 
unconsciousness.  
Symptoms of overexposure may be headache, dizziness, tiredness, nausea and 
vomiting.  
May include moderate to severe erythema (redness) and moderate edema (raised 
skin), nausea, vomiting, headache.  
No data is available on the product itself. No 
data is available on the product itself. No data 
is available on the product itself. No data is 
available on the product itself.  
 
12. ECOLOGICAL INFORMATION  
 
No data available No 
data available No data 
available  





SOY FLOUR  
 
U.S. DOT - Appendix B -  
Marine Pollutan  
Not Listed  
 
U.S. DOT - Appendix B - 
Severe Marine Pollutants  
Not Listed  
 
United Kingdom - The Red  
List:  
Not Listed  
 
Components  Germany VCI (WGK)  World Health Organization Ecotoxicity - Fish Species  
 
SOY FLOUR  
 
Not Listed  
(WHO) - Drinking Water  
Not Listed  
Data  
Not Listed  
 
Components  Ecotoxicity - Freshwater  Ecotoxicity - Microtox Data Ecotoxicity - Water Flea  
Algae Data  Data  





SOY FLOUR  
Not Listed  
 
EPA - ATSDR Priority List  
 
Not Listed  
Not Listed  
 
EPA - HPV Challenge  
Program Chemical List  
Not Listed  
Not Listed  
 
California - Priority Toxic  
Pollutants 
Not Listed  
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Components 
SOY FLOUR  
 
 
California - Priority Toxic Pollutants  




California - Priority Toxic Pollutants  
Not Listed  
 
13. DISPOSAL CONSIDERATIONS  
 
 






Contaminated packaging:  
 
Waste disposal must be in accordance with appropriate  
Federal, State, and local regulations. This product, if  
unaltered by use, may be disposed of by treatment at a 
permitted facility or as advised by your local hazardous  
waste regulatory authority. Residue from fires extinguished 
with this material may be hazardous.  
Do not re-use empty containers  
 
14. TRANSPORT INFORMATION  
 
 
UN/Id No:  Not regulated  
 
DOT:  








TDG (Canada):  






U.S. DOT - Appendix A Table 1 - Reportable Quantities  








IMDG - Hazard Classifications  Not Applicable  
 
Components  U.S. DOT - Appendix B - Marine Pollutan U.S. DOT - Appendix B - Severe Marine  
Pollutants  







15. REGULATORY INFORMATION  
 
 
International Inventories  
 
Components 
SOY FLOUR  
Inventory - United States TSCA - Sect. 8(b)  Not Listed 
Canada DSL Inventory List -  Not Listed  
 
 
U.S. regulations:  
Components  California Proposition 65 Massachusetts Right to New Jersey Right to  Pennsylvania Right to Know  
SOY FLOUR  
- 
Not Listed  
Know List:  
Not Listed  
Know List:  
Not Listed  
List:  
Not Listed  
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Florida substance List:  
 
Not Listed  
 
 
Rhode Island Right to  
Know List:  
Not Listed  
 
 
Illinois - Toxic Air  
Contaminants  




Connecticut - Hazardous Air  
Pollutants 
Not Listed  
 
Components  SARA 313 Emission  CERCLA/SARA - Section NTP:  IARC:  
reporting/Toxic Release 302 Extremely Haz  
of Chemicals  
SOY FLOUR  Not Listed  Not Listed  None  None  
 

















Prepared by: Health & Safety  
 
The above is your notification as to the SARA 313 listing for this product(s) pursuant 
to Section 313 of Title III of the Superfund Ammendments and Reauthorization Act of 
1986 and 40 CFR Part 372.  
 
If you are unsure if you are subject to the reporting requirements of Section 313, or  
need more information, please call the EPA Emergency Planning and Community  
Right-To-Know Information Hotline: (800) 535-0202 or (202) 479-2499 (in 
Washington, DC or Alaska).  
 
The above information is your notice as to the Right-to-Know listings of the stated  
product(s). Individual states will list chemicals for a variety of reasons including, but 
not limited to, the compounds toxicity; carcinogenic, tumorigenic and/or reproductive 
hazards; and the compounds environmental impact if accidentally released.  
 
16. OTHER INFORMATION  
Disclaimer: The information and recommendations contained herein are based upon tests believed to be reliable.  
However, MP Biomedicals does not guarantee the accuracy or completeness NOR SHALL ANY OF THIS  
INFORMATION CONSTITUTE A WARRANTY, WHETHER EXPRESSED OR IMPLIED, AS TO THE SAFETY OF THE  
GOODS, THE MERCHANTABILITY OF THE GOODS, OR THE FITNESS OF THE GOODS FOR A PARTICULAR  
PURPOSE. Adjustment to conform to actual conditions of usage maybe required. MP Biomedicals assumes no  
responsibility for results obtained or for incidental or consequential damages, including lost profits arising from the use of 
these data. No warranty against infringement of any patent, copyright or trademark is made or implied.  
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1 Identification of the substance/mixture and of the company/undertaking  
 
• Product identifier  
• Trade name: Soybean Oil  
• Article number: 104687  
• CAS Number:  
8 0 0 1 -2 2 -7  
• EC number:  
2 3 2 -2 7 4 -4  
• Details of the supplier of the safety data sheet  
• Manufacturer/Supplier:  
MP Biomedicals, LLC  
29525 Fountain Parkway  
Solon, OH 44139  
United States  
www.mpbio.com  
• Information department: Product safety department  
• Emergency telephone number: CHEMTREC: 1-800-424-9300 (1-703-527-3887)  
 
 
2 Hazards identification  
 
• Classification of the substance or mixture  
The substance is not classified according to the Globally Harmonized System (GHS).  
• Classification according to Directive 67/548/EEC or Directive 1999/45/EC Not applicable.  
• Information concerning particular hazards for human and environment: Not applicable.  
• Label elements  
• GHS label elements Void • Hazard 
pictograms Void  
• Signal word Void  
• Hazard statements Void  
• Additional information: Void  
• Classification system:  
• NFPA ratings (scale 0 - 4)  
Health = 0  
0 1 0 
Fire = 1  
Reactivity = 0  
 







Health = 0  
Fire = 1  
REACTIVITY 0  Reactivity = 0  
 
• Other hazards  
• Results of PBT and vPvB assessment • PBT: 
Not applicable. • vPvB: Not applicable.  
 
 
3 Composition/information on ingredients  
 
• Chemical characterization: Substances  
• CAS No. Description  
8001-22-7 Soybean Oil  










Printing date 01/16/2013  
 
Trade name: Soybean Oil  
 
 
• Identification number(s)  
• EC number: 232-274-4  
 
 
4 First aid measures  
 
• Description of first aid measures  
Safety Data Sheet  
acc. to OSHA HCS  









(Contd. of page 1)  
• General information: No special measures required.  
• After inhalation: Supply fresh air; consult doctor in case of complaints. • After 
skin contact: Generally the product does not irritate the skin.  
• After eye contact: Rinse opened eye for several minutes under running water. • After 
swallowing: If symptoms persist consult doctor.  
• Information for doctor:  
• Most important symptoms and effects, both acute and delayed No further relevant information available.  
• Indication of any immediate medical attention and special treatment needed  
No further relevant information available.  
 
 
5 Firefighting measures  
 
• Extinguishing media  
• Suitable extinguishing agents: Use fire fighting measures that suit the environment.  
• Special hazards arising from the substance or mixture No further relevant information available.  
• Advice for firefighters  
• Protective equipment: No special measures required.  
 
 
6 Accidental release measures  
 
• Personal precautions, protective equipment and emergency procedures Not required. • 
Environmental precautions: No special measures required.  
• Methods and material for containment and cleaning up:  
Absorb with liquid-binding material (sand, diatomite, acid binders, universal binders, sawdust).  
• Reference to other sections  
No dangerous substances are released.  
See Section 7 for information on safe handling.  
See Section 8 for information on personal protection equipment. See 
Section 13 for disposal information.  
 
 
7 H an dl i n g an d s t or age  
 
• Handling:  
• Precautions for safe handling No special measures required.  
• Information about protection against explosions and fires: No special measures required.  
• Conditions for safe storage, including any incompatibilities  
• Storage: 15-30 °C  
• Requirements to be met by storerooms and receptacles: No special requirements. • 
Information about storage in one common storage facility: Not required. • Further 
information about storage conditions: None.  
• Specific end use(s) No further relevant information available.  
USA  
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Trade name: Soybean Oil  
 
(Contd. of page 2)  
 
 
8 Exposure controls/personal protection  
 
• Additional information about design of technical systems: No further data; see item 7.  
• Control parameters  
• Components with limit values that require monitoring at the workplace: Not required.  
• Additional information: The lists that were valid during the creation were used as basis.  
• Exposure controls  
• Personal protective equipment:  
• General protective and hygienic measures:  
The usual precautionary measures for handling chemicals should be followed.  
• Breathing equipment: Not required.  
• Protection of hands:  
The glove material has to be impermeable and resistant to the product/ the substance/ the preparation.  
Due to missing tests no recommendation to the glove material can be given for the product/ the preparation/ the 
chemical mixture.  
Selection of the glove material on consideration of the penetration times, rates of diffusion and the degradation  
• Material of gloves  
The selection of the suitable gloves does not only depend on the material, but also on further marks of quality and  
varies from manufacturer to manufacturer.  
• Penetration time of glove material  
T h e e x a c t b re a k t h r o u g h t im e h a s t o b e f o u n d o u t b y t h e m a n u f a c tu re r o f t h e p ro t e c ti v e g lo v e s a n d h a s to b e  
observed.  
• Eye protection: Goggles recommended during refilling.  
 
 
9 Physical and chemical properties  
 
• Information on basic physical and chemical properties  
• General Information  
• Appearance:  
Form: 
Color:  
• Odor:  
• Odour threshold:  
• pH-value:  
• Change in condition  
Melting point/Melting range: 
Boiling point/Boiling range:  
• Flash point:  
• Flammability (solid, gaseous):  
• Ignition temperature:  
Decomposition temperature:  
• Auto igniting:  
• Danger of explosion:  




Not determined.  
Characteristic  
Not determined.  









Not determined.  
Not determined.  
Product does not present an explosion hazard.  
 
 
Not determined. Not 
determined.  
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• Vapor pressure:  
• Density at 20 °C (68 °F):  
• Relative density • 
Vapour density  
• Evaporation rate  
• Solubility in / Miscibility with  
Water:  
Safety Data Sheet  







Not determined.  
0.917 g/cm³ (7.652 lbs/gal)  
Not determined. 
Not determined. 
Not determined.  
 
 
Not miscible or difficult to mix.  
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• Partition coefficient (n-octanol/water): Not determined.  
• Viscosity:  
Dynamic: 
Kinematic:  
Organic solvents:  




10 Stability and reactivity  
 
• Reactivity  
• Chemical stability  
Not determined.  
Not determined.  
0 .0 %  
No further relevant information available.  
• Thermal decomposition / conditions to be avoided: No decomposition if used according to specifications. • 
Possibility of hazardous reactions No dangerous reactions known. • Conditions to avoid No further relevant 
information available.  
• Incompatible materials: No further relevant information available.  
• Hazardous decomposition products: No dangerous decomposition products known.  
 
 
11 Toxicological information  
 
• Information on toxicological effects  
• Acute toxicity:  
• Primary irritant effect:  
• on the skin: No irritant effect. • on the 
eye: No irritating effect.  
• Sensitization: No sensitizing effects known.  
• Additional toxicological information:  
When used and handled according to specifications, the product does not have any harmful effects according to  
our experience and the information provided to us. The 
substance is not subject to classification.  
• Carcinogenic categories  
• IARC (International Agency for Research on Cancer)  
Substance is not listed.  
• NTP (National Toxicology Program)  
Substance is not listed.  
 
 
12 Ecological information  
 
• Toxicity  
• Aquatic toxicity: No further relevant information available.  
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• Persistence and degradability No further relevant information available.  
• Behavior in environmental systems:  
• Bioaccumulative potential No further relevant information available. • 
Mobility in soil No further relevant information available.  
• Additional ecological information:  
• General notes: Generally not hazardous for water  
• Results of PBT and vPvB assessment • PBT: 
Not applicable. • vPvB: Not applicable.  
• Other adverse effects No further relevant information available.  
 
 
13 Disposal considerations  
 
• Waste treatment methods  
• Recommendation: Smaller quantities can be disposed of with household waste.  
• Uncleaned packagings:  
• Recommendation: Disposal must be made according to official regulations.  
 
 
14 Transport information  
 
• UN-Number  
• DOT, ADR, IMDG, IATA  
• UN proper shipping name  
• DOT, ADR, IMDG, IATA  
• Transport hazard class(es) • 
DOT, ADR, IMDG, IATA  
• Class  
• Packing group  
• DOT, ADR, IMDG, IATA  
• Environmental hazards:  
• Marine pollutant:  
• Special precautions for user  
• Transport in bulk according to Annex II of  
MARPOL73/78 and the IBC Code  



















Not applicable.  
 
 
Not applicable.  
- 
 
• Safety, health and environmental regulations/legislation specific for the substance or mixture  
• Sara  
• Section 355 (extremely hazardous substances):  
Substance is not listed.  
• Section 313 (Specific toxic chemical listings):  
Substance is not listed.  
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Trade name: Soybean Oil  
 
 
• TSCA (Toxic Substances Control Act):  
Substance is listed.  
• Proposition 65  
• Chemicals known to cause cancer:  
Substance is not listed.  
Safety Data Sheet  
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• Chemicals known to cause reproductive toxicity for females:  
Substance is not listed.  
• Chemicals known to cause reproductive toxicity for males:  
Substance is not listed.  
• Chemicals known to cause developmental toxicity:  
Substance is not listed.  
• Carcinogenic categories  
• EPA (Environmental Protection Agency)  
Substance is not listed.  
• TLV (Threshold Limit Value established by ACGIH)  
Substance is not listed.  
• NIOSH-Ca (National Institute for Occupational Safety and Health)  
Substance is not listed.  
• OSHA-Ca (Occupational Safety & Health Administration)  
Substance is not listed.  
• GHS label elements Void  
• Hazard pictograms Void  
• Signal word Void  
• Hazard statements Void  
• Chemical safety assessment: A Chemical Safety Assessment has not been carried out.  
 
 
16 Other information  
T h i s i n fo r m a t i o n i s b a s e d o n o u r p r e se n t k n o w l e d g e . H o w e v e r , t h is s h a l l n o t c o n s t i t u t e a g u a ra n t e e f o r a n y  
specific product features and shall not establish a legally valid contractual relationship.  
• Department issuing MSDS: Product safety department  
• Abbreviations and acronyms:  
A D R : A c c o r d e u r o p é e n s u r l e t r a n s p o r t d e s ma r c h a n d i s e s d a n g e r e u s e s p a r R o u t e ( E u r o p e a n A g r e e m e n t c o n c e r n i n g t h e In t e r n a t i o n a l  
Carriage of Dangerous Goods by Road)  
ACGIH: American Conference of Governmental Industrial Hygienists  
EINECS: European Inventory of Existing Commercial Chemical Substances  
CAS: Chemical Abstracts Service (division of the American Chemical Society)  
NFPA: National Fire Protection Association (USA)  























1. PRODUCT AND COMPANY IDENTIFICATION  
 
sigma-aldrich.com  
SAFETY DATA SHEET  
Version 5.3  
Revision Date 12/22/2014  
Print Date 03/30/2015  
1.1  Product identifiers  
Product name  
 
 















Poly(ethylene glycol)  
 
81280 Fluka  
 
25322-68-3  
1.2  Relevant identified uses of the substance or mixture and uses advised against  
Identified uses  : Laboratory chemicals, Manufacture of substances  
1.3  Details of the supplier of the safety data sheet  
Company  : Sigma-Aldrich  
3050 Spruce Street  
SAINT LOUIS MO 63103  
USA  
Telephone  : +1 800-325-5832  
Fax  : +1 800-325-5052  
1.4  Emergency telephone number  
Emergency Phone #  : (314) 776-6555  
 








Classification of the substance or mixture  
Not a hazardous substance or mixture.  
GHS Label elements, including precautionary statements  
Not a hazardous substance or mixture.  
Hazards not otherwise classified (HNOC) or not covered by GHS - none  
 
3. COMPOSITION/INFORMATION ON INGREDIENTS  
3.1  Substances  
Synonyms  : PEG  
 
Formula  : (C2H4O)nH2O CAS-No. 
 : 25322-68-3 EC-No. 
 : 500-038-2  
 
 
Component  Classification  Concentration  
PEG 10000  
<= 100 %  
 
4. FIRST AID MEASURES  
4.1  Description of first aid measures  
If inhaled  
If breathed in, move person into fresh air. If not breathing, give artificial respiration.  
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In case of skin contact  
Wash off with soap and plenty of water.  
In case of eye contact  
Flush eyes with water as a precaution.  
If swallowed  
Never give anything by mouth to an unconscious person. Rinse mouth with water.  
4.2  Most important symptoms and effects, both acute and delayed  
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in section 11  
4.3  Indication of any immediate medical attention and special treatment needed  
No data available  
 














Extinguishing media  
Suitable extinguishing media  
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.  
Special hazards arising from the substance or mixture  
Carbon oxides  
Nature of decomposition products not known.  
Carbon oxides  
Advice for firefighters  
Wear self-contained breathing apparatus for firefighting if necessary.  
Further information  
No data available  
 












Personal precautions, protective equipment and emergency procedures  
Avoid dust formation. Avoid breathing vapours, mist or gas. For 
personal protection see section 8.  
Environmental precautions  
Do not let product enter drains.  
Methods and materials for containment and cleaning up  
Sweep up and shovel. Keep in suitable, closed containers for disposal.  
Reference to other sections  
For disposal see section 13.  
 









Precautions for safe handling  
Provide appropriate exhaust ventilation at places where dust is formed.  
For precautions see section 2.2.  
Conditions for safe storage, including any incompatibilities  
Keep container tightly closed in a dry and well-ventilated place.  
Specific end use(s)  
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated  
 
8. EXPOSURE CONTROLS/PERSONAL PROTECTION  
8.1  Control parameters  
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Component  CAS-No.  Value  Control  Basis  
parameters  
PEG 10000  25322-68-3  TWA  10.000000  USA. Workplace Environmental  
mg/m3  Exposure Levels (WEEL)  
TWA  10.000000  USA. Workplace Environmental  
mg/m3  Exposure Levels (WEEL)  
8.2  Exposure controls  
Appropriate engineering controls  
General industrial hygiene practice.  
Personal protective equipment  
Eye/face protection  
Use equipment for eye protection tested and approved under appropriate government standards such as 
NIOSH (US) or EN 166(EU).  
Skin protection  
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without  
touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in 
accordance with applicable laws and good laboratory practices. Wash and dry hands.  
Full contact  
Material: Nitrile rubber  
Minimum layer thickness: 0.11 mm  
Break through time: 480 min  
Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M)  
Splash contact  
Material: Nitrile rubber  
Minimum layer thickness: 0.11 mm  
Break through time: 480 min  
Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M)  
data source: KCL GmbH, D-36124 Eichenzell, phone +49 (0)6659 87300, e-mail sales@kcl.de, test method:  
EN374  
If used in solution, or mixed with other substances, and under conditions which differ from EN 374, contact the  
supplier of the CE approved gloves. This recommendation is advisory only and must be evaluated by an  
industrial hygienist and safety officer familiar with the specific situation of anticipated use by our customers. It should 
not be construed as offering an approval for any specific use scenario.  
Body Protection  
Choose body protection in relation to its type, to the concentration and amount of dangerous substances, and  
to the specific work-place., The type of protective equipment must be selected according to the concentration and 
amount of the dangerous substance at the specific workplace.  
Respiratory protection  
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired, use type  
N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and approved under 
appropriate government standards such as NIOSH (US) or CEN (EU).  
Control of environmental exposure  
Do not let product enter drains.  
 
9. PHYSICAL AND CHEMICAL PROPERTIES  








Fluka - 81280  
Appearance  
Odour  
Odour Threshold  
pH  
Melting point/freezing  
point  
Form: solid  
No data available No 
data available No 
data available  
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f)  Initial boiling point and  No data available  
boiling range  
g)  Flash point  No data available h) 
 Evaporation rate  No data available  









explosive limits  
Vapour pressure  
Vapour density  




No data available  
No data available  














Water solubility  








Oxidizing properties  




No data available  
 
 
No data available  
 
 
No data available  
No data available No data 
available  
9.2  Other safety information  
No data available  
 


















No data available  
Chemical stability  
Stable under recommended storage conditions.  
Possibility of hazardous reactions  
No data available  
Conditions to avoid  
No data available  
Incompatible materials  
Strong oxidizing agents  
Hazardous decomposition products  
Other decomposition products - No data available  
In the event of fire: see section 5  
 
11. TOXICOLOGICAL INFORMATION  
11.1  Information on toxicological effects  
Acute toxicity  
LD50 Oral - Rat - 50,000 mg/kg  
Remarks: Kidney, Ureter, Bladder:Other changes.  
Inhalation: No data available  
Dermal: No data available  
No data available  
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Skin corrosion/irritation  
No data available  
Serious eye damage/eye irritation  
No data available  
Respiratory or skin sensitisation  
No data available  
Germ cell mutagenicity  












No component of this product present at levels greater than or equal to 0.1% is identified as  
probable, possible or confirmed human carcinogen by IARC.  
No component of this product present at levels greater than or equal to 0.1% is identified as a  
carcinogen or potential carcinogen by ACGIH.  
No component of this product present at levels greater than or equal to 0.1% is identified as a  
known or anticipated carcinogen by NTP.  
No component of this product present at levels greater than or equal to 0.1% is identified as a  
carcinogen or potential carcinogen by OSHA.  
Reproductive toxicity  
No data available  
No data available  
Specific target organ toxicity - single exposure  
No data available  
Specific target organ toxicity - repeated exposure  
No data available  
Aspiration hazard  
No data available  
Additional Information  
RTECS: Not available  
 
 


















No data available  
Persistence and degradability  
No data available  
Bioaccumulative potential  
No data available  
Mobility in soil  
No data available  
Results of PBT and vPvB assessment  
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted  
Other adverse effects  
No data available  
 
13. DISPOSAL CONSIDERATIONS  
13.1  Waste treatment methods  
Product  
Offer surplus and non-recyclable solutions to a licensed disposal company.  
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Contaminated packaging  
Dispose of as unused product.  
 
14. TRANSPORT INFORMATION  
DOT (US)  
Not dangerous goods  
 
IMDG  
Not dangerous goods  
 
IATA  
Not dangerous goods  
 
15. REGULATORY INFORMATION  
SARA 302 Components  
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.  
SARA 313 Components  
This material does not contain any chemical components with known CAS numbers that exceed the threshold (De 
Minimis) reporting levels established by SARA Title III, Section 313.  
SARA 311/312 Hazards  
No SARA Hazards  
Massachusetts Right To Know Components  
No components are subject to the Massachusetts Right to Know Act.  
Pennsylvania Right To Know Components  
CAS-No.  Revision Date  
PEG 10000  25322-68-3  
New Jersey Right To Know Components  
CAS-No.  Revision Date  
PEG 10000  25322-68-3  
California Prop. 65 Components  
This product does not contain any chemicals known to State of California to cause cancer, birth defects, or any other 





16. OTHER INFORMATION  
HMIS Rating  
Health hazard:  0 
Chronic Health Hazard:  
Flammability:  0Physical 
Hazard  0 
NFPA Rating  
Health hazard:  0Fire 
Hazard:  0Reactivity 
Hazard:  0 
Further information  
Copyright 2014 Sigma-Aldrich Co. LLC. License granted to make unlimited paper copies for internal use only.  
The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a  
guide. The information in this document is based on the present state of our knowledge and is applicable to the  
product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the  
product. Sigma-Aldrich Corporation and its Affiliates shall not be held liable for any damage resulting from handling  
or from contact with the above product. See www.sigma-aldrich.com and/or the reverse side of invoice or packing slip for 
additional terms and conditions of sale.  
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Preparation Information  
Sigma-Aldrich Corporation  
Product Safety - Americas Region  
1-800-521-8956  



































































Fluka - 81280  Page 7 of 7  
Page 1/7  
Safety Data Sheet  
acc. to OSHA HCS  
Printing date 04/04/2013  Reviewed on 04/04/2013  
 
 
1 Identification of the substance/mixture and of the company/undertaking  
 
• Product identifier  
• Trade name: Polyethylene Glycol, MW 8000  
• Article number: 195445  
• CAS Number:  
2 5 3 2 2 -6 8 -3  
• NLP Number:  
5 0 0 -0 3 8 -2  
• Details of the supplier of the safety data sheet  
• Manufacturer/Supplier:  
MP Biomedicals, LLC  
29525 Fountain Parkway  
Solon, OH 44139  
United States  
www.mpbio.com  
• Information department: Product safety department  
• Emergency telephone number: CHEMTREC: 1-800-424-9300 (1-703-527-3887)  
 
 
2 Hazards identification  
 
• Classification of the substance or mixture  
The substance is not classified according to the Globally Harmonized System (GHS).  
• Classification according to Directive 67/548/EEC or Directive 1999/45/EC Not applicable.  
• Information concerning particular hazards for human and environment: Not applicable.  
• Label elements  
• GHS label elements Void • Hazard 
pictograms Void  
• Signal word Void  
• Hazard statements Void  
• Classification system:  
• NFPA ratings (scale 0 - 4)  
Health = 0  
0 1 0 
Fire = 1  
Reactivity = 0  
 







Health = 0  
Fire = 1  
REACTIVITY 0  Reactivity = 0  
 
• Other hazards  
• Results of PBT and vPvB assessment • PBT: 
Not applicable. • vPvB: Not applicable.  
 
 
3 Composition/information on ingredients  
 
• Chemical characterization: Substances  
• CAS No. Description  
25322-68-3 Polyethylene glycol  
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Trade name: Polyethylene Glycol, MW 8000  
 
 
• Identification number(s) • 
NLP Number: 500-038-2  
 
 
4 First aid measures  
 
• Description of first aid measures  
Safety Data Sheet  
acc. to OSHA HCS  
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• General information: No special measures required.  
• After inhalation: Supply fresh air; consult doctor in case of complaints. • After 
skin contact: Generally the product does not irritate the skin.  
• After eye contact: Rinse opened eye for several minutes under running water. • After 
swallowing: If symptoms persist consult doctor.  
• Information for doctor:  
• Most important symptoms and effects, both acute and delayed No further relevant information available.  
• Indication of any immediate medical attention and special treatment needed  
No further relevant information available.  
 
 
5 Firefighting measures  
 
• Extinguishing media  
• Suitable extinguishing agents: Use fire fighting measures that suit the environment.  
• Special hazards arising from the substance or mixture No further relevant information available.  
• Advice for firefighters  
• Protective equipment: No special measures required.  
 
 
6 Accidental release measures  
 
• Personal precautions, protective equipment and emergency procedures Not required.  
• Environmental precautions: Do not allow to enter sewers/ surface or ground water. • 
Methods and material for containment and cleaning up: Pick up mechanically.  
• Reference to other sections  
No dangerous substances are released.  
See Section 7 for information on safe handling.  
See Section 8 for information on personal protection equipment. See 
Section 13 for disposal information.  
 
 
7 H an dl i n g an d s t or age  
 
• Handling:  
• Precautions for safe handling No special measures required.  
• Information about protection against explosions and fires: No special measures required.  
• Conditions for safe storage, including any incompatibilities  
• Storage: 15-30 °C  
• Requirements to be met by storerooms and receptacles: No special requirements. • 
Information about storage in one common storage facility: Not required. • Further 
information about storage conditions: None.  
• Specific end use(s) No further relevant information available.  
USA  
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8 Exposure controls/personal protection  
 
• Additional information about design of technical systems: No further data; see item 7.  
• Control parameters  
• Components with limit values that require monitoring at the workplace:  
25322-68-3 Polyethylene glycol  
WEEL 10 mg/m³  
(H); MW>200  
• Additional information: The lists that were valid during the creation were used as basis.  
• Exposure controls  
• Personal protective equipment:  
• General protective and hygienic measures:  
The usual precautionary measures for handling chemicals should be followed.  
• Breathing equipment: Not required.  
• Protection of hands:  
The glove material has to be impermeable and resistant to the product/ the substance/ the preparation.  
Due to missing tests no recommendation to the glove material can be given for the product/ the preparation/ the 
chemical mixture.  
Selection of the glove material on consideration of the penetration times, rates of diffusion and the degradation  
• Material of gloves  
The selection of the suitable gloves does not only depend on the material, but also on further marks of quality and  
varies from manufacturer to manufacturer.  
• Penetration time of glove material  
T h e e x a c t b re a k t h r o u g h t im e h a s t o b e f o u n d o u t b y t h e m a n u f a c tu re r o f t h e p ro t e c ti v e g lo v e s a n d h a s to b e  
observed.  
• Eye protection: Not required.  
 
 
9 Physical and chemical properties  
 
• Information on basic physical and chemical properties  
• General Information  
• Appearance:  
Form: 
Color:  
• Odor:  
• Odour threshold:  
• pH-value:  
• Change in condition  
Melting point/Melting range: 
Boiling point/Boiling range:  
• Flash point:  
• Flammability (solid, gaseous):  
• Ignition temperature:  
Decomposition temperature:  
• Auto igniting:  
Solid  
Not determined.  
Characteristic  
Not determined.  





199 °C (390 °F)  
Product is not flammable.  
 
 
Not determined.  
Not determined.  
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• Danger of explosion:  
• Explosion limits:  
Lower: 
Upper:  
• Vapor pressure:  
• Density:  
• Relative density • 
Vapour density  
• Evaporation rate  
• Solubility in / Miscibility with  
Water:  
Product does not present an explosion hazard.  
 
 
Not determined. Not 
determined.  
Not applicable. Not 
determined.  






• Partition coefficient (n-octanol/water): Not determined.  
• Viscosity:  
Dynamic: 
Kinematic:  
Organic solvents:  
Solids content:  




10 Stability and reactivity  
 
• Reactivity  
• Chemical stability  
Not applicable.  
Not applicable.  
0 .0 %  
1 0 0 .0 %  
No further relevant information available.  
• Thermal decomposition / conditions to be avoided: No decomposition if used according to specifications. • 
Possibility of hazardous reactions No dangerous reactions known. • Conditions to avoid No further relevant 
information available.  
• Incompatible materials: No further relevant information available.  
• Hazardous decomposition products: No dangerous decomposition products known.  
 
 
11 Toxicological information  
 
• Information on toxicological effects  
• Acute toxicity:  
• Primary irritant effect:  
• on the skin: No irritant effect. • on the 
eye: No irritating effect.  
• Sensitization: No sensitizing effects known.  
• Additional toxicological information:  
When used and handled according to specifications, the product does not have any harmful effects according to  
our experience and the information provided to us. The 
substance is not subject to classification.  
• Carcinogenic categories  
• IARC (International Agency for Research on Cancer)  
Substance is not listed.  
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Trade name: Polyethylene Glycol, MW 8000  
 
 
• NTP (National Toxicology Program)  
Substance is not listed.  
 
 
12 Ecological information  
 
• Toxicity  
Safety Data Sheet  
acc. to OSHA HCS  
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• Aquatic toxicity: No further relevant information available.  
• Persistence and degradability No further relevant information available.  
• Behavior in environmental systems:  
• Bioaccumulative potential No further relevant information available. • 
Mobility in soil No further relevant information available.  
• Additional ecological information:  
• General notes:  
Water hazard class 1 (Self-assessment): slightly hazardous for water  
Do not allow undiluted product or large quantities of it to reach ground water, water course or sewage system.  
• Results of PBT and vPvB assessment  
• PBT: Not applicable. • vPvB: 
Not applicable.  
• Other adverse effects No further relevant information available.  
 
 
13 Disposal considerations  
 
• Waste treatment methods  
• Recommendation: Smaller quantities can be disposed of with household waste.  
• Uncleaned packagings:  
• Recommendation: Disposal must be made according to official regulations.  
 
 
14 Transport information  
 
• UN-Number  
• DOT, ADR, ADN, IMDG, IATA  
• UN proper shipping name  
• DOT, ADR, ADN, IMDG, IATA  
• Transport hazard class(es)  
• DOT, ADR, ADN, IMDG, IATA  
• Class  
• Packing group  
• DOT, ADR, IMDG, IATA  
• Environmental hazards:  
• Marine pollutant:  
• Special precautions for user  
• Transport in bulk according to Annex II of  















Not applicable.  
 
 
Not applicable.  











Page 6/7  
Safety Data Sheet  
acc. to OSHA HCS  
Printing date 04/04/2013  Reviewed on 04/04/2013  
 
Trade name: Polyethylene Glycol, MW 8000  
 
 
(Contd. of page 5)  




15 Regulatory information  
 
• Safety, health and environmental regulations/legislation specific for the substance or mixture  
• Sara  
• Section 355 (extremely hazardous substances):  
Substance is not listed.  
• Section 313 (Specific toxic chemical listings):  
Substance is not listed.  
• TSCA (Toxic Substances Control Act):  
Substance is listed.  
• Proposition 65  
• Chemicals known to cause cancer:  
Substance is not listed.  
• Chemicals known to cause reproductive toxicity for females:  
Substance is not listed.  
• Chemicals known to cause reproductive toxicity for males:  
Substance is not listed.  
• Chemicals known to cause developmental toxicity:  
Substance is not listed.  
• Carcinogenic categories  
• EPA (Environmental Protection Agency)  
Substance is not listed.  
• TLV (Threshold Limit Value established by ACGIH)  
Substance is not listed.  
• NIOSH-Ca (National Institute for Occupational Safety and Health)  
Substance is not listed.  
• OSHA-Ca (Occupational Safety & Health Administration)  
Substance is not listed.  
• GHS label elements Void  
• Hazard pictograms Void  
• Signal word Void  
• Hazard statements Void  
• Chemical safety assessment: A Chemical Safety Assessment has not been carried out.  
 
 
16 Other information  
T h i s i n fo r m a t i o n i s b a s e d o n o u r p r e se n t k n o w l e d g e . H o w e v e r , t h is s h a l l n o t c o n s t i t u t e a g u a ra n t e e f o r a n y  
specific product features and shall not establish a legally valid contractual relationship.  
• Department issuing MSDS: Product safety department  
• Abbreviations and acronyms:  
A D R : A c c o r d e u r o p é e n s u r l e t r a n s p o r t d e s ma r c h a n d i s e s d a n g e r e u s e s p a r R o u t e ( E u r o p e a n A g r e e m e n t c o n c e r n i n g t h e In t e r n a t i o n a l  
Carriage of Dangerous Goods by Road)  
IMDG: International Maritime Code for Dangerous Goods  
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(Contd. of page 6)  
DOT: US Department of Transportation  
IATA: International Air Transport Association  
ACGIH: American Conference of Governmental Industrial Hygienists  
EINECS: European Inventory of Existing Commercial Chemical Substances  
CAS: Chemical Abstracts Service (division of the American Chemical Society)  
NFPA: National Fire Protection Association (USA)  






















































SAFETY DATA SHEET  
according to the (US) Hazard Communication Standard (29 CFR 1910.1200)  
 
Revision Date 06/05/2014  
 
 
SECTION 1. Identification  





Version 1.2  
Product number  103965  
Product name  Iron(II) sulfate heptahydrate for analysis EMSURE® ACS,ISO,Reag.  
Ph Eur  
CAS-No.  7782-63-0  
 
Relevant identified uses of the substance or mixture and uses advised against  
Identified uses  Reagent for analysis  
 
Details of the supplier of the safety data sheet  
Company  EMD Millipore Corporation | 290 Concord Road, Billerica, MA 01821,  
United States of America | General Inquiries: +1-978-715-4321 |  




Emergency telephone  800-424-9300 CHEMTREC (USA)  
+1-703-527-3887 CHEMTREC (International)  
24 Hours/day; 7 Days/week  
 
 
SECTION 2. Hazards identification  
GHS Classification  
Acute toxicity, Category 4, Oral, H302  
Skin irritation, Category 2, H315 Eye 
irritation, Category 2, H319  
For the full text of the H-Statements mentioned in this Section, see Section 16.  
 
GHS-Labeling  







Signal Word  
Warning  
 
Hazard Statements  
H302 Harmful if swallowed. H315 
Causes skin irritation.  
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H319 Causes serious eye irritation.  
 
Precautionary Statements  
P302 + P352 IF ON SKIN: Wash with plenty of soap and water.  
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact  
lenses, if present and easy to do. Continue rinsing.  
 
OSHA Hazards  
This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR  
1910.1200). This information is based on 29 CFR 1910.1200 criteria prior to adoption of the GHS and may 
deviate from the GHS information.  
Other hazards  
None known.  
 
 
SECTION 3. Composition/information on ingredients  
Formula  FeSO₄ * 7H₂O  FeO₄S * 7H₂O (Hill)  
Molar mass  278.02 g/mol  
 
 
Hazardous ingredients  
Chemical Name ( Concentration)  
CAS-No.  
Iron(II) sulphate heptahydrate ( >= 90 % - <= 100 % )  
7782-63-0  
Exact percentages are being withheld as a trade secret.  
 
 
SECTION 4. First aid measures  
Description of first-aid measures  
Inhalation  
After inhalation: fresh air.  
Skin contact  
After skin contact: wash off with plenty of water. Remove contaminated clothing.  
Eye contact  
After eye contact: rinse out with plenty of water. Call in ophthalmologist.  
Ingestion  
After swallowing: immediately make victim drink water (two glasses at most). Consult a  
physician.  
Never give anything by mouth to an unconscious person.  
Most important symptoms and effects, both acute and delayed  
Diarrhea, Bloody vomiting, irritant effects  
The following applies to soluble iron compounds: nausea and vomiting after swallowing. The 
absorption of large quantities is followed by cardiovascular disorders. Toxic effect on liver and 
kidneys.  
 
Indication of any immediate medical attention and special treatment needed  
No information available.  
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SECTION 5. Fire-fighting measures  
Extinguishing media  
Suitable extinguishing media  
Use extinguishing measures that are appropriate to local circumstances and the surrounding  
environment.  
Unsuitable extinguishing media  
For this substance/mixture no limitations of extinguishing agents are given.  
 
Special hazards arising from the substance or mixture  
Not combustible.  
Ambient fire may liberate hazardous vapors.  
Fire may cause evolution of:  
Sulfur oxides  
 
Advice for firefighters  
Special protective equipment for fire-fighters  
Stay in danger area only with self-contained breathing apparatus. Prevent skin contact by  
keeping a safe distance or by wearing suitable protective clothing.  
Further information  
Suppress (knock down) gases/vapors/mists with a water spray jet. Prevent fire extinguishing  
water from contaminating surface water or the ground water system.  
 
SECTION 6. Accidental release measures  
Personal precautions, protective equipment and emergency procedures  
Advice for non-emergency personnel: Avoid inhalation of dusts. Avoid substance contact.  
Ensure adequate ventilation. Evacuate the danger area, observe emergency procedures, consult an 
expert.  
Advice for emergency responders: Protective equipment see section 8.  
 
Environmental precautions  
Do not empty into drains.  
 
Methods and materials for containment and cleaning up  
Cover drains. Collect, bind, and pump off spills.  
Observe possible material restrictions (see sections 7 and 10).  
Take up dry. Dispose of properly. Clean up affected area. Avoid generation of dusts.  
 
 
SECTION 7. Handling and storage  
Precautions for safe handling  
Observe label precautions.  
 
Conditions for safe storage, including any incompatibilities  
Tightly closed. Dry. Protected from light.  
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SECTION 8. Exposure controls/personal protection  
Exposure limit(s)  
Ingredients  
Basis  Value  Threshold  Remarks  
limits  






Time Weighted Average  
(TWA):  
Recommended  
exposure limit (REL):  
Time Weighted Average  
(TWA):  
1 mg/m³  
 
1 mg/m³  
 
1 mg/m³  
Expressed as: as Fe  
 
Expressed as: as Fe  
 
Expressed as: as Fe  
 
Engineering measures  
Technical measures and appropriate working operations should be given priority over the use of personal  
protective equipment.  
Individual protection measures  
Protective clothing should be selected specifically for the workplace, depending on concentration and quantity of  
the hazardous substances handled. The chemical resistance of the protective equipment should be inquired at  
the respective supplier.  
Hygiene measures  
Immediately change contaminated clothing. Apply skin- protective barrier cream. Wash hands  
and face after working with substance.  
Eye/face protection  
Safety glasses  
Hand protection  
Chemical-resistant, impervious gloves complying with an approved standard should be worn at  
all times when handling chemical products if a risk assessment indicates this is necessary.  
Other protective equipment:  
protective clothing  
Respiratory protection  
required when dusts are generated.  
Use a properly fitted, air-purifying or air-fed respirator complying with an approved standard if a risk assessment  
indicates this is necessary. Respirator selection must be based on known or anticipated exposure levels, the 
hazards of the product and the safe working limits of the selected respirator.  
 
 
SECTION 9. Physical and chemical properties  
Physical state  solid  
 
Color  blue green  
 
Odor  odorless  
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Melting point  
 
 
Boiling point  
 
Flash point  
 
Evaporation rate  
 
Flammability (solid, gas)  
 
Lower explosion limit  
 
Upper explosion limit  
 
Vapor pressure  
 





Relative density  
 
Water solubility  
 
 
Partition coefficient: n-  
octanol/water  
Autoignition temperature  
 
Decomposition temperature  
 
Viscosity, dynamic  
 
Explosive properties  
 
Oxidizing properties  
 
Ignition temperature  
 
Bulk density  




at 50 g/l  
68 °F ( 20 °C)  
 
> 60 °C  
Elimination of water of crystallization  
 
No information available.  
 
does not flash  
 
No information available.  
 
No information available.  
 
not applicable  
 
not applicable  
 
No information available.  
 
No information available.  
 
1.89 g/cm³  
at 68 °F ( 20 °C)  
 
No information available.  
 
ca. 400 g/l  
at 68 °F ( 20 °C)  
 
No information available.  
 
No information available.  
 
> 572 °F ( > 300 °C)  
 
not applicable  
 




not combustible  
 




SECTION 10. Stability and reactivity  
Reactivity  
See below  
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Chemical stability  
Sensitivity to light  
releases water of crystallization when heated.  
 
Possibility of hazardous reactions  
increased reactivity with:  
Bases, Oxidizing agents  
 
Conditions to avoid  
Exposure to moisture.  
 
Incompatible materials  
no information available  
 
Hazardous decomposition products  
in the event of fire: See section 5.  
 
 
SECTION 11. Toxicological information  
Information on toxicological effects  
Likely route of exposure  
Eye contact, Skin contact, Ingestion  
Acute oral toxicity  




Acute inhalation toxicity  
 
Symptoms: Possible damages:, mucosal irritations  
Skin irritation  
Causes skin irritation.  
Eye irritation  
Causes serious eye irritation.  
Sensitization  
In animal experiments:  
Result: negative  
(IUCLID)  
Genotoxicity in vitro  
Ames test  
Result: negative  
(Lit.)  
Specific target organ systemic toxicity - single exposure  
The substance or mixture is not classified as specific target organ toxicant, single exposure.  
Specific target organ systemic toxicity - repeated exposure  
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Aspiration hazard  



















Further information  
Systemic effects:  
No ingredient of this product present at levels greater than or 
equal to 0.1% is identified as probable, possible or confirmed 
human carcinogen by IARC.  
No ingredient of this product present at levels greater than or  
equal to 0.1% is identified as a carcinogen or potential 
carcinogen by OSHA.  
No ingredient of this product present at levels greater than or  
equal to 0.1% is identified as a known or anticipated carcinogen by 
NTP.  
No ingredient of this product present at levels greater than or  
equal to 0.1% is identified as a carcinogen or potential 
carcinogen by ACGIH.  
After swallowing of large amounts:  
Bloody vomiting, Diarrhea, drop in blood pressure  
The following applies to soluble iron compounds: nausea and vomiting after swallowing. The 
absorption of large quantities is followed by cardiovascular disorders. Toxic effect on liver and 
kidneys.  
Other dangerous properties can not be excluded.  
Handle in accordance with good industrial hygiene and safety practice.  
 
 
SECTION 12. Ecological information  
Ecotoxicity  
Toxicity to fish  
LC50 Poecilia retiaculata (guppy): 925 mg/l; 96 h (IUCLID)  
Toxicity to daphnia and other aquatic invertebrates  
EC50 Daphnia magna (Water flea): 152 mg/l; 48 h (anhydrous substance) (IUCLID)  
Toxicity to bacteria  
EC0 Pseudomonas fluorescens: 100 mg/l; 24 h (anhydrous substance) (IUCLID)  
Persistence and degradability  
No information available.  
Bioaccumulative potential  
No information available.  
Mobility in soil  
No information available.  
 
Additional ecological information  
Discharge into the environment must be avoided.  
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SECTION 13. Disposal considerations  
The information presented only applies to the material as supplied. The identification based on characteristic(s)  
or listing may not apply if the material has been used or otherwise contaminated. It is the responsibility of the  
waste generator to determine the toxicity and physical properties of the material generated to determine the  
proper waste identification and disposal methods in compliance with applicable regulations. Disposal should be  
in accordance with applicable regional, national and local laws and regulations.  
 
 
SECTION 14. Transport information  
Land transport (DOT)  
Not classified as dangerous in the meaning of transport regulations.  
 
Air transport (IATA)  
Not classified as dangerous in the meaning of transport regulations.  
 
Sea transport (IMDG)  
Not classified as dangerous in the meaning of transport regulations.  
 
 
SECTION 15. Regulatory information  
United States of America  
OSHA Hazards  
Toxic by ingestion  
Skin irritant Eye irritant  
This information is based on 29 CFR 1910.1200 criteria prior to adoption of the GHS, and may  
deviate from the GHS information on the label and in section 2.  
 
SARA 311/312 Hazards  
Acute Health Hazard  
 
 
SARA 313  
SARA 313: This material does not contain any chemical components with known CAS numbers  
that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313.  
SARA 302  
SARA 302: No chemicals in this material are subject to the reporting requirements of SARA Title  
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Clean Water Act  
The following Hazardous Substances are listed under the U.S. CleanWater Act, Section 311, Table 116.4A:  
Ingredients  
Iron(II) sulphate heptahydrate  
The following Hazardous Chemicals are listed under the U.S. CleanWater Act, Section 311, Table 117.3:  
Ingredients  
Iron(II) sulphate heptahydrate  
DEA List I  
Not listed  
DEA List II  
Not listed  
 
US State Regulations  
 
Massachusetts Right To Know  
Ingredients  
Iron(II) sulphate heptahydrate  
Pennsylvania Right To Know  
Ingredients  
Iron(II) sulphate heptahydrate  
New Jersey Right To Know  
Ingredients  
Iron(II) sulphate heptahydrate  
California Prop 65 Components  
This product does not contain any chemicals known to the State of California to cause cancer,  
birth, or any other reproductive defects.  
Notification status  
TSCA:  All components of the product are listed in the TSCA-inventory.  
 




SECTION 16. Other information  
 
 
Training advice  
Provide adequate information, instruction and training for operators.  
 
Full text of H-Statements referred to under sections 2 and 3.  
H302  Harmful if swallowed.  
H315  Causes skin irritation.  
H319  Causes serious eye irritation.  
 
Key or legend to abbreviations and acronyms used in the safety data sheet  
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Revision Date06/05/2014  
 
 
The information contained herein is based on the present state of our knowledge. It characterizes the product with regard to  
appropriate safety precautions. It does not represent a warranty of any product properties and we assume no liability for any  
loss or injury which may result from the use of this information. Users should conduct their own investigations to determine  
the suitability of the information.  
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Version 1.0  
Product number  108342  
Product name  D(+)-Glucose monohydrate for microbiology  
 
 
Relevant identified uses of the substance or mixture and uses advised against  
Identified uses  Reagent for analysis  
 













SECTION 2. Hazards identification  
 
GHS-Labeling  
EMD Millipore Corporation | 290 Concord Road, Billerica, MA 01821,  
United States of America | SDS Phone Support: +1-978-715-1335 | 
General Inquiries: +1-978-751-4321 | Monday to Friday, 9:00 AM to  
4:00 PM Eastern Time (GMT-5)  
 
e-mail: mm_sds@merckgroup.com  
 
800-424-9300 CHEMTREC (USA)  
+1-703-527-3887 CHEMTREC (International)  
24 Hours/day; 7 Days/week  
Not a dangerous substance according to GHS.  
 
OSHA Hazards  
While this material is not considered hazardous by the OSHA Hazard Communication Standard (29  
CFR 1910.1200), this MSDS contains valuable information critical to the safe handling and proper use  
of the product. This MSDS should be retained and available for employees and other users of this 
product.  
Other hazards  
None known.  
 
 
SECTION 3. Composition/information on ingredients  
Formula  C₆H₁₂O₆ * H₂O (Hill) CAS-
No.  14431-43-7  
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SECTION 4. First aid measures  
Description of first-aid measures  
Inhalation  
After inhalation: fresh air.  
Skin contact  
 
108342  
D(+)-Glucose monohydrate for microbiology  
 
 
No hazardous ingredients according to the OSHA Hazard  
Communication Standard 29 CFR 1910.1200.  
 
Version 1.0  
After skin contact (particles, dusts): Rinse with water.  
Eye contact  
After eye contact: rinse out with plenty of water.  
Ingestion  
After swallowing (large amounts): consult doctor if feeling unwell.  
Never give anything by mouth to an unconscious person.  
Most important symptoms and effects, both acute and delayed  
We have no description of any toxic symptoms.  
 
Indication of any immediate medical attention and special treatment needed  
No information available.  
 
 
SECTION 5. Fire-fighting measures  
Extinguishing media  
Suitable extinguishing media  
Water, Carbon dioxide (CO2), Foam, Dry powder  
Unsuitable extinguishing media  
For this substance/mixture no limitations of extinguishing agents are given.  
 
Special hazards arising from the substance or mixture  
Combustible material  
 
Advice for firefighters  
Special protective equipment for fire-fighters  
In the event of fire, wear self-contained breathing apparatus.  
 
SECTION 6. Accidental release measures  
Personal precautions, protective equipment and emergency procedures  
Advice for non-emergency personnel: Avoid inhalation of dusts. Evacuate the danger area,  
observe emergency procedures, consult an expert.  
Advice for emergency responders: Protective equipment see section 8.  
 
Environmental precautions  
No special precautionary measures necessary.  
 
Methods and materials for containment and cleaning up  
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Observe possible material restrictions (see sections 7 and 10).  
Take up dry. Dispose of properly. Clean up affected area. Avoid generation of dusts.  
 
 
SECTION 7. Handling and storage  
Precautions for safe handling  
Observe label precautions.  
 
Conditions for safe storage, including any incompatibilities  
Tightly closed. Dry.  
Store at +15°C to +25°C (+59°F to +77°F).  
 
 
SECTION 8. Exposure controls/personal protection  
Exposure limit(s)  
Contains no substances with occupational exposure limit values.  
Engineering measures  
Technical measures and appropriate working operations should be given priority over the use of personal  
protective equipment.  
Individual protection measures  
Protective clothing should be selected specifically for the workplace, depending on concentration and quantity of  
the hazardous substances handled. The chemical resistance of the protective equipment should be inquired at the 
respective supplier.  
Hygiene measures  
Change contaminated clothing. Wash hands after working with substance.  
Eye/face protection  
Safety glasses  
Hand protection  
Chemical-resistant, impervious gloves complying with an approved standard should be worn at all times when  
handling chemical products if a risk assessment indicates this is necessary.  
Recommended:  
full contact:  
Glove material:  Nitrile rubber  
Glove thickness:  0.11 mm  
Break through time:  > 480 min  
 
splash contact:  
Glove material:  Nitrile rubber  
Glove thickness:  0.11 mm  
Break through time:  > 480 min  
 
Respiratory protection  
required when dusts are generated.  
Use a properly fitted, air-purifying or air-fed respirator complying with an approved standard if a risk assessment  
indicates this is necessary. Respirator selection must be based on known or anticipated exposure levels, the 
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SECTION 9. Physical and chemical properties  












Melting point  
 
Boiling point  
 
Flash point  
 
Evaporation rate  
 
Flammability (solid, gas)  
 
Lower explosion limit  
 
Upper explosion limit  
 
Vapor pressure  
 
Relative vapor density  
 
Relative density  
 
Water solubility  
 
 




Autoignition temperature  
 
Decomposition temperature  
 
Viscosity, dynamic  
 
Ignition temperature  
 







No information available.  
 
6-7  
at 100 g/l  
68 °F ( 20 °C)  
 
ca. 181 °F ( 83 °C)  
 
No information available.  
 
No information available.  
 
No information available.  
 
No information available.  
 
No information available.  
 
No information available.  
 
No information available.  
 
No information available.  
 
No information available.  
 
1,000 g/l  
at 68 °F ( 20 °C)  
 
log Pow: -3.29  
(anhydrous substance) Bioaccumulation is not expected (log  
Pow <1).  
 
No information available.  
 
No information available.  
 
No information available.  
 
ca. 932 °F ( 500 °C)  
 
ca. 630 kg/m³  
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SECTION 10. Stability and reactivity  
Reactivity  
Risk of dust explosion.  
 
Chemical stability  
releases water of crystallization when heated.  
 
Possibility of hazardous reactions  
Strong oxidizing agents  
 
Conditions to avoid  
no information available  
 
Incompatible materials  
no information available  
 
Hazardous decomposition products  
no information available  
 
 
SECTION 11. Toxicological information  
Information on toxicological effects  
Likely route of exposure  
Eye contact, Skin contact, Ingestion  
Acute oral toxicity  
LD50 rat: 25,800 mg/kg (anhydrous substance) (RTECS)  
 
Specific target organ systemic toxicity - single exposure  
The substance or mixture is not classified as specific target organ toxicant, single exposure.  
Specific target organ systemic toxicity - repeated exposure  
The substance or mixture is not classified as specific target organ toxicant, repeated exposure.  
Aspiration hazard  















No ingredient of this product present at levels greater than or  
equal to 0.1% is identified as probable, possible or confirmed 
human carcinogen by IARC.  
No ingredient of this product present at levels greater than or  
equal to 0.1% is identified as a carcinogen or potential 
carcinogen by OSHA.  
No ingredient of this product present at levels greater than or  
equal to 0.1% is identified as a known or anticipated carcinogen by 
NTP.  
No ingredient of this product present at levels greater than or  
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equal to 0.1% is identified as a carcinogen or potential  
carcinogen by ACGIH.  
 
Further information  
Our own experience has provided no indication of any hazardous potential.  
Further data:  
Substances which occur in nature  
Handle in accordance with good industrial hygiene and safety practice.  
Substance which occurs in the human body under physiological conditions.  
 
 
SECTION 12. Ecological information  
Ecotoxicity  
Toxicity to fish  
LC0 fish: 60,000 mg/l (anhydrous substance) (External MSDS)  
Persistence and degradability  
Biodegradability  
48 %; 5 d  
OECD Test Guideline 301D  
(External MSDS)  
Readily biodegradable.  
Bioaccumulative potential  
Partition coefficient: n-octanol/water  
log Pow: -3.29  
(anhydrous substance) Bioaccumulation is not expected (log Pow <1).  
Mobility in soil  
No information available.  
Other adverse effects  
Additional ecological information  
No ecological problems are to be expected when the product is handled and used with due care  
and attention.  
 
 
SECTION 13. Disposal considerations  
The information presented only applies to the material as supplied. The identification based on characteristic(s)  
or listing may not apply if the material has been used or otherwise contaminated. It is the responsibility of the  
waste generator to determine the toxicity and physical properties of the material generated to determine the  
proper waste identification and disposal methods in compliance with applicable regulations. Disposal should be in 
accordance with applicable regional, national and local laws and regulations.  
 
 
SECTION 14. Transport information  
Land transport (DOT)  
Not classified as dangerous in the meaning of transport regulations.  
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Not classified as dangerous in the meaning of transport regulations.  
 
 
Sea transport (IMDG)  




SECTION 15. Regulatory information  
United States of America  
OSHA Hazards  
No OSHA Hazards  
This information is based on 29 CFR 1910.1200 criteria prior to adoption of the GHS, and may  
deviate from the GHS information on the label and in section 2.  
SARA 311/312 Hazards  
No SARA Hazards  
 
Clean Water Act  
This product does not contain any Hazardous Substances listed under the U.S. CleanWater Act, Section 311,  
Table 116.4A.  
This product does not contain any Hazardous Chemicals listed under the U.S. CleanWater Act, Section 311, 
Table 117.3.  
Massachusetts Right To Know  
Remarks  
No components are subject to the Massachusetts Right to Know Act.  
Pennsylvania Right To Know  
Ingredients  
D-(+)-glucose  
water of crystallization  
New Jersey Right To Know  
Ingredients  
D-(+)-glucose  
water of crystallization  
California Prop 65 Components  
This product does not contain any chemicals known to the State of California to cause cancer,  
birth, or any other reproductive defects.  
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SECTION 16. Other information  
 
108342  
D(+)-Glucose monohydrate for microbiology  
 
 
On TSCA Inventory  
 
All components of this product are on the Canadian DSL.  
 
Version 1.0  
 
 
















Training advice  
Provide adequate information, instruction and training for operators.  
 
Key or legend to abbreviations and acronyms used in the safety data sheet  
Used abbreviations and acronyms can be looked up at www.wikipedia.org.  
 
 
The information contained herein is based on the present state of our knowledge. It characterizes the product with regard to  
appropriate safety precautions. It does not represent a warranty of any product properties and we assume no liability for any  
loss or injury which may result from the use of this information. Users should conduct their own investigations to determine the 
suitability of the information.  







































Product Name  




Recommended Use  
 
Company  
Fisher Scientific  
One Reagent Lane  
Fair Lawn, NJ 07410 











Appearance Off-white  
 
 
Target Organs  
 
Potential Health Effects  
 
Acute Effects  





Materialision Date 08-Nov-2012 Sheet 
Safety Data  
Rev  
 
1. PRODUCT AND COMPANY IDENTIFICATION  
 
 
Calcium carbonate  
C63-10, C63-3  
 
Precipitated chalk; Aragonite; Agricultural limestone  
 
Laboratory chemicals  
 
Emergency Telephone Number  
CHEMTREC®, Inside the USA: 800-  
424-9300  








Emergency Overview  
Irritating to eyes and skin. May cause irritation of respiratory tract.  
 
Physical State Solid  
 
 






Irritating to eyes.  
Irritating to skin. May be harmful in contact with skin.  
May cause irritation of respiratory tract. May be harmful if inhaled.  
 
 


























odor odorless  
Ingestion  May be harmful if swallowed. Ingestion may cause gastrointestinal irritation, nausea, vomiting  
and diarrhea.  
 
Chronic Effects  None known.  
 
See Section 11 for additional Toxicological information.  
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Component  CAS-No  Weight %  
Calcium carbonate  471-34-1  >95  
 
4. FIRST AID MEASURES  
 
 
Eye Contact  
 
 












Flash Point  
Method  
 
Autoignition Temperature  




Suitable Extinguishing Media  
 
 
Unsuitable Extinguishing Media  
 
Hazardous Combustion Products  
 
 
Rinse immediately with plenty of water, also under the eyelids, for at least 15 minutes. Obtain 
medical attention.  
 
Wash off immediately with plenty of water for at least 15 minutes. Obtain medical attention.  
 
Move to fresh air. If breathing is difficult, give oxygen. Get medical attention immediately if 
symptoms occur.  
 
Do not induce vomiting. Obtain medical attention.  
 
Treat symptomatically.  
 
5. FIRE-FIGHTING MEASURES  
 
 
Not applicable  
No information available.  
 
No information available.  
 
No data available No 
data available  
 
Substance is nonflammable; use agent most appropriate to 
extinguish surrounding fire..  
 
No information available.  
 
No information available.  
 
Sensitivity to mechanical impact  No information available. 
Sensitivity to static discharge  No information available.  
 
Specific Hazards Arising from the Chemical  
Thermal decomposition can lead to release of irritating gases and vapors.  
 
Protective Equipment and Precautions for Firefighters  
As in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full protective  
gear.  
 
NFPA  Health 1  Flammability 0  Instability 0  Physical hazards N/A  
 
6. ACCIDENTAL RELEASE MEASURES  
 
 
Personal Precautions  Ensure adequate ventilation. Use personal protective equipment. Avoid dust formation.  
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Engineering Measures  
 
 
Exposure Guidelines  
formation.  
 
7. HANDLING AND STORAGE  
 
 
Wear personal protective equipment. Ensure adequate ventilation. Do not get in eyes, on skin, 
or on clothing. Avoid ingestion and inhalation. Avoid dust formation.  
 
Keep containers tightly closed in a dry, cool and well-ventilated place.  
 
8. EXPOSURE CONTROLS/PERSONAL PROTECTION  
 
 
Ensure that eyewash stations and safety showers are close to the workstation location. Ensure 
adequate ventilation, especially in confined areas.  
 
Component  ACGIH TLV  OSHA PEL  NIOSH IDLH  
Calcium carbonate  TWA: 10 mg/m3  
TWA: 5 mg/m3  
 
 
Component  Quebec  Mexico OEL (TWA)  Ontario TWAEV  
Calcium carbonate  TWA: 10 mg/m3  
 
 
NIOSH IDLH: Immediately Dangerous to Life or Health  
 
Personal Protective Equipment  
Eye/face Protection  
 
Skin and body protection  







Physical State  
Appearance  
odor  
Odor Threshold  
pH  
Vapor Pressure  
Vapor Density  
Viscosity  
Boiling Point/Range 
Melting Point/Range  
Decomposition temperature  
Flash Point  
Evaporation Rate  
Specific Gravity  
Solubility  
log Pow  
Molecular Weight  
Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's  
eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166. 
Wear appropriate protective gloves and clothing to prevent skin exposure.  
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN  
149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits 
are exceeded or if irritation or other symptoms are experienced.  
 






No information available.  
8-9  
No information available. No 
information available. No 
information available. No 
information available.  
825°C / 1517°F  
825 °C  
Not applicable  
No information available. No 
information available.  
Slightly soluble in water  







Page 3 / 7  
Thermo Fisher Scientific - Calcium carbonate  Revision Date 08-Nov-2012  
_____________________________________________________________________________________________  
 
9. PHYSICAL AND CHEMICAL PROPERTIES  







Conditions to Avoid  
 
Incompatible Materials  
 
Hazardous Decomposition Products  
 
Hazardous Polymerization  
 





Acute Toxicity  
C Ca O3  
 
10. STABILITY AND REACTIVITY  
 
 
Stable under normal conditions.  
 
Incompatible products. Excess heat. Avoid dust formation.  
 
Strong oxidizing agents, Acids  
 
Carbon monoxide (CO), Carbon dioxide (CO2), Calcium oxides  
 
Hazardous polymerization does not occur.  
 
None under normal processing..  
 




Component Information  
Component  















LD50 Oral  




Irritating to eyes and skin  
 





LD50 Dermal  





LC50 Inhalation (Dust)  








Mutagenic Effects  
 
Reproductive Effects  
 




Other Adverse Effects  
 
 
Endocrine Disruptor Information  
 




No information available.  
 
No information available.  
 
No information available.  
 
No information available.  
 
No information available.  
 
The toxicological properties have not been fully investigated.. See actual entry in RTECS for 
complete information.  
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Do not empty into drains  
 
Persistence and Degradability  
 

































International Inventories  
 
No information available  
 
No information available  
 
No information available  
 
 
13. DISPOSAL CONSIDERATIONS  
 
 
Chemical waste generators must determine whether a discarded chemical is classified as a  
hazardous waste. Chemical waste generators must also consult local, regional, and national 
hazardous waste regulations to ensure complete and accurate classification.  
 
 




Not regulated  
 
 
Not regulated  
 
 
Not regulated  
 
 




15. REGULATORY INFORMATION  
Component  TSCA  DSL  NDSL EINECS ELINCS  NLP  PICCS  ENCS  AICS  CHINA  KECL  




X - Listed  
E - Indicates a substance that is the subject of a Section 5(e) Consent order under TSCA. F - Indicates 
a substance that is the subject of a Section 5(f) Rule under TSCA.  
N - Indicates a polymeric substance containing no free-radical initiator in its inventory name but is considered to cover the designated polymer 
made with any free-radical initiator regardless of the amount used.  
P - Indicates a commenced PMN substance  
R - Indicates a substance that is the subject of a Section 6 risk management rule under TSCA.  
S - Indicates a substance that is identified in a proposed or final Significant New Use Rule T - 
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XU - Indicates a substance exempt from reporting under the Inventory Update Rule, i.e. Partial Updating of the TSCA Inventory Data Base 
Production and Site Reports (40 CFR 710(B).  
Y1 - Indicates an exempt polymer that has a number-average molecular weight of 1,000 or greater.  
Y2 - Indicates an exempt polymer that is a polyester and is made only from reactants included in a specified list of low concern reactants that comprises 
one of the eligibility criteria for the exemption rule.  
 
 
U.S. Federal Regulations  
 
TSCA 12(b) Not applicable  
 
SARA 313  
Not applicable  
 
 
SARA 311/312 Hazardous Categorization  
Acute Health Hazard  
Chronic Health Hazard  
Fire Hazard  
Sudden Release of Pressure Hazard  
Reactive Hazard  
 
Clean Water Act  
Not applicable  
 
 




Not applicable  
 
CERCLA  
Not Applicable  
 
California Proposition 65  
This product does not contain any Proposition 65 chemicals.  
 
 
State Right-to-Know  
Not applicable  
 






Reportable Quantity (RQ):  N 
DOT Marine Pollutant  NDOT 
Severe Marine Pollutant  N 
 
U.S. Department of Homeland Security  
This product does not contain any DHS chemicals.  
 
Other International Regulations  
 




This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations (CPR) and the 
MSDS contains all the information required by the CPR.  
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Creation Date  
 
Print Date  
 













16. OTHER INFORMATION  
 
 
Regulatory Affairs  
Thermo Fisher Scientific  






(M)SDS sections updated 2  
The information provided on this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date  
of its publication. The information given is designed only as a guide for safe handling, use, processing, storage,  
transportation, disposal and release and is not to be considered as a warranty or quality specification. The information  
relates only to the specific material designated and may not be valid for such material used in combination with any other 
material or in any process, unless specified in the text.  
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SAFETY DATA SHEET  
according to the (US) Hazard Communication Standard (29 CFR 1910.1200)  
 
Revision Date 10/14/2014  
 
 
SECTION 1. Identification  





Version 1.3  
Product number  101217  
Product name  Ammonium sulfate for analysis EMSURE® ACS,ISO,Reag. Ph Eur CAS-
No.  7783-20-2  
 
Relevant identified uses of the substance or mixture and uses advised against  
Identified uses  Reagent for analysis  
 
Details of the supplier of the safety data sheet  
Company  EMD Millipore Corporation | 290 Concord Road, Billerica, MA 01821,  
United States of America | General Inquiries: +1-978-715-4321 |  





Emergency telephone  800-424-9300 CHEMTREC (USA)  
+1-703-527-3887 CHEMTREC (International)  
24 Hours/day; 7 Days/week  
 
 
SECTION 2. Hazards identification  
 
GHS-Labeling  
Not a dangerous substance according to GHS.  
 
Other hazards  
None known.  
 
 
SECTION 3. Composition/information on ingredients  
Formula  (NH₄)₂SO₄  H₈N₂O₄S (Hill)  







SECTION 4. First aid measures  
Description of first-aid measures  
Inhalation  
After inhalation: fresh air.  
 
No hazardous ingredients according to the OSHA Hazard  
Communication Standard 29 CFR 1910.1200.  
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Product number  101217  Version 1.3  
Product name  Ammonium sulfate for analysis EMSURE® ACS,ISO,Reag. Ph Eur  
 
 
Skin contact  
In case of skin contact: Take off immediately all contaminated clothing. Rinse skin with water/  
shower.  
Eye contact  
After eye contact: rinse out with plenty of water.  
Ingestion  
After swallowing: make victim drink water (two glasses at most). Consult doctor if feeling unwell.  
Never give anything by mouth to an unconscious person.  
Most important symptoms and effects, both acute and delayed  
The following applies to ammonium salts in general: after swallowing: local irritation symptoms,  
nausea, vomiting, diarrhea. Systemic effect: after the uptake of very large qantities: drop in blood 
pressure, collapse, CNS disorders, spasms, narcotic conditions, respiratory paralysis, hemolysis.  
 
Indication of any immediate medical attention and special treatment needed  
No information available.  
 
 
SECTION 5. Fire-fighting measures  
Extinguishing media  
Suitable extinguishing media  
Use extinguishing measures that are appropriate to local circumstances and the surrounding  
environment.  
Unsuitable extinguishing media  
For this substance/mixture no limitations of extinguishing agents are given.  
 
Special hazards arising from the substance or mixture  
Not combustible.  
Ambient fire may liberate hazardous vapors.  
Fire may cause evolution of:  
nitrogen oxides, Sulfur oxides  
 
Advice for firefighters  
Special protective equipment for fire-fighters  
In the event of fire, wear self-contained breathing apparatus.  
Further information  
Suppress (knock down) gases/vapors/mists with a water spray jet. Prevent fire extinguishing  
water from contaminating surface water or the ground water system.  
 
 
SECTION 6. Accidental release measures  
Personal precautions, protective equipment and emergency procedures  
Advice for non-emergency personnel: Avoid inhalation of dusts. Evacuate the danger area,  
observe emergency procedures, consult an expert.  
Advice for emergency responders: Protective equipment see section 8.  
 
Environmental precautions  
Do not empty into drains.  
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Product number  101217  Version 1.3  
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Methods and materials for containment and cleaning up  
Cover drains. Collect, bind, and pump off spills.  
Observe possible material restrictions (see sections 7 and 10).  
Take up dry. Dispose of properly. Clean up affected area. Avoid generation of dusts.  
 
 
SECTION 7. Handling and storage  
Precautions for safe handling  
Observe label precautions.  
 
Conditions for safe storage, including any incompatibilities  
Tightly closed. Dry.  
Store at +5°C to +30°C (+41°F to +86°F).  
 
 
SECTION 8. Exposure controls/personal protection  
Exposure limit(s)  
Contains no substances with occupational exposure limit values.  
Engineering measures  
Technical measures and appropriate working operations should be given priority over the use of personal  
protective equipment.  
Individual protection measures  
Protective clothing should be selected specifically for the workplace, depending on concentration and quantity of  
the hazardous substances handled. The chemical resistance of the protective equipment should be inquired at the 
respective supplier.  
Hygiene measures  
Change contaminated clothing. Wash hands after working with substance.  
Eye/face protection  
Safety glasses  
Hand protection  
Chemical-resistant, impervious gloves complying with an approved standard should be worn at  
all times when handling chemical products if a risk assessment indicates this is necessary.  
Respiratory protection  
required when dusts are generated.  
Use a properly fitted, air-purifying or air-fed respirator complying with an approved standard if a risk assessment  
indicates this is necessary. Respirator selection must be based on known or anticipated exposure levels, the 
hazards of the product and the safe working limits of the selected respirator.  
 
 
SECTION 9. Physical and chemical properties  
Physical state  solid  
 
Color  colorless  
 
Odor  odorless  
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Product number  






Melting point  
 
Boiling point/boiling range  
 
Flash point  
 
Evaporation rate  
 
Flammability (solid, gas)  
 
Lower explosion limit  
 
Upper explosion limit  
 
Vapor pressure  
 





Relative density  
 
Water solubility  
 
 
Partition coefficient: n-  
octanol/water  
Autoignition temperature  
 
Decomposition temperature  
 
Viscosity, dynamic  
 
Explosive properties  
 
Oxidizing properties  
 
Ignition temperature  
 
Bulk density  
 
101217  
Ammonium sulfate for analysis EMSURE® ACS,ISO,Reag. Ph Eur  
 
 
ca. 5  
at 100 g/l  
 
(decomposition), Not applicable  
 
Not applicable  
 
does not flash  
 
No information available.  
 
No information available.  
 
Not applicable  
 
Not applicable  
 
No information available.  
 
Not applicable  
 
1.77 g/cm³  
at 68 °F ( 20 °C)  
 
No information available.  
 
754 g/l  
at 68 °F ( 20 °C)  
 
No information available.  
 
No information available.  
 
> 455 °F ( > 235 °C)  
 
No information available.  
 




Not applicable  
 
ca. 850 kg/m³  
 




SECTION 10. Stability and reactivity  
Reactivity  
See below  
 
Chemical stability  
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Possibility of hazardous reactions  
Exothermic reaction with:  
chlorates, with, heat nitrates, 
with, Heat.  
Risk of explosion with:  
chlorates, with, Acids  
nitrates, with, Potassium  
nitrates, with, Acids  
nitrites, sodium hypochlorite  
Generates dangerous gases or fumes in contact with:  
alkalines, Possible formation of:, Ammonia  
 
Conditions to avoid  
Strong heating (decomposition).  
 
Incompatible materials  
no information available  
 
Hazardous decomposition products  
in the event of fire: See section 5.  
 
 
SECTION 11. Toxicological information  
Information on toxicological effects  
Likely route of exposure  
Eye contact, Skin contact, Ingestion  
Acute oral toxicity  
LD50 Rat: 2,840 mg/kg (IUCLID)  
 
Skin irritation  
Rabbit  
Result: No irritation  
(IUCLID)  
Eye irritation  
Rabbit  
Result: No eye irritation  
(IUCLID)  
Genotoxicity in vitro  
Ames test  
Result: negative  
Method: OECD Test Guideline 471  
Mutagenicity (mammal cell test): chromosome aberration.  
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Specific target organ systemic toxicity - single exposure  
The substance or mixture is not classified as specific target organ toxicant, single exposure.  
Specific target organ systemic toxicity - repeated exposure  
The substance or mixture is not classified as specific target organ toxicant, repeated exposure.  
Aspiration hazard  



















Further information  
No ingredient of this product present at levels greater than or equal 
to 0.1% is identified as probable, possible or confirmed human 
carcinogen by IARC.  
No ingredient of this product present at levels greater than or  
equal to 0.1% is identified as a carcinogen or potential 
carcinogen by OSHA.  
No ingredient of this product present at levels greater than or  
equal to 0.1% is identified as a known or anticipated carcinogen by 
NTP.  
No ingredient of this product present at levels greater than or  
equal to 0.1% is identified as a carcinogen or potential 
carcinogen by ACGIH.  
The following applies to ammonium salts in general: after swallowing: local irritation symptoms,  
nausea, vomiting, diarrhea. Systemic effect: after the uptake of very large qantities: drop in blood 
pressure, collapse, CNS disorders, spasms, narcotic conditions, respiratory paralysis, hemolysis.  
Further hazardous properties cannot be excluded but unlikely when the product is handled  
appropriately.  
Handle in accordance with good industrial hygiene and safety practice.  
 
 
SECTION 12. Ecological information  
Ecotoxicity  
Toxicity to fish  
LC50 Danio rerio (zebra fish): 420 mg/l; 96 h (IUCLID)  
Toxicity to daphnia and other aquatic invertebrates  
EC50 Daphnia magna (Water flea): 129 mg/l; 48 h (IUCLID)  
Persistence and degradability  
No information available.  
Bioaccumulative potential  
No information available.  
Mobility in soil  
No information available.  
 
Additional ecological information  
Biological effects:  
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Fertilizing effect possible.  
Discharge into the environment must be avoided.  
 
 
SECTION 13. Disposal considerations  
The information presented only applies to the material as supplied. The identification based on characteristic(s)  
or listing may not apply if the material has been used or otherwise contaminated. It is the responsibility of the waste 
generator to determine the toxicity and physical properties of the material generated to determine the  
proper waste identification and disposal methods in compliance with applicable regulations. Disposal should be in 
accordance with applicable regional, national and local laws and regulations.  
 
 
SECTION 14. Transport information  
Land transport (DOT)  
Not classified as dangerous in the meaning of transport regulations.  
 
Air transport (IATA)  
Not classified as dangerous in the meaning of transport regulations.  
 
Sea transport (IMDG)  
Not classified as dangerous in the meaning of transport regulations.  
 
 
SECTION 15. Regulatory information  
United States of America  
SARA 313  
The following components are subject to reporting levels established by SARA Title III, Section  
313:  
Ingredients  
ammonium sulphate  7783-20-2  100 %  
SARA 302  
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section  
302.  
Clean Water Act  
This product does not contain any Hazardous Substances listed under the U.S. CleanWater Act, Section 311,  
Table 116.4A.  
This product does not contain any Hazardous Chemicals listed under the U.S. CleanWater Act, Section 311, Table 
117.3.  
DEA List I  
Not listed  
DEA List II  
Not listed  
 
US State Regulations  
 
Massachusetts Right To Know  
Ingredients  
ammonium sulphate  
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Product number  
Product name  
 
 
Pennsylvania Right To Know  
Ingredients  
ammonium sulphate  
New Jersey Right To Know  
Ingredients  
ammonium sulphate  
 
101217  
Ammonium sulfate for analysis EMSURE® ACS,ISO,Reag. Ph Eur  
 
Version 1.3  
California Prop 65 Components  
This product does not contain any chemicals known to the State of California to cause cancer,  
birth, or any other reproductive defects.  
Notification status  
TSCA:  All components of the product are listed in the TSCA-inventory.  
 




SECTION 16. Other information  
 
 
Training advice  
Provide adequate information, instruction and training for operators.  
 
Key or legend to abbreviations and acronyms used in the safety data sheet  
Used abbreviations and acronyms can be looked up at www.wikipedia.org.  
 
 
Revision Date10/14/2014  
 
 
The information contained herein is based on the present state of our knowledge. It characterizes the product with regard to  
appropriate safety precautions. It does not represent a warranty of any product properties and we assume no liability for any  
loss or injury which may result from the use of this information. Users should conduct their own investigations to determine the 
suitability of the information.  
























Printing date 03/10/2014  
 
 
1 Identification  
 
• Product identifier  
• Trade name: alpha-Amylase  
• Article number: 100447  
• CAS Number:  
9 0 0 0 -9 0 -2  
• EC number:  
2 3 2 -5 6 5 -6  
• Index number:  
6 4 7 -0 1 5 -0 0 -4  
Safety Data Sheet  
acc. to OSHA HCS  




Reviewed on 03/10/2014  
• Details of the supplier of the safety data sheet  
• Manufacturer/Supplier:  
MP Biomedicals, LLC  
29525 Fountain Parkway  
Solon, OH 44139  
United States  
www.mpbio.com  
• Information department: Product safety department  
• Emergency telephone number: CHEMTREC: 1-800-424-9300 (1-703-527-3887)  
 
 
2 Hazard(s) identification  
 
• Classification of the substance or mixture  
 
GHS08 Health hazard  
 
 
Resp. Sens. 1 H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.  
• Classification according to Directive 67/548/EEC or Directive 1999/45/EC  
Harmful  
May cause sensitisation by inhalation.  
• Information concerning particular hazards for human and environment: Not applicable.  
• Label elements  
• GHS label elements The substance is classified and labeled according to the Globally Harmonized System (GHS).  







• Signal word Danger  
• Hazard-determining components of labeling:  
Amylase, alpha-  
• Hazard statements  
May cause allergy or asthma symptoms or breathing difficulties if inhaled.  
• Precautionary statements  
If medical advice is needed, have product container or label at hand.  
Keep out of reach of children. Read label 
before use.  
In case of inadequate ventilation wear respiratory protection. Avoid 
breathing dust/fume/gas/mist/vapours/spray.  
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Trade name: alpha-Amylase  
 
 
(Contd. of page 1)  
If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.  
IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.  
Dispose of contents/container in accordance with local/regional/national/international regulations.  
• Classification system:  
• NFPA ratings (scale 0 - 4)  
Health = 0  
0 0 0 
Fire = 0  
Reactivity = 0  
 







Health = *0  
Fire = 0  
REACTIVITY 0  Reactivity = 0  
 
• Other hazards  
• Results of PBT and vPvB assessment • PBT: 
Not applicable. • vPvB: Not applicable.  
 
 
3 Composition/information on ingredients  
 
• Chemical characterization: Substances  
• CAS No. Description  
9000-90-2 Amylase, alpha-  
• Identification number(s)  
• EC number: 232-565-6  
• Index number: 647-015-00-4  
 
 
4 First-aid measures  
 
• Description of first aid measures  
• After inhalation: Supply fresh air; consult doctor in case of complaints. • After 
skin contact: Generally the product does not irritate the skin.  
• After eye contact: Rinse opened eye for several minutes under running water. • After 
swallowing: If symptoms persist consult doctor.  
• Information for doctor:  
• Most important symptoms and effects, both acute and delayed No further relevant information available.  
• Indication of any immediate medical attention and special treatment needed  
No further relevant information available.  
 
 
5 Fire-fighting measures  
 
• Extinguishing media  
• Suitable extinguishing agents:  
CO2, extinguishing powder or water spray. Fight larger fires with water spray or alcohol resistant foam.  
• Special hazards arising from the substance or mixture No further relevant information available.  
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(Contd. of page 2)  
• Advice for firefighters  
• Protective equipment: No special measures required.  
 
 
6 Accidental release measures  
 
• Personal precautions, protective equipment and emergency procedures Not required.  
• Environmental precautions: Do not allow to enter sewers/ surface or ground water.  
• Methods and material for containment and cleaning up:  
Dispose contaminated material as waste according to item 13.  
• Reference to other sections  
See Section 7 for information on safe handling.  
See Section 8 for information on personal protection equipment. See 
Section 13 for disposal information.  
 
 
7 H an dl i n g an d s t or age  
 
• Handling:  
• Precautions for safe handling  
Ensure good ventilation/exhaustion at the workplace.  
Prevent formation of dust.  
• Information about protection against explosions and fires: No special measures required.  
• Conditions for safe storage, including any incompatibilities  
• Storage: 2-8 °C  
• Requirements to be met by storerooms and receptacles: No special requirements. • 
Information about storage in one common storage facility: Not required.  
• Further information about storage conditions:  
Store in dry conditions.  
Protect from humidity and water.  
• Specific end use(s) No further relevant information available.  
 
 
8 Exposure controls/personal protection  
 
• Additional information about design of technical systems: No further data; see item 7.  
• Control parameters  
• Components with limit values that require monitoring at the workplace: Not required.  
• Additional information: The lists that were valid during the creation were used as basis.  
• Exposure controls  
• Personal protective equipment:  
• General protective and hygienic measures:  
Keep away from foodstuffs, beverages and feed.  
Wash hands before breaks and at the end of work.  
• Breathing equipment:  
In case of brief exposure or low pollution use respiratory filter device. In case of intensive or longer exposure use  
respiratory protective device that is independent of circulating air.  
• Protection of hands:  
 
 
Protective gloves  
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(Contd. of page 3)  
The glove material has to be impermeable and resistant to the product/ the substance/ the preparation.  
Due to missing tests no recommendation to the glove material can be given for the product/ the preparation/ the 
chemical mixture.  
Selection of the glove material on consideration of the penetration times, rates of diffusion and the degradation  
• Material of gloves  
The selection of the suitable gloves does not only depend on the material, but also on further marks of quality and  
varies from manufacturer to manufacturer.  
• Penetration time of glove material  
T h e e x a c t b re a k t h r o u g h t im e h a s t o b e f o u n d o u t b y t h e m a n u f a c tu re r o f t h e p ro t e c ti v e g lo v e s a n d h a s to b e  
observed.  
• Eye protection: Not required.  
 
 
9 Physical and chemical properties  
 
• Information on basic physical and chemical properties  
• General Information  
• Appearance:  
Form: 
Color:  
• Odor:  
• Odour threshold:  
• pH-value:  
• Change in condition  
Melting point/Melting range: 
Boiling point/Boiling range:  
• Flash point:  
• Flammability (solid, gaseous):  
• Ignition temperature:  
Decomposition temperature:  
• Auto igniting:  
• Danger of explosion:  
• Explosion limits:  
Lower: 
Upper:  
• Vapor pressure:  
• Density:  
• Relative density • 
Vapour density  
• Evaporation rate  
• Solubility in / Miscibility with  
Water:  
Solid  
Not determined.  
Characteristic  
Not determined.  





Not applicable.  
Product is not flammable.  
 
 
Not determined.  
Not determined.  
Product does not present an explosion hazard.  
 
 
Not determined. Not 
determined.  
Not applicable. Not 
determined.  






• Partition coefficient (n-octanol/water): Not determined.  
• Viscosity:  
Dynamic:  Not applicable. 
Kinematic:  Not applicable.  
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Organic solvents:  
Solids content:  




10 Stability and reactivity  
 
• Reactivity  
• Chemical stability  
Safety Data Sheet  







0 .0 %  
1 0 0 .0 %  
No further relevant information available.  
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• Thermal decomposition / conditions to be avoided: No decomposition if used according to specifications. • 
Possibility of hazardous reactions No dangerous reactions known. • Conditions to avoid No further relevant 
information available.  
• Incompatible materials: No further relevant information available.  
• Hazardous decomposition products: No dangerous decomposition products known.  
 
 
11 Toxicological information  
 
• Information on toxicological effects  
• Acute toxicity:  
• Primary irritant effect:  
• on the skin: No irritant effect. • on the 
eye: No irritating effect.  
• Sensitization: Sensitization possible through inhalation.  
• Additional toxicological information:  
• Carcinogenic categories  
• IARC (International Agency for Research on Cancer)  
Substance is not listed.  
• NTP (National Toxicology Program)  
Substance is not listed.  
 
 
12 Ecological information  
 
• Toxicity  
• Aquatic toxicity: No further relevant information available.  
• Persistence and degradability No further relevant information available.  
• Behavior in environmental systems:  
• Bioaccumulative potential No further relevant information available. • 
Mobility in soil No further relevant information available.  
• Additional ecological information:  
• General notes:  
Water hazard class 1 (Self-assessment): slightly hazardous for water  
Do not allow undiluted product or large quantities of it to reach ground water, water course or sewage system.  
• Results of PBT and vPvB assessment  
• PBT: Not applicable. • vPvB: 
Not applicable.  
• Other adverse effects No further relevant information available.  
USA  
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13 Disposal considerations  
 
• Waste treatment methods  
• Recommendation:  
Safety Data Sheet  
acc. to OSHA HCS  








(Contd. of page 5)  
Must not be disposed of together with household garbage. Do not allow product to reach sewage system.  
• Uncleaned packagings:  
• Recommendation: Disposal must be made according to official regulations. • 
Recommended cleansing agent: Water, if necessary with cleansing agents.  
 
 
14 Transport information  
 
• UN-Number  
• DOT, ADR, ADN, IMDG, IATA  
• UN proper shipping name  
• DOT, ADR, ADN, IMDG, IATA  
• Transport hazard class(es)  
• DOT, ADR, ADN, IMDG, IATA  
• Class  
• Packing group  
• DOT, ADR, IMDG, IATA  
• Environmental hazards:  
• Marine pollutant:  
• Special precautions for user  
• Transport in bulk according to Annex II of  
MARPOL73/78 and the IBC Code  



















Not applicable.  
 
 
Not applicable.  
- 
 
• Safety, health and environmental regulations/legislation specific for the substance or mixture  
• Sara  
• Section 355 (extremely hazardous substances):  
Substance is not listed.  
• Section 313 (Specific toxic chemical listings):  
Substance is not listed.  
• TSCA (Toxic Substances Control Act):  
Substance is listed.  
• Proposition 65  
• Chemicals known to cause cancer:  
Substance is not listed.  
• Chemicals known to cause reproductive toxicity for females:  
Substance is not listed.  
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• Chemicals known to cause reproductive toxicity for males:  
Substance is not listed.  
• Chemicals known to cause developmental toxicity:  
Substance is not listed.  
• Carcinogenic categories  
• EPA (Environmental Protection Agency)  
Substance is not listed.  
• TLV (Threshold Limit Value established by ACGIH)  
Substance is not listed.  
• NIOSH-Ca (National Institute for Occupational Safety and Health)  
Substance is not listed.  
• OSHA-Ca (Occupational Safety & Health Administration)  
Substance is not listed.  
• GHS label elements The substance is classified and labeled according to the Globally Harmonized System (GHS).  







• Signal word Danger  
• Hazard-determining components of labeling:  
Amylase, alpha-  
• Hazard statements  
May cause allergy or asthma symptoms or breathing difficulties if inhaled.  
• Precautionary statements  
If medical advice is needed, have product container or label at hand.  
Keep out of reach of children. Read label 
before use.  
In case of inadequate ventilation wear respiratory protection. Avoid 
breathing dust/fume/gas/mist/vapours/spray.  
If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.  
IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.  
Dispose of contents/container in accordance with local/regional/national/international regulations.  
• Chemical safety assessment: A Chemical Safety Assessment has not been carried out.  
 
 
16 Other information  
T h i s i n fo r m a t i o n i s b a s e d o n o u r p r e se n t k n o w l e d g e . H o w e v e r , t h is s h a l l n o t c o n s t i t u t e a g u a ra n t e e f o r a n y  
specific product features and shall not establish a legally valid contractual relationship.  
• Department issuing MSDS: Product safety department  
• Date of preparation / last revision 03/10/2014 / -  
• Abbreviations and acronyms:  
A D R : A c c o r d e u r o p é e n s u r l e t r a n s p o r t d e s ma r c h a n d i s e s d a n g e r e u s e s p a r R o u t e ( E u r o p e a n A g r e e m e n t c o n c e r n i n g t h e In t e r n a t i o n a l  
Carriage of Dangerous Goods by Road)  
ACGIH: American Conference of Governmental Industrial Hygienists  
EINECS: European Inventory of Existing Commercial Chemical Substances  
CAS: Chemical Abstracts Service (division of the American Chemical Society)  
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NFPA: National Fire Protection Association (USA)  
HMIS: Hazardous Materials Identification System (USA)  

























































SAFETY DATA SHEET  
17-AAG  
Page: 1  
 
Revision: 06/06/2013  
Supersedes Revision: 10/15/2012  
 
Cayman Chemical Company 1180 E. 




Section 1. Identification of the Substance/Mixture and of the  
1.1  Product Code:  11039  
Product Name:  17-AAG  
Synonyms:  17-demethoxy-17-(2-propenylamino)-geldanamycin; BMS 722782; CP 127374; KOS 953; NSC  
330507; Tanespimycin;  
1.2  Relevant identified uses of the substance or mixture and uses advised against  
Relevant identified uses:  For research use only, not for human or veterinary use.  
1.3  Details of the Supplier of the Safety Data Sheet  
Company Name:  Cayman Chemical Company  
Emergency Contact:  CHEMTREC Within USA and Canada:  +1 (800)424-9300  
Alternate Emergency Contact:  CHEMTREC Outside USA and Canada:  +1 (703)527-3887  
Information:  Cayman Chemical Company  +1 (734)971-3335  
Web site address:  www.caymanchem.com  
Section 2. Hazards Identification  
GHS Classification  
Flammable Liquids, Category 2  
Acute Toxicity: Inhalation, Category 3  
 
 
Acute Toxicity: Oral, Category 3  
 
 
Acute Toxicity: Skin, Category 3  
 
 
Target Organ Systemic Toxicity (single  
exposure), Category 1  
Placard  
Flame  
Skull and  
crossbones  
Skull and  
crossbones  
Skull and  
crossbones  
Health hazard  












GHS hazard phrase  
Highly flammable liquid and vapor  
Toxic if inhaled  
 
 
Toxic if swallowed  
 
 
Toxic in contact with skin  
 
 
Causes damage to organs {eyes}.  













GHS Response Phrases:  
H225: Highly flammable liquid and vapor.  
H331: Toxic if inhaled.  
H301: Toxic if swallowed.  
H311: Toxic in contact with skin.  
H370: Causes damage to organs {eyes}.  
P210: Keep away from {heat/sparks/open flames/hot surfaces}. - No smoking.  
P280: Wear {protective gloves/protective clothing/eye protection/face protection}. 
P261: Avoid breathing {dust/fume/gas/mist/vapours/spray}. P264: Wash {hands} 
thoroughly after handling.  
P361+364: Take off immediately all contaminated clothing and wash it before reuse. 
P260: Do not breathe {dust/fume/gas/mist/vapours/spray}.  
P303+361+353: IF ON SKIN (or hair): Remove/take off immediately all contaminated clothing.  
Rinse skin with water/shower.  
P304+340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable 
for breathing.  
P311: Call a {POISON CENTER/doctor/...}.  
P301+310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. 
P330: Rinse mouth.  
P302+352: IF ON SKIN: Wash with plenty of soap and water. 
P312: Call a {POISON CENTER/doctor/...} if you feel unwell. 
P321: Specific treatment {see ... on this label}.  
P307+311: IF exposed: Call a POISON CENTER or doctor/physician.  
Multi-region format  
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GHS Storage and Disposal Phrases:  Please refer to Section 7 for Storage and Section 13 for Disposal information.  










Target Organs:  
 
LD 50 / LC 50:  
Harmful vapors.  
Material may be irritating to the mucous membranes and upper respiratory tract. 
May be fatal or cause blindness if swallowed.  
May cause eye, skin, or respiratory system irritation.  
Toxic if swallowed, inhaled, or absorbed through the skin.  
Toxic: danger of very serious irreversible effects through inhalation, in contact with skin and if 
swallowed.  
To the best of our knowledge, the toxicological properties have not been thoroughly investigated.  
Central nervous system, Eyes, Gastrointestinal System, Respiratory system, Skin. 
Please refer to Section 11.  
Medical Conditions Generally Aggravated By No data available.  
Exposure:  
Section 3. Composition/Information on Ingredients  
Hazardous Components (Chemical Name)  CAS #  Concentration  EC#  Risk Phrases  RTECS #  
1.  17-AAG  75747-14-7  0.1 %  NA  No phrases apply.  LX8932000  
































In Case of Inhalation:  
 
 
In Case of Skin Contact:  
 
 
In Case of Eye Contact:  
 
 




Important Symptoms and Effects,  
Section 4. First Aid Measures  
Overexposure may cause: confusion, dermatitis, headache, drowsiness, dizziness, gastrointestinal  
disturbance, optic nerve damage (blindness), nausea, unconsciousness, vomiting, visual 
disturbance, weakness. May cause convulsions.  
Once methanol is absorbed into the body, it is very slowly eliminated.  
Remove to fresh air. If not breathing, give artificial respiration or give oxygen by trained  
personnel. Get immediate medical attention.  
Immediately wash skin with soap and plenty of water for at least 20 minutes. Remove  
contaminated clothing. Get medical attention if symptoms occur. Wash clothing before reuse.  
Hold eyelids apart and flush eyes with plenty of water for at least 20 minutes. Have eyes  
examined and tested by medical personnel.  
Wash out mouth with water provided person is conscious. Never give anything by mouth to an  
unconscious person. Get medical attention. Do NOT induce vomiting unless directed to do so by 
medical personnel.  
No data available.  
Both Acute and Delayed:  
4.3  Indication of any immediate medical  No data available.  
attention and special treatment needed:  






Suitable Extinguishing Media:  
 
 
Unsuitable Extinguishing Media:  
 
Flammable Properties and Hazards:  
Use alcohol-resistant foam, carbon dioxide, water, or dry chemical spray.  
Use water spray to cool fire-exposed containers.  
A solid water stream may be inefficient.  
Can release vapors that form explosive mixtures at temperatures at or above the flashpoint.  
Container explosion may occur under fire conditions. 
Emits toxic fumes under fire conditions. Sensitive to static 
discharge.  
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Flash Pt:  11.00 C  Method Used: Closed Cup  
Autoignition Pt:  385.00 C  
Explosive Limits:  LEL:  6.0%  at 25.0 C  UEL:  36.0  at 25.0 C  
Hazardous Combustion Products:  No data available.  
5.3  Fire Fighting Instructions:  As in any fire, wear self-contained breathing apparatus pressure-demand (NIOSH approved or  
equivalent), and full protective gear to prevent contact with skin and eyes. 
Note: Flammable as diluted in methanol.  
Section 6. Accidental Release Measures  
6.1  Protective Precautions, Protective  Avoid breathing vapors and provide adequate ventilation.  
Equipment and Emergency Procedures:  As conditions warrant, wear a NIOSH approved self-contained breathing apparatus, or respirator,  
and appropriate personal protection (rubber boots, safety goggles, and heavy rubber gloves).  
6.2  Environmental Precautions:  Take steps to avoid release into the environment, if safe to do so.  
6.3  Methods and Material For  Contain spill and collect, as appropriate.  
Containment and Cleaning Up:  Transfer to a chemical waste container for disposal in accordance with local regulations.  












Precautions To Be Taken in Storing:  
Avoid breathing dust/fume/gas/mist/vapours/spray.  
Avoid prolonged or repeated exposure. Keep 
away from sources of ignition.  
Take precautionary measures against static discharge.  
Keep away from heat, sparks, and flame.  
Keep container tightly closed.  
Store in accordance with information listed on the product insert.  
Hazard Label Information:  Avoid contact with skin and eyes.  Do not reuse this container.  Use with adequate ventilation.  
Wash thoroughly after handling.  
Section 8. Exposure Controls/Personal Protection  
Hazardous Components (Chemical Name)  CAS #  OSHA PEL  ACGIH TWA  Other Limits  
1.  17-AAG  75747-14-7  No data.  No data.  No data.  
2.  Methanol  67-56-1  PEL: 200 ppm  TLV: 200 ppm  No data.  
STEL: 250 ppm  
Hazardous Components (Chemical Name)  CAS #  Britain EH40  France VL  Europe  
1.  17-AAG  75747-14-7  No data.  No data.  No data.  
2.  Methanol  67-56-1  TWA: 266 mg/m3 (200 ppm)  TWA: 260 mg/m3 (200 ppm)  TWA: 260  
STEL: 333 mg/m3 (250 ppm)  STEL: 1300 mg/m3 (1000  mg/m3  
ppm)  
Protective Equipment Summary - Hazard  Compatible chemical-resistant gloves  Eye wash station in work area  Lab coat  Safety  
Label Information:  glasses Safety shower in work area  Vent Hood  
8.2.1  Engineering Controls (Ventilation  Use process enclosures, local exhaust ventilation, or other engineering controls to control airborne  
etc.):  levels below recommended exposure limits.  
8.2.2.1 Eye Protection:  
 
8.2.2.2 Protective Gloves:  
 
Other Protective Clothing:  
 
8.2.2.3 Respiratory Equipment (Specify  
Type):  
 
Work/Hygienic/Maintenance Practices:  
Safety glasses  
Compatible chemical-resistant gloves  
Lab coat  
NIOSH approved respirator, as conditions warrant.  
 
Do not take internally.  
Facilities storing or utilizing this material should be equipped with an eyewash and a safety 
shower.  
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8.2.3  Environmental Exposure Controls:  No data available.  
Section 9. Physical and Chemical Properties  
9.1  Information on Basic Physical and Chemical Properties  
Physical States:  [ ] Gas  [ X ] Liquid  [ ] Solid  
Appearance and Odor:  Solution  
Melting Point:  No data.  
Boiling Point:  No data.  
Flash Pt:  11.00 C  Method Used: Closed Cup  
Evaporation Rate:  No data.  
Explosive Limits:  LEL:  6.0%  at 25.0 C  UEL:  36.0  at 25.0 C  
Vapor Pressure (vs. Air or mm Hg):  
 
Vapor Density (vs. Air = 1):  
 
Specific Gravity (Water = 1):  
 
Solubility in Water:  
 
Autoignition Pt:  
 
Explosive Properties:  
 
Oxidizing Properties:  
96 MM_HG at 20.0 C No data. 
No data. No data. 385.00 C  
No data available. No data 
available.  
9.2  Other Information  
Percent Volatile:  No data.  
Formula:  C31H43N3O8  
Molecular Weight:  585.70  
Section 10. Stability and Reactivity  
10.1  Reactivity:  No data available.  
10.2  Stability:  Unstable [  ] Stable [ X ]  
10.3  Stability Note(s):  Stable if stored in accordance with information listed on the product insert.  
10.4  Conditions To Avoid:  heat, flames and sparks  
10.3  Polymerization:  Will occur [  ] Will not occur [ X ]  
10.5  Incompatibility - Materials To Avoid:  acids  
acid anhydrides  
acid chlorides alkali 
metals  
oxidizing agents reducing 
agents  
10.6  Hazardous Decomposition Or  carbon dioxide  
Byproducts:  carbon monoxide  
Section 11. Toxicological Information  
11.1  Information on Toxicological Effects:  The toxicological effects of this product have not been thoroughly studied.  
 
Methanol - Toxicity Data: Oral LD50 (rat): 5,600 mg/kg; Oral LD50 (rabbit): 14,200 mg/kg; 
Inhalation LC50 (rat): 64,000 ppm (4h); Inhalation LC50 (mouse): 61,100 ppm (134 m); Skin  
LD50 (rabbit): 15,800 mg/kg; Oral LDLO (human): 143 mg/kg;  
Methanol - Irritation Data: Skin (rabbit): 20 mg (24h) moderate; Eyes (rabbit): 40 mg moderate;  
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Chronic Toxicological Effects:  Methanol - Investigated as a mutagen and reproductive effector.  
Only select Registry of Toxic Effects of Chemical Substances (RTECS) data is presented here. 
See actual entry in RTECS for complete information.  
Methanol RTECS Number: PC1400000  
Hazardous Components (Chemical Name)  CAS #  NTP  IARC  ACGIH  OSHA  
1.  17-AAG  75747-14-7  n.a.  n.a.  n.a.  n.a.  
























LAND TRANSPORT (US DOT)  
Section 12. Ecological Information  
Avoid release into the environment.  
Runoff from fire control or dilution water may cause pollution.  
Section 13. Disposal Considerations  
Dispose in accordance with local, state, and federal regulations.  
Section 14. Transport Information  
 
DOT Proper Shipping Name  
 
DOT Hazard Class:  
 
DOT Hazard Label:  
 
UN/NA Number:  
 
Packing Group:  
Methanol Solution  
3 (6.1)  
COMBUSTIBLE LIQUID, POISON  
1230  
II  
14.1  LAND TRANSPORT (European ADR/RID)  
ADR/RID Shipping Name  Methanol Solution  
UN Number:  1230  
Hazard Class:  3 (6.1) - COMBUSTIBLE LIQUID, POISON  
Packing Group:  II  
14.3  AIR TRANSPORT (ICAO/IATA)  
 
ICAO/IATA Shipping Name  
 
UN Number:  
 
Hazard Class:  
 
Packing Group:  
 
IATA Classification:  
 
Additional Transport Information:  
Methanol Solution  
1230  
3 (6.1) - COMBUSTIBLE LIQUID, POISON  
II  
3, 6.1  
Transport in accordance with local, state, and federal regulations.  
Section 15. Regulatory Information  
European Community Hazard Symbol codes  F: Highly Flammable; T: Toxic  
 
European Community Risk and Safety Phrases  
R11  - Highly flammable.  
R39/23/24/25 - Toxic: danger of very serious irreversible effects through inhalation, in contact with skin and if swallowed.  
S7  - Keep container tightly closed.  
S16  - Keep away from sources of ignition.  
S24/25  - Avoid contact with skin and eyes.  
S33  - Take precautionary measures against static discharges.  
S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection.  
S45  - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)  
US EPA SARA Title III  
 
Hazardous Components (Chemical Name)  CAS #  Sec.302 (EHS)  Sec.304 RQ  Sec.313 (TRI)  Sec.110  




Multi-region format  
SAFETY DATA SHEET  
17-AAG  
Page: 6  
 
Revision: 06/06/2013  
Supersedes Revision: 10/15/2012  
Hazardous Components (Chemical Name)  CAS #  Sec.302 (EHS)  Sec.304 RQ  Sec.313 (TRI)  Sec.110  
2.  Methanol  67-56-1  No  Yes 5000 LB  Yes  No  
Other US EPA or State Lists  
 
Hazardous Components (Chemical Name)  CAS #  CAA HAP,ODC  CWA NPDES  TSCA  CA PROP.65  
1.  17-AAG  75747-14-7  No  No  No  No  
2.  Methanol  67-56-1  HAP  No  Inventory  Yes  
Regulatory Information Statement:  This SDS was prepared in accordance with Regulation (EC) No.1272/2008 and European  
Directive 67/548/EEC as amended.  
Section 16. Other Information  
Revision Date:  06/06/2013  
Company Policy or Disclaimer  
DISCLAIMER: This information is believed to be accurate and represents the best information currently available to us. However, we make no warranty of  
merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their 
own investigations to determine the suitability of the information for their particular purposes.  
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Section 1: Chemical Product and Company Identification  
 
Product Name: Ethyl alcohol 200 Proof  
Catalog Codes: SLE2248, SLE1357  
CAS#: 64-17-5  
RTECS: KQ6300000  
TSCA: TSCA 8(b) inventory: Ethyl alcohol 200 Proof 
CI#: Not applicable.  
Synonym: Ethanol; Absolute Ethanol; Alcohol; Ethanol  
200 proof; Ethyl Alcohol, Anhydrous; Ethanol, undenatured;  
Dehydrated Alcohol; Alcohol  
Chemical Name: Ethyl Alcohol  
Chemical Formula: CH3CH2OH  
 
Contact Information:  
Sciencelab.com, Inc.  
14025 Smith Rd.  
Houston, Texas 77396  
US Sales: 1-800-901-7247  
International Sales: 1-281-441-4400  
Order Online: ScienceLab.com  
CHEMTREC (24HR Emergency Telephone), call:  
1-800-424-9300  
International CHEMTREC, call: 1-703-527-3887  
For non-emergency assistance, call: 1-281-441-4400  
 
 




Name  CAS #  % by Weight  
Ethyl alcohol 200 Proof  64-17-5  100  
 
 
Toxicological Data on Ingredients: Ethyl alcohol 200 Proof: ORAL (LD50): Acute: 7060 mg/kg [Rat]. 3450 mg/kg [Mouse]. 
VAPOR (LC50): Acute: 20000 ppm 8 hours [Rat]. 39000 mg/m 4 hours [Mouse].  
 
 
Section 3: Hazards Identification  
 
Potential Acute Health Effects:  
Hazardous in case of skin contact (irritant), of eye contact (irritant), of inhalation. Slightly hazardous in case of skin contact 
(permeator), of ingestion.  
Potential Chronic Health Effects:  
Slightly hazardous in case of skin contact (sensitizer). CARCINOGENIC EFFECTS: A4 (Not classifiable for human or  
animal.) by ACGIH. MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. Mutagenic for bacteria and/or yeast. 
TERATOGENIC EFFECTS: Classified PROVEN for human. DEVELOPMENTAL TOXICITY: Classified Development toxin  
[PROVEN]. Classified Reproductive system/toxin/female, Reproductive system/toxin/male [POSSIBLE]. The substance is toxic  
to blood, the reproductive system, liver, upper respiratory tract, skin, central nervous system (CNS). Repeated or prolonged 
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Section 4: First Aid Measures  
 
Eye Contact:  
Check for and remove any contact lenses. Immediately flush eyes with running water for at least 15 minutes, keeping eyelids 
open. Cold water may be used. Get medical attention.  
Skin Contact:  
In case of contact, immediately flush skin with plenty of water. Cover the irritated skin with an emollient. Remove contaminated  
clothing and shoes. Cold water may be used.Wash clothing before reuse. Thoroughly clean shoes before reuse. Get medical 
attention.  
Serious Skin Contact:  
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek medical attention.  
Inhalation:  
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical 
attention if symptoms appear.  
Serious Inhalation:  
Evacuate the victim to a safe area as soon as possible. Loosen tight clothing such as a collar, tie, belt or waistband. If  
breathing is difficult, administer oxygen. If the victim is not breathing, perform mouth-to-mouth resuscitation. Seek medical 
attention.  
Ingestion:  
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious 
person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms appear.  




Section 5: Fire and Explosion Data  
 
Flammability of the Product: Flammable.  
Auto-Ignition Temperature: 363°C (685.4°F)  
Flash Points: CLOSED CUP: 12.78°C (55°F). OPEN CUP: 17.78°C (64°F) (Cleveland).  
Flammable Limits: LOWER: 3.3% UPPER: 19%  
Products of Combustion: These products are carbon oxides (CO, CO2).  
Fire Hazards in Presence of Various Substances:  
Highly flammable in presence of open flames and sparks, of heat. Slightly flammable to flammable in presence of oxidizing 
materials.  
Explosion Hazards in Presence of Various Substances:  
Risks of explosion of the product in presence of mechanical impact: Not available. Slightly explosive in presence of open 
flames and sparks, of heat, of oxidizing materials, of acids.  
Fire Fighting Media and Instructions:  
Flammable liquid, soluble or dispersed in water. SMALL FIRE: Use DRY chemical powder. LARGE FIRE: Use alcohol foam, 
water spray or fog.  
Special Remarks on Fire Hazards:  
Containers should be grounded. CAUTION: MAY BURN WITH NEAR INVISIBLE FLAME Vapor may travel considerable  
distance to source of ignition and flash back. May form explosive mixtures with air. Contact with Bromine pentafluoride is likely to 
cause fire or explosion. Ethanol ignites on contact with chromyl chloride. Ethanol ignites on contact with iodine heptafluoride gas. 
It ignites than explodes upon contact with nitrosyl perchlorate. Additon of platinum black catalyst caused ignition.  
Special Remarks on Explosion Hazards:  
Ethanol has an explosive reaction with the oxidized coating around potassium metal. Ethanol ignites and then explodes on 
contact with acetic anhydride + sodium hydrosulfate (ignites and may explode), disulfuric acid + nitric acid, phosphorous(III) 
oxide platinum, potassium-tert-butoxide+ acids. Ethanol forms explosive products in reaction with the following compound :  
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ammonia + silver nitrate (forms silver nitride and silver fulminate), iodine + phosphorus (forms ethane iodide), magnesium  
perchlorate (forms ethyl perchlorate), mercuric nitrate, nitric acid + silver (forms silver fulminate) silver nitrate (forms ethyl 
nitrate) silver(I) oxide + ammonia or hydrazine (forms silver nitride and silver fulminate), sodium (evolves hydrogen gas). 
Sodium Hydrazide + alcohol can produce an explosion. Alcohols should not be mixed with mercuric nitrate, as explosive  
mercuric fulminate may be formed. May form explosive mixture with manganese perchlorate + 2,2-dimethoxypropane. Addition of 




Section 6: Accidental Release Measures  
 
Small Spill:  
Dilute with water and mop up, or absorb with an inert dry material and place in an appropriate waste disposal container.  
Large Spill:  
Flammable liquid. Keep away from heat. Keep away from sources of ignition. Stop leak if without risk. Absorb with DRY earth,  
sand or other non-combustible material. Do not touch spilled material. Prevent entry into sewers, basements or confined  
areas; dike if needed. Be careful that the product is not present at a concentration level above TLV. Check TLV on the MSDS 




Section 7: Handling and Storage  
 
Precautions:  
Keep locked up.. Keep away from heat. Keep away from sources of ignition. Ground all equipment containing material. Do  
not ingest. Do not breathe gas/fumes/ vapor/spray. Wear suitable protective clothing. In case of insufficient ventilation, wear  
suitable respiratory equipment. If ingested, seek medical advice immediately and show the container or the label. Avoid 
contact with skin and eyes. Keep away from incompatibles such as oxidizing agents, acids, alkalis, moisture.  
Storage:  
Store in a segregated and approved area. Keep container in a cool, well-ventilated area. Keep container tightly closed and 




Section 8: Exposure Controls/Personal Protection  
 
Engineering Controls:  
Provide exhaust ventilation or other engineering controls to keep the airborne concentrations of vapors below their respective 
threshold limit value. Ensure that eyewash stations and safety showers are proximal to the work-station location.  
Personal Protection:  
Splash goggles. Lab coat. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Gloves. Use a 
respirator if the exposure limit is exceeded.  
Personal Protection in Case of a Large Spill:  
Splash goggles. Full suit. Vapor respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid  
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this 
product.  
Exposure Limits:  
TWA: 1900 (mg/m3) from OSHA (PEL) [United States] TWA: 1000 (ppm) from OSHA (PEL) [United States] TWA: 1900 (mg/  
m3) from NIOSH [United States] TWA: 1000 (ppm) from NIOSH [United States] TWA: 1000 (ppm) [United Kingdom (UK)]  
TWA: 1920 (mg/m3) [United Kingdom (UK)] TWA: 1000 STEL: 1250 (ppm) [Canada]Consult local authorities for acceptable 




Section 9: Physical and Chemical Properties  
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Mild to strong, rather pleasant; like wine or whiskey. Alcohol-like; Ethereal, vinous.  
Taste: Pungent. Burning.  
Molecular Weight: 46.07 g/mole  
Color: Colorless. Clear  
pH (1% soln/water): Not available.  
Boiling Point: 78.5°C (173.3°F)  
Melting Point: -114.1°C (-173.4°F)  
Critical Temperature: 243°C (469.4°F)  
Specific Gravity: 0.789 (Water = 1) Vapor 
Pressure: 5.7 kPa (@ 20°C)  
Vapor Density: 1.59 (Air = 1) Volatility: 
Not available.  
Odor Threshold: 100 ppm  
Water/Oil Dist. Coeff.: The product is more soluble in water; log(oil/water) = -0.3 
Ionicity (in Water): Not available.  
Dispersion Properties: See solubility in water, methanol, diethyl ether, acetone.  
Solubility:  
Easily soluble in cold water, hot water. Soluble in methanol, diethyl ether, acetone.  
 
 
Section 10: Stability and Reactivity Data  
 
Stability: The product is stable.  
Instability Temperature: Not available.  
Conditions of Instability: Incompatible materials, heat, sources of ignition.  
Incompatibility with various substances: Reactive with oxidizing agents, acids, alkalis. 
Corrosivity: Non-corrosive in presence of glass.  
Special Remarks on Reactivity:  
Ethanol rapidly absorbs moisture from the air. Can react vigorously with oxiders. The following oxidants have been  
demonstrated to undergo vigorous/explosive reaction with ethanol: barium perchlorate, bromine pentafluoride, calcium  
hypochlorite, chloryl perchlorate, chromium trioxide, chromyl chloride, dioxygen difluoride, disulfuryl difluoride, fluorine nitrate,  
hydrogen peroxide, iodine heptafluoride, nitric acid nitrosyl perchlorate, perchloric acid permanganic acid, peroxodisulfuric 
acid, potassium dioxide, potassium perchlorate, potassium permanganate, ruthenium(VIII) oxide, silver perchlorate, silver 
peroxide, uranium hexafluoride, uranyl perchlorate. Ethanol reacts violently/expodes with the following compounds: acetyl  
bromide (evolves hydrogen bromide) acetyl chloride, aluminum, sesquibromide ethylate, ammonium hydroxide & silver 
oxide, chlorate, chromic anhydride, cyanuric acid + water, dichloromethane + sulfuric acid + nitrate (or) nitrite, hydrogen  
peroxide + sulfuric acid, iodine + methanol + mercuric oxide, manganese perchlorate + 2,2-dimethoxy propane, perchlorates, 
permanganates + sulfuric acid, potassium superoxide, potassium tert-butoxide, silver & nitric acid, silver perchlorate, sodium  
hydrazide, sulfuric acid + sodium dichromate, tetrachlorisilane + water. Ethanol is also incompatible with platinium, and  
sodium. No really safe conditions exist under which ethyl alcohol and chlorine oxides can be handled. Reacts vigorously with  
acetyl chloride  
Special Remarks on Corrosivity: Not available. 
Polymerization: Will not occur.  
 
 
Section 11: Toxicological Information  
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Routes of Entry: Absorbed through skin. Dermal contact. Eye contact. Inhalation. Ingestion.  
Toxicity to Animals:  
WARNING: THE LC50 VALUES HEREUNDER ARE ESTIMATED ON THE BASIS OF A 4-HOUR EXPOSURE. Acute oral  
toxicity (LD50): 3450 mg/kg [Mouse]. Acute toxicity of the vapor (LC50): 39000 mg/m3 4 hours [Mouse].  
Chronic Effects on Humans:  
CARCINOGENIC EFFECTS: A4 (Not classifiable for human or animal.) by ACGIH. MUTAGENIC EFFECTS: Mutagenic for 
mammalian somatic cells. Mutagenic for bacteria and/or yeast. TERATOGENIC EFFECTS: Classified PROVEN for human.  
DEVELOPMENTAL TOXICITY: Classified Development toxin [PROVEN]. Classified Reproductive system/toxin/female,  
Reproductive system/toxin/male [POSSIBLE]. Causes damage to the following organs: blood, the reproductive system, liver, 
upper respiratory tract, skin, central nervous system (CNS).  
Other Toxic Effects on Humans:  
Hazardous in case of skin contact (irritant), of inhalation. Slightly hazardous in case of skin contact (permeator), of ingestion.  
Special Remarks on Toxicity to Animals:  
Lowest Published Dose/Conc: LDL[Human] - Route: Oral; Dose: 1400 mg/kg LDL[Human child] - Route: Oral; Dose: 2000 mg/  
kg LDL[Rabbit] - Route: Skin; Dose: 20000 mg/kg  
Special Remarks on Chronic Effects on Humans:  
May affect genetic material (mutagenic) Causes adverse reproductive effects and birth defects (teratogenic) , based on  
moderate to heavy consumption. May cause cancer based on animal data. Human: passes through the placenta, excreted in 
maternal milk.  
Special Remarks on other Toxic Effects on Humans:  
Acute potential health effects: Skin: causes skin irritation Eyes: causes eye irritation Ingestion: May cause gastrointestinal tract  
irritation with nausea, vomiting, diarrhea, and alterations in gastric secretions. May affect behavior/central nervous system  
(central nervous system depression - amnesia, headache, muscular incoordination, excitation, mild euphoria, slurred speech,  
drowsiness, staggaring gait, fatigue, changes in mood/personality, excessive talking, dizziness, ataxia, somnolence, coma/  
narcosis, hallucinations, distorted perceptions, general anesthetic), peripherial nervous system (spastic paralysis)vision  
(diplopia). Moderately toxic and narcotic in high concentrations. May also affect metabolism, blood, liver, respiration (dyspnea), 
and endocrine system. May affect respiratory tract, cardiovascular(cardiac arrhythmias, hypotension), and urinary systems.  
Inhalation: May cause irritation of the respiratory tract and affect behavior/central nervous system with symptoms similar to 
ingestion. Chronic Potential Health Effects: Skin: Prolonged or repeated skin contact may casue dermatitis, an allergic  




Section 12: Ecological Information  
 
Ecotoxicity: Ecotoxicity in water (LC50): 14000 mg/l 96 hours [Rainbow trout]. 11200 mg/l 24 hours [fingerling trout].  
BOD5 and COD: Not available.  
Products of Biodegradation:  
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.  
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic. 




Section 13: Disposal Considerations  
 
Waste Disposal:  




Section 14: Transport Information  
 
DOT Classification: CLASS 3: Flammable liquid.  
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Identification: : Ethanol UNNA: 1170 PG: II  




Section 15: Other Regulatory Information  
 
Federal and State Regulations:  
California prop. 65: This product contains the following ingredients for which the State of California has found to cause cancer, 
birth defects or other reproductive harm, which would require a warning under the statute: Ethyl alcohol 200 Proof (in alcoholic  
beverages) California prop. 65: This product contains the following ingredients for which the State of California has found  
to cause birth defects which would require a warning under the statute: Ethyl alcohol 200 Proof (in alcoholic beverages)  
Connecticut hazardous material survey.: Ethyl alcohol 200 Proof Illinois toxic substances disclosure to employee act: Ethyl 
alcohol 200 Proof Rhode Island RTK hazardous substances: Ethyl alcohol 200 Proof Pennsylvania RTK: Ethyl alcohol 200  
Proof Florida: Ethyl alcohol 200 Proof Minnesota: Ethyl alcohol 200 Proof Massachusetts RTK: Ethyl alcohol 200 Proof  
Massachusetts spill list: Ethyl alcohol 200 Proof New Jersey: Ethyl alcohol 200 Proof Tennessee: Ethyl alcohol 200 Proof  
California - Directors List of Hazardous Substances (8 CCR 339): Ethyl alcohol 200 Proof TSCA 8(b) inventory: Ethyl alcohol  
200 Proof  
Other Regulations:  
OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200). EINECS: This product is on the 
European Inventory of Existing Commercial Chemical Substances.  
Other Classifications:  
WHMIS (Canada):  
CLASS B-2: Flammable liquid with a flash point lower than 37.8°C (100°F). CLASS D-2A: Material causing other toxic effects 
(VERY TOXIC).  
DSCL (EEC):  
R11- Highly flammable. S7- Keep container tightly closed. S16- Keep away from sources of ignition - No smoking.  
HMIS (U.S.A.):  
Health Hazard: 2  
Fire Hazard: 3  
Reactivity: 0  
Personal Protection: E  
National Fire Protection Association (U.S.A.):  
Health: 2  
Flammability: 3  
Reactivity: 0  
Specific hazard:  
Protective Equipment:  
Gloves. Lab coat. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Wear appropriate respirator 




Section 16: Other Information  
 
References:  
-SAX, N.I. Dangerous Properties of Indutrial Materials. Toronto, Van Nostrand Reinold, 6e ed. 1984. -Material safety data  
sheet emitted by: la Commission de la Santé et de la Sécurité du Travail du Québec. -Hawley, G.G.. The Condensed  
Chemical Dictionary, 11e ed., New York N.Y., Van Nostrand Reinold, 1987. -The Sigma-Aldrich Library of Chemical Safety 
Data, Edition II. HSDB, RTECS, and LOLI databases.  
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Other Special Considerations: Not available.  
Created: 10/09/2005 05:28 PM  
Last Updated: 05/21/2013 12:00 PM  
 
The information above is believed to be accurate and represents the best information currently available to us. However, we 
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume 
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for 
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for 
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com 
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MATERIAL SAFETY DATA SHEET  
Cat# 1564-1, -5, Geldanamycin  MSDS DATE: Feb 21, 2012  
 
SECTION 1: PRODUCT AND COMPANY IDENTIFICATION  
 
PRODUCT NAME:  Geldanamycin  
 
PRODUCT CODES:  Cat# 1564-1, -5  
 
MANUFACTURER:  BioVision, Inc.  
ADDRESS:  155 S. Milpitas Boulevard, Milpitas, CA 95035  
 
EMERGENCY PHONE: 858-373-8066  
CHEMTREC PHONE:  
OTHER CALLS:  408-493-1800 
FAX PHONE:  408-493-1801  
 






SECTION 3: HAZARDS IDENTIFICATION  
 
































1564-1: 1 mg  








Safety Information  
See below  
OSHA Hazards: Target organ effect, Carcinogen, Teratogen  
Target Organs: Liver, Pancreas, Kidney, Gastrointestinal tract, Skeletal muscle  
GHS Classification: Acute toxicity, Oral (Category 5)  





Signal word:  Warning  
Hazard statement(s):  H303 May be harmful if swallowed.  
Precautionary statement(s): none  
HMIS Classification  
Health hazard: 1  
Chronic Health Hazard: *  
Flammability: 0  
Physical hazards: 0  
NFPA Rating  
Health Hazard: 1  
Fire: 0  
Reactivity Hazard: 0  
Potential Health Effects  
Inhalation: May be harmful if inhaled. May cause respiratory tract irritation. Skin: 
May be harmful if absorbed through skin. May cause skin irritation. Eyes: May 
cause eye irritation.  
Ingestion: May be harmful if swallowed.  
 
SECTION 4: FIRST AID MEASURES  
 
General advice: Consult a physician. Show this safety data sheet to the doctor in attendance. Move out of dangerous area.  
If inhaled: If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician. In 
case of skin contact: Wash off with soap and plenty of water. Consult a physician. In case of eye contact: Flush 
eyes with water as a precaution.  
If swallowed: Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.  
 
5: FIRE-FIGHTING MEASURES  
 
Condition of flammability: Not flammable or combustible.  
Suitable extinguishing media: Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.  
Special protective equipment for fire-fighters: Wear self-contained breathing apparatus for firefighting if necessary.  
Hazardous combustion products: Hazardous decomposition products formed under fire conditions— carbon oxides, nitrogen oxides.  
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SECTION 6: ACCIDENTAL RELEASE MEASURES  
 
Personal precautions: Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist, gas, or dust. Ensure 
adequate ventilation. Evacuate personnel to safe areas.  
Environmental precautions: Prevent further leakage or spillage if safe to do so. Do not let product enter drains.  
Methods for cleaning up: Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for 
disposal.  
 
SECTION 7: HANDLING AND STORAGE  
 
Precautions for safe handling  
Avoid formation of dust and aerosols. Provide appropriate exhaust ventilation at places where dust is formed.  
Conditions for safe storage  
Keep container tightly closed in a dry and well-ventilated place.  
Recommended storage temperature: -20 °C  
 
SECTION 8: EXPOSURE CONTROLS/PERSONAL PROTECTION  
 
Contains no substances with occupational exposure limit values.  
Personal protective equipment  
Respiratory protection  
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired, use type N95 (US) or type P1  
(EN 143) dust masks. Use respirators and components tested and approved under appropriate government standards such as 
NIOSH (US) or CEN (EU).  
Hand protection  
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer  
surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and 
good laboratory practices. Wash and dry hands.  
Eye protection  
Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN  
166(EU).  
Skin and body protection  
Choose body protection in relation to its type, to the concentration and amount of dangerous substances, and to the specific work-  
place. The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at 
the specific workplace.  
Hygiene measures  
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of the workday.  
 





Water Solubility:  
Specific Gravity (g/ml):  
Boiling Point (°C): 
Melting Point (°C):  
Flash Point (°C):  




SECTION 10: STABILITY AND REACTIVITY  
 
Property  
Chemical stability  
Conditions to avoid:  
Materials to avoid:  
Hazardous decomposition products:  
 
SECTION 11: TOXICOLOGICAL INFORMATION  
 
Geldanamycin:  
Acute toxicity: LD50 Oral - rat - 2,500 mg/kg  
Skin corrosion/irritation: no data available  
Serious eye damage/eye irritation: no data available 
Respiratory or skin sensitization: no data available  
 
Geldanamycin  
Yellow to orange solid  
No data available No 
data available No data 
available No data 
available No data 
available No data 
available No data 






Stable under recommended storage conditions  
No data available  
Strong oxidizing agents  
Carbon oxides, nitrogen oxides  
Germ cell mutagenicity: Genotoxicity in vitro - mouse - lymphocyte: DNA inhibition  
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Carcinogenicity:  








No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or 
confirmed human carcinogen by IARC.  
No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential 
carcinogen by ACGIH.  
No component of this product present at levels greater than or equal to 0.1% is identified as a known or anticipated 
carcinogen by NTP.  
No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential 
carcinogen by OSHA.  
Reproductive toxicity: no data available  
Teratogenicity: Possible risk of congenital malformation in the fetus.  
Specific target organ toxicity - single exposure (GHS): no data available  
Specific target organ toxicity - repeated exposure (GHS): no data available  
Aspiration hazard: no data available  
Potential Health Effects  
Inhalation: May be harmful if inhaled. May cause respiratory tract irritation. Skin: 
May be harmful if absorbed through skin. May cause skin irritation. Eyes: May 
cause eye irritation.  
Ingestion: May be harmful if swallowed.  
Signs and Symptoms of Exposure: Effects may be delayed. Pulmonary edema, irregular breathing, stomach/intestinal disorders, nausea,  
vomiting, dizziness, drowsiness, increased liver enzymes, and/or weakness. Heavy or prolonged skin exposure may result in the absorption of 
harmful amounts of material.  
Synergistic effects: no data available  
Additional information: RTECS: LX8920000  
 
SECTION 12: ECOLOGICAL INFORMATION  
 
Geldanamycin:  
Persistence and degradability: no data available  
Toxicity: no data available  
Bioaccumulative potential: no data available  
Mobility in soil: no data available  
PBT and vPvB assessment: no data available  
Other adverse effects: no data available  
 
SECTION 13: DISPOSAL CONSIDERATIONS  
 
Product: Offer surplus and non-recyclable solutions to a licensed disposal company. Contact licensed professional waste disposal service to  
dispose of this material. Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an  
afterburner and scrubber.  
Contaminated packaging: Dispose of as unused product.  
 
SECTION 14: TRANSPORT INFORMATION  
 
Geldanamycin:  
DOT (US): Not dangerous goods. IMDG: Not 
dangerous goods. IATA: Not dangerous 
goods.  
 
SECTION 15: REGULATORY INFORMATION  
 
Geldanamycin:  
OSHA Hazards: Target organ effect, Carcinogen, Teratogen  
SARA 302 Components: SARA 302: No chemical in this material are subject to the reporting requirements of SARA Title III, Section 302. 
SARA 313 Components: SARA 313: This material does not contain any chemical components with known CAS numbers that exceed the 
threshold (De Minimis) reporting levels established by SARA Title II, Section 313.  
SARA 311/312 Hazards: Chronic Health Hazard  
Massachusetts Right To Know Components: No components are subject to the Massachusetts Right to Know Act.  
Pennsylvania Right To Know Components: Geldanamycin, CAS-No. 30562-34-6  
New Jersey Right To Know Components: Geldanamycin, CAS-No. 30562-34-6  
California Prop. 65 Components: This product does not contain any chemicals known to State of California to cause cancer, birth defects, or 
any other reproductive harm.  
 
EU regulations  
Component  Risk Phrases  Safety Phrases  
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SECTION 16: OTHER INFORMATION  
 
OTHER INFORMATION:  




MSDS DATE: Feb 21, 2012  
The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a  
guide. The information in this document is based on the present state of our knowledge and is applicable to the  
product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the  
product. BioVision, Inc., shall not be held liable for any damage resulting from handling or from contact with the 
























































Material Safety Data Sheet  
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Section 1: Chemical Product and Company Identification  
 
Product Name: Yeast extract  
Catalog Codes: SLY1108  
CAS#: 8013-01-2  
RTECS: ZF6610000  
TSCA: TSCA 8(b) inventory: Yeast extract 
CI#: Not available.  
Synonym:  
Chemical Name: Not available.  
Chemical Formula: Not available.  
 
Contact Information:  
Sciencelab.com, Inc.  
14025 Smith Rd.  
Houston, Texas 77396  
US Sales: 1-800-901-7247  
International Sales: 1-281-441-4400  
Order Online: ScienceLab.com  
CHEMTREC (24HR Emergency Telephone), call:  
1-800-424-9300  
International CHEMTREC, call: 1-703-527-3887  








Name  CAS #  % by Weight  
Yeast extract  8013-01-2  100  
 




Section 3: Hazards Identification  
 
Potential Acute Health Effects: Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of 
inhalation.  
Potential Chronic Health Effects:  
Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation. CARCINOGENIC 
EFFECTS: Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available. 




Section 4: First Aid Measures  
 
Eye Contact: Immediately flush eyes with running water for at least 15 minutes, keeping eyelids open. Cold water may be 
used.  
Skin Contact:  
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After contact with skin, wash immediately with plenty of water. Gently and thoroughly wash the contaminated skin with running  
water and non-abrasive soap. Be particularly careful to clean folds, crevices, creases and groin. Cold water may be used. 
Cover the irritated skin with an emollient. If irritation persists, seek medical attention. Wash contaminated clothing before 
reusing.  
Serious Skin Contact: Not available.  
Inhalation: Allow the victim to rest in a well ventilated area. Seek immediate medical attention. 
Serious Inhalation: Not available.  
Ingestion:  
Do not induce vomiting. Loosen tight clothing such as a collar, tie, belt or waistband. If the victim is not breathing, perform 
mouth-to-mouth resuscitation. Seek immediate medical attention.  
Serious Ingestion: Not available.  
 
 
Section 5: Fire and Explosion Data  
 
Flammability of the Product: May be combustible at high temperature.  
Auto-Ignition Temperature: Not available. Flash 
Points: Not available.  
Flammable Limits: Not available.  
Products of Combustion: Not available.  
Fire Hazards in Presence of Various Substances: Not available.  
Explosion Hazards in Presence of Various Substances:  
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in 
presence of static discharge: Not available.  
Fire Fighting Media and Instructions:  
SMALL FIRE: Use DRY chemical powder. LARGE FIRE: Use water spray, fog or foam. Do not use water jet.  
Special Remarks on Fire Hazards: Not available.  
Special Remarks on Explosion Hazards: Not available.  
 
 
Section 6: Accidental Release Measures  
 
Small Spill:  
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading water on 
the contaminated surface and dispose of according to local and regional authority requirements.  
Large Spill:  
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water on the 
contaminated surface and allow to evacuate through the sanitary system.  
 
 
Section 7: Handling and Storage  
 
Precautions:  
Keep away from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate the residue under a 
fume hood. Ground all equipment containing material. Do not breathe dust.  
Storage:  
Keep container dry. Keep in a cool place. Ground all equipment containing material. Keep container tightly closed. Keep in a 
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Section 8: Exposure Controls/Personal Protection  
 
Engineering Controls:  
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended  
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants 
below the exposure limit.  
Personal Protection: Safety glasses. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent.  
Gloves.  
Personal Protection in Case of a Large Spill:  
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid  
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this 
product.  




Section 9: Physical and Chemical Properties  
 
Physical state and appearance: Solid. (Granular solid.)  
Odor: Characteristic. Taste: Not 
available.  
Molecular Weight: Not available. Color: 
Yellowish.  
pH (1% soln/water): Not available. Boiling 
Point: Not available. Melting Point: 
Decomposes.  
Critical Temperature: Not available. Specific 
Gravity: Not available. Vapor Pressure: Not 
applicable. Vapor Density: Not available. 
Volatility: Not available.  
Odor Threshold: Not available.  
Water/Oil Dist. Coeff.: Not available. Ionicity 
(in Water): Not available.  
Dispersion Properties: See solubility in water. 




Section 10: Stability and Reactivity Data  
 
Stability: The product is stable.  
Instability Temperature: Not available. 
Conditions of Instability: Not available.  
Incompatibility with various substances: Not available. 
Corrosivity: Non-corrosive in presence of glass.  
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Special Remarks on Reactivity: Not available.  
Special Remarks on Corrosivity: Not available. 




Section 11: Toxicological Information  
 
Routes of Entry: Not available.  
Toxicity to Animals:  
LD50: Not available. LC50: Not available.  
Chronic Effects on Humans: Not available.  
Other Toxic Effects on Humans: Slightly hazardous in case of skin contact (irritant), of ingestion, of inhalation. 
Special Remarks on Toxicity to Animals: Not available.  
Special Remarks on Chronic Effects on Humans: Not available.  




Section 12: Ecological Information  
 
Ecotoxicity: Not available.  
BOD5 and COD: Not available.  
Products of Biodegradation:  
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.  
Toxicity of the Products of Biodegradation: The products of degradation are more toxic. 




Section 13: Disposal Considerations  
 




Section 14: Transport Information  
 
DOT Classification: Not a DOT controlled material (United States).  
Identification: Not applicable.  




Section 15: Other Regulatory Information  
 
Federal and State Regulations: TSCA 8(b) inventory: Yeast extract  
Other Regulations: Not available..  
Other Classifications:  
WHMIS (Canada): Not controlled under WHMIS (Canada).  
DSCL (EEC):  
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This product is not classified according to 
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National Fire Protection 











































Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or 















08:33 PM  
Last Updated: 
05/21/2013 12:00 PM  
 The information above is believed to be accurate and represents the best information currently 
available to us. However, we make no warranty of merchantability or any other warranty, express or 
implied, with respect to such information, and we assume no liability resulting from its use. Users 
should make their own investigations to determine the suitability of the information for their particular 
purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third 
party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, 































Appendix C – Vendor Sheets 

 600 Main Street, Sharpsville PA 16150 
T
  
Specific Equpiment Specifications & Pricing: 
 
130L, Dished Top and Bottom Heads, 316L Stainless Steel, 10-15 Ra ID, 
Electropolished, welds ground smooth and flush.  32 Ra AVG OD with welds ground 
smooth and flush.  Top head has (2) 2” Tri-Clamp Ferrules, (1) 1” Ferrule, and (1) 6” 
Hand Hole.  Agitator Flange is (1) 6” 150# RFSO Flange for LIGHTNIN XP650 
Agitator with Hydrofoil Impellers. Vessel is ASME Rated for 30 psig @ 250F, Jacket is 
Dimple Style and rated for 150 psig @ 250°F 
  
$19,765.00……lead time is 10-12 weeks ARAD 
  
3250L, Dished Top and Bottom Heads, 316L Stainless Steel, 10-15 Ra ID, 
Electropolished, welds ground smooth and flush.  32 Ra AVG OD with welds ground 
smooth and flush.  Top head has (2) 2” Tri-Clamp Ferrules, (1) 1” Ferrule, and (1) 18” 
Manway.  Agitator Flange is (1) 8” 150# RFSO Flange for LIGHTNIN XP650 Agitator 
with Hydrofoil Impellers. Vessel is ASME Rated for 30 psig @ 250F, Jacket is Dimple 
Style and rated for 150 psig @ 250°F 
  
$51,995.00……lead time is 18-20 weeks ARAD 
  
Add Bottom Entry STERIDOSE Magnetic Drive Mixer………………..$16,795.00 
  
80,000L  Dished Top and Bottom Heads, 316L Stainless Steel, 10-15 Ra ID, 
Electropolished, welds ground smooth and flush.  32 Ra AVG OD with welds ground 
smooth and flush.  Top head has (8) 2” Tri-Clamp Ferrules, (7) 1” Ferrule, and (1) 24” 
Manway.  Agitator Flange is (1) 12” 150# RFSO Flange for LIGHTNIN XP Agitator 
with Hydrofoil Impellers. Vessel is ASME Rated for 30 psig @ 250F, Jacket is Dimple 
Style and rated for 150 psig @ 250°F 
$302,765.00……lead time is 24-26 weeks ARAD 
80,000L (Storage Vessel)  Flat Top and Sloped Bottom, 316L Stainless Steel, 32 Ra 
AVG ID, welds ground smooth and flush.  32 Ra AVG OD with welds ground smooth 
and flush.  Top head has (8) 2” Tri-Clamp Ferrules, (10) 1” Ferrule, and (1) 24” 
Manway  
$79,650.00……lead time is 16-18 weeks ARAD 
Harris E. Rogner- Sales Engineering Manager 
Sharpsville Container Corporation |hrogner@scacon.com 
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CR Series  






S P E C I F I C AT I O N S  
 



















B C B C 
FRONT VIEW  SIDE VIEW  FRONT VIEW  SIDE VIEW  SIDE VIEW  
 
MODELS  CR4†  CR10†  CR21†  CR42†  CR85†  CR135†  
Performance characteristics  
Throughput ft3/hr {l/hr}  4 {113}  10 {283}  21 {595}  42 {1189}  85 {2407}  135 {3823}  
Heater energy source  electric or natural gas electric or natural gas  electric or natural gas electric or natural gas  electric or natural gas electric or natural gas  
Air circuit  open or closed loop  open or closed loop  open or closed loop  open or closed loop  open or closed loop  open or closed loop  
Dimensions inches {mm}  
A - Overall crystallizer height  159.2 {4043.7}  169.0 {4292.6}  192.5 {4889.5}  226.8 {5760.7}  261.8 {6649.7}  281.1 {7139.9} 
B - Overall crystallizer width  66.0 {1676.4}  66.0 {1676.4}  69.0 {1752.6}  79.1 {2009.1}  86.3 {2192.0}  98.3 {2496.8} C 
- Overall crystallizer depth  70.5 {1790.7}  75.0 {1905.0}  70.1 {1780.5}  81.4 {2067.6}  94.2 {2392.7}  106.3 {2700.0} 
D - Blower height†  NA  NA  37.8 {960.1}  37.8 {960.1}  37.8 {960.1}  45.8 {1163.3} E - Blower width† 
 NA  NA  32.5 {825.5}  32.5 {825.5}  32.5 {825.5}  37.5 {952.5} F - Blower depth† 
 NA  NA  68.4 {1734.4}  70.4 {1788.2}  77.5 {1968.5}  80.6 {2047.2}  
Approximate weight lbs {kg}  
Crystallizer installed  2863 {1299}  3130 {1420}  3315 {1504}  4422 {2006}  6590 {2989}  7754 {3517} 
Surge bin installed  270 {122}  270 {122}  650 {295}  650 {295}  650 {295}  650 {295} 
Blower installed  NA  NA  700 {318}  800 {363}  900 {408}  1100 {499}  
Voltage total amps  
230V/3 phase/60 Hz  38.8  NA  NA  NA  NA  NA 
400V/3 phase/50 Hz  22.3  55.6  107.5  159.1  292.5  305.3 
460V/3 phase/60 Hz  19.3  48.4  93.5  138.4  254.4  265.5 
575V/3 phase/60 Hz  15.5  38.7  74.8  110.7  203.5  212.4  
Discharge type (via rotary air lock)  
Surge bin 10 ft3{281 l/hr}  standard  standard  standard  NA  NA  NA  
Surge bin 17 ft3 {481 l/hr}  NA  NA  NA  standard  standard  standard  





<90 dbA @5 ft.  
 
SPECIFICATION NOTES:  
 







The blowers on models CR4 and CR10 are located on the stand. Blowers on  
models CR21, CR42, CR85 and CR135 are independent of the stand, adequate  
space will need to be planned for positioning of the blower on these models.  
 
Specifications may change without notice. Consult a Conair representative for the 












uoP series: Heat & mass transfer oPerations  
Distillation Columns - uOP3  
NEW & IMPROVED UOP3CC + UOP3BM  
 
New: LabVIEW™ software options  
 
Unique* eight point sample & feed sieve plate column sections  
 
S a m p l e & f e e d p o i n t s a t eve r y t r a y  
 
C o l u m n c a n u s e f l a m m a b l e s o l ve n t s  
 




Considerable advances in the instrumentation and 
control of distillation columns have been made in  
recent years, prompted by the advent of computer-  
linked systems supported by software packages  
for handling plant operating data. To reflect these 
advances, Armfield has developed two new state-  
of-the-art laboratory-based distillation columns 
that enable safe hands-on practical training for  
student engineers and plant operators:-  
> A continuous or batch operation, computer-  
© Armfield Ltd. 2012  compatible column (model reference UOP3CC),  
which enables a full range of demonstrations  
from the introductory stages of a process 
engineering course through to the more  
complex demonstrations of modern control 
strategies.  
> A batch-only operated version (model reference  
UOP3BM) manually controlled, permits  
comprehensive study of the basic principles of 
distillation.  
> Both units are designed for safe options  
using flammable solvents.  
 
The Armfield UOP3CC and UOP3BM have been significantly  
improved with the addition of sampling ports on each of 
the trays.  
Previously, the thermocouple was  
removed in order to take a sample.  
The new sampling ports enable vapour 
or liquid samples to be drawn from each 
of the sieve plates by simply inserting a  
hypodermic needle into the septum seal 
whilst the distillation is in full, continuous  
operation. In addition, sample ports can  




PR O D U C T 
S  
each sieve plate.  
 
The ports are now fitted as standard, and  
are available as a retrospective install 
to existing UOP3CC & UOP3BM units.  
<E X T E N D E D >  
WARRANTY 
2years  
Contact Armfield for more details.  
A
N  
TY O  
 
N ALL ARMFI  ELD  
 
Above: Computer interfaced distillation column UOP3CC shown with safe area console  























 Fig. 1: Column pressure drop as a function of  Fig. 2: Column overall efficiency as a function of  Fig. 3: McCabe-Thiele construction for batch  
boil-up rate  boil-up rate  distillation at total reflux (methylcyclohexane-toluene  
mixture, atmospheric pressure, boiler power 1.0kW)  
 
 
LABORATORY WORK ASSIGNMENT CAPABILITIES  
 
For Batch Distillation Column UOP3BM -  
under manual control:  
n pressure drop across the column as a function of  
boil-up rate (Fig. 1)  
n column efficiency as a function of boil-up rate, at  
total reflux (Fig. 2)  
n plate-to-plate temperature profiles along the column  
n McCabe-Thiele construction of operating line (Fig. 3) n 
distillation at constant reflux ratio: variation of top  
product composition with time (Fig. 4)  
n mass balance across the system  
n manual control of reflux ratio, for example to achieve  
a top product of specified composition  
n comparison of packed column with sieve plate  
column performance  





























Training on the UOP3CC.  Close-up of new column section  






 Fig. 4: Batch distillation:  UOP3CC Safe area console  
variation of composition with time at fixed reflux ratio of 5:1 (methylcyclohex-  





For Computer-Interfaced Distillation Column UOP3CC only  
- continuous operation, manual or computer operation:  
n includes all demonstrations listed for UOP3BM  
under 'Batch Distillation Column'  
n continuous, steady state distillation including  
temperature profiles and McCabe-Thiele analysis  
n distillation under reduced pressure conditions  
(Fig. 5 - page 6)  
n comparison of packed and plate column  
continuous operation (Table 1)  
n effect of feed pre-heat (Fig. 6)  
n effect of feed position (Table 2)  
n demonstration of azeotropic distillation (Fig. 7)  
n computer control assignments:  
- the on-line use of mimic diagrams (Fig. 8)  
- setting up data logging and subsequent analyses of  
captured data, including use of spreadsheets (Fig. 9)  
- batch distillation at constant reflux ratio  
(Fig. 10 - page 6) or varying with time  
- batch distillation with reflux ratio control from a  
column temperature (Fig. 11 - page 6)  
- continuous distillation with three-term control of  
reboiler heater from a column temperature  
- continuous distillation with top temperature  
controlling reflux ratio  
- continuous distillation with temperature control of  




n proprietary controller demonstrations:  
- PLC control of reboiler heater and/or reflux ratio and  
alarm functioning (requires Armfield PCT19BR unit  
incorporating an industry-standard PLC) (Figs. 13 & 14)  
- demonstration of PC supervision of PLC and PID  
controllers - an introduction to distributed control  
systems  
- PID analog control of reboiler heater from column  
temperature (requires Armfield PCT20H unit  


















Fig. 8: On-line mimic diagram during batch distillation at constant reflux ratio  
 
[Table]  
- optimum controller settings for changes in feed rate,  
composition or temperature  
- alternative, user-originated control algorithms  
- process dynamics e.g. monitoring and controlling plant  









Figs 1, 2, 3 and 4 and Table 2: Results taken from Armfield UOP3CC Distillation  
Column in the Process Laboratories of the Department of Chemical Engineering,  
University of Aston, U.K. courtesy of Dr. J. D. Jenkins  
Fig. 9: Typical results displayed in tabular format  
DESCRIPTION  
 
Batch Distillation Column (Manual) UOP3BM 
The unit is a self-contained and fully instrumented  
distillation facility, suitable for practical laboratory 
work relevant to the teaching of unit operations.  
The equipment employs galvanically isolated intrinsically  


































enable safe distillation of standard test mixtures such as  
methylcyclohexane-toluene, methyl alcohol-water etc.  
The equipment consists of two interconnected units:  
a floor standing process unit and a bench-mounted 
control console.  
The following features are included:  
Process Unit  
n a 50mm diameter plate distillation column containing  
eight sieve plates and downcomers. Every plate includes  
a temperature sensor positioned to measure accurately 





































Cooling water  
 
 





of each plate temperature sensor are not more than  
1.5mm diameter, to ensure rapid dynamic response.  
n a 50mm packed column supplied as a separate item,  
but readily interchangeable with the plate column by  
the user, for comparative studies of the two types of 
















Feed pump  
 
Bottom product  
receiver  
n electrically heated reboiler of sufficient capacity for up  
to two hours of batch operation. The reboiler heater is  
protected against overheating and by a low level alarm.  
n an overhead condenser with cooling water flow  
measurement and adjustment.  
n a condensate collecting vessel, equipped with double  
overflow weirs and exit pipes to enable separation of 
immiscible liquids.  
n a reflux return valve, solenoid operated, to provide for  
0%-100% reflux, adjustable by electrical signal.  
n a differential manometer connected to the top and  
bottom of the column, to monitor column pressure drop.  
n a vacuum system with gauge to enable distillation  
studies at reduced pressures down to 200mbar(abs).  
n sampling points throughout the system for  
composition analyses.  
n materials of construction for surfaces in contact with the  
process fluids are; glass, stainless steel, PTFE or similar 
solvent-resistant materials.  
n overall height of the process unit does not exceed 2.5  
metres (8.2ft).  
n lagging is provided, although it is possible to see at least  
one plate in operation with distillation in progress.  
n maximum operating temperature inside the column  
operation is at least 130 ˚ C.  
Temp sensor  
UOP3CC Only  
 
Schematic diagram of Armfield distillation columns  
 
Control Console  
n monitoring and selectable display of at least 13 system  
temperatures, including those of the liquid on each tray, 
the reboiler and across the condenser.  
n monitoring, display and manual adjustment of:  
i) the electrical power to the reboiler heater. 
ii) the reflux ratio setting.  
n front panel connections to enable the user to connect  
0-5 Volt industry-standard analog or programmable  
logic controllers, to provide on-line control of the boil- 
up rate or reflux ratio from chosen column temperature  
measurements. The connection points also permit 
the use of standard laboratory chart recorders and  
data loggers. (Up to two temperature measurements 
simultaneously).  
n mains power connection (single phase 3kW max. supply)  
protected by Residual Current Device. No-volt protection 
safety circuits to prevent unintentional start-up.  
n individual circuits protected against excess current with  
resetable circuit breakers.  
DESCRIPTION  
 
Computer-Interfaced Distillation Column UOP3CC  
This unit incorporates all the features of the manually  
operated batch column described on opposite page  
(UOP3BM) but includes the following additional items:  
Process Unit  
n two 5 litre feed vessels, with rapid changeover to permit  
step changes in feed composition to be made.  
n peristaltic feed pump, range 0-0.25 litres/minute  
adjustable by voltage input variation to the pump 
motor controller.  
n electrically heated reboiler of sufficient capacity for one-  
two hours of batch operation, but equipped with an  
internal overflow when continuous operation is required.  
n a bottoms product heat exchanger which may either be  
water cooled or used as a (variable) feed pre-heater.  
n alternative column feed points and the ability to vary the  
inlet feed temperature to the column.  
n dosing feed vessel, connected to the column for the  
continuous addition of a third liquid component, which,  
together with the condensate phase separator vessel, 
enables the study of azeotropic distillation.  
n temperature sensors in each flow stream entering and  
leaving the condenser and of the feed, product system 
and reboiler temperatures.  
Control Console  
n monitoring and selectable display of at least 14 system  
temperatures, including those of the liquid on each tray,  
the reboiler, across the condenser, and of the feed and 
product streams.  
n monitoring, display and manual adjustment of:  
i) the electrical power to the reboiler heater. 
ii) the reflux ratio setting. iii) the feed rate 
setting.  
n ribbon cable connector at rear of the console allows  
the use of standard laboratory chart recorders and data 
loggers (all measurements simultaneously).  
n USB connector at the rear of the unit allows connection  
to a user supplied PC, via the integral USB interface.  
n remote/manual switch is provided on the front panel of  
the console to enable simple changeover from PC to front 
panel control to be made by the operator.  
n power and motor control circuits shut down automatically  
with loss of computer control signals (when in computer 























PID controller screen from Armfield software  
Armsoft 306 software included as standard  
n bespoke Armsoft-306 Windows based software, enables  
real time data acquisition via USB port, mimic diagram 
of process tabular and graphical display of results, and 
export to external spreadsheet.  
n fully configurable, multiple loop control strategies.  
control options include:  
i) manual control of feed rate, reboiler power and  
reflux ratio.  
ii) alarm setting.  
iii) adjustable PID control of the power to the  
reboiler heater from a temperature sensor.  
iv) alternative algorithms for controlling the  
reflux ratio, in particular by programmed  
variation with time and from a column 
temperature.  
v) 'two point' temperature control of reboiler  
power and reflux ratio simultaneously.  
n full help facilities including presentation screen to provide  
a brief overview of the equipment, and detailed texts  
giving all the information required to run the experiments.  
LabVIEW software  
n as an alternative to the Armsoft-306 software, the  
software to control the UOP3CC can be supplied in the  
LabVIEW™ format. Two versions are available:  
- UOP3CC-LV-RT is a run time version of the  
software. It does not require that LabVIEW™ is  
installed on the computer and requires no further 
license to run the software.  
- UOP3CC-LV-SC is aimed at experienced LabVIEW™  
developers. It includes all the source files so that 
users can amend the software and optimise it to 
their own requirements. To use UOP3CC-LV-SC, 
the National Instruments LabView development  
program must be installed on the computer  
(i.e.. NI Developer Suite 2012), complete with all 
appropriate licenses. (Armfield do not supply the 
National Instruments software).  
 








Distillation column control using an Armfield PCT19BR Industrial PLC Unit  
 
Comparison of batch distillation for different  
reflux ratio control strategies  
 
 
Effect of operating parameters on column temperature profile  
(Feed rate of 60ml/min, 60% trichlorethylene/40% methylene  










Fig. 10: Constant reflux ratio  
 








































feed to top of column  
Time  Compositions, m.f. MCH  Power  Reflux  Temperatures, ˚ C  
Packed column  48.4˚C  82.5 ˚C  Feed  Overheads  Bottoms  Input, kW  Ratio  Reboiler  O/H Line  Top Plate  
13.40 0.293  
Plate column  48.0˚C  85.0 ˚C  
15.00  0.79  2:1  108.8  103.4  103.5  
Conditions:  15.15  0.77  2:1  108.4  103.0  102.7  
Feed: 60ml/min of 60:40 trichlorethylene/methylene  
chloride  
Reboiler power: 0.75kW  
Reflux ratio: 2:1  
Ambient feed temperature: 17˚C 


































Table 1: Comparison of temperatures across packed and  Table 2: Results for an alternative feed position  
plate columns  
 
PCT19BR Industrial PLC controller  
 
 
INSTALLATION REQUIREMENTS  
 
 
Solvent resistant level floor.  
Either a flameproofed room or in an area where a 2 metre  
clear and uninterrupted space on each and every side  
and above the unit can be maintained and into which no  
potentially spark producing equipment should be allowed 
to enter.  
Electrical supply:  
 






PLC unit incorporating Allen Bradley SLC500 complete  
with proprietary ladder logic set-up program (requiring  
user-supplied PC). This program is initially configured  
by Armfield for two analogue input/output control loops  
suited to the UOP3 Distillation Column unit (either BM 
or CC versions), but may be re-configured by users via 







220-240V/1ph/50Hz @ 13A  
120V/1ph/60Hz @ 25A 
220V/1ph/60Hz @ 13A  
220-240V/1ph/50Hz @ 13A  
120V/1ph/60Hz @ 25A 




PID controller, incorporating a Honeywell UDC3300  
series unit, with voltage/mA input and output for  
single loop control and alarm configurations. Suitable  
for both UOP3BM and CC versions. A software  
package is supplied on disk to demonstrate the basic  
Cold water supply:  
15 litres/min at 2.0bar pressure (min.)  
Venting:  
exhaust line to fume cupboard or to safe discharge area  
outside of laboratory.  
NB: The distillation unit is floor mounted and is supplied  
already connected to the bench- mounting control  
console by sufficient armoured cable to allow the 2m 
clear space to be maintained around the column.  
ESSENTIAL ACCESSORIES  
 
Analytical equipment, suitable for composition  
analyses of any particular liquid mixture selected by 
the user (e.g. refractometer).  
For UOP3CC only:-  
Windows PC with USB port. (not supplied by Armfield)  
 
 
Note: It is not possible to upgrade a UOP3BM unit  
to a UOP3CC unit, owing to the complexity of the  
flameproof barriers within the UOP3CC control console.  
principles of SCADA whereby a user-supplied PC can 
address the PID controller on-line.  
DISCOVER WITH  
ORDERING SPECIfICATION - UOP3BM  
Batch Distillation Column (manual):  
• Self-contained sieve plate distillation column unit including  
reboiler, condenser and reflux tank, suitable for use with  
flammable solvents and fully instrumented for batch operation  
• Eight feed and sample points  
• Temperatures throughout the process including those on each  
and every sieve plate are monitored and displayed on a bench  
mounted control console, via a selector switch. The console 
also houses controls for the power supplied to the reboiler  
heater and for reflux ratio settings between 0 and 100%  
• The console front panel connections enable the use of  
standard laboratory recorders and data loggers and of  
industry-standard PID and PLC controllers (not supplied)  
• A U-tube manometer is incorporated to measure  
pressure drop over the distillation column  
• The 50mm diameter sieve plate column may be readily  
interchanged with a packed column supplied as an alternative  
• A vacuum system enables operation at reduced  
pressures down to 200mbar(abs)  
• The unit is supplied completely assembled including  
lagging, and a comprehensive instruction manual describes 




OVERALL DIMENSIONS  
ORDERING SPECIfICATION - UOP3CC  
Computer-interfaced Distillation Column:  
• Self-contained sieve plate distillation column unit including  
feed vessels and pump, reboiler, condenser, reflux separator, 
product collecting tanks, bottoms product cooler/feed pre-  
heater, suitable for use with flammable solvents and fully  
instrumented for both batch and continuous operation  
• Eight feed and sample points  
• Temperatures throughout the process including those on each  
and every sieve plate are monitored and displayed on a bench  
mounted control console, via a selector switch. The console 
also houses controls for the power supplied to the reboiler  
heater and for reflux ratio settings between 0 and 100%  
• The console front panel connections enable the use of  
standard laboratory recorders and data loggers and of  
industry-standard PID and PLC controllers (not supplied)  
• The console is designed to be connected to a PC  
(not supplied), and software is provided to enable  
on-line data logging, real time trend monitoring and  
PID control loops to be set up, monitored and  
configured by the user via a mimic diagram  
• A U-tube manometer is incorporated to measure  
pressure drop over the distillation column  
• A vacuum system enables operation at reduced  
pressures down to 200mbar(abs)  
• A third feed vessel is supplied such that, with the reflux  
phase separator, azeotropic distillation may be demonstrated  
Process Unit:  
Height: 2.25m  
Control Console:  
Height: 0.30m  
• The 50mm diameter sieve plate column may be readily  
interchanged with a packed column supplied as an alternative  
Width: 0.85m  Width:  0.52m  • The unit is supplied completely assembled including  
Depth: 0.80m  Depth: 0.40m  lagging, and a comprehensive instruction manual describes 
commissioning, maintenance and instructional assignments  
SHIPPING SPECIfICATION  
Packed Volume:  




OVERALL DIMENSIONS  
Process Unit:  Control Console:  
Height: 2.25m  Height: 0.42m  
Width: 0.85m  Width:  0.52m  
Depth: 0.80m  Depth: 0.40m  
 
306  SHIPPING SPECIfICATION  
 








Packed Volume:  
Gross Weight:  
3.5m³  
450 kg  
 
 
Armsoft 306 - 64/32-bit Windows compatible software  
FOR FURTHER INFORMATION ON THE ADVANCED FEATURES  
 
*Armfield UOP3CC and UOP3BM are the the only units on the market with this  
sampling capability, and the column is unique in that it can use flammable  
s o l ve n t s. I n a d d i t i o n , s a m p l e p o r t s c a n b e u t i l i s e d a s a d d i t i o n a l f e e d p o s i t i o n s 
o n  





each sieve plate.  
Co r r e c t a t t i m e o f p r o d u c t r e l e a s e .  
 




U.S. Office:  
 
scan QR code* to visit our website  
* Scan with smartphone with  
<E X T E N D E D >  
Armfield Limit  






































Armfieldouse, edest street, 
Limit  
Armfield nc.  
WARRANTY  
<E X T E N D E D >  
WARRANTY  Bridge House, West street,  
QR code scanning software installed.  
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Pharmaceutical  




The processes in the pharmaceutical industry  
have the highest and most precise require- 
ments in terms of quality. In result, suppliers 
of pharmaceutical equipment should comply 
with the highest requirements in accordance 
with GMP. Biomashin produces and supplies 
pharmaceutical equipment in accordance 
with Good manufacturing Practice (GMP) and 
accompanied by validating documentation IQ, 
OQ, FAT, SAT inclusively. For reactors with max- 
imum allowable working pressure > 0.5 bar we 
offer product certification in accordance with 
PED 97/23/EC.  
 
Reactors are used for heat treatment, stirring,  
mixing and treatment of liquid and creamy 
components, living organisms inclusively, as 
well as active biochemical ingredients. Lead- 
ing producers in the pharmaceutical industry 
use our reactors to produce infusion solutions, 
gels, etc.  
 
 
Reactor, basic design  
n Made of stainless steel AISI 316L/AISI316Ti  
n Wide range of volumes  
n Surfaces in contact with the product Ra  
1.6÷0.4 µm  
 
The pharmaceutical and cosmetic industry  
requires complex process tanks and solutions 
consisting of different aggregated systems 
with various configurations.  
 
Biomashinostroene AD has a wide product  
range of tanks and apparatuses for the phar- 
maceutical industry. We use the latest inven- 
tions in terms of engineering and production 

















Ability to work under pressure and vacu-  
um  
Heat-exchanging device - inner or outer  
serpentine  
Agitator/Stirring mechanism in accor-  
dance with the application of the reactor,  
viscosity and density of the product  
Insulation with mineral wool or PU-foam,  
covered with fully welded insulation clad-  
ding  
Safety armature and electro-sensors for  















































The application of the mixing & melting tanks  
































































The term "homogenization" means a process of emulsification of the  
fluid in another or uniform dispersion of solids in a liquid to increase  
liquid and creamy products.  
 
Melting tanks are used in the cosmetics indus-  
try to melt aqueous and oil phase when pro- 










Made of stainless steel AISI 316L/AISI304  
 
Volumes from 100l to 1000l  
 
Surfaces in contact with the product Ra 1.6÷0.4 µm  
 
Ability to work under pressure and vacuum  
Heat-exchanging device - dimple jacket or outer serpentine  
made of half pipe  
density, stability, durability, aroma and other qualities of the products.  
 
Biomashin offers tanks for homogenizers for cosmetic emulsions used  
for production of creams, gels, tooth paste, cleansing milk, etc.  
 
 









Agitator/Stirring mechanism in accordance with the product  
Insulation with mineral wool or PU-foam, covered with fully  
welded insulation cladding  
 












Made of stainless steel AISI 316L/AISI316Ti  
Surface in contact with the product Ra 1.6÷0.4 µm  
Volume from 100 to 1000l  
Ability to work under pressure and vacuum 
Heat-exchanging device - outer serpentine  
Insulation with mineral wool or PU-foam,  

















































The containers that Biomashin offers and produces have various ap-  
plications - servicing, storage, stirring/mixing, and transportation of 
pharmaceutical products. They could be used for powdered products, 
granules, capsules, or tablets.  
 
We offer a variety of types and volumes that correspond to the dif-  
ferent needs. Our containers are designed in such a way, so that they 
could be serviced by pallets or forklifts with maximum solidity, preci- 
sion and durability.  
 
Biomashin produces and supplies pharmaceutical containers in accor-  
dance with Good Manufacturing Practice (GMP) and accompanied by 








































S&T heat-exchangers are widely spread. Their simplified design makes  
them a perfect solution when it comes to heating or cooling processes 
for wide application.  
 
Biomashinostroene AD is equipped with up-to-date machines suitable  
for the production of S&T heat-exchangers made of stainless steel. We 
have highly efficient equipment for the production of plates. To fix the 
tubes to the plates, we use specialized instruments as well as auto- 
matic orbital welding heads.  
 
Biomashin's equipment and technologies, as well as experience, allow  
us to cover all hygiene standards for heat-exchangers used in the phar- 
maceutical and food industries.  
 
For heat-exchangers working under pressure we offer product certifi-  
cation in accordance with PED 97/23/EC. During their construction we 








Made of stainless steel AISI 316L/AISI 304  
Surfaces in contact with the product Ra 1.6÷0.4 µm  
Ability of insulation with mineral wool and fully  
welded insulation cladding  
Biomashinostroene AD covers the highest levels of quality of welded  
joints with the support and supervision of our welding control and 





Quality and Environment  
 
The management of Biomashin builds a corporate cultu- 
re aimed at creating quality products and mentality to- 
wards meeting customers' needs and bringing satisfaction. 
Consequently, the following certificates are implemented  
in the company:  
n System for Quality Control ISO 9001:2008 which is per-  
manently and precisely controlled and upgraded  
n Product certification in accordance to the Pressure  
Equipment Directive EC 97/23/EG - PED  
n A system for Occupational Health & Safety Advisory  
Services: BS OHSAS 18001:2007  
n GOST-R - a quality certificate in accordance to the  
requirements of the Russian Federation  
n RTN (Russian Technonadzor) for producing vessels un-  
der pressure in accordance to the requirements of the  
Russian Federation  
These certificates allow Biomashin to export and legitima-  
te its products on the territory of the European Union, 
Switzerland, Russia and the countries from the former Soviet 











Bulgaria - 4003 Plovdiv 160 
Vassil Aprilov Blvd. tel. 
+359 (32) 951 603 tel. 





















Only the best  
technology will  
lead you to  





























a solution  ahead  
 
Rosenmund  












































Products and services  
 
ROSENMUND - progress by tradition  
 
Filters and Filter/Dryers  
 
Universal Dryers  
 
Spherical Dryers  
 
Pan Dryers  
 
Double Conical Dryers  
 


























Process steps  
































6. Drying/cooling  7. Discharging  
3 




A closely linked system of  
innovative products and effective services  
is the guarantee for complete success.  









Rosenmund offers a comprehensive range of innovative  
products that meet the highest standards of quality for the  
pharmaceutical and chemical industry: from separators 
for solid and liquid materials to high-performance filter 
systems and dryers to engineered systems.  
 
In addition, Rosenmund offers a  
complete range of control systems  











Rosenmund divisions  
Universal Dryers  
Pan Dryers  
Spherical Dryers  
Engineered  
Systems  
Gas circulation  
systems  
semi-automatic or fully  
automatic systems  
via PLC/DCS. This wide  
range of products is  
perfectly supplemented  
by a comprehensive  
range of services,  
for which highly motivated  
and qualified specialists are 
available around the globe.  
 
 
Range of services:  
Testing  





After-sales services  
 
Range of products:  
Engineered systems  
Separation & drying of liquid and solid material:  
Filters · Filter/Dryers · Dryers  
The following materials are available for manufacturing:  
Stainless steel · Hastelloy · Alloy · Glass-Lined  
Heating/Cooling systems  
Vacuum systems  
Gas recirculation systems  
Control systems  
Product discharge and containment systems  
Pilot Plant Facility  
 
Rosenmund spherical dryer 1000 l  
 
 
All electrical and mechanical Rosenmund 
devices are in conformance with ATEX 95  
(European directive 94/9/EC).  
 
Spare parts and rental program:  
A wide range of rental machines  
Recycling & range of used products  
On-site service & maintenance program  
Spare parts service  










Advanced technologies  
have a long tradition at 
Rosenmund.  
For almost 200 years, Rosenmund has been known for  
innovative products that are accompanied by first-rate 
performance in service and customer support.  
The company was founded in Liestal/Switzerland in 1810, and 
today it is an extremely successful technology leader in the 
global market.  
 
Rosenmund has acquired an excellent reputation with  
pioneering developments such as the very first Filter/Dryer,  
Rosenmund VTA AG  
Liestal, Switzerland  
and it has consistently increased its technological lead 
since then. Today, Rosenmund is one of the world's best 
known manufacturers of mechanical separators, filters, 
dryers, and engineered systems for the pharmaceutical and 
chemical industry. And this committed company puts all 
its effort into extending this lead even further  
in the future!  
 
 
Rosenmund S.A.S.  




























1810 Foundation of the company  
1965 First vacuum filter  
with mechanical discharge  
1969 First automatic pressure filter  
with mechanical discharge  
1970 First pilot plant 1976 
First Filter/Dryer  
1981 First Nutrex reactor/Filter/Dryer  
1981 First sterile Filter/Dryer  
1984 First paddle filter, Filter/Dryer  
with contact drying  
1985 Basel innovation prize for Nutrex system  
1994 ISO 9001 certification  
1994 1,000th machine produced  
1995 Acquisition of the  
Guedu company (France)  
1995 First Spherical Dryer 1999 
Rosenmund becomes  
a subsidiary of  
De Dietrich (France)  
2001 Acquisition of Glatt Inox  
dryer technology  
 







a solution  ahead  
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The elementary advantages  
of the innovative Rosenmund filter  
and Filter/Dryer technology:  
• Optimum efficiency  
• Professional high performance 
• Total flexibility • Easy cleaning  
(CIP/WIP and SIP).  
 
 
Whether in the chemical, pharmaceutical or food  
industry - Rosenmund filters and Filter/Dryers  
prove themselves through a very high efficiency in  
washing and isolating solids, even in the most  
difficult production processes. The high-performance  
Rosenmund filters can also be converted to  
Filter/Dryers simply and quickly, by the addition of 
upgraded features.  
 
Side discharge.  
The ideal application spectrum for side discharge:  
Multi-purpose production with frequent product changes.  
Processes with stringent  
requirements for low-
particle and  
sterile production.  
Limited building heights.  
 
Special design features:  
Side discharge valve with 
metal-to-metal seal.  
Side discharge valve for pressure-tight closure 
after each product discharge - without prior  
cleaning of the sealing areas! Ideal for automatic  
process control and contamination-free production.  
Rosenmund Easiclean side discharge valve for  
manual cleaning in the case of difficult products.  
Two- or three-blade agitator for an efficient agitation 
and discharge process.  
Quick-lock bayonet or C-clamp main flange closure.  
 
Total discharge with the 
Gas Knife system.  
The Rosenmund Gas Knife  
is a unique and innovative  
solution that enables  
a total product  
discharge without  




























Gas Knife System  
 
Rosenmund  
Filter/Dryer 0,4 m2  
Rosenmund Filter/Dryer 2 m2 sterile version  
Glass-Lined Filter/Dryer.  
The great demand for non-corrosive Filter/Dryers  
led to this joint development between De Dietrich and  
Rosenmund. The innovative Glass-Lined/Hastelloy  
construction guarantees maximum resistance to  
Rosenmund Filter/Dryer 0,4 m2  
chemical solutions and aggressive solvents.  
 
 




Cleaning and Decontamination  
(CIP/WIP and SIP).  
CIP/WIP and SIP systems are an integral part of  
Rosenmund's process equipment range, including steam  
sterilisation and aseptic use. The application of specialised  
spray systems and sterilisation methods validation of the vessel 
preparation process.  
 
Special applications: microwave drying.  
The use of microwaves for chemical processes  
provides clear advantages:  
Improved heat transfer to the product. 
Volumetric and selective heating. No harmful 
substances.  
Gentle and fast drying of difficult products. Low 
energy consumption.  
Rosenmund Filter/Dryer 0.4 m2  
Reduced drying times, especially in the case of  
temperature-sensitive products and when conventional heat 



















Nominal  Used  Max. cake  Drive  Empty weight  Container  
2-blade agitator  area m2  volume l/m3  volume l/m3  power kW  approx. kg  D mm  H mm  S mm  
F F/D  F F/D  F F/D  F F/D  F F/D  F F/D  F F/D  F F/D  
0,03  17  6 1,5  320  203  1960  200  
0,06  35  12  3 600  288  2670  200  
0,1  0,1  80  80  30  30  4 4 1000 1000  400  400  1910 2240  250 250 
0,2  0,2  145  145  55  55  4 5,5  1500 1500  550  550  2320 2560  250 250 
0,3  0,3  185  185  75  75  4 5,5  2000 2000  630  630  2420 2660  250 250 
0,4  0,4  350  350  130  130  5,5  7,5  2500 2500  750  750  2420 2660  250 250 
0,6  0,6  490  490  185  185  5,5  7,5  3000 3000  900  900  2710 2940  300 300  
1 1 1,05  1,05  0,44 0,44  7,5  11  3500 3500  1200 1200  3450 3850  400 400  
1,5  1,5  1,4  1,4  0,6  0,6  11  11  4500 4500  1400 1400  3450 3850  400 400  
2 2 1,8  1,8  0,8  0,8  11  11  5000 5000  1600 1600  3450 3850  400 400 
2,5  2,5  2,3  2,3  1 1 11  15  6000 6000  1800 1800  3450 4150  400 400 3
 3 2,9  2,9  1,2  1,2  15  18,5  8000 8000  2000 2000  3850 4200  400 400 4
 4 3,7  3,7  1,6  1,6  15  18,5  9000 9000  2300 2300  3900 4250  400 400 5
 5 5,2  5,2  2,4  2,4  18,5  22  10000 10000  2500 2500  4250 4750  500 500 6
 6 6,4  6,4  3 3 18,5  22  12000 12000  2800 2800  4250 4750  500 500 8
 8 7,9  9,9  4 4 22  37  14000 14000  3200 3200  4400 5450  500 500  
10  10  10,2  12,5  5,3  5,3  22  37  18000 18000  3700 3700  4500 5100  500 500  
D 
12  12  13,9  15,4  6,2  6,2  25  37  22000 22000  4000 4000  5100 5250  500 500  
16  16  16,8  18,7  7,85 7,85  30  45  26000 26000  4500 4500  5100 5250  500 500  
F = Filter  F/D = Filter/Dryer  
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Universal Dryer  
 
 
The innovation: agitator  
and chopper in one system.  
 
The horizontal construction  
with an integrated agitator/chopper  
system and full-area heating  
allows an unequalled application 
spectrum and extremely short drying  
times with the highest possible  
fill volume.  
The better the mixing, the more efficient the drying.  
To achieve a maximum drying performance,  
Rosenmund has integrated a high-speed rotating  
chopper in one of the two agitator arms of the  
horizontal dryer. This chopper moves through the 
product with the agitator, efficiently breaking up  
lumps of agglomerates (wet or dry) but also providing 
additional mixing capability.  
 
Fast drying through full-
area heating.  
Maximum heat transfer input to the product is achieved  
by heating the total vessel area and the agitator.  
A further advantage is the formation of an especially  
fine product powder in the dryer, which accelerates the heat 
transfer and thus the drying. The particle size of  
the product can be decrease further by the addition of a 
fixed stator to the agitator system.  
 
Wet or dry chopping.  
Wet or dry chopping with the chopper/stator  
combination can make further milling or sieving  
steps unnecessary. The wet milling reduces the thermal  
strain on the product. In addition, a good milling 
effect is often achieved with an appropriate grain  
size distribution. For products that are sensitive to 
high-shear agitation, the chopper can be removed 
quickly and easily.  
 
Huge flexible degree of filling  
due to a high torque and a  
very good mixing effect of the 
agitator/chopper system.  
Hydraulic drives for the agitator and chopper ensure  
Assembly:  
Rosenmund Standard Dryer 4000 l  
Rosenmund  
Universal Dryer 8000 l  a consistently high torque, even with low rotational  
speeds. Therefore the dryer can be filled between 
20-90% of total capacity whilst retaining optimal  
agitation, mixing and drying performance. This huge  
degree of flexibility makes it possible to dry batch  
sizes that have greatly varying volumes and products 
that have greatly varying physical characteristics.  
Regardless of whether you have suspensions, solutions  
or filter-moist products - lumpy transition phases in 
which the agitator and chopper require more power 
can be easily overcome.  
 
 
Agitator with chopper  
F 
Agitator with chopper  
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Agitator to wall clearance  
prevents crust formation and  Important advantages summarised: 
product overheating.  
• Chopper integrated in the agitator arm.  
The special construction of the agitator (results in a  • Reliable lumpbreaking.  
typical wall clearance of 2-5 mm) therefore the entire  • Small particle / grain size.  
interior surface of the dryer is evenly coated. Crust  • Wet and dry milling.  
formation is therefore absolutely minimised and heat  • Drying independent of the initial product consistency.  
is applied evenly to the product during the entire drying  • Small agitator to wall clearance.  
process. Since the agitator is supported at both ends  • Hinged door for easy inspection.  
of the shaft, it results smaller wall clearances than those  • Full-surface heating of the agitator and vessel.  
in spherical and pan dryers can be achieved whilst  • High torque means maximum filling volume. 
maintaining the very high agitator torque!  • Complete encasing of the drive system.  
• Single-nozzle device on the agitator for applying  
Special version.  nitrogen (N2) or liquids for granulation.  
Standard Dryer with three-arm agitator instead  
of chopper.  
 
Easy inspection  
through the front door.  
The hinged front door, which can be quickly and  
easily opened for inspection, provides access to the entire  
diameter of the cylinder. The agitator is held in place 
by the main bearing.  
• Pilot scale trials can be conducted in the  























































































Empty weight  































































































The trendsetting spherical dryer  
range with top or bottom drive  
is the latest development of the proven  
Rosenmund dryers that achieve the highest 
performance standards. A versatile solution  































Rosenmund Spherical Dryer  
with bottom drive 100 l  
Spherical Dryers  
 
 
Cleaned in a flash. Emptied completely.  
The easy cleaning and simple emptying are the most  
convincing features of the Rosenmund spherical dryer. 
Its simple structure, the spherical vessel and the slide  
ring seal above the product area make CIP/WIP cleaning  
and SIP sterilisation possible with a few spray balls or  
ARD nozzles. Cleaning fluids and dissolved product  
residues run out through the drain fittings at the lowest 
point of the vessel. Along with the slope in the direction  
of the outlet valve, this enables a complete and fast  
product discharge. The product outlet is a special ball 
valve that seals the vessel with minimum volume.  
 
Maximum mixing  
with the three-arm agitator.  
The spherical dryer achieves a high degree of mixing  
via a three-arm agitator with a high rational speed.  
By heating the agitator, the heat-exchange area can be  
increased further, thus improving heat transfer and  
preventing wet goods from being baked onto the hub 
and blades. These are the ideal prerequisites for short 
drying times and a reproducible drying results.  
 
High speed chopper  
reduces agglomerate formation.  
To prevent the formation of agglomerates that avoid  
moisture from being removed from the product, an  
additional chopper will improve results in many cases.  
The vertically arranged chopper brings two decisive 
advantages: First of all, it helps to achieve consistent 
results that are practically independent of the filling 
volume. Secondly, no wet product is sprayed on parts 
of the walls that the agitator does not reach.  
 
Everything in view during inspection!  
To allow quick inspection at any time, the top driven  
spherical dryer can be opened easily, by swivelling  
up the lower half of the sphere. This simple operation is 
achieved by a hydraulic part-turn actuator driving  
open a bayonet quicklock main flange, all at the  
touch of button! The dryer can be fixed to the ceiling,  





















Rosenmund Spherical Dryer  















Rosenmund Spherical Dryer  















Rosenmund Spherical Dryer  





Rosenmund Spherical Dryer  





Explosion pressure surges?  
No problem at all!  Important advantages at a glance:  
Since dryers are usually designed for vacuum operation,  • Drying, mixing and granulating.  
the risk of thermal decomposition or dust explosion requires  • Fast and easy cleaning (CIP/WIP and SIP).  
them to be designed for higher pressures in many cases.  • Total product discharge.  
The spherical shape with maximum volume and minimum  • Short drying times.  
surface is the ideal geometry for an explosion containing  • Reproducible drying result.  
vessel. The ball valve will remain in the sealed position  • Heatable agitator.  
even if a power failure occurs, and it is a reliable component  • Vertical chopper/lumpbreaker.  
in this fail-safe principle. A construction that is resistant to  • Easy to inspect.  
explosion pressure surges is therefore easily accomplished!  • Assembly in ceiling.  














Rosenmund Spherical Dryer  
with bottom drive 100 l  
 
 



















Nominal  Used  Drive  Empty weight  Container  
volume l  volume l  power kW  approx. kg  D mm  H mm  L mm  H1 mm  
t. d. b. d.  t. d. b. d.  t. d. b. d.  t. d. b. d.  t. d. b. d.  t. d. b. d.  t. d. b. d.  t. d. b. d.  
25  25  4 500  400  2500  1200  900  
50  50  47  58  10  7,5  1200 800  495  495  2600 2000  1350 1285  900  300 
100  100  131  155  15  11  1500 1300  695  695  2700 2455  1500 1700  900  895  
200  200  204  230  20  18,5  1800 1600  805  805  2800 3050  1650 1860  900 1115 
300  300  283  320  22  22  1800 1800  898  898  2900 3150  1950 2020  900 1225  
400  400  427  457  30  37  3000 2800  1030 1030  3450 3610  2000 2115  900 1390 
600  600  675  722  33  45  4000 3500  1200 1200  3850 3890  2225 2222  1050 1425  
D 
1000 1000 






























1700 1535  
1900 
2265  














Pan Dryers  
 
 
Field-proven and reliable: the 
Filter/Dryer design.  
Heated agitator  
with adjustable speed.  
 
The pan dryer is based on  
the well established and proven  
Filter/Dryer technology; here, however,  
the porous filter bottom is replaced  
with a heated flat bottom.  
The simple change in the design of the heated flat  
bottom enlarges the heating area considerably.  
The agitator of the pan dryer is also normally heated  
and is equipped with speed control. Many elements 
such as the metallically sealed side discharge valve have 
been taken from the proven Filter/Dryer range.  
 
Fast agitator  
replaces the chopper.  
The top driven pan dryer (alternatively with bottom  
drive as well) relies on rotational velocity. A particularly  
fast agitator with a circumferential speed of up to  
3 m/s (spherical dryer only around 1.5 m/s) ensures  
optimum mixing. The lifting and lowering agitator also  
provides mixing on the vertical axis. At the same time, 
the minimal agitator to wall clearance keeps the wall  
free from product crust. The rotational high speed of the  
agitator combined with its vertical translation does not 
require the use of a chopper.  
 
Slide ring seal  
without product contact.  
As with the spherical dryer, the mechanical seal of the  
pan dryer is also advantageously located outside of  
the product area. Depending on the application, it can  
either be lubricated with gas or liquid. The axial motion  
of the agitator is sealed by metal bellows, as with the 
Filter/Dryer.  
 
Rosenmund Pan Dryer  












Rosenmund Pan Dryer  



















Easy internal inspection.  
Important advantages at a glance:  
Inspection is easily possible when the pan bottom is lowered,  
as with the spherical dryer. In the case of frequent cleaning  • Proven Filter/Dryer technology.  
and opening cycles, the pan dryer is also ideally equipped  • Agitator speed-controlled and heated.  
with a time-saving main flange bayonet quick-lock fitting  • Fast cleaning (CIP/WIP and SIP). 
instead of C-clamps.  • Simple emptying.  
• Short drying times.  



































































































Empty weight  






























































De Dietrich  
Double conical  
dryer SR  
 
 
The glass lined double conical dryer Field-proven and reliable: type 
SR is a device that was designed the Dryer principle.  
for drying easily flowing products.  
The rotation of the double cone A proven concept.  
allows the product to be mixed -  
without an internal agitator. The design of the double conical dryer combines the  
drying and mixing function in one simple and stable  
device. The operation and maintenance costs are very low. 
The drying times are reduced to an acceptable level.  
As a result, this concept provides a simple solution for 




Double Conical Dryer SR 1600 clean room design:  
reverse mechanical sealing and vacuum tube on the same side  
























The advantages of a glass lined coating.  
The characteristics of the glass lined coating provide  
special solutions for numerous processes:  
Anti-corrosion, when the dry solution is 
not chemically neutral.  
Fire polishing and anti-sticking, the dry mass 
does not stick.  
Anti-contamination for products that 
require a 100% metal-free contact. Easy 





Various options:  
Important advantages at a glance:  
Adjustable lump breakers (choppers) for materials  
that tend to become lumpy.  • Functional design. 
Insulation and special coating.  • Simple operation.  
Heated cover to prevent condensation.  • Problem-free cleaning. 
"Clean room" version with minimised dead zones  • Low operating costs.  
and remote control for filling, emptying and  • Wide range of options. 
cleaning functions.  
Stainless steel design available.  
 
A De Dietrich product.  
The double conical dryer is part of the De Dietrich  
product range. Like Rosenmund, this company  
is a member of the French group De Dietrich Process  





















Double Conical Dryer SR 1000:  


















Type Container Heating Drive  Empty  
SR  volume area  power  weight  Dimensions in mm  








































1795 x 900 
2355 x 1200 
2705 x 1500 
3084 x 1700 
3384 x 2000 
3937 x 2300 






























































Pilot Plant Facility  
 
 
Experiments and process optimisation  




for all customers.  
 
The decisive step from theory  
to practice. In the recently built  
technical centre pilot plant,  
customers can perform practical  
experiments and test process  
optimisation steps with experienced  






















Rosenmund technical centre, Universal Dryer 100 l  
No two customers are alike. No two problems are the  
same. From years of experience, we know that every  
equipment is unique. Every customer has his own  
products, which are manufactured on different premises 
by individual employees - based on different ideas. For this 
reason, we offer comprehensive services to  
individually optimise our product range of delivery - at 
our new technical centre.  
 
A completely new technical centre.  
The fully equipped Rosenmund technical centre  
opened in November 2002. This international test  
centre provides Rosenmund customers from the  
pharmaceutical and chemical industry with a complete  
range of services. The technical centre is designed for  
carrying out industrial experiments with products from  
the chemical and pharmaceutical industry. The recognised  
core competence lies in the area of the concentration  
and drying of API (Active Pharmaceutical Ingredients) 
that contain solvents.  
 
Plant and know-how  
from one supplier.  
The Liestal technical centre provides Rosenmund  
customers with comprehensive competence that  
significantly simplify the decision-making involved  
in selecting plants and machines. Do you want to change 
or optimise your process? For this purpose, you will want to 
compare systems - for example, between a horizontal,  
vertical or spherical dryer. No problem at the new technical 
centre; our experimental units are at your disposal.  
Since we provide all the systems, we can guarantee you 


















Direct advantages  
for Rosenmund customers:  
• Shorter equipment commissioning times through  
determination of product suitability correct system 
selection and process sequence specification.  
• Optimisation of processing times through precise  
scale-up and / or estimation of vessel residence 
times throughout the process route.  
• Determination of effective cleaning processes  
(CIP/WIP and SIP).  
• Determination of the selection criteria according  
to customer evaluation, e.g. drying time,  
quality (crystal shape, activity etc.), emptying, 
CIP-capability, price.  
 
 




































Due to their special design,  
which fulfils all GMP standards,  
Rosenmund equipment allows  
































Summary of  
Rosenmund Tech Centre  
Pilot Plant Capability:  
Data acquisition and analysis.  
Scale-up experiments as a basis for projection to  
production sizes in respect to filtration and drying time,  
fill volume, recrystallisation and particle size distribution. 
Optimisation of the process sequence. Machine 
optimisation.  
Product trials for equipment selection and to 

































Universal  Spherical  Evapor  Pan  
Dryer  Dryer  evaporator  Dryer  





















Profit from the We not only perform the planning and integration of  
superior competence of our product in your buildings, we also partner with our  
high-tech solutions! customers to provide fully engineered solutions from  
concept stage to performance qualification.  
 
Product handling.  
We provide almost everything to do with the filter and  
vacuum dryer: screens/sieves, lifting columns, containers,  
container mixers, insulation valves, weighing systems 

















Training and courses.  
Should your personnel already be trained on the new  
control system when the plant is delivered? Or does your  
process first have to be optimised on the new plant?  
 
We will be happy to support you with 
























ROSENMUND VTA AG  




Great Britain  
QV
F  
PROCESS SYSTEMS Ltd.  
Stafford  
Phone +44 1785 609 900  
 
Brazil  
DE DIETRICH  
DO BRAZIL  
São Paulo  
Phone +55 11 6703 73 80  
Rosenmund is a subsidiary of the  
French De Dietrich technology group.  
Rosenmund customers therefore  
have quick access to the technology,  
the know-how and the global service of an  
international company at all times.  
You benefit from this!  
 
Service without limitation or borders.  
Whether you need advice or troubleshooting,  
information or services - we provide you  
with a quick and direct connection  
worldwide through our global sales and 
service network. This guarantees short  
reaction times and excellent service.  
The addresses of our factories and sales  
representatives are found here.  
Phone +41 61 925 11 11  




DE DIETRICH  
PROCESS SYSTEMS S.A.S.  
Headquarters  
BP 8 -F 67110 Zinswiller 
Phone +33 3 88 53 23 00  
Fax +33 3 88 53 23 99 
sales@dedietrich.com  
 
DE DIETRICH  
PROCESS SYSTEMS S.A.S.  
Courcouronnes Site (EIVS) 
Phone +33 1 69 47 04 00  
Fax +33 1 67 47 04 10  
eivs@eivs.fr  
 
ROSENMUND S.A.S.  
Semur en Auxois  
Phone +33 3 80 97 12 23  




QVF EGINEERING  
Mainz  
Phone +49 61 31 97 04 0 




IVIA N.V.  
Heverlee-Leuven  
Phone +32 16 40 5000  




IVIA B.V.  
GM Breda  
Phone +31 765 42 15 44  
Fax +31 765 42 15 76  
info@ivia.nl  




DE DIETRICH PROCESS 
SYSTEMS IRELAND Ltd.  
Shannon  
Phone +353 61 366 925  





TANABE WILLTEC Inc.  
Osaka 
Phone +81 6 6356 11 55  




DE DIETRICH EQUIPOS 
QUIMICOS S.L.  
Barcelona  
Phone +34 93 21 88 613  
Fax +34 93 21 84 709  
comercial@dedietrichbcn.com  
 
South Africa  
DE DIETRICH SOUTH  
AFRICA (PTY) Ltd.  
Dunswart  
Phone +27 11 918 41 31  




DE DIETRICH  
PROCESS SYSTEMS Inc.  
Union, NJ  
Phone +1 908 686 49 00  
Fax +1 908 686 83 40  
sales@ddpsinc.com  
 
Charlotte, NC  
Phone +1 704 587 04 40  
Fax +1 704 588 68 66  
rosenmund@ddpsinc.com  




DE DIETRICH  
SINGAPORE (PTE) Ltd.  
Phone +65 6 861 12 32  




DE DIETRICH PROCESS  
SYSTEMS  
Shanghai  
Phone +86 21 5261 0128/5261 0097  




DE DIETRICH PROCESS  
SYSTEMS  
Andheri (East), Mumbai 72  
Phone +91 22 2850 5794/2850 5731  
Fax +91 22 2850 5731  
 
Russia  
DE DIETRICH PROCESS  
SYSTEMS  
Sergey Grabovski  




DE DIETRICH  
SINGAPORE (PTE) Ltd.  
(Thailand Office)  
Bangkok  
Phone +66 91 29 55 92  
















































































The pump  
of choice  
for industry  










Watson-Marlow Pumps Group  
is acknowledged as the world's 
leading manufacturer of positive 
displacement pumps.  
 
 
Founded on over 50 years of 
supplying trusted engineering  
and process expertise across a  
wide range of industries and with 
over one million pumps installed  
worldwide, our products and 
solutions are tried, tested and 
proven to deliver.  
 
 
Our vision  
At Watson-Marlow our vision is  
to deliver products, services and  
knowledge of such excellence  
that Watson-Marlow Pumps  
Group will be the first choice for 
pump technology and process 






The revolutionary Qdos 30  









Mor e t ha n on e m illion p u m ps  
installed worldwide  
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Watson-Marlow Pumps Group  
consistent, year-on-year growth,  










No other company shares our  
level of experience and knowledge  
£124.5m  
£118.4m  of positive displacement pump  































































Watson-Marlow is committed  
to continuous investment in  
innovation, technology leadership  
and advanced manufacturing 
techniques.  
We have grown significantly in  
recent years through selective  
acquisitions and strategic 
investment.  
Watson-Marlow is now comprised  
of six distinct businesses and six  
world-class manufacturing facilities. 
This has strengthened our portfolio,  
expanded our accessible markets  
and significantly increased our 
market share.  
 
 
As a wholly-owned subsidiary of 
Spirax Sarco Engineering Group  
plc, (LSE:SPX) we are part of  
a global organisation which 
employs over 4,500 people  
worldwide, enjoys consistent  
and profitable growth, and has  
been quoted on the London  
Stock Exchange for more than 
40 years.  
2 

































Our roots lie in positive  
displacement pump  
technology. As the  
acknowledged leader in  
our field, Watson-Marlow  
products are the pumps  
of choice for applications  
requiring accuracy,  

































Watson-Marlow Pumps Group is comprised  
of six established brands, each with their own  
areas of expertise:  
 
 




precision tubing  
 
 
aseptic filling and 
capping systems  
 
 
heavy-duty hose pumps  
 
 
sinusoidal pumps  
 
solutions for OEM customers  







No other company shares the same  
experience and knowledge of positive  
displacement pump technology as  
































Watson-Marlow is also the only pump 
company in the world to  
manufacture and supply its own 
precision tubing.  
Watson-Marlow Tubing offers  
accurate, long-term performance.  
Our tubing complements our  
peristaltic pumps and enables  
our customers to deploy end-to-  
end solutions for their pumping  
requirements from a single reliable and 


















As nothing but the tube touches the fluid, the  
risk of contamination in the pump is eliminated.  
Pump action is created by compressing the tube  
between rotating rollers and a track. Between each  
roller pass, the tube recovers to create a vacuum  
and draws in fluid. Complete tube closure provides  
the pump with its action, preventing backflow  
Peristaltic pumps have  
become the first choice  
of pump for chemical  
and industrial metering 
applications.  
Watson-Marlow peristaltic  
pumps are simple to install, 
operate and maintain.  
and siphoning, and eliminating the need for 
check-valves when the pump is not running.  
Widely accepted as the world's fastest growing  
pump type, peristaltic pumps have no valves, seals  
or glands. Peristaltic pumps have a number of  
advantages over other pump types: they provide 
superior flow rate stability and metering accuracy;  
have extensive chemical compatibility; and are 








The liquid being filled only contacts the FDA 
approved pump tubing and the filling nozzle.  
Modular bottle handling including conveying, filling,  
capping and sealing, with users able to choose  
from simple manual filling to semi-automatic filling  
or fully automated systems designed to deliver  
volumes ranging from 0.1ml to 100ml with a  
Flexicon Liquid Filling  
equipment facilitates high  
accuracy aseptic filling  
(±0.5%) and easy product  
changeover without issues 
of cross-contamination or 
cleaning validation.  
filling accuracy of ±0.5% which is check-weighed  
throughout the filling batch, with adjustments made  
automatically if required. Accusil™ tubing fulfils  
biopharmaceutical requirements and is ideal for 











The pump's exclusive sinusoidal rotor overcomes 
the limitations of conventional rotary lobe pumps 
to produce powerful suction with low shear, low 
pulsation and gentle handling.  
MasoSine pumps can be dismantled, cleaned,  
and running again in 20 minutes. No special  
MasoSine sinusoidal  
process pumps offer a  
highly reliable, economic  
method of fluid transfer  
ideally suited to high  
pressure, hygienic  
operations in sectors such 
as food manufacture.  
skills or tools are required and the task can be 
completed by production line operatives rather 
than maintenance engineers. They offer a flow 
capacity up to 91.2 m³/hr and pressures up to  
15 bar. They can safely pump high viscosity  
products, while their innovative yet simple  









With operating pressures to 16 bar and flow rates 
to 80 m³/hr, our pumps save time and money by 
successfully handling the toughest applications.  
Bredel hose pumps are the ideal pump for a vast  
range of industry applications, including chemical,  
ceramics, water and waste treatment, food and  
Bredel is the world's largest  
manufacturer of hose  
pumps and hose element  
materials. Our positive  
displacement pumps are 
working non-stop around 
the world.  
beverage, print and packaging. Our positive  
displacement pumps have no valves, seals or  
glands, and the fluid contacts only the bore of the 
hose. They are simple to install and operate, and 











The company's tubing product range has been 
developed in-line with key market drivers such 
as derivative-free, low leachable materials, high  
reliability, security of supply and - where  
required - single-use technology. The product  
range on offer is vast - 10 different materials 
and 50 different sizes, from 0.13 to 40mm.  
H ig h q u a l i t y t u b i ng i s  
precisely why increasing  
numbers of customers are 
turning to Watson-Marlow,  
a major global player in  
tubing design, manufacture  
and supply, specifically  
for the biopharmaceutical 
industry.  
In Watson-Marlow's state-of-the-art cleanrooms  
the company manufactures Pumpsil premium  
quality platinum-cured (and post cured) silicone  
tube, Bioprene, a unique thermoplastic elastomer  
(TPE) tube, and, most recently PureWeld XL,  
which is a thermoplastic elastomer tubing  
designed to deliver purity and performance in 







Peristaltic pumps have clear advantages when  
handling fluids containing small particles such as 
those in endoscopy or dental surgery equipment.  
Compact in size, the pumps function as their  
own check valve so avoiding the need for further  
expense or system complication in equipment 
often severely restricted by space.  
Zero contamination and  
virtually maintenance-free  
pumping are just two of the 
reasons Alitea OEM pumps  
are specified for medical  
devices and environmental 
analysers.  
With over 300 drive speeds and voltages, 130  
pumphead variants and 60 tubing sizes, we are  
confident we can offer medical and diagnostic  
equipment designers and manufacturers the best 
solution to their pumping needs.  
All pumps have a long and predictable service  
life, with minimal downtime and spares inventory,  
providing the lowest whole life cost of any OEM 











































At Watson-Marlow, we  
have always been one step  
ahead of the competition.  
Product innovation is  
the foundation of our 






Our smallest pump, operating at its lowest speed, 
would take nearly 13,000 years to pump what our  
l a r g e s t p u m p, a t i t s h i g h e s t s p e e d , c a n p u m p i n 








































Our strong connections with the market means we 
understand customer needs, and we continuously  
research to identify new product opportunities.  
Our current products aim to be best-in-class, and  
our new products are winning market share from 
other positive displacement pump types, such as 
diaphragm, lobe and progressive cavity.  
We are committed to investing in technology  
to fully integrate our products and systems  
with customers' processes. This allows them  
to increase plant efficiency and reduce their 











































Our goal is to help our customers  
maximise their throughput and 
achieve cost reductions.  
 
As part of our commitment to continual  
improvement, our design teams encourage 
customer feedback throughout the product  
development process. This enables us to  
ensure we are designing products that meet our 
customers needs, now and in the future.  
Our approach concept, CASE (Consult, Audit,  
Specify and Ensure) means we work closely with  
our customers to identify the potential for even  
better product performance and then specify the 
exact solution to deliver that improvement.  
 
•   
•  
•  
•   
 
Minimising downtime  
Improving end-product quality  
Minimising wastage  



























































Watson-Marlow is a global  
business, but we deliver 












































With direct sales operations in 24 countries and 
distributors in a further 50, we are better placed  
than any other pump manufacturer to respond to 
the needs of our customers.  
Customer support is provided through a network  
of industry specialists and technical support  
teams. This ensures our customers always benefit 
from local knowledge and sector expertise.  
No matter where your business operates,  


































Direct sales operations in 24 countries and 
















We recognise that our people are equally  
important as our technology. Ongoing investment 
in training and development for all our staff lies at 
the core of Watson-Marlow's corporate philosophy.  
Our people understand the importance of  
providing the highest standard of service to our  
customers, at every level. We work with them  
to develop their understanding of our customers, 
their applications and the pressures which affect 
























At every level, our team is committed  
to helping customers:  
•  increase productivity  
•  improve their processes  







































At Watson-Marlow, we continually work  
to improve our environmental performance  
in the design, development and manufacture of 




As an ISO14001 certified company, we have  
implemented a range of measures to safeguard 
and minimise our impact on the environment.  
These include eliminating use of chemical  
substances, using recyclable materials where  
possible and reducing energy consumption 
during manufacture.  
We have incorporated specific design features  
into our products to reduce energy consumption 





A key requirement for customers selecting our 
products is environmental improvement. Waste 
water treatment, for example, where our pumps 
are ideally suited to chemical dosing.  
Our technical expertise and knowledge regarding  
the application of our products is a key factor in 
maximising the production and process benefits  
that can be achieved; all of which have a significant 









































Our "Value for Life" 
promise means that  
everything we design is 




Watson-Marlow equipment has an unrivalled  
reputation for quality and dependability. We combine  
this with our "Value for Life" promise, meaning that  
everything we design and manufacture is built to last.  
We apply our technical expertise to the application  
of our products, services and engineered solutions.  
This maximises the benefits of the products we 
supply, ensuring customers always get the right 
solution for their application.  
In selecting Watson-Marlow, you can be confident  
that you will also receive the reliability, quality and  
performance that sets Watson-Marlow apart as the  
world's leading manufacturer of positive displacement pumps 









Where our one million 
pumps keep industry 
productive.  
 
Watson-Marlow pumps save time and  
money worldwide by successfully handling the 
toughest applications in a broad range  




fully automatic aseptic filling, plugging and 
capping systems.  
Food and beverage:  
clean-in-place applications, dairy, bakery, 
flavourings and additives.  
Mining:  
reagents, polymers and floccullants.  
Water and waste:  
sodium hypochlorite, hydrofluorosilic acid and 
ferric chloride.  
OEM applications:  
medical devices and environmental analysis.  
Chemical:  
safe containment of acids, alkalis and bases.  
Engineering:  
spray coating and waste recovery.  
Ceramics:  
eliminating pinholes, contamination and pulsing.  
Paint and pigments:  
dispersion mill feed, pigment and latex transfer.  
Print and packaging:  
varnishes, inks, coatings and adhesives, with no 
colour cross-contamination or aeration.  
Pulp and paper:  
dyes, brighteners, sizing agents, retention aids 









A Spirax-Sarco Engineering Company  
 
 
Watson-Marlow Pumps Group has six world-class  
factories supported by direct sales operations in 24  
countries and distributors in more than 50 countries.  








Watson-Marlow online  
 
Our engineers around the world can help you choose  
the perfect pump and tubing for your needs.  
 
More information? Our brochures are on our website  































Watson-Marlow Innovation in 
Full Flow  
Tel: +44 (0) 1326 370370  
 
Watson-Marlow Pumps Group  
Falmouth,Cornwall TR114RU,UK 
The information in this document is believed to be correct, but 
Watson-Marlow  
Pumps Group accepts no liability for any errors it contains, and 
reserves the right to alter specifications without notice. WARNING: 
These products are not designed for use in, and should not be used 
for, patient-connected applications. Watson-Marlow,  
info@wmpg.com  w w w. w m p g . c o m  
Pumpsil, PureWeld, LoadSure, LaserTraceability, Bioprene and Marprene are  
registered trademarks of Watson-Marlow Limited. STA-PURE PCS and STA-PURE 









































































The patented Sani-Matic ULTRAFLOW is a self-contained,  
compact, and portable system programmed to accommodate a  
























ULTRAFLOW 110  
• 74"L x 33"W x 80"H  
• Operating range of 5-110 GPM @ 60 psig  
• Electric or steam heat available  
• For process tank diameters up to 10' • 
For process line diameters up to 3"  
OPERATING REQUIREMENTS  
variety of single-use, recirculated CIP applications. Designed for  




• Small Footprint. Space-saving design for installations with limited  
floor space. Fits through standard doorways with ease.  
 
• Wide Operating Range. The systems range from 2-45 GPM and  
5-110 GPM and are able to clean small and large applications.  
 
• Self-Cleaning. Self-cleans without extra step, and eliminates cross-  
contamination.  
 
• Portable. Positioned on low-friction casters for easy movement  
between process suites. No expensive supply and return line 
installation required.  
 
• Water & Chemical Savings. The high-turbulence flow rate and low  
water requirements for operation reduce the amount of water and 
chemicals needed for a complete clean.  
 
• Low Outlets? No Problem. Returns solutions with entrained air to  
accommodate vessels with low and restricted outlets.  
 
ULTRAFLOW 45  
• 62"L x 24"W x 73"H  
• Operating range of 2-45 GPM @ 55 psig  
• Electric or steam heat available  
• For process tank diameters up to 4.5'  
• For process line diameters up to 2"  
OPERATING REQUIREMENTS  




NPT, 10 scfm @ 90 psig  Instrument Air  1/ " NPT, 10 scfm @ 90 psig 2 
Water Supply  
 
Drain  
Dry Weight  
Electrical Power  
(electric heater)  
Electrical Power  
(steam heat)  
Two 1" tri-clamps, WFI, DI, potable  
< 2 GPM @ 25 psig, 20 -˚ 80˚C  
2" tri-clamp (programmable to meet app)  
1,000 lbs (approximate)  
• 15 kW, 50 amps @ 460 VAC, 3 Ph, 60 Hz  
• 30 kW, 68 amps @ 460 VAC, 3 Ph, 60 Hz  
27 amps @ 460 VAC, 3 Ph, 60 Hz  
Water Supply  
 
Drain  
Dry Weight  
Electrical Power  
(electric heater)  
Electrical Power  
(steam heat)  
Two 1" tri-clamps, WFI, DI, potable  
< 2 GPM @ 25 psig, 20 -˚ 80˚C  
2" tri-clamp (programmable to meet app)  
900 lbs (approximate)  
• 12kW, 27 amps @ 460 VAC, 3 Ph, 60 Hz  
• 24kW, 43 amps @ 460 VAC, 3 Ph, 60 Hz  
11 amps @ 460 VAC, 3 Ph, 60 Hz  
Plant Steam  1 /2" flange, 540 lbs/hr @ 50 psig 1 Plant Steam  1/ " 
2 
flange, 195 lbs/hr @ 50 psig  
Plant Condensate  
CIP Supply 
CIP Return  
1" flange  
2" tri-clamp, 5-110 GPM @ 60 psig  
2" or 3 tri-clamp,  
5-110 GPM @ 11' of head @ 80˚ C  
Plant Condensate  
CIP Supply 
CIP Return  
1/ " flange 2 
1 1/2" tri-clamp, 2-45 GPM @ 55 psig  
2" tri-clamp, 2-45 GPM @ 8.5' of head @ 80° C  
(p) 800-356-3300  (f) 608-222-5348  www.sanimatic.com  1915 S. Stoughton Rd., Madison, WI 53716  
BIO-PHARM  
Eductor Return System  




































Water Flow  



















Motive solution is pumped to the eductor through this nozzle.  
Vacuum is created within the eductor through a series of velocity  
changes. The velocity of the solution exiting the nozzle is reduced in the wide 
body and then increased again as solution exits the top of the eductor.  
A mixture of air and solution (in the return line) rushes in to satisfy the vacuum  
within the eductor. The volume of both air and liquid is greater than that being 
supplied to the vessel.  
Returned air and solution enter the chamber through the top port.  
Centrifugal action spins the solution around the walls of the chamber, forcing  




Air Separation Chamber  
 










































































































































































































































Rinse Step  
The separator tank (3) is filled through one  
of the two separator tank water fill valves (1).  
The supply pump (2) draws the water from the  
separator tank (3) and delivers the solution  
to the process through the discharge control  
valve (4) at a programmed flow rate. At the 
same time, solution is pumped through the  
eductor (5) and back into the separator tank  
(3) inlet, thereby creating a vacuum at the 
CIP return connection. The high turbulence  
created within the ULTRAFLOW prevents  
the settling of any solids and self-cleans the 
system. The rinse step is followed by a drain 
step. Typically, a series of 3 to 4 rinse/drain 
steps are utilized for the final rinse.  
 
 
Drain Step  
The discharge control valve (4) is closed 
and solution from the separator tank (3)  
is pumped through the eductor (5) and  
back into the separator tank (3) inlet,  
which creates a vacuum at the CIP return 
connection. Returning solutions create a  
high-level condition in the separator tank (3)  
causing the drain control valve (6) to bleed 
solution to drain at a set flow rate until the 
process and separator tank (3) are empty.  
 
 
Wash Step  
The separator tank (3) is filled through one  
of the two separator tank water fill valves (1)  
The supply pump (2) draws the water from the 
separator tank (3) and delivers the solution to  
the process through the discharge control valve  
(4) at a programmed flow rate. At the same  
time, solution is pumped through the eductor 
(5) and back into the separator tank (3) inlet, 
thereby creating a vacuum at the CIP return  
connection. The high turbulence created within  
the ULTRAFLOW prevents the settling of any  
solids and self-cleans the system. CIP solution  
temperatures are elevated utilizing a heater (7) 
in the recirculation loop. Chemical solutions (8) 
are injected into the highly turbulent separator 
tank (3) and controlled through conductivity.  
 
 










Functional Specifications (FS)  
Configuration Specification (CS)  
Factory Acceptance Test (FAT)  
Site Acceptance Test (SAT)  
Installation and Operation Qualification (IQ/OQ)  
Traceability matrix  
ISA Data Sheets  
Cleaning and passivation report  
Digital weld video record (Borescope)  
• Allen-Bradley CompactLogix (standard)  
• Allen-Bradley PanelView HMI  
• Ethernet communication  
• 40 customizable cleaning cycle programs  
• Report ticket printer available  
• UL listed, 304SS, NEMA 4X enc
(p) 800-356-3300  (f) 608-222-5348  www.sanimatic.com  1915 S. Stoughton Rd., 
Madison, WI 53716 BP-UF 0414  
 
QVF® PHARMA REACTOR  
Series  
Reaction units are of considerable  
importance to the chemical and 
pharmaceutical industry in production 
and development. Particularly where 
small volumes are concerned batchwise 




¾ 16 to 63 litre compact version  
¾ Innovative vessel design  
Function  
The QVF® PHARMA REACTOR is  
specially designed for the two process 
stages of reaction and distillation. The 
reaction stage operates under total reflux, 
whereupon the solvent can be distilled 
off as effectively as possible in the 
concentration phase. Both stages can be 
carried out under either positive pressure 
(+0.6 barg) or vacuum. The materials of 
construction used are borosilicate glass 
3.3, glass-lined steel and PTFE.  
 
addition to the temperature of the vessel 
content and the distillate, the pressure is 
indicated by a tantalum membrane 
manometer. A bursting disk provides 
protection against excess pressure. The 
rotation speed of the glass lined impeller 
stirrer can be adjusted by means of the 
handwheel on the drive.  
All the valves are located close to the 
vessel involved, thus enabling direct 
and correct operation. Valve V8 controls 
the adjustment of the integral reflux 
separator.  
¾ Matching GMP requirements  
Distillation overhead ASSEMBLY Reaction vessel  
The distillation overhead assembly is  The enamelled reaction vessel developed  
made of components from the QVF®  by De Dietrich Process Systems for 
SUPRA-Line meeting the requirements  the QVF® PHARMA REACTOR has the  
economic solutions.  
Pharmaceutical applications provided 
the user requirements for the design of 
the QVF® PHARMA REACTOR. The 
development goals were maximum purity 
and optimized heat and mass transfer  
combined with suitability for GMP use.  
To suit the availability of space in the 
majority of laboratories the QVF® PHARMA 
REACTOR is designed in a compact layout 
with reduced headroom requirements for 
reaction vessel capacities from 16 to 63 
liters.  
of the Pressure Equipment Directive and  
the equipment safety regulations. The 
components made of borosilicate glass 
3.3 larger than DN25 are accordingly CE- 
marked. With its buttress glass flanges 
the QVF® SUPRA-Line not only provides 
a GMP-compliant connection but also a 
wide variety of well thought-out individual 
solutions.  
To ensure that the equipment drains 
completely the horizontal product piping 
is largely installed at an angle of 5°. The 
inclined condenser has a rinsing neck 
and the receiver vessel can be emptied 
and rinsed during the process by means  
following special features:  
•  Block flange for connection to the  
glass cover (1)  
•  Heating jacket up to the flange (2)  
•  Support brackets without thermal  
bridge (3)  
•  Block flange with minimal dead space  
bottom outlet valve (4)  
•  Polished insulating jacket with foam  
glass, stainless steel, tightly welded (5)  
•  White enamel to improve visual control (6)  
 





































of valve V3.  
The integral sampling valve V9 is used to 
take samples from the actual distillate flow, 
even when operating under vacuum. In the 
basic version of the QVF® PHARMA 
REACTOR the instrumentation is equipped 
with all basic functions. In  










Fig. 1: QVF® Pharma Reaktor 16-63 l  Fig. 2: QVF® Pharma Reactor  Fig. 3: Special reaction vessel developed dy DDPS  
In addition to the basic benefits of the  
flat glass buttress end the QVF® SUPRA- flange 
has two special features which make it the 
obvious choice for GMP- compliant plant. All 
nominal bores up to DN 300 have fire-polished 
sealing faces and a groove. The groove stabilises 
and ensures positive location of the PTFE gasket 
seated on the extremely smooth sealing face. 
Together with the GMP compliant gasket, which, 
via centering in the groove and on the outer 
edge, effects a seal on the inside diameter of the 
flange, the flat buttress end provides a coupling 
with minimal dead space fully draining in pipelines 
laid out at an angle of at least 5°.  
Modular construction  
Because of its modular construction the  
basic version of the QVF® PHARMA REACTOR 
can be expanded to handle various special 
functions. The following  
options are, therefore, available:  
 
•  Hydraulic lifting device for the  
reaction vessel  
•  Phase separator  
 
•  Electronic speed indicator  
 
•  Version for increased pressure  
 
•  Coated glass components  
 
•  Weighing cells for reactor, feed and  
distillate vessel  
•  Double-acting mechanical seal  
 
•  Anchor, turbine and propeller  
type stirrers  























De Dietrich Process Systems GmbH  
Hattenbergstraße 36 Tel.: +49 (0) 61 31/97 04-0  
































































































FielRtgerCMieedoaCritical Processing i 
Th  i ht ho c f r  
P h a r m a c e u t i c a l G r a d e M i c ro - M e d i a ® S e r i e s D e p t h F i l t e 
r M e d i a , f o r m u l a t e d w i t h c e l l u l o s e , w e t s t re n g t h re s i n a n d  
diatomite and/or perlite is specifically designed for use in 
critical pharmaceutical and biotech applications. All  
c o m p o n e n t s a re l i s t e d i n t h e C F R a s g e n e r a l l y re c o g n i z e d 
as safe for contact with food as dictated by 21CFR 176.170.  
P h a r m a c e u t i c a l G r a d e M i c ro - M e d i a ® S e r i e s D e p t h F i l t e 
r  
M e d i a i s m a n u f a c t u re d i n a c c o rd a n c e w i t h E r t e l A l s o p D r u g  
Master File located at the United States Food and Drug  
A d m i n i s t r a t i o n C e n t e r f o r D r u g E v a l u a t i o n a n d R e s e a rc h .  
 
Composition  
ErtelAlsop Micro-Media® filter sheets are composed of  
cellulose pulp, Diatomaceous Earth and/or Perlite, or  
C e l P u re ® f o r t h e X L S e r i e s ™ , a n d a w e t s t re n g t h re s i n ,  
which charge modifies the media to exhibit a net positive  
charge referred to as Zeta Potential. This allows for the  
highly efficient removal of particles smaller than the filter's 

















Pilot Testing - Rentals  
F o r i n - p l a n t t e s t i n g a n d s c a l e - u p p ro c e d u re s , E r t e l A l s o p  
offers a variety of lab filters for rent. A portion of rental fees can 
be applied to the purchase of your full production filter.  
 
The Format to Fit Your Needs  







Blood Fractions  
Sera  
C e l l C u l t u re M e d i a  
A c t i v e P h a r m a c e u t i c a l I n g re d i e n t 
s  
Large Volume Parenterals 
Small Volume Parenterals  
to fit your application. Filter sheets, discs and Pak® Lenticular  
C a r t r i d g e s a re a l l a v a i l a b l e t o p ro v i d e y o u w i t h p ro d u c t t o o p t i m i z e  
y o u r a p p l i c a t i o n . E r t e l A l s o p a l s o m a n u f a c t u re s a c o m p l e t e l i n e o f  
filter machinery, from Small Batch and Pilot Scale Lab Filters to 
Plate and Frame Filters, Sealed Disc Filters and Pak® Lenticular 
Cartridge Housings.  
Product Testing  
Product testing is always available either at your facility,  
t h ro u g h o u r n e t w o r k o f d i s t r i b u t o r s , o r a t o u r i n - h o u s e 
laboratory.  
 
F o r o v e r 8 0 y e a r s , E r t e l A l s o p h a s b e e n p ro a c t i v e l y s o l v i n g t h e d e p t h  
filtration problems of industry. We originated and patented the Pak®  
Lenticular Cartridge concept. We created the BioClean™ Sanitary  
Filter Plate Assembly to accommodate the stringent cleaning 
standards of the pharmaceutical industry.  
 








































0.8 µm  
0.45 µm  
0.3 µm  
0.25 µm  
P-Grade Micro-Media®  
 
T h e m o s t a c c u r a t e w a y t o o p t i m i z e y o u r p ro c e s s i s t h 
ro u g h l a b o r a t o r y s c a l e t e s t i n g . S a m p l e s o f P - G r a d e M i c 
ro - M e d i a ® , M i c ro - M e d i a ® X L S e r i e s ™ , o r M i c ro - 
Clear™ Media are available at no charge. Authorized E r t e l 
A l s o p re p re s e n t a t i v e s a re e q u i p p e d t o r u n t r i a l s o n - s i t e , o 
r p ro d u c t s a m p l e s m a y b e s e n t d i re c t l y t o E r t e l A l s o p f o r t e s 
t i n g w i t h p r i o r a p p ro v a l .  
 
Table to the left is for reference only.  
 
* Contains Cellulose, Perlite, and DE ** 
Contains Cellulose, High Purity DE  









Flow Rates  
Chart shows flow characteristics of  
E r t e l A l s o p M i c ro - M e d i a ® a t 1 0 p s i  




















Filter Media  
ErtelAlsop filter media is available for any application and/or operating condition, and is chosen based on your specific  
operating conditions, the performance required by the filtering media, and criteria given to us by you and/or by sample p ro c e s 
s i n g w e d o i n o u r l a b .  
 
ErtelAlsop offers the widest varieties of filter media including 100% cellulose pads, cellulose and diatomaceous earth pads,  
c e l l u l o s e a n d C e l p u re ® d i a t o m a c e o u s e a r t h p a d s , c e l l u l o s e a n d p e r l i t e p a d s , a n d c e l l u l o s e a n d a c t i v a t e d c a r b o n p a d s .  
 
All filter pads are manufactured to very high standards for a wide range of applications in the pharmaceutical, chemical,  
cosmetic, electric utility and food and beverage markets. ErtelAlsop also offers a Validation Guide to assist in the validation  
of its filter pads in your process. The Validation Guide contains information regarding raw materials, extractables, and  
general information about the product. The combination of ErtelAlsop "P" grade filter pads and ErtelAlsop's BioClean™ plate 






For additional  













PO Box 3358  
Kingston, NY 12402 US  
 
ErtelAlsop.com  
800.553.7835 Telephone  









Keep in touch.  
Join our Newsletter to learn  
about the latest filter best  
practices and more!  
 
























































































































Integritest 4 ® 
Series  
Automated Filter Integrity  
Test Instruments and Central  
Instrument Management  
Tool Software  
 Portable, easy to use  Easy-to-use, portable, networkable,* and fully-automated  
 Reliable, accurate measurements integrity test systems that offer reliable, repeatable  
measurements fast  









Network model is 21 CFR Part 11  
compliance ready  
Centralized administration with  
IMT software  
Available in multiple languages  
 
The Integritest 4 instrument is an easy-to-use, 
portable, fully-automated integrity test system.  
Available in either a standalone or networkable  
configuration, the Integritest 4 instrument offers 
reliable and repeatable integrity test data.  
The intuitive touch screen user interface streamlines  
the test while the accelerated testing capability 
provides users with more time for processing.  
On-site calibration support and diagnostic  
capability minimizes downtime, saving time  
and money. Leveraging a proven test algorithm,  
the Integritest 4 instrument performs bubble point,  
diffusion, enhanced bubble point, and HydroCorrSM  
(Millipore water-based test for hydrophobic filters)  
tests on a wide range of filters including disks, 
cartridges and TFF filters, virus, and asymmetric 
membrane filters.  
The rugged, ergonomic design of the system  
enables users to easily carry the Integritest 4  
The networked configuration enables users to quickly  
perform an integrity test, print the results on a shared 
network printer and automatically store test reports on 
a network data repository.  
instrument to any site. The standalone  
configuration enables users to print the results 
on the onboard printer.  
 
 
Data Sheet  *Integritest 4N only  
The Integritest 4N networkable configuration  
enables users to print results directly to any 
networked printer via Ethernet connection.  
The Integritest 4N instrument is 21 CFR Part 11  
compliance ready for electronic records and  
electronic signatures, improving productivity and 
facilitating record keeping.  
 
Easy to Use  
The Integritest 4 instrument features a graphical  
user interface with touch-screen menus and intuitive 
icons for faster testing, enabling more effective use 
of production equipment and resources. Millipore 
and customer specific filter testing information can  
be easily entered on-site. Test results can be printed  
using the built-in printer. Printed test results can be  
customized to include operator, batch, or other 
desired data.  
• Intuitive, multilingual graphical user interface  
• 10-inch touch-screen color SVGA display  
with active matrix  
• Pivoting base for easy adjustment of  
display angle  
• Bar code input for easy filter identification  
and data entry*  
• Utilizes market-leading Windows XP®  
embedded operating system  
• Customized interface based on operational roles  
• Context-based online help  
 
Accurate, Reliable Results  
The instrument has been designed and qualified to  
achieve high test accuracy. To ensure correct  
performance, the software automatically checks the  
functionality of the computer and pneumatic 
manifold components prior to each test. User  
programmable test parameters allow for more case 
specific testing when needed for analysis.  
Rugged Industrial Design  
The exterior surfaces can be easily wiped clean  
with alcohol or bleach. Instrument-grade inlet and  
outlet connections on the pneumatic manifold  
assembly minimize leaks, providing accurate results.  
• Compact industrial design with quick-connect  
ports for easy set up  
• External valve array prevents back flow of fluids  
into the instrument  
• Modular hardware design allows for easy  
servicing on location  
• Durable, onboard printer produces a printout  
that does not fade, even when wet  
• Easily field calibrated for routine maintenance  
and record keeping  
 
Sound Algorithm  
The Integritest 4 instrument uses a software algorithm  
to determine the bubble point of a filter. The  
accuracy of this algorithm is key to proving that  
your filter is integral. Our algorithm is based on a  
mathematically proven tangent method. Unlike other  
solutions on the market today, it extrapolates the 
accurate portion of a flow curve while avoiding  
dependencies on the volatile portions. This, in  
combination with an event-based capture of the  
flow curve, gives you the most reliable, sustainable 
method of bubble point testing.  
• Supports all traditional tests such as bubble point  
and diffusion  
• Optional accelerated test allows you to quickly  
obtain accurate, repeatable results  
• Accurate, reliable testing for asymmetric  
bubble point  
• Programmable prepressurization for properly  
testing multilayer virus removal filters  
• New pressure hold test to test vessels, valves,  














*Requires external bar code reader  
2 
Networkable Configuration  
Leveraging the built-in networking capability of the  
Integritest 4N instrument together with the Windows 
XP® tool kit, users can share a networked printer for  
central printout of test reports. The software also  
enables electronic signatures for sign-off of test  
reports, which can be transferred to a central data  
repository for the backup of all Integritest 4N  
instrument test reports. The Integritest 4N instrument  
can also support wireless Ethernet communication 
eliminating the need to physically plug the unit into  
the network.  
 
21 CFR Part 11 Compliance Ready  
The Integritest 4N software meets the technical  
requirements of FDA regulation 21 CFR Part 11 
for electronic records and electronic signatures.  
 
Increase Process Speed  
When integrated into a network, final filter integrity  
test results are uploaded into the main control system  
enabling an immediate stop/go decision, improv- 
ing the pharmaceutical production process without 
compromising quality control.  
 
Central Instrument Management  
Tool Software  
 
Centralized instrument management and  
















The ability to manage remote instruments via a  
networked PC, streamlines operations as well as  
optimizing integrity testing consistency and reliability 
throughout manufacturing.  
The Integritest 4N Central Instrument Manage-  
ment Tool (Central IMT) software allows centralized  
management of all Integritest 4N instruments  
integrated to a network domain, improving manu-  
facturing and system administrator productivity .  
The Integritest 4N Central IMT software enables  
system administrators to:  
• Manage Users  
- Assign users to instruments  
- Define user roles  
- No need to create user IDs or assign  
passwords*  
- Track password* changes  
• Manage Integritest 4N Instruments  
- Add or change test definitions  
- Define report formats  
- Track the addition and deletion of users*  
• Manage Filter Test Reports  
- Define data repository location  
• Automatically download setups when Integritest  
4N instruments are logged onto the network  
• Organize instrument groups  
• Automatically generate remote backups  
- Periodically  
- Information for instrument recovery and  
event logs  
• Security  
- Domain controller assigned user names  
 
Assign Instruments and Users to  
Logical Groups  
• Users are selected from the domain of users  
provided by the domain controller  
• Tests are assigned to defined instruments in the  
group  
• An instrument tab lists all the instruments added  
to the Central IMT software. All checked 
instruments are part of the group.  
• Report transfer, remote backup and electronic  









*The central IMT software uses the same ID and password  
used to log onto a company's network domain.  
 
3 
Consistent, Effective and Reliable Integrity  
Tester Instrument Management  
Centralized user and instrument management of all  
Integritest 4N test systems enhances testing consis- 
tency and repeatability. Central IMT allows a user  
in one location to access and configure multiple  
instruments in several locations. A test can be 
entered on one PC and added to a group of  
Integritest 4N instruments without having to access  
each instrument individually. A password change 
on one instrument automatically propagates to all 
instruments on the same network when a domain 
controller is used.  
Available Expedited Instrument  
Validation Service  
The Integritest 4 instrument was developed and  
validated according to the GAMP Guide for  
Validation of Automated Systems. Validation reports 
are available for review during an on-site audit.  
The Integritest 4 instrument can be validated on-site 
using a validation protocol customized for you and 
executed by a Millipore Access® Services team.  
 
Comprehensive Services and Support  
Access Services is available to conduct installation,  
calibration and validation on-site. Millipore offers a  
proven validation protocol that tests the range of  
filters and tests used in a facility.  
F i g u r e 1 . The Integritest 4N systems can be connected  












Networked Attached  
Millipore Service Representatives  
offer factory or on-site mainte- 
nance and repair services.  
 
The Requirement of  
Integrity Testing  
Regulatory agencies require  
integrity testing of sterilizing  
grade filters as well as the  
integrity of process critical filters,  
such as bioburden reduction  
Printer  Storage (NAS) or  
PC File Server  
filters, which directly affect  
product quality. For production  
operators, supervisors, and  
validation managers who need  
F i g u r e 2 . The Integritest 4N systems can also be  
networked to a domain-controlled Local Area Network 
(LAN).  
 
PC with Central  
IMT Software  
Domain  
to perform on-site filter integrity 
tests, the Integritest 4 instrument 
is a solution that is easy to 
learn  
and gives you the confidence  
and assurance you need for your  
test results. Users can conduct  
Controller  Corporate Network  
bubble point, diffusion, en-  
 
Print Server and Central  
Data Repository File Server  
hanced bubble point, HydroCorr  
and pressure hold tests on disk,  
cartridge and TFF filters, virus,  
Hub   
 
Printer  













Test Accuracy (at standard, stable conditions)  
Test Type  
Diffusion (Standard  
and Accelerated)  
 
30 Second Diffusion*  
 
Bubble Point (BP) Standard  
Bubble Point Asymmetric  
Range  
Flow rates < 20 mL/min  
Flow rates  20 mL/min (water)  
Flow rates  20 mL/min (alcohol)  
Flow rates < 20 mL/min  
Flow rates  20 mL/min  
345-6205 mbar (5-90 psig) 
345-6205 mbar (5-90 psig)  
Accuracy  
 1mL/min  
 5%  
 10%  
 2 mL/min  
 15% /-10%  
 68.9 mbar (1 psig) < 
344.7 mbar (5 psig)  
Accelerated BP Hydrophilic PVDF 345-6205 mbar (5-90 psig)   137.9 mbar (2 psig) 
Accelerated BP Hydrophobic PTFE 345-6205 mbar (5-90 psig)   206.8 mbar (3 psig)  
HydroCorr  Flow rates < 0.4 mL/min   0.02 mL/min  
Flow rates  0.4 mL/min   5%  
Virus Diffusion  Flow rates < 20 mL/min   2 mL/mi  
Flow rates  20 mL/min   10%  
Pressure Hold  Pressure drops < 68.9 mbar (1 psig) 3.5 mbar (0.05 psi)  
Pressure drops  68.9 mbar (1 psig)  5%  
 
*Used in accelerated enhanced bubble point and asymmetric enhanced bubble point tests.  
 
Test Reproducibility (at standard, stable conditions)  
Coefficient of variation (CV) or standard deviation (sn-1)  
Test Type  
Diffusion*  
 
All Bubble Point Tests  
HydroCorr  
 
Virus Diffusion  
 
Pressure Hold  
Range  
Flow rates < 20 mL/min  
Flow rates  20 mL/min  
345-6205 mbar (5-90 psig)  
Flow rates < 0.4 mL/min  
Flow rates  0.4 mL/min  
Flow rates < 20 mL/min  
Flow rates  20 mL/min  
Pressure drops < 68.9 mbar (1 psi)  
Pressure drops  68.9 mbar (1 psi)  
Reproducibility  
sn-1 2 mL/min  
CV  10%  
CV 10%  
sn-1 0.04 mL/min  
CV  10%  
sn-1 2 mL/min  
CV  10%  
sn-1 6.9 mbar  
(0.1 psi) CV  10%  
 
*Diffusion reproducibility is not specified for the 30 second diffusion test.  
 
Test Specifications  
Test Type  Configuration Range  Operating Range  
Diffusion*  47 mm disks -  Diffusion rate: 1 - 750 mL/min  
12 round x 30 in. systems Test pressure: 345-6550 mbar (5-95 psig)  
Capsules to TFF systems  
Bubble Point (All Except  47 mm disks -  Test pressure: 345-6205 mbar  
Accelerated Hydrophobic) 3 round x 30 in. systems  (5-90 psig)  
Accelerated Hydrophobic 47 mm disks -  Test pressure: 345-6205 mbar  
Bubble Point  1 round x 30 in. systems  (5-90 psig)  
HydroCorr  47 mm disks (Aervent-50) - Test pressure: 345-6205 mbar (5-90 psig)  
 
Virus Diffusion  
 
Pressure Hold  
3 round x 30 in. systems  
25 mm disks -  
3 round x 30 in. systems  
Up to 12 round x  
30 in. systems  
Flow rate: 0.01 - 10 mL/min  
Diffusion rate: 1 - 600 mL/min  
Test pressure: 345-6550 mbar (5-95 psig)  
Test pressure: 345-6550 mbar  
(5-95 psig)  
 
* Pneumatic flow rate is at least 2500 mL/min at 5516 mbar (80 psi). The operating range claim of 750 mL/min is based upon the  
qualification testing of a 12 x 30-inch filter configuration. However, the maximum physical capacity of the pneumatic module is 




Specifications (continued)  
 
Power Requirements  
Voltage  
Current rating  
 
Compressed Gas  
Inlet pressure  
 
 
Operating pressure range  
 
Environmental  
Storage temperature  
Operating temperature  
Humidity  
 







Software operating system  
Port 1 
Port 2  
Port 3*  
 
*Integritest 4N only  
90 -264 volts AC, 50/60 Hz  




Clean, dry air or nitrogen source of 2.4 - 8.2 bar  
(35 -120 psi) at least 1.03 bar (15 psi) greater  
than the highest test pressure  




-20 to 80 °C  
1 to 40 °C  




37.2 cm (14.6 in.)  
41.6 cm (16.4 in.) 
25.4 cm (10.0 in.)  




Windows XP embedded  
5-pin DIN connector for service access  
PS/2 Bar code reader input 



























System Attributes  
 
 
Comprehensive library of integrity testing modes  
that include diffusion (standard, accelerated/virus);  
bubble point (standard/asymmetric/accelerated;  
enhanced BP; HydroCorr test; pressure hold  
Intuitive, multilingual, easy to use 10.4 in. SVGA  
touch user interface  
Rugged, por table industrial design  
Developed according to GAMP 4 Guidelines  
Network Ready  
Ethernet printer support  
Remote Integritest 4N database backup with  
Networked Attached Storage (NAS) or networked  
server PC  
Automatic filter test report transfer and storage on  
a central repository with a NAS or networked PC  
when electronic signature requirements are met  
Meets the technical requirements of 21 CFR Part 11  
From a networked PC:  
- Add or change network definitions - 
Define users and user permissions  
- Track additiom and deletions of users  
- Track changing of passwords  
- Organize instruments into groups  
 































Integritest 4N Used with  





























Ordering Information  
Description  
Integritest 4 Standalone Instrument**  
Integritest 4N Instrument**  
Integritest 4 External Valve Array 
Integritest 4 Field Calibration Kit  
Integritest 4 Printer Paper (3 pack)  
Integritest 4 Printer Ribbon Cartridge (3 pack)  
Integritest 4N Central IMT Software  
Integritest 4 Inlet Tubing with Dessicant Air Filter  
** Includes power cord, external valve array and operators manual  
Catalogue No.  
XIT4 S00 01  
XIT4 N00 01 
XIT4S PEVA 01 
XIT4SP FCA 01  
P83071 
P83075  












 To Place an Order or Receive Technical Assistance  
In the U.S. and Canada, call toll-free  
1-800-MILLIPORE (1-800-645-5476)  
In the U.S., Canada and Puerto Rico, fax orders  
to 1-800-MILLIFX (1-800-645-5439)  
Outside of North America contact your local office.  
To find the office nearest you visit www.millipore.com/offices  
Internet: www.millipore.com  














Millipore, Integritest and Access are registered trademarks of Millipore Corporation. 
HydroCorr is a service mark of Millipore Corporation.  
Windows XP is a registered trademark of Microsoft Corporation.  
Lit. No. DS1675EN00 Rev. C 08/07 Printed in U.S.A. 07-237  
© 2007 Millipore Corporation, Billerica, MA 01821 U.S.A. All rights reserved.  
BIOLOGICAL SAFETY CABINETS  
Class II, Type A2 Biological Safety Cabinet  
 


















































The publications listed below form a part of this section to the extent referenced. The 
publications are referred to within the text by the basic designation only.  
 
NATIONAL ASSOCIATION OF ARCHITECTURAL METAL MANUFACTURERS (NAAMM)  
NAAMM MFM (1988) Metal Finishes Manual  
NSF INTERNATIONAL (NSF)  
NSF 49 (2007) Class II (Laminar Flow) Biosafety Cabinetry  
UNDERWRITER'S LABORATORY (UL)  
UL Standard 61010-1  
 
DESIGN AND PERFORMANCE CRITERIA  
 
A. Provide biological safety cabinets with workspace for testing and experimentation of  
low to moderate risk agents in the Classes and Types indicated, as defined by NSF  
International NSF/ANSI 49. Class II cabinets shall provide protection of experiment from 
ambient environment and protection of ambient environment from experiment.  
 
B. Biological safety cabinets shall operate in an efficient and sustainable manner.  
Electrical consumption of new units shall be no greater than: 170 watts for nominal  
width 3 foot unit; 200 watts nominal width 4 ft unit; 310 watts for nominal width 5 foot unit; 




Product Data - Biological safety cabinets  
Biological safety cabinets - Compliance with NSF/ANSI 49  
Biological safety cabinets - Operating and Service Manuals  
Biological safety cabinets - Demonstration  
Factory Test Reports  
 
QUALITY ASSURANCE  
 
A. Each cabinet will be certified by UL for electrical safety and integrity.  
B. Each cabinet will be NSF listed and approved for design, construction and  
performance.  
C. A factory test for each cabinet validating proper performance including:  
1. Cabinet integrity test with pressure decay or soap bubble leak  
2. HEPA Filter leak test of downflow and exhaust filters  
3. Downflow air velocity and uniformity  
4. Inflow air velocity  




A. Manufacturer  
Company with minimum ten years documented experience in the construction of NSF Listed 
and Approved Class II biological safety cabinets.  
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Cabinet shall be an NSF Listed and Approved Class II biological safety cabinet.  
1.6  WARRANTY  
a.  Manufacturer's warranty against defects in material or workmanship covering parts  
and labor must be available for a period of five years. Standard exceptions for 
filters, lamps and glass shall apply.  
 
 






































A. Thermo Scientific  
 
CLASS II TYPE A2 BIOLOGICAL SAFETY CABINETS  
1. Exterior dimensions  
a. Nominal 3 ft width - 61.8"H x 39.4"W x 31.5"D (1568mm H x 1000mm W x  
800mm D)  
b. Nominal 4 ft width - 61.8"H x 51.2"W x 31.5"D (1568mm H x 1300mm W x  
800mm D)  
c. Nominal 5 ft width - 61.8"H x 63"W x 31.5"D (1568mm H x 1600mm W x  
800mm D)  
d. Nominal 6 ft width - 61.8"H x 74.8"W x 31.5"D (1568mm H x 1900mm W x  
800mm D)  
2. Additional Height Range with Stand  
a. Adjustable Height Stand - Work surface heights from 30 to 38" (750 to 950  
mm) adjustable in 2" increments, overall cabinet height from 88.5" to 95.4"  
(2248 to 2448 mm) [stand is 26.8" to 34.7", 680 to 880 mm]  
b. Motorized Stand - Work surface heights from 30 to 38" (750 to 950 mm),  
overall cabinet height from 88.6" to 96.5" (2249 to 2449 mm) [stand is 26.8" to  
34.6", 680 to 880 mm]  
c. Castor Stand - Work surface heights at 30" (760 mm), overall cabinet height is  
88.6" (2350 mm) [stand is 680 mm]  
3. Interior dimensions  
a. Nominal 3 ft width - 30.7"H x 35.4"W x 24.8"D (780mm H x 900mm W x  
630mm D)  
b. Nominal 4 ft width - 30.7"H x 47.2"W x 24.8"D (780mm H x 1200mm W x  
630mm D)  
c. Nominal 5 ft width - 30.7"H x 59.1"W x 24.8"D (780mm H x 1500mm W x  
630mm D)  
d. Nominal 6 ft width - 30.7"H x 70.9"W x 24.8"D (780mm H x 1800mm W x  




A. Cabinet shell shall use steel no less than 19 gauge (0.0394" thick) and validated to  
meet the NSF performance specification where top front edge shall not move forward  
more than 0.063 inches (1.6 mm) from the static position when a 250 lb (110 kg) lateral  
force is applied to the top rear edge and the top of the sides shall not move forward  
more than the same amount when the same force is applied to the top of the opposite side.  
 
B. Unit shall have all metal plenums designed for easy removal at filter change. (Non-  
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C. To facilitate cleaning, the interior sides and rear wall of the work area shall be of one  
piece no less than 19 gauge (0.0394" thick) Type 304 stainless steel construction with  
No. 4 finish. The joins between the side and rear interior walls shall have coved corners of no 
smaller than 0.406" radii.  
D. An efficient means of adjusting the downflow and inflow separately shall be provided.  
Additional penetrations of the shell of the cabinet should be avoided.  
E. Corrosion resistant ball valve for drain from trough beneath the work surface. F. 
Externally mounted fluorescent lighting fixture.  
G. One supply and one exhaust, scan-tested, zero-probe HEPA filter, 99.995% percent  
efficient on most penetrating particle size (H14 per EN 1822), serviceable and 
removable from front of unit.  
H. Two duplex receptacles, GFI protected with total load capacity of at least 5 amps. I. 
Single power cord 12 ft in length with a NEMA plug 5-15P. J. Corrosion resistant diffuser 
below the downflow filter.  
K. Protective screen to prevent foreign objects from being drawn into fans.  
L. A minimum of six media valves (at least three on each side, for vacuum or other)  
available on the cabinet.  





































PERFORMANCE REQUIREMENTS  
A. Work access opening inflow velocity: Acceptable operating range 100 - 110 fpm.  
B. Inflow compensation controlling inflow velocity with 3% of set value with 100% increase  
in filter loading.  
C. Visual indicator on the front panel for the following features:  
1. Compensation reserve capability.  
2. Hours of operation  
3. Inflow velocity display (feet per minute)  
4. Downflow velocity display (feet per minute)  
5. Night Set-Back mode  
6. UV on  
7. Receptacles on  
8. Operating speed airflow  
9. Front window position  
D. No HEPA filter leakage  0.01% of upstream concentration.  
E. Downflow velocity ± 5 fpm of NSF/ANSI validated nominal value.  
F. All downflow measurements within 20% of average.  
G. Separate downflow and inflow velocity flow alarms to signal overall variation greater  
than 20% from set values.  
H. Airflow smoke patterns test acceptable  
1. Downflow is smooth with no dead spots or upward flow.  
2. Smoke released behind view screen moves smoothly down and does not escape  
from the cabinet.  
3. Smoke released outside the cabinet will not escape from the cabinet once drawn in  
or billow over the work surface or penetrate onto it.  
4. No smoke released in the work area 2 inches from the window side or top edges  
will escape from the cabinet.  
I. Power consumption: Not to exceed 170 watts for nominal 3 ft width, 200 watts for  
nominal 4 ft width or 400 watts for nominal 6 ft width.  
J. Reduced flow or Night Set-Back mode allowing reduction in airflow and energy  
consumption while maintaining cleanliness and containment when not in operation.  
Power consumption during reduced flow or Night Set-Back not to exceed 70 watts for 
nominal 3 ft or 4 ft widths, and 120 watts for nominal 5 ft and 6 ft widths.  
 
ERGONOMIC OPERATION REQUIREMENTS  
A. 10° sloped front (the top of the cabinet is slanted away from the operator) to provide  










Work area illumination: No less than 120 footcandles at the worksurface  
Noise: No greater than 65 dB(A)  
Front and back of window easily cleanable without special tools.  
Armrests must sit above front air intake grill and be easily removable  
Available UV disinfection cycle  
1. adjustable UV exposure time saved in memory to facilitate consistent operation  





A. Thimble connections for external exhaust allowing external exhaust variation of 30%:  
Nominal 3 ft width with 8 inch opening - 269 cfm  
Nominal 3 ft width with 10 inch opening - 336 cfm  
Nominal 4 ft width with 8 inch opening - 360 cfm  
Nominal 4 ft width with 10 inch opening - 450 cfm  
Nominal 5 ft width with 8 inch opening -448 cfm  
Nominal 5 ft width with 10 inch opening - 560 cfm  
Nominal 6 ft width with 8 inch opening - 540 cfm  











External exhaust alarm (as required by NSF 2012)  
Universal Piping to top, side and bottom, up to two pre-plumbed penetrations per side  
Floor anchoring brackets  
Service valve taps 
Adjustable footrest  
Ergolign saddle stool  
IV bag holder  
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Recycling Services  
 
 




Typical Solvents Recycled  
Chemical Name  
Methylene Chloride 
Tetrachloroethylene  
1,1,1 Trichloroethane  
Trichloroethylene  
Trichlorotrifluoroethane  
Perchloroethylene (Dry Cleaning Filters)  
N-Methyl-2-Pyrrolidone  

















Clean Harbors Recycling Services offer a full range of  
solvent recycling options from traditional recycling to  
tolling, or a combination of the two. Recovered  
products, which are not returned to customers, are 
available for sale.  
 
Our flexible operations, combined with chemical  
knowledge and engineering expertise, bring advanced  
solutions to the challenges of separation and purification.  
During the recovery process, components of the  
solvent/chemical streams are isolated and purified to 
high-quality product specifications.  
 
Clean Harbors Recycling Services employees are experts  
in recycling and tolling. All processing meets strict  
Ethanol Solutions*  
*Excluding Specially Denatured Alcohols  
Methanol  
Isopropyl Alcohol  
Isopropyl Alcohol (High Water)  
Toluene  
Xylenes (ortho-, meta-, para-)  
Tetrahydrofuran  
Acetone  
Methyl Ethyl Ketone  
Ethyl Acetate  
Petroleum Distillates  
Petroleum Distillates (Dry Cleaning Filters)  
Naptha  



















local, state, federal regulations, and customer 
requirements.  
 
Recycling - We provide recycling services, where the  
product is recycled to our high quality specifications and 
sold on the secondary market.  
Tolling - Our tolling programs provide a closed loop  
cycle in which the customer's spent solvents are  
recycled to their precise specifications and returned 
directly to them.  
Examples of Solvents for Tolling  
 
Customized Solutions - Customized solutions that  
utilize traditional recycling with tolling to meet  






Decalin (Decahydronaphthalene)  
N,N-Dimethyl Acetamide  
Dimethyl Sulfoxide  
1-Ethyl-2-Pyrrolidone  
Isoamyl Alcohol  
 
Recycled Materials for Sale - High quality recycled  
materials are sold through Service Chemical, LLC a full  




Clean Harbors Recycling Services • 221 Sutton Street • North Andover, MA 01845 • 978.685.2121 • www.cleanharbors.com  



















































The MVE CryoSystem Series combines the benefits of low nitrogen consumption with mid-range vial capacity to meet the diverse  
needs of today's professionals worldwide. The lightweight and low-space demands of these containers make them the most economi- cal 
units in their class.  
 
Features Include:  
• Designed for large capacity storage  
• Low liquid nitrogen consumption  
• Convenient lightweight package  
 
18  ML111001 E  




A Durable, tamper-proof lid design  
 
 




C Canisters  
 
 
D Strong, lightweight aluminum construction  
 
 
E Advanced chemical vacuum retention system  
 
 
F Spider design on platform for easy retrieval and  
insertion of product canisters  
 
 
G Liquid Nitrogen Reservoir  
 
CryoSystem  CryoSystem  CryoSystem  CryoSystem  
750  2000  4000  6000  
Maximum Storage Capacity  
Number of Canisters  6 4 4 6 
Number of 1.2 & 2.0 ml vials 100/box  - 2,000  4,000  6,000  
Number of 1.2 & 2.0ml via 25/box  750  - - -Boxes per Rack  5
 5 10  10  
Performance  
LN2 Capacity L  47.4  61.0  121.0  175.0 
Static Evaporation Rate* L/day  0.39  0.85  0.99  0.99 
Working Volume L  47  51  111  165 
Normal Working Duration**, Full Days  76  38  70  104  
Unit Dimensions  
Neck Opening in. (mm)  5.0 (127)  8.5 (216)  8.5 (216)  8.5 (216) 
Overall Height in. (mm)  26.50 (673)  27.25 (692)  38.00 (965)  37.75 (959) 
Outer Diameter in. (mm)  20 (508)  22 (559)  22 (559)  26 (665) 
Weight Empty lb. (kg)  42 (19.0)  58 (26.3)  81 (36.7)  103 (46.7) 
Weight Full lb. (kg)  126 (57)  182 (82.5)  300 (136)  425 (193)  
 
* Static evaporation rate and static holding time are nominal. Actual rate and holding time will be affected by the nature of container use, atmospheric conditions, and manufac-  
turing tolerances.  
** Normal Working Duration is an arbitrary reference, to estimate container performance under normal operating conditions. Actual working time may vary due to current atmospheric conditions, container  




TWO Year Standard Warranty • THREE Year Vacuum Warranty 
Conforms to MDD 93/42/EEC, the Medical Device Directive for the 
EU 
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